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Abstract  
This thesis focuses on the history of embryonic stem cell research, spanning in 
particular the nineteenth and twentieth centuries.  As yet, there has not been a 
comprehensive history of embryonic stem cell research carried out, which is a 
particular aim of this thesis.  The first two chapters consider the conceptualisation of 
the stem cell, and the development and diversity of relevant disciplines and their 
establishment in the twentieth century; in particular, this covers heredity, genetics, 
embryology and development.  This is illustrated through the use of experimental 
embryology, or ‘fantastical experiments’, that were proposed in the nineteenth 
century, and carried out in the twentieth.  The third chapter considers the theoretical 
and practical links between cancer and embryonic cells.  The fourth and fifth chapters 
explore the isolation and culture of murine and human embryonic stem cells, focusing 
on the social, political, and economic factors affecting stem cell research, and the 
motivations behind the isolation of embryonic stem cells in the 1980s and 1990s.  The 
sixth chapter queries whether the history presented suggests that a new stem cell 
concept is emerging. 
There are three questions that this thesis aims to answer.  Firstly, what are the 
(historical) social and political influences that affect (embryonic) stem cell research?  
Evidence presented suggests that this has occurred from the nineteenth century, and 
continues today.  Secondly, this thesis queries the importance of cell fate, and cell fate 
studies, to embryonic stem cell research.  Since one of the two abilities of stem cells 
is the ability to differentiate, cell fate and studies of cell fate are central to developing 
a stem cell concept, and may also be influential in changing that concept in the future.  
Lastly, this thesis asks which paradigms have affected embryonic stem cell research 
throughout its history.  In particular, the genetic paradigm is shown to be influential 
from the early twentieth century onwards.  More recently, it has been proposed that 
stem cell research needs to undergo a paradigm shift, from the stem cell entity view, 
to the stem cell state view.  This is also explored through the thesis, with the aim of 
generating a better understanding of stem cells for future researchers. 
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1. General introduction 
As yet, there has not been a comprehensive history of embryonic stem cell 
(ESC) research carried out, with studies into the history and philosophy of stem cell 
research being distinct (with only little integration), and covering finite sections of 
stem cell research.  A particular aim of this thesis is to generate a more 
comprehensive overview and discussion of ESC research.  Histories of other types of 
stem cell have been produced, in particular haematopoietic stem cell research 
(discussed below).  Other studies that have considered ESC research have focused on 
ethics or legislation, particularly as this varies greatly from country to country. 
In order to provide a more extensive overview of ESC research, this thesis 
aims to further analyse several facets of ESC research that are generally known (such 
as the isolation of murine ESCs in the early 1980s, and human ESCs in the late 
1990s), but from a previously under-considered aspect, or in an effort to examine 
some of the wider questions currently being asked in the history and philosophy of 
biology more generally.  The thesis begins with an exploration of the 
conceptualisation of the cell, and especially the ESC.  Chapter 2 also begins in the 
nineteenth century, and explores the relationship between heredity and embryology, 
genetics and ESC research, up to the twenty-first century.  The third chapter focuses 
on a comparison of cancer and embryonic development from the nineteenth to the 
twentieth century; the recognised parallels are still discussed at length in current 
biological science.  An immediate development of the mid-twentieth-century 
experiments which showed comparisons between cancer and stem cell biology was 
the work of Gail Martin and Martin Evans, who utilised their experiences with 
embryonal carcinoma cells (ECCs) to isolate and culture the first ESCs from mice in 
the 1980s; the fourth chapter therefore considers how political, social, and economic 
factors affected scientific research in the UK and USA in the 1970s and 1980s.  The 
fifth chapter takes a different approach, exploring the reason for the seventeen-year 
delay between the isolation of mouse and human ESCs.  Lastly, Chapter 6 integrates 
history and philosophy to consider whether a new stem cell concept is emerging in the 
twenty-first century. 
 
Through this thesis, the aim is to provide some answers for three research 
questions in particular.  Firstly, what is the role of social and political context in stem 
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cell research?  As already highlighted, society can affect science, and science can 
affect society1; the one aim of this thesis is to demonstrate that there is indeed a ‘two-
way street’ for a science (i.e. stem cell research), with science influencing society, 
whilst society also influences science.  Stem cell research may be a particularly 
interesting way of studying this phenomenon, since it is so intimately linked with 
notions of individual and state development. 
The second question asks what the importance or significance of cell fate 
research is.  This, arguably, is linked to the first question, and its interest in social, 
political, and individual development.  It has been argued previously that actual 
research has been driven by a greater need for understanding of cell fate, particularly 
at the beginning of the twentieth century2; this thesis will ask whether this hundred-
year old approach is still appropriate for stem cell research today. 
Moreover, this ties-in with the third research question: what is the role of 
paradigms in research?  This thesis demonstrates that there are clear links between, 
for example, stem cell research, embryology, evolution, and so on.  There was a key 
phase of development for both heredity and embryology research in the late 
nineteenth and early twentieth centuries, then genetics and stem cell research from the 
mid-twentieth century onwards, which appears to have deeply linked these areas of 
research.  It is argued through this thesis that stem cell research carried out from the 
mid-twentieth century onwards was carried out under the significant influence of a 
genetics paradigm.  Also explored in this thesis is the demonstration that stem cell 
research up until the twenty-first century has been interpreted on the assumption that 
stem cells are entities.  Arguably then, experimental design has been based on the 
genetics paradigm, whilst results have been interpreted based on the stem cell entity 
paradigm (although of course there is some cross-over).  This thesis asks whether this 
is still a useful approach to stem cell research in the twenty-first century; whilst the 
importance of genetics for our understanding of stem cells is still significant, it may 
not be the only method on which to base experimental design.  Likewise, assuming 
that stem cells are entities may not be the only way of interpreting experimental 
results. 	
																																																								
1 Bensaude-Vincent, 2009; Wilson, 2011. 
2 As described in, for example, Maienschein, 1978. 
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Approaches 
This thesis uses a variety of methods to demonstrate the wide-ranging 
approaches that can be taken to the history of ESC research.  Included in the research 
chapters of this thesis are approaches from social history, cultural history, the history 
of ideas, and participant observation, for example.  Considering the three research 
aims of this project, this thesis may also be moving towards the science and 
technology studies (STS) approach, particularly as STS is generally concerned with 
contemporary science, and is interested in scientific practice ‘in action’3.  This said, 
although there is discussion of contemporary stem cell research throughout this thesis, 
and a clear interest in how the research was carried out at the bench, there is also 
historical discussion of prior stem cell studies.  The importance of archival materials 
may appear essential to such an endeavour, however these resources were generally 
unavailable for this project.  This project focuses in particular on research, and the 
work carried out in laboratories.  This means that, for much of the period explored in 
this thesis (i.e. the late twentieth and twenty-first centuries), there are no archives 
available4.  Where enquiries were made, researchers were either reluctant to share 
laboratory notebooks, were still using these notebooks, or, universities that held such 
notebooks could not release them (reasons for this varied slightly, however were 
generally based on the requirement that the researcher who made the notes needed to 
have died before these could be released, and even then would have needed to have 
died many years prior to the notes being released).  This made the study of every-day 
experiments almost impossible.  For this reason, the project makes use of scientific 
publications as its window to the laboratory.  This is a relatively under-used resource 
in itself, particularly for more recent research; this is likely due to the complex, 
specialised nature of the research papers now published, which, arguably, are now 
only accessible to those who understand the language and terminology used, and the 
way in which scientific publications are created.  Since I have prior experience of 
both of these facets, it seemed logical to make use of these publications as primary 
sources for this research.  The usefulness of looking at published papers as a source 																																																								
3 For example, see Asdal, 2012 p 380. 
4 Earlier periods covered in this thesis, particularly in Chapters 1 and parts of 2 and 3, of 
course would have archival material more readily available.  However, due to the nature of 
these sections of the thesis, secondary literature (based on archival research) is adequate.  In 
addition, it is unlikely that this researcher’s current grasp of the German language would be at 
a standard high enough to refer to many untranslated primary sources from the nineteenth 
century. 
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for understanding knowledge production in the sciences has been highlighted by 
Hannah Landecker (see below).  The original research articles published in ESC 
research and related disciplines have been utilised extensively in this project.  In part, 
this has been a way to circumnavigate the issue above regarding laboratory books, 
and another that could arise with oral histories (such as misremembering, or telling a 
well-rehearsed story – see below).  Secondly, as noted by Ohad Parnes, “published 
accounts may be no less useful for the reconstruction of an implicit investigative 
pathway than the unpublished research notes”5.  Since the laboratory notebooks are 
not available, Parnes would argue that the published papers are potentially just as 
useful for understanding research development. 
Hannah Landecker (an anthropologist), also makes use of this somewhat 
neglected historical resource in Culturing life: How cells became technologies, 
particularly focusing on the ‘materials and methods’ sections of scientific 
publications.  This has been referred to as an “infrastructural approach”, and is 
successfully used as a technique throughout Culturing life: to follow methods of 
researchers6.  The ‘materials and methods’ sections of scientific papers have also 
provided some of the primary sources utilised in this thesis, since there is a continual 
focus on laboratory stem cell research, of which the materials and methods used are of 
significance.  Using these sources, Landecker composed a history of techniques for 
enabling tissues to survive and grow ex vivo, juxtaposing theory and practicality, 
science and society, to “emphasize that these accounts…are not just ‘popular’ 
renditions of science but ways that scientists themselves narrate assumption-altering, 
philosophically disturbing technical change in their practices and objects”7.  This has 
also been acknowledged in this thesis, where scientific publications have been utilised 
to develop narratives.  Alongside this, a further range of commentators have been 
examined to generate a more comprehensive stem cell history than what scientists 
alone could provide.  For example, the influence of the biotechnology company 
Geron is clear in the history of hESC isolation and culture; the work of Michael West 
in establishing links with James Thomson and John Gearhart has clear significance 
for the narrative produced (see Chapter 5). 
																																																								
5 Parnes, 2003 p 135. 
6 Littlefield and Pollock, 2011 p 611. 
7 Landecker, 2007 p 161. 
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The context of the scientific work carried out, experimental results, and the 
history of ideas are approaches used throughout this thesis to emphasise the 
importance and/or influence of the social context (and scientific cultural context) in 
the development of the framework for ESC research from the nineteenth century 
onwards. The use of personal memories, and how such memories can be used to 
construct past events, has been utilised in various types of cultural history, and is 
often represented in various media, such as films and books8.  In the history of 
science, this approach is particularly popular, although often the memories of those 
recorded are often those perceived as ‘leaders’ in their field, as opposed to the 
‘everyday’ scientist.  As early as the 1960s, this was argued to be problematic, since 
histories would no longer be constructed by “hanging” histories off the “pegs” of 
“great men”9.  In this thesis, although there are many recognisable names mentioned 
throughout, the focus as been on the work produced, and the studies carried out, rather 
than using individuals as the starting-point for discussion.  The purpose of this 
approach is to move away from the potentially whiggish style of history that may be 
generated by centring attention on the achievements of individuals, towards exploring 
how and why any researcher would carry out the studies described in this thesis.  Oral 
histories could have been another way of obtaining further insight, however runs the 
risk of fueling the celebration of individuals.  Nevertheless, it was initially believed 
that this would have been able to provide useful material for this thesis.  
Unfortunately, most of those contacted said that they would not be willing to be 
interviewed, or were unavailable, or simply did not respond to a request.  Contact was 
only established with one researcher mentioned in this thesis, and that is Gail Martin.  
Martin was kind enough to respond to a written, email questionnaire, and some of her 
responses were used in Chapter 4. 
 From this approach, follows the relevance of social history to the history of 
science.  Again, social, political, and economic contexts were demonstrated to be 
relevant to the history of science in the early twentieth century, particularly in the 
European and American, ‘philosophically-informed’ approach to the history of 
ideas10.  I am inclined to agree with John Dunn with regards to the history of ideas; 
Dunn stated that the history of ideas should incorporate “the histories of particular 																																																								
8 For example, Confino, 1997. 
9 The Science News Letter, 1963 p 134. 
10 For example, see Fox, 2006 p 414. 
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intellectual practices, of science, history, political theory, economics, theology, 
etc.”11; I have made use of political, social, and economic contexts throughout this 
thesis to more accurately situate the context in which scientific research was 
occurring.  In some situations, there are clear relationships between political, social, 
and economic factors, and ESC research. This is similar to the cross-disciplinary 
approach (falling under the category of STS) as carried out by Landecker, who 
provided a valuable insight into cell culture, whilst enabling appreciation for the 
usefulness of inter- or cross-disciplinary work in the (historical) study of biological 
science, its techniques, people, theories, and objects. 
 Chapter 1, discussing the history of the conceptualisation of the ESC, 
particularly makes use of approaches from the history of ideas.  For example, the 
political situation in nineteenth-century Germany affected the reception of research 
published by various researchers.  The popularity of these publications affected which 
terms and ideas became incorporated into the concept of the cell, and the ESC. In 
Duncan Wilson’s Tissue culture in science and society, Wilson focuses on tissue 
culture in Britain, however there is relatively little comparison between the 
development of tissue culture in Britain (and the public reception of this technique) 
and other countries or regions.  In particular it would have perhaps been useful to 
include some comparison with Germany, since up until the mid-twentieth century, 
this region of Europe was considered to be at the forefront of biology, as 
demonstrated by the significant numbers of high-quality, influential publications 
produced in German at the time, as described in Chapter 1 of this thesis.  Chapter 2 
considers the development of disciplines relevant to ESC research, and therefore 
particularly makes use of approaches from the history of ideas in scientific culture.  
This examination of discipline development then also implicitly requires a history of 
technology; one way in which different disciplines emerge is not only intellectually, 
but also following the development and integration of new technologies (and 
specialist techniques) into scientific research. Chapter 3, considering the links 
between cancer and embryonic development through the nineteenth and twentieth 
centuries, also makes use of the history of ideas approach to look at how theories on 
cancer development paralleled with ideas on embryogenesis. 
																																																								
11 Dunn, 1968 p 100. 
INTRODUCTION  8 
 
Chapter 4 especially focuses on the political and economic affects on scientific 
research direction, specifically drawing on the history of politics in the USA and UK.  
This chapter uses the isolation and culture of mouse ESCs to look at the interaction 
between the public, politics, and economics.  These connections have been made with 
regard to other related topics in the history of biology (such as the STS approach 
taken by Wilson in Tissue culture in science and society [see below]), although have 
not yet been discussed with regard to a specific episode in ESC history. Although 
Chapter 5 examines the history of ESCs via critical analysis of the motivations and 
goals behind the isolation and culture of human ESCs in the 1990s, there is a clear 
requirement for the social, political, and economic factors to be considered, as well as 
the scientific context (i.e. the work carried out in the laboratory), for the motivations 
and goals of human ESC isolation to become apparent.  Again, although some 
personal accounts have been previously used to construct the event of human ESC 
isolation, such as Thomson’s version provided by Parson12, Chapter 5 of this thesis 
demonstrates that it is only when these are considered alongside other contexts that 
the more comprehensive history emerges.  It then becomes possible, in this instance, 
to add further evidence supporting the position taken by Michel Morange (that the 
motivations and goals of mouse ESC isolation were different to those of human ESC 
isolation). 
Just as I argue that Wilson uses tissue culture as an object to describe the 
interplay between science and society, Melinda Bonnie Fagan’s Philosophy of stem 
cell biology: Knowledge in flesh and blood uses stem cell biology to review studies in 
the philosophy of science13.  Fagan carefully and accurately described the science (of 
stem cell biology), as well as clarifying new methods in the philosophy of science, 
and Wilson carefully and accurately described the science (of tissue culture), as well 
as moving towards a useful new method in the history of science.   This perhaps 
indicates the successful development of a useful new approach, integrating history, 
philosophy, anthropology, and sociology of science.  Making use of such an 
integrated approach, Chapter 6 combines history of science with philosophy of 
science to examine whether stem cells are entities or whether stemness is a state.  The 																																																								
12 Parson, 2004. 
13 Fagan’s book also contains some references to cell culture, and the philosophical 
considerations of understanding cultured cells and tissues as model organisms, and these 
cultures as part of larger model experimental systems. 
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approach taken in this chapter is particularly useful, since it enables further analysis 
of historical events to be carried out based on the preceding philosophical arguments.  
For example, in Chapter 6 of this thesis, theories from historical ESC research are 
examined alongside more recent research.  The advantage of Wilson’s (STS) 
approach notwithstanding, his work appears to suggest that tissue culture stands for 
the whole of science, which of course is untrue. Although, as Wilson highlights, some 
have claimed that such work opened up a public discussion about entities rarely 
considered outside of a laboratory, Wilson’s book demonstrated that such a discussion 
has been open for almost a century.  Although some generalisations can be made, it is 
important to consider the context of tissue culture in biology and science as a whole.  
This is a factor that has been considered throughout this thesis, but which is most 
clear in Chapter 6.  Lucie Laplane’s discussion of the philosophy of cancer stem cell 
biology is geared firmly towards generating a way of thinking about cancer stem cells 
that is useful to those working in the laboratory, researching not only the biology of 
cancer stem cells, but also those who want to exploit the existence of cancer stem 
cells to produce more effective therapeutics (a more detailed review of Laplane’s 
work is included below).  This approach has a clear appeal to biologists, and 
especially those who are interested in finding new ways to carry out stem cell 
research, or to think about how stem cells function in vivo.  This thesis also aims to 
draw on this recent work in the philosophy of stem cell research, integrating history 
and philosophy to, like Laplane, generate a study that will appeal not only to 
historians or philosophers, but to biologists as well.  This is most clearly done in 
Chapter 6, which examines how the history of stem cell research can inform the 
philosophy, and practice, of experimental research in the future. 	
 
2. Situating this thesis 
Research into the history and philosophy of stem cells, stem cell science, and 
stem cell research is a relatively recent trend, which has been focused on particular 
nuances.  It is important to note here that the ethics of stem cell research has been 
given far greater consideration than the history (and, to an extent, the philosophy); 
although it is impossible to refer to stem cell research (especially embryonic stem cell 
research) in the past two centuries without discussing ethical considerations, this will 
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not be the focus of this thesis.  Instead, where ethical arguments are relevant, they are 
used to generate historical and philosophical context, and inform discussion. 
The historical consideration of stem cell research has increased significantly 
since the isolation and culture of hESCs in 1998, making this field a twenty-first 
century topic of interest.  Several researchers, particularly historians, have written on 
topics either on stem cell research specifically, or associated areas.  Work on topics 
associated with stem cell research have generally been carried out since the twentieth 
century, and more complete works have been produced.  For example, on the history 
of tissue culture, Wilson has produced a history of British tissue culture in the 
twentieth century, whereas Hannah Landecker has published on the history of North 
American cell culture (from an anthropological perspective) (both of these texts are 
reviewed in further detail below).  Likewise, several larger scale studies of 
embryology, experimental embryology, and developmental research have been 
produced; established scholars in history of biology have been involved in such 
studies, such as Jane Maienschein.  Maienschein for example has published several 
books on these topics (two of which are also further discussed below). 
The history of stem cell research has, as yet, not been the topic of such in-
depth study.  This is not to say however that no histories of stem cell research exist; 
these have been restricted thus far to book chapters and research articles.  Several 
scholars have published work of particular relevance to this thesis, such as Ariane 
Dröscher, Christina Brandt, A-H Maehle, Alison Kraft, and Melinda Cooper14.  
Dröscher’s, Maehle’s, and Brandt’s research has been focused on the early history of 
stem cell research, and in particular how ‘the stem cell’ was established, both 
conceptually and linguistically.  Dröscher’s work especially influenced the decision to 
include such a discussion in the first chapter of this thesis, establishing how the 
Stammzelle was conceived as a term and a concept.  As demonstrated in Chapter 1, 
the history of this early, theoretical work heavily influenced the approach taken by 
researchers, as the stem cell concept was developed, and how it would fit-in alongside 
Cell Theory, evolutionary theory, and developmental biology.  Melinda Cooper’s 
work focuses on later research in stem cell history, and in particular how experimental 
research was carried out in the laboratory.  Cooper’s historical assessments of both 
teratoma research and haematopoietic research have been useful examples to follow 																																																								
14 Such as Brandt, 2012; Cooper 2009; Dröscher, 2002 and 2012; Kraft, 2009 and 2011; and 
Maehle, 2011. 
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for their methodology and approach (although teratoma research was also highly 
relevant to ESC research, as highlighted in Chapter 3). Likewise, Kraft’s work has 
also focused on haematopoietic stem cell research.  Kraft is especially interested in 
stem cell research carried out during the Cold War period, into the late twentieth 
century.  Kraft is currently working on a book concerning the emergence of the stem 
cell from the therapeutic view, focusing on bone marrow transplantation and the 
potential for regenerative medicine.  The scientific, clinical, and commercial 
development of the stem cell: From radiobiology to regenerative medicine is expected 
to be published at the end of 2017.  What has been published specifically on the 
history of stem cell research so far then has pinpointed specific aspects of research, 
such as the initial conceptualisation, evolution and selection of terminology, and 
discrete histories of particular laboratory research.  In this thesis, I aim to add to these 
topics individually, and also bring them together to generate a ‘bigger picture’ view of 
the past two centuries of ESC study.   
As previously mentioned, the history of biomedical and biological research 
has not existed in isolation, and has, in the twenty-first century in particular, become 
entangled with considerations from philosophy of science.  Very recently, Melinda 
Bonnie Fagan and Lucie Laplane have published books specifically on the topic of the 
philosophy of stem cells.  Fagan’s book is a highly philosophical work, applying well-
known approaches in the philosophy of science to stem cell research.  This includes, 
for example, utilising logical methods to produce models, describing stem cell 
capabilities or properties.  Laplane’s 2016 book focuses more specifically on cancer 
stem cells; the philosopher Laplane worked in laboratories alongside cancer stem cell 
biologists, which has clearly influenced the approach she has taken.   
 In order to further establish how this thesis fits into current research in ‘stem 
cell studies’, six recent books will be considered in more detail, including books on 
the history of teratoma research, cell and tissue culture, stem cell policy, and the 
philosophy of stem cell science.  These books were selected since they focus on 
specific aspects of research also relevant to this thesis (Sornberger’s Dreams and due 
diligence; Fagan’s Philosophy of stem cell biology) or because they take a similar 
methodological approach to topics closely linked with this thesis (Wilson’s Tissue 
culture in science and society; Landecker’s Culturing life; Laplane’s Cancer stem 
cells).  Other works are on topics directly related to the subject matter presented in 
this thesis (Maienschein’s Whose view of life? and Embryos under the microscope; 
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Gottweis, Salter, and Waldby’s The global politics of embryonic stem cell research; 
the edited volume Differing routes to stem cell research). 
 
Dreams and Due Diligence 
 In the late 1950s and early 1960s, two researchers began working together to 
investigate the potential usefulness of radiation therapy for those with blood cancers.   
These researchers, Ernest McCulloch (1926-2011) and James Till (1931-), when 
carrying out their routine experiments, would happen across an unexpected result that, 
one could argue, was the beginning of experimental stem cell research.   As part of 
their investigations, Till and McCulloch would irradiate mice, resulting in the death of 
bone marrow cells (those responsible for generating red and white blood cells).   
Transplanting new bone marrow cells from a healthy donor should, Till and 
McCulloch hypothesised, re-populate the bone marrow with healthy cells, resulting in 
re-population of healthy cells in the blood system.   Unexpectedly, when dissecting 
recipient mice, McCulloch observed that the donor cells had not only re-populated the 
bone marrow, but had also settled in the spleen.   The donor cells had generated 
tumours, resulting in growths in the spleen.   The tumours contained cells descended 
from single donor cells; Till and McCulloch decided to refer to these cells as ‘colony-
forming units’ - i.e., cells that could form colonies of other cells (note here the 
borrowing of the term ‘colony’ from bacteriology).   By isolating and culturing these 
colony-forming units, Till and McCulloch isolated and cultured the first stem cells in 
vitro. 
 For this reason, Till and McCulloch are recognised for having made a crucial 
step towards the enormous field that is stem cell research today.   Till and 
McCulloch’s finding has been rewarded with both the Lasker and Gairdner awards, 
indicating significant recognition amongst their peers.   Their project however seems 
to be little-known outside the area of cell biology, and it has been implied that this 
was due to Till and McCulloch’s work having been overlooked by the Nobel Prize 
committees15.   Their work had received a small flurry of interest again following the 
death of McCulloch in 2011; writing in 2012, researcher in pathology, Paul 
Moorehead, admitted that he had only recently heard of the research results of Till 
and McCulloch, which he referred to as somewhat “embarrassing”, comparing this to 
																																																								
15 Sornberger, 2011. 
INTRODUCTION  13 
 
“a geneticist who had never heard of James D Watson, Francis Crick, and Rosalind 
Franklin!”16. 
 In particular, this appears to be a significant issue for veteran science 
journalist Joe Sornberger, who has written to date the only book based solely on the 
isolation of stem cells by Till and McCulloch.   (McCulloch published his own book 
in 2003, The Ontario Cancer Institute: Successes and reverses at Sherbourne Street, 
that would refer to the finding of colony-forming units, alongside a history of the 
institute and other stories from the researchers who had worked there.)  Although 
Sornberger’s book was published by an academic publisher (University of Toronto 
Press), it is not a text written in an academic style, nor, apparently, to appeal to an 
academic audience.   It appears to those who read Sornberger’s book that the aim is to 
raise awareness of the work of Till and McCulloch, but this approach leaves 
something to be desired; for example, the chapter entitled ‘Little Fame…No Nobel’ 
does little more than complain about the lack of this Prize for his fellow Canadians.    
 Although Sornberger’s aim is clearly to provide Till and McCulloch with the 
recognition they deserve, a few further insights can be gained from Dreams and due 
diligence.  For example, there are efforts to refer to some of Till and McCulloch’s 
students and colleagues, placing them in context alongside other relevant Canadian 
science research leaders.   Sornberger’s strength as a science journalist is also 
observed in his useful, accessible descriptions of Till and McCulloch’s scientific 
work.   The latter half of the book, again highlighting it’s expected readership to be 
amongst the general public, is concerned with general topics in stem cell research - 
twenty-first century developments, ethics, regenerative medicine, stem cell therapies.   
This helps the reader to put the work of Till and McCulloch in context to some degree 
(Sornberger is insistent on reminding the reader of the grand leading pioneers of 
Canadian research), but latter chapters could be more explicitly relevant to the 
observation of colony-forming units. 
 Dreams and due diligence suffers somewhat in its structure, since it moves 
constantly between different topics (although the single agenda of the book is 
apparent throughout), and insists on constantly reminding the reader of the differing 
personalities of the protagonists; not something particularly unusual for researchers, 
who have a variety of backgrounds and personalities!  This appears to be an important 																																																								
16 Moorehead, 2012 p E989. 
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point for Sornberger, even providing the title of the book (McCulloch’s ‘dreams’ and 
Till’s ‘due diligence’); Sornberger fails however to elaborate on why this is of such 
significance for the groundbreaking work that Till and McCulloch carried out.  In 
fact, it appears that both had a similar approach to their research, believing that the 
application of methods from the physical sciences would bear fruit in the biomedical 
sciences. 
 Sornberger’s aim to highlight the relevance of Till and McCulloch’s work is 
noble; as previously noted by Moorehead, there are few working in highly relevant 
fields today that appreciate the importance of the first recognition of stem cells in the 
laboratory.   In the context of this thesis, Till and McCulloch’s work is highly 
relevant; their work was the first to enable any stem cells to be isolated and cultured 
in vitro.  This was a significant step in making stem cells experimentally available to 
researchers, and therefore the first step beyond learning through theory and 
observation alone. 
 It was Till and McCulloch’s work that provided the initial influence for this 
project; a development of my Masters’ dissertation querying whether the concept of 
the stem cell changed after their isolation17.  The notion of the stem cell concept is 
explored further in this thesis, both historically (Chapter 1) and in its current state 
(Chapter 6). 
 
Viewing life  
 Drawing on her background in the history of biology, and in particular 
embryology and evolutionary developmental biology (‘evodevo’), Jane Maienschein 
highlights how current discourses in these disciplines have been forged through the 
twentieth century in Whose view of life? Embryos, cloning and stem cells (2003).  
Maienschien has since published a further book, Embryos under the microscope: The 
diverging meanings of life (2014), which focuses on human embryos, embryology, 
and development.  Each of Maienschein’s books demonstrate that historical concepts 
remain influential in the twentieth century.  Maienschein showed that despite some 
scientific researchers believing that they may have developed a new technique or new 
idea, much of these notions had been previously conceived; this perhaps suggests that 
scientists would benefit from knowing more about the history of their fields.  For 																																																								
17 Lancaster, 2009. 
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example, Maienschien highlighted that Aristotle studied development by using chick 
embryos, suggesting an early form of preformation theory (discussed in further detail 
in Chapter 1 of this thesis, in its eighteenth- and nineteenth-century context). 
The motif that runs through Maienschein’s works is the movement from 
theoretical, to observed, to experimental subject.  The ‘observed’ stage of 
embryogenesis (and, to a point, stem cells) came into its own following the 
development of microscopy; this thesis identifies some of this research in Chapter 1 
and Chapter 2, as microscopy develops and more can be learned about the cell and its 
components.  As noted above, Sornberger believed that Till and McCulloch’s 
research, that moved the stem cell from the observed to the experimental, was the 
stuff of Nobel Prizes; this was previously explored in my MA dissertation project, 
which queried whether the concept of the stem cell changed after Till and 
McCulloch’s work which resulted in stem cells being available for experimentation.  
The conclusions of this project have been more fully realised through this later 
project, cumulating in the examination of the stem cell paradigm in Chapter 6. 
Not only does Maienschein show how scientific antecedents discussed and 
considered ‘modern’ ideas, she also noted the mirroring of discussions regarding such 
innovations between historical discussions and discourses that are occurring in the 
early twenty-first century.   For example, Maienschein noted the debates over 
recombinant DNA technologies and their uses in the 1970s; these, claimed 
Maienschein, parallel some of the discussions of stem cells and cloning in the late 
twentieth century and early twenty-first century.  Maienschein observed the 
importance of the popular press in such debates, and how influential the press is in 
forming the opinion of the public (highlighting reports such as one on the cloning of 
Dolly in the New York Times, which included comments about cloning Jesus).  A role 
for public opinion becomes clear again in Chapter 4 of this thesis, where it is clearly 
shown how public opinion can influence economic policy, influencing funding 
availability for scientific research. 
 This is just one example of how Maienschein demonstrated how context-
dependent science and scientific research is; for the general reader, it may help to 
reveal how influential the general public and the mass media (and politicians) are on 
science policy, research, and its application.   Maienschein is well-placed to 
accurately comment on this too, being a previous science advisor to Arizona’s 
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congressman18.   This theme runs clearly through Whose view of life?, with the first 
half presenting various historical debates, and the latter half focusing on more current, 
controversial, topics.  In this thesis, I also aim to show how important historical 
context is to the practice of science through Chapters 1 and 2.  Later in this thesis, and 
especially in Chapter 4 and 5, it becomes clear how influential social, ethical, 
economic and political contexts are as well. 
 Maienschein discussed some of these contexts with particular reference to 
more controversial techniques, such as somatic cell nuclear transfer (SCNT), 
defending freedom of scientific endeavour.  The importance of ethical discourse is of 
course highlighted by Maienschein, who rightly asserted that any reduction to an 
‘ethics versus science’ argument is unsatisfactory, since the issues discussed are far 
more complex than this basic reduction allows for.  In this thesis, although there is not 
a specific focus on the ethics of stem cell research (this is a topic covered many times 
by historians, scientists, and philsophers in the recent past), the role of ethical 
considerations and its effects on stem cell research are a consideration.  Just as 
Maienschein highlighted this through discussion of SCNT, this thesis demonstrates 
that ethical considerations had a role in the isolation and culture of hESCs in the 
1990s, for example (Chapter 5). 
 A criticism of Maienschein’s books is that there could have been more on 
social, economic, and political perspectives, although these are not entirely lacking.    
For example, Maienschein criticised the lack of public debate concerning funding and 
patents (with reference to projects in genetics and genomics), which would certainly 
have benefitted from social and economic discourse.  For example, Chapters 4 and 5 
of this thesis, exploring mESC and hESC research respectively, demonstrate clearly 
that the research carried out was directly affected by the social, economic, and 
political contexts of the 1980s and 1990s.  Maienschein argued that embryo research 
in particular should be about science and research, all but ignoring the various other 
approaches that are important, such as patents (and capitalism in general for scientific 
and medical research), and women’s rights (in the context of IVF, for example).  
Scientific research, particularly biomedical research, cannot exist in a vacuum away 
from the social, political, economic, and ethical contexts such as those highlighted in 
this thesis. 																																																								
18 Löwy, 2005. 
INTRODUCTION  17 
 
 Despite what may be argued to be a lack of context, Maienschein produces 
extremely useful histories, lacking the presentist mirage often accumulated (perhaps 
unconsciously) by some when referring to topics that are still current in biological and 
biomedical sciences research today (such as Sornberger, referred to above, perhaps).   
Maienschein asks questions of historical experiments and theories such as ‘what 
experimental tests were devised?’, and ‘why is our hypothesis plausible?’ in order to 
help her readers understand the scientific context of the discourses and research 
occurring.   Dipping slightly into the waters of philosophy of science, Maienschein 
also demonstrates how experiments (and experimental design) can be reliable or 
fallible, using specific examples of historical work in developmental and 
embryological research.   This flows from discussion about how prevailing theories 
can became sterile, then outdated, and not in keeping with more recent experimental 
results.  Such theories are displaced by new ideas, better at explaining any newly-
observed phenomena.  This is also demonstrated throughout this thesis, occurring 
throughout the two centuries of stem cell research covered across the research 
chapters. 
As noted above, Maienschein referred to several steps in research, the first 
three being the hypothetical, then the observed, and then the experimental.  The 
experimental embryo arose at the turn of the nineteenth and twentieth centuries, in the 
laboratories of, for instance, Wilhelm Roux, Hans Driesch, and TH Morgan; all such 
work features in Chapters 1 and 2 of this thesis.  The differences between the 
theoretical, observed, and experimental stem cell are demonstrated to be relevant in 
this thesis, which highlights the transitions between these three.  It is interesting to 
note when researchers recognise the shift between the theoretical, the observed, and 
the experimental.  In this thesis, it is argued that researchers are still interpreting their 
experimental results as if they were still working under the paradigm of the theoretical 
or observed stem cell.  Maienschein developed this idea further however, adding 
another four steps.  Following the hypothetical, the observed, and the experimental is 
the inherited embryo, a phase ushered-in by the increase in heredity and genetics 
research in the mid-twentieth century.  This is more closely considered in the second 
chapter of this thesis.  The inherited embryo was swiftly followed in the 1960s by the 
computerised embryo, where improvements in software and computing power 
enabled computer modelling to demonstrate embryonic and evolutionary 
development.   The sixth step was the visualisation of the human embryo for the first 
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time, which occurred in the 1970s, as Patrick Steptoe and Robert Edwards worked 
towards fertilising a human egg in vitro, which could then be re-implanted for in vivo 
development. The final step identified by Maienschien is the constructed, or 
engineered, embryo.   Like embryonic development, the constructed embryo was 
initially theoretical – Jacques Loeb attempted to create such an embryo in the early 
twentieth century – before becoming realised in the late twentieth century, when 
researchers such as Beatrice Mintz and Ian Wilmut carried out their studies on 
mammalian embryos (generally under the umbrella of ‘cloning’ research)19, again 
noted in Chapter 2 of this thesis. 
 
Cell and tissue culture 
 Two books of especial interest have been written on the history of cell and 
tissue culture: Hannah Landecker’s Culturing life: How cells became technologies 
(2007)20, and the more recent book by Duncan Wilson, Tissue culture in science and 
society: The public life of a biological technique in twentieth century Britain (2011).   
Culturing life has a US-focus, and Wilson’s book helps to include more history of the 
British contribution to early cell and tissue culture.  Although now generally 
considered to be a somewhat regular, even mundane technique in current biomedical 
and biological science, the survival and proliferation of cells outside the body was 
once regarded as ground breaking, and as Andrew Reynolds has observed, many of 
the “more recent biotechnologies would be impossible without it”21; this of course 
includes the ESC research discussed in this thesis.  These books are so important in 
the context of this thesis since they have influenced the overall approach.  In 
particular, this includes the use of scientific publications as primary sources (as in 
Landecker) and highlighting the important role of society in scientific research (as in 
Wilson). 
According to Wilson, there are not always two opposing sides of ‘the public’ 
and ‘science’.  As he observed in his introduction, “the scientists who used tissue 
culture were only one group in a dynamic network that also comprised journalists, 
authors, documentary makers, anti-vivisection and pro-life groups, bioethicists, 
																																																								
19 Huistra, 2015. 
20 Culturing life won the 2008 History of Science Society’s Suzanne J Levinson Prize. 
21 Reynolds, 2011 p 149. 
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lawyers and politicians”22.  Covering a century of tissue culture – from Ross Granville 
Harrison’s (1870-1959) experiments with neural cells in 1907 to the first artificially 
created replacement organ transplants in 2006, and modern art installations using 
animal cells cultured on scaffolds – Wilson used tissue culture to show the evolving 
relationship of science and the public, with a focus on Britain.  Other previous works 
have considered the relationship between science and the public, including 
popularisation of science; initially it may be troublesome to see what Wilson can add 
to this.  For example, science popularisation has been studied since science first 
became a professional pursuit, and is part of an arsenal we can use to examine the 
relationship between science and society23.  It is Wilson’s specific approach however 
that is the novelty in Tissue culture in science and society; far from going back over 
well-trodden ground of examining the relationships between science and the public 
via the popularisation of science, Wilson brings together history, anthropology, and 
sociology to investigate the changing public attitudes to  science. 
Just as functioning society required every individual to have their inter-
dependent roles and their place (the butcher, the draper, the councilor, the grocer), the 
same was considered for tissues of the organism.  This is demonstrated to be the case 
in the historical study of the stem cell concept (Chapter 1), particularly in Germany.  
Wilson also noted the ‘cell state’ effect on US and British thinking; in the first chapter 
of this thesis, the popular USA cell lineage studies are mentioned; this fits neatly into 
Wilson’s appraisal of the period.  The Great Depression of the 1930s had led to 
significant unemployment and unprecedented shifts in society, and its problems were 
equated with the uprooting of tissues from their organised, specific place in the 
organism (i.e. attempts to maintain them in the laboratory)24.  Such a shift led us to 
consider how science is affecting societies, and how the public view of science is 
socially constructed. The biomedical sciences constitute one area where research can 
have obvious effects on society.  Wilson has been shrewd to select tissue culture as an 
object to examine how such construction might take place; arguably, this thesis 
demonstrates that stem cell research is also a suitable lens through which to view the 
effects of science on society, and perhaps even more clearly, the effect of society on 
scientific research.  As has been previously highlighted by Roger Cooter and Stephen 																																																								
22 Wilson, 2011 p 3. 
23 Bensaude-Vincent, 1988; 2009. 
24 Willmer, 1935. 
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Pumfrey (1994), it is not always possible to separate the production and consumption 
or communication of science, and Wilson supports this idea. 
Is Wilson investigating the socioconstruction of science, or considering the 
technoscientific construction of societies?  The former, suggests Bernadette 
Bensaude-Vincent, has been “thoroughly investigated” in the past by historians of 
science, and what is needed now is an examination of the technoscientific25.  In Tissue 
culture in science and society, Wilson works towards the latter.   There is some detail 
regarding the origins of scientific knowledge, such as the laboratory, however Wilson 
has clearly attempted to observe the effects of the increasing construction of societies 
by science and technology.  This approach has also influenced the approach taken in 
particular sections of this thesis, especially in Chapters 4 and 5, where the interactions 
between science and society are shown to be significant for scientific research. 
In the latter half of the book, where it is most relevant, Wilson managed to 
hint at the notion of multiple ‘sciences’ and multiple ‘publics’.  Wilson highlighted 
the importance of several relevant parties (such as politicians, ethicists, artists, 
researchers), all arguably on the ‘science’ side, as well as several groups of ‘publics’ 
(journalists, educated lay persons, voters, recipients of certain medical treatments, for 
example), with some falling into multiple categories.  In her work, Bensaude-Vincent 
preferred the term ‘citizens’ to ‘the public’, in order to highlight the more active role 
of individuals in society26.  I believe Wilson’s intention is the same: to demonstrate 
the role of science and scientific research in the maturation of modern Western 
democracy.  Here then is further evidence that Wilson has contributed to an 
exploration of the technoscientific construction of British society.  All such parties are 
also shown to have significant roles in the history of ESC research, as evidenced 
throughout this thesis, and in particular through Chapters 3, 4, and 5. 
 
Although the beginnings of cell culture technique development lay in the late 
nineteenth century, Landecker also takes the work of Harrison as her starting point; 
Harrison’s 1907 publications report on the survival of tissue fragments in his 
laboratory for several weeks.   Harrison demonstrated that cells could live ex vivo for 
some time, which was an interesting novelty amongst the scientific community; 
novelty is probably the most appropriate term here, since few knew what to do with 																																																								
25 Bensaude-Vincent, 2009,  p 365. 
26 Bensaude-Vincent, 2009. 
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this new research tool, including Harrison himself.  Eventually of course, researchers 
would find a use for the new technique of ‘tissue culture’.  Harrison’s hanging drop 
method was good for maintaining (and differentiating) individual neurons, but other 
methods were needed to culture other cell types en masse, as Alexis Carrel (1873-
1944) would attempt to do at the Rockefeller Institute.  Culture conditions enabling 
(or encouraging) both self-renewal and differentiation would become key for ESC 
research. 
Tissue culture in science and society explained how tissue culture became a 
‘high profile tool’ in the 1920s and 1930s, with a specific focus on the Cambridge 
Research Hospital (CRH) and scientist Thomas SP Strangeways.  Development of 
tissue culture methods reflected a shift towards experiment in biological sciences – no 
longer was biological study based solely on observation of natural phenomena (as 
noted by Maienschein).  Not only could biological materials now be experimented on, 
tissue culture warped the view of organisms - whole bodies were now seen as a stack 
of raw materials that could be removed and re-used elsewhere – the opportunity to 
control nature was on the horizon. 
In 1929, the new Director of the re-named Strangeways Research Laboratory 
(from the CRH), Honor Fell, continued the science communication tradition, and 
made attempts to explain the uses and benefits of tissue culture to the general public.  
The mixed results of her efforts could have been a combination of journalists wanting 
a good story, and scientists being unable to provide this; as David Knight says, the 
day-to-day work of scientists can be rather dull27.  Despite this, ex-British Prime 
Minister (1902-1905) and President of the British Association for the Advancement of 
Science (1904), Arthur Balfour, emphasised the economic and cultural importance of 
science and research in interwar Britain28.  This is demonstrated in Chapter 4 and 
Chapter 5 of this thesis; these chapters also show that the effect occurs in the opposite 
direction as well – scientific research is clearly affected by economic contexts and 
social influence.  Alongside a government-encouraged admiration for modern science 
and technical breakthrough however was fear and insecurity; Wilson remarked that 
significant numbers of films produced in the early 1930s presented science as a route 
to catastrophe.  Knight has suggested that there was a ‘loss of scientific innocence’ 
after World War I, with science being viewed as concerned with vested interests of 																																																								
27 Knight, 2006. 
28 ibid. 
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investors, not the inoffensive, disinterested investigation previously considered.  As 
the motives of scientists were questioned, some public distrust followed29.  Again, this 
is shown to have had an effect later in the twentieth century; consideration of the 
social context for mESC and hESC research (Chapters 4 and 5) clearly show that 
public distrust was able to influence political policy, and affect the availability of 
funding for particular research projects.  For example, legislation would dictate that 
Thomson could not use federal funding or facilities for his hESC isolation research 
(instead depending on the private sector) (Chapter 5). 
Both Culturing life and Tissue culture in science and society consider the 
advances made in tissue culture techniques during inter-war and post-war Britain, and 
their commercialisation.  In the ongoing fight against disease, tissue culture could 
now play a significant role and would be portrayed in a more heroic light by the 
media.  World Wars I and II shifted the focus of scientific research towards more 
practical uses.  As highlighted in Chapter 4 of this thesis, the economic downturn of 
the early 1980s had a similar affect, particularly in Britain.  Arguably, such 
commercialisation and focus on the application of techniques resulted in useful 
standardisation of tissue culture in the mid-twentieth century.  Standardisation of cell 
lines was part of the motivation of Gail Martin and Martin Evans’ work in the 1970s 
and 1980s, demonstrating that this factor was an ongoing concern – as again shown 
when John Gearhart and James Thomson began working on the isolation and culture 
of hESCs in the 1990s (Chapters 3, 4 and 5).  Alongside this was the realisation that 
tissue culture, no longer simply an interesting phenomenon, could be clinically 
relevant.  Again, this mirrors the realisation of something similar by Martin Evans in 
the 1980s, as he made his isolated mESCs clinically relevant by producing animal 
models of disease (Chapter 4).  John Gearhart was also drawn into isolation and 
culture of hESCs through the need for a more clinically relevant tool for his research 
(Chapter 5).  
 Furthermore, usefulness of cell culture for genetics and heredity research 
became evident in the 1950s and 1960s, including the fusion of cells from different 
species.   That these hybrid cells could survive demonstrated that, at least at the 
cellular level, there was some unity between species that must (biologically) allow 
such blending.  Just as Maienschein reminded us that there is a relevance to 																																																								
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theoretical biology (preceding practical, or experimental, biology), Landecker noted 
that cell culture resulted in an entire shift of meaning of ‘life’ and ‘organism’; these 
themes appear throughout Landecker’s history, focusing on cell culture as a tool 
linking nineteenth-century physiology to twentieth-century genetics.  In this thesis, I 
aim to provide a complementary overview, such as discussing development of 
disciplines in Chapter 2.  The second chapter of this thesis clearly shows that there 
were many links between embryology, cell culture, and genetics that, arguably, have 
lasted into the twenty-first century.  In fact, this thesis has shown that whilst earlier 
studies may have been influenced by the (then unknown) mechanism of heredity and 
inheritance, later twentieth-century and twenty-first-century studies continue to be 
carried out under a genetics paradigm.  Biological sciences held a different position in 
the public mind in the early decades of the twentieth century compared to, for 
example, the physical sciences.  Different research traditions were emerging, and 
there was, in some cases, little communication between the proponents of these 
different fields. 
In the laboratory, tissue culture was becoming essential to several disciplines, 
including pharmacological sciences and genetics.  By the 1960s, cells had become 
“easily accessible, available, and manipulable”30.  Landecker has suggested that the 
malleability cell biology demonstrated was not primarily about the creation of 
‘artificial monsters’, but about demonstrating the plasticity of life31.  The parallels 
between both the biology and the study of the pathological and non-pathological are 
highlighted throughout this thesis, most notably in Chapter 3.  Although Landecker 
suggested that such parallels were recognised in the mid-twentieth century, as it 
became paired with the possibilities by experimental research, Chapter 3 shows that 
such parallels were certainly considered in the nineteenth century, and possibly 
before. 
Notwithstanding the apparent lack of consideration given to the ethical and 
legal issues connected with tissue sample collection through most of the twentieth 
century, Wilson’s sixth chapter engaged with this important matter.  Wilson reported 
that there was a generally positive attitude towards human tissue culture during the 
1960s and 1970s, due to the positive spin created by anti-vivisectionists, who saw 
tissue culture as a method that could replace experiments on living animals.  The 1967 																																																								
30 Landecker, 2007 p 201. 
31 ibid p 232. 
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Abortion Act however caused concern in some sections of society, with Catholic 
claims that perhaps abortions would be encouraged in order to provide foetal tissue 
for research.  Such attitudes became part of the discussion of IVF research, which 
itself was historically important for the later isolation and culture of hESCs.  Wilson 
helpfully described the contemporary legalities of human tissue use: surgical 
procedures required consent, which, when given, implied abandonment of removed 
tissue (including foetal tissue).  Researchers then felt that once they cultured this, it 
became their property.  Professionals from a variety of specialisms commented on the 
collection and use of foetal tissue, which became entangled with the pro-life 
movement of the mid-1970s.  Developments in the storage and culture of human 
tissue greatly expanded the opportunities for its use, and therefore increased demand.  
As the market increased, so did the commodification of human tissue in this context32.  
The demand for foetal tissue would have been increased since no human embryonic 
cell lines existed in the 1970s and 1980s.  Although a donor may afford different 
cultural values and individual rights to bodily materials, there was a temptation to 
suggest that this was somewhat negated by a sort of clinical detachment33.  This 
would not only affect a physician treating an individual or a scientist receiving a 
donation, but a patient: the patient is more likely to feel detached from removed 
diseased tissue than removed healthy tissue.  The MRC and National Institutes of 
Health (NIH), in the UK and USA respectively, responded to changes in public 
feeling by funding attempts to create foetal cell lines.  Following several legal cases 
concerning tissue and cell line ownership in the USA, queries regarding ownership 
began appearing in 1980s Britain. 
The Thatcher government of the late 1980s encouraged commercial incentives 
in biological sciences, and a 1988 Lancet article claiming that collection of and 
testing on removed tissues was not covered by the 1961 Human Tissue Act, led to an 
empowering of patients; patients now had the option of whether to donate tissue or 																																																								
32 Lesley Sharp (2000) has highlighted that commodification of the body is not a new 
phenomenon, or one that is particular to medicalisation of the body in the modern era.   The 
body, “either in its entirety or fragmented form has long been an object of economic, social, 
and symbolic use in a host of societies” (p 292).   Political and military frameworks have also 
commodified the body, and have separated bodies based on class, age, race or gender, for 
example.   In a biological and medical research context, bodies have been used as objects by 
anatomists and collectors, and in history the pauper’s body was frequently worth more dead 
than alive. 
33 Andrews and Nelkin, 1998 p 53. 
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not.  Patients were no longer considered to have ‘abandoned’ any tissues following 
surgical procedures, and more attention began to be paid to personal data learned 
from genetic analysis.  The Thatcher government’s policies on biological science 
research becomes an important focal point in Chapter 4 of this thesis, particularly 
considering how policy and funding availability affected research directions. 
 
Stem cell history and policy 
 By the end of the twentieth century, stem cells had become a beacon of 
biological and biomedical science, glowing with mysterious scientific and medical 
potential, whilst blushing with moral and ethical issues.   From this, some non-
scientists have become interested in the history, philosophy, sociology, and legality of 
stem cell research and regenerative medicine, publishing various papers on the topic.   
One of the first books to begin compiling such studies on stem cell research was put 
together by Renato G Mazzolini and Hans-Jörg Rheinberger, in Differing routes to 
stem cell research: Germany and Italy (2012).   The volume is based on a conference 
held at the Italo-German Historical Institute in Trento, in 2010, which addressed two 
questions in particular: where did stem cell research come from, and why have 
international (in this case, German and Italian) manifestations varied so greatly? 
 Historical accounts led the discussion, by considering conceptual changes 
through the history of stem cell research.   This included discourses on terminology 
(examining Ernst Haeckel’s Stammzelle, for example), to the influence of American 
teratoma research in the mid-twentieth century.   There are also comparisons drawn 
between various branches of biological study in the nineteenth and twentieth 
centuries, such as between pathology (in particular cancer) and embryology, again 
considering the influence of embryonal carcinoma cell lines derived in the 1970s.  
These are all discussions examined at length and in greater detail in this thesis.  What 
also becomes clear from the historical discussion is that the stem cell as an object is 
multifaceted34, and that there is no single history of stem cell research, but several, 
depending on which facet of the ‘stem cell’ one wishes to explore.  Again, this is 
highlighted throughout this thesis, as different historical approaches demonstrate 
various ESC discourses; other stem cell histories have also shown that several 
																																																								
34 Capocci, 2014. 
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histories are needed to explore the variety of stem cell types, such as the work carried 
out by Cooper and Kraft, for example, on haematopoietic stem cell history. 
 After the historical perspectives, there followed consideration of the 
sociology, legal, and biological aspects of (embryonic) stem cell research, especially 
focusing on the differences between German and Italian research (which was not 
apparent in the first historical chapters).   Usually, it is the approach taken to ESC 
research in the UK that is written about in this way, since UK legislation is relatively 
permissive.   Both Italian and German laws however are, in contrast, relatively 
restrictive, although for different reasons.   This section of the volume is highly 
influenced by Sheila Jasanoff’s “civic epistemology”, which is used to frame how 
legislation in Italy and Germany has developed35. 
Increasingly in the twenty-first century, discourses on stem cell research are 
beginning to enlarge from the initial science/ethics/faith discussion, to include debate 
regarding economic, legal, social, and political factors.  In particular, Herbert 
Gottweis, Brian Salter, and Catherine Waldby initiate discussion between the more 
familiar biology and ethics, and less familiar political dimensions, in The global 
politics of human embryonic stem cell science (2009).  The political analysis provided 
by Gottweis, Salter, and Waldby is based on large national and international research 
projects, providing a useful transnational approach (and making the ‘global’ of the 
title worthy of its name).  The authors also make use of interdisciplinary methods, 
utilising sociology, anthropology, politics, and economics in their work; although 
occasionally this makes the book a slightly fragmented read, overall, the book holds 
together.  The “transnational influence” of factors such as investment in 
biotechnology, alongside regional influence of individual laws (by country, or state) 
for example, are highlighted by Gottweis, Salter, and Waldby, who argue that such 
economics, politics and “power” aid in explaining country or state attitudes and 
regulations for stem cell research36.  Gottweis, Salter, and Waldby call this the “post-
welfare state”, in which the welfare of citizens is given a lower priority than ‘big 
business’, such as biotechnology firms, and regulations are formed based on this 
arrangement of political interest, as countries compete with each other for industrial 
finance37, demonstrated by the reduction in national healthcare and welfare budgets38.  																																																								
35 For example, see Jasanoff, 2007 p 247-271. 
36 Blaser, 2010 p 100. 
37 Gottweis, Salter, and Waldby, 2009 p 29. 
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For example, following the Bush administration’s limit on stem cell research in the 
USA, activities in other countries were driven by the potential ability to fill this 
perceived gap in the market.  Despite this, almost every country has a different set of 
regulations for stem cell research, which is explored in this book. 
 Gottweis, Salter, and Waldby introduce the concept of biomedicalisation39 (as 
an extension of medicalisation40), with particular reference to stem cells and 
marketisation, that has affected the technological developments and economic 
investments in ESC research in the latter years of the twentieth century, creating “a 
global techno-managerial paradigm in health policy”41.  This is highlighted further by 
discussion referring to the marketisation of human tissue (especially, for example, 
human oocytes and “reproductive tourism”42), intellectual property rights, commercial 
interests, and the effects such factors have on policy decisions in various countries.  
Human ESCs and related tissues become known for their “biovalue”43: a global, 
economic yield generated by biotechnology companies in their biomedicalisation of 
cell biology.  Although Chapter 5 focuses on the lead up to the isolation and culture of 
hESCs, there is evidence in this history that supports the claims made by Gottweis, 
Salter, and Waldby.  In particular, the potential commercial benefits of the isolation 
and culture of hESCs, and the development of standardised cell lines, was thought to 
be potentially fruitful enough for biotechnology company Geron to invest in both 
Thomson and Gearhart’s work.  If federal policy and economics had enabled public 
funding of Thomson or Gearhart’s work, there is a distinct possibility that private 
funding and the almost immediate commercialisation of their work would not have 
been required.  It is also possible that hESCs may have been isolated and cultured 
sooner. 
 The middle section of The global politics of embryonic stem cell research 
followed this line of enquiry by beginning with discussion of global regulations, 
ethical questions, and local policy development post-Dolly (1996)44, and more 
detailed consideration of regulations in regions that one review called an “ethical 
																																																																																																																																																														
38 McCall, 2010. 
39 Clarke et al., 2003. 
40 Zola, 1972. 
41 Gottweis, Salter, and Waldby, 2009 p 13. 
42 Caplan and Bürkli, 2009 p 15. 
43 Gottweis, Salter, and Waldby, 2009 p 8. 
44 Blaser, 2010; Caplan and Bürkli, 2009. 
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potpourri”45; regulation in Britain, USA, Japan, Italy, South Korea, and Germany 
have previously been discussed46.  This volume neatly brings together interviews and 
policy histories for these countries, but generally adds little original research to the 
discussion.  For example, policy shifts under different administrations in the USA 
(Clinton to Bush to Obama), contrasting Buddhism and science policy in Japan and 
South Korea, and restrictive legislation in Germany, have all been examined 
elsewhere47.  The global politics of embryonic stem cell science would have been 
completed and in press prior to several important and influential stem cell policy 
decisions of 2008, such as the reduced restrictions for German stem cell research, 
changes initiated in the USA as Barak Obama became president, or the 2008 
amendments to the UK’s Human Embryology and Fertilisation Act, which could have 
added to work previously published. 
 
Stem cell philosophy 
 There have, very recently, been two books published concerning the 
philosophy of stem cell research: Melinda Bonnie Fagan’s Philosophy of stem cell 
biology: Knowledge in flesh and blood (2014), and Lucie Laplane’s Cancer stem 
cells: Philosophy and therapies (2016).   The publication of such texts demonstrates 
that the early twenty-first century is not just becoming known for its advances in stem 
cell biology, but also for its reflections on stem cell research.   There is in addition 
perhaps a more coherent field of ‘stem cell studies’ emerging, which, according to the 
statements made in several published works, aims to engage with and inform global 
stem cell research and policies.   The book by Fagan, and especially the one by 
Laplane, certainly appear to be in this category. 
 Fagan’s book has been referred to as “a superb discussion of this exciting field 
of contemporary science”48; being the first book-length philosophical consideration of 
the topic, Fagan’s book will no doubt become a ‘yard-stick’ by which other attempts 
will be measured.   Fagan appears to acknowledge the responsibility of writing the 
first such book, carefully explaining the relevant scientific details of stem cell 
biology, including the relevant scientific concepts, techniques, and, to an extent, 																																																								
45 Caplan and Bürkli, 2009 p 15. 
46 For example, see Robertson, 1999; Ayer, 2002; Tauer, 2004.  
47 For example, see Walters, 2004; Wolfrum and Zeller, 1999. 
48 Ioannidis, 2015 p 285. 
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history.   The book is organised to begin relatively generally, deepening arguments 
and detailing complications as one reads through. 
The book is separated into three parts, the first focusing on the 
conceptualisation of stem cells for research.   The second, middle part is concerned 
with examining general debates in the philosophy of biology, and showing how these 
are relevant to stem cell research.   The final part links stem cell research with clinical 
medicine and systems biology.   What appears to be missing is a focus at some point 
in the book on the importance of the cell’s environment; although mentioned several 
times, there is no single section where Fagan draws together all of these notes to 
historically and biologically contextualise them.   For example, somatic cell nuclear 
transfer has demonstrated that, theoretically, every cell (and not only stem cells) has 
the capacity for self-renewal and differentiation (in the appropriate environment).   
There is no discussion of what this sort of data means for the concept of pluripotency. 
Steps towards providing this discourse have been taken in Chapter 6 of this thesis. 
 In particular, Fagan noted that, like in several other experimental biological 
areas, there is a lack of ‘general theories’, such as those found in physics, for 
example.   Instead, the foundation of experimental biology are models, which makes 
stem cell science appear rather disunified, presenting a significant methodological 
problem for philosophers of science49.   Fagan’s approach to this is to make use of 
(abstract) models and develop models herself.   Making use of a much-used stem cell 
definition stating that stem cells are cells capable of both differentiation and self-
renewal, Fagan generates the “abstract stem cell model”, where self-renewal and 
differentiation potential or capability are the “minimal unifying framework” for stem 
cell research50.   This becomes a way of demonstrating that stem cell research is not 
necessarily disunified, and, once she has established this, Fagan can then continue her 
book based on this model.   For example, the model enables us to identify whether a 
cell is or is not a stem cell.   This is an important distinction for research, Fagan 
claimed, as it demonstrates that there are two branches of stem cell research (based on 
a methodological difference): tissue-specific research, concentrating on those stem 
cells restricted to particular tissues, and pluripotent cell research, which focuses on 
cells with pluripotent properties.   Unity can even be found after accepting this divide, 
Fagan stressed, stating that ultimately stem cell research, despite the lack of single 																																																								
49 ibid p 286. 
50 Fagan, 2013b p 45. 
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methodology or approach, has the same therapeutic goal51.  This is not something that 
has been universally accepted however; for example, the important role of stem cell 
research historically in development studies, and how stem cells are increasingly 
being used in a variety of disciplines as models themselves are also relevant. 
 In addition to generating a first comprehensive philosophy of stem cells, 
Fagan considers general theories and ideas in the philosophy of science, and how they 
can apply specifically to stem cell research.   For example, Fagan queries how 
experimental results from large populations of cells can tell us about the ways 
individual cells behave, and how we can accurately measure the capacities or 
potentials of single cells; these problems are referred to as “the stem cell uncertainty 
principle”52.   In addition to these issues concerning individual stem cells or stem cell 
populations, Fagan also observed that there remains some discontinuity in the term 
stem cell, and whether the term identifies a single cell, a cell population, or various 
cell types; this reminds us of the discussions by Holger Maehle and Ariane Dröscher 
in particular, and the explorations of the early uses of the term Stammzelle or stem 
cell53 (as further explored in Chapter 1 of this thesis).   Experimental results are 
interpreted in light of such varied theories, and would therefore benefit from some 
unity54.   The ‘stemness alternative’ has previously been suggested as a way to 
overcome the aforementioned uncertainty, suggesting that the stem cell may be able 
to move along a variety of “differentiation states”55, rather than every cell having the 
same signature (which has been the favoured model up until now).  This model is 
carefully examined in detail through Chapter 6 of this thesis.  Although Fagan agreed 
that there are some merits in this idea (such as the action of a stem cell being 
influenced by its environmental context), she is largely critical. 
 In contrast, Laplane neatly demonstrated that her version of the stemness 
model is practically applicable and useful to stem cell research.  In a book published 
in mid-2016, Laplane considered how viewing cancer stem cells (CSCs) differently 
might affect experimental design, and lead to new cancer treatments.  Central to 
Laplane’s theory is that all tumour cells are not equal, generally consisting of small 
numbers of highly proliferative cells, and larger numbers of 																																																								
51 Ioannidis, 2015. 
52 Fagan, 2013b p 64. 
53 Maehle, 2011; Dröscher, 2014. 
54 Germain, 2014. 
55 Fagan, 2013b p 71. 
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differentiating/differentiated cells.  At least some of these cells appear to be stem-cell 
like – i.e., they have the ability to both self-renew and differentiate, which is what 
maintains the growth of the tumour.  These are CSCs.  The parallels between CSCs 
and ESCs, and how this has been exploited in research, is discussed in Chapter 3 of 
this thesis.  The existence of CSCs would explain how cancers could reoccur, even 
after chemo- or radiotherapies, and can apparently ‘strike’ at any time, and almost 
anywhere in the body.  Furthermore, the development of secondary tumours, some far 
away from the primary tumour site, could also occur by the movement of CSCs 
through the body.  In short, CSC theory explains important facets of our current 
understanding of cancer, including why patients are never considered ‘cured’.  On the 
other hand, understanding CSCs may give us another weapon in our arsenal for 
treating cancer. 
Laplane also included a useful historical overview, demonstrating that the 
CSC concept emerged from teratoma research (as discussed in greater depth in 
Chapter 3 of this thesis), and haematopoietic cancers.  More recently, cell-sorting 
technology introduced in the latter years of the twentieth century has resulted in 
something of a boom in CSC research.  Laplane noted in particular the work of John 
Dick, who transplanted purported leukaemic stem cells from sick mice into healthy 
mice.  Dick found that these transplanted cells acted like stem cells (i.e. with the 
ability to both self-renew and differentiate), but would generate leukaemic cells 
instead of healthy cells.  Laplane therefore suggested that the study of CSCs should 
not be separated from the study of ‘normal’ (i.e. non-pathological) stem cells; again, 
this is explored further in this thesis, in Chapter 3, although the parallels between the 
abnormal and normal can be observed at several points through ESC history. 
With this in mind, Laplane argued that for successful cancer treatments to be 
developed, we must begin with stem cell biology.  Laplane carefully unpacked current 
semantics and concepts in stem cell research, but identified issues with the way 
researchers think about stem cells (and their properties), and the experimental results.  
Stem cell and cancer biologist Hans Clevers has suggested that there has been 
“fuzziness” in stem cell definitions, which has affected experimental design, 
interpretation of results, and communication of findings56.  This is where Laplane 
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delivers a new concept of stem cells that may affect experimental design in the future, 
with four possible stem cell ‘types’, based on philosophical concepts: 
1) That the properties of a stem cell (i.e. self-renewal and differentiation 
ability) are intrinsic, and therefore independent of its environment 
(“categorical”) 
2) That these intrinsic properties of a stem cell only emerge under the 
appropriate environmental conditions (“dispositional”) 
3) That these properties of stem cells are extrinsic, and can be induced by 
environmental factors (“relational”) 
4) That the properties of stem cells are actually extrinsic properties of tissues, 
rather than individual cells (“systemic”). 
Laplane’s four potential stem cell types require further laboratory investigation, since 
no experiments have been designed under this new stem cell concept, nor have any 
results been interpreted in light of Laplane’s ideas.  It is not immediately clear how 
any currently studied stem cells fit into Laplane’s framework, yet it could still be 
valuable for future research, since it is applicable to experimental work.  It is clear 
from Clevers’ enthusiasm for Laplane’s alternative way of conceiving stem cells that 
the research community may be looking for new approaches to cell biology, and are 
open to suggestions from philosophy57.  Although this thesis approaches this in a 
slightly different way (primarily from interpreting the historical results of 
experimentation), Chapter 6 demonstrates that a new way of conceiving stem cells 
may be fruitful for experimental research in the future. 	
3. Thesis overview 
This thesis focuses on the history of embryonic stem cell research in Europe 
and the USA, during the nineteenth and twentieth centuries.  Specifically, it will ask 
what the role of political and social context has on stem cell research is, what the 
significance of cell fate and cell fate research is, and under which paradigms ESC 
research developed, including whether these paradigms are still useful in the twenty-
first century.  The thesis will investigate several aspects of ESC history to help answer 
these questions; this includes exploration of the stem cell concept through history, the 
role of heredity and genetics research and paradigms, the parallels between cancer and 																																																								
57 ibid. 
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stem cell research, the social, political, and economic factors that governed the 
isolation and culture of mESCs and hESCs, including their use, and lastly, whether 
we should consider stem cells as entities, or ‘stemness’ as a state. 
The first chapter of this thesis therefore explores the paradigms under which 
the term ‘Stammzelle’ developed; since German natural philosophy was so influential 
in developing the concept of the stem cell, there will be a particular focus on this 
region and research in the earlier sections of this chapter.  An overview of German 
nineteenth-century research into the life sciences provides important context, enabling 
us to appreciate how the concept of the cell developed, and how this came to be the 
proposed fundamental unit of life.  Linking studies in embryology and evolution, 
Ernst Haeckel (1834-1919) developed the notion of a stem cell in two different 
contexts: initially as the first unicellular organism, from which other life evolved, then 
the fertilised egg, from which the entire embryo could develop.  These ideas were 
popularised in English, particularly at the turn of the twentieth century.  Of particular 
significance was the use of the term ‘stem cell’ in Edmund Beecher Wilson’s (1856-
1939) textbook The Cell, which was published in several editions.  This appeared to 
solidify the use of the term in English, alongside use of ‘stem cell’ by researchers 
from Eastern Europe, where the term seemed to be in general scientific use.  Wilson 
was also part of a small group in the USA undertaking cell lineage studies.  The role 
of cell fate (as examined through lineage studies) became increasingly important for 
stem cell research through the twentieth century – possibly due to the influence of the 
early American approach. 
Chapter 2 begins similarly to the previous chapter in that it examines the 
history of the conceptualisation of the cell nucleus.  This becomes relevant as the 
paradigm of genetics is a theme emerging through this thesis, as a way in which stem 
cells have been explored, particularly in the twentieth (and into the twenty-first) 
century.  In order to examine the manner in which genetics becomes so influential in 
ESC research, Garland Allen’s claim that genetics initially developed under the 
embryology paradigm is tested.  Using historical examples from the field of 
experimental biology (and in particular experimental embryology), this chapter argues 
that there is a difference between the conceptual and the chronological development 
of heredity, genetics, and embryology.  Through examination of specific experiments 
from nineteenth- and twentieth-century life science, the chapter demonstrates that the 
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disciplines of genetics and embryology remain closely linked into the late twentieth 
century. 
In order to throw light on another discipline linked to ESC research, the third 
chapter of this thesis considers the parallels between cancer and ESC knowledge and 
understanding.  The chapter begins with a brief history of cancer, focusing on the 
nineteenth-century suggestion that cancer could arise from cells remaining in the adult 
from embryonic development.  Later experimental work using mouse teratomas 
(tumours of germ cell origin) in the mid-twentieth century highlighted similarities 
between development and growth of these cancers, and embryogenesis.  This chapter 
identifies several ways in which cancer and development were studied either in 
parallel, or were directly compared, in the mid- to late twentieth century.  This 
includes biochemical studies, the study of cell fate (perhaps a link to the earlier cell 
lineage studies highlighted in Chapter 1), and, briefly, the role of the niche.  Lastly, 
this chapter considers the cancer stem cell (CSC) concept; this idea appears to be 
fashionable at various times throughout the twentieth century, however is having 
another moment in the early twenty-first century, particularly as it may be applicable 
to cancer treatment.  The last part of Chapter 3 is devoted to comparing the CSC and 
ESC concept, in light of the experiments and observations previously noted in this 
chapter, and Chapter 1. 
Continuing to examine the links between pathological and non-pathological 
development, Chapter 4 continues where Chapter 3 concluded, with the research on 
teratomas in the mid-twentieth century.  Since ESCs were not available for 
experimental research, teratoma cells were considered a useful alternative.  After 
developing methods to culture these murine embryonal carcinoma cells (ECCs), 
similar techniques were applied to mouse embryos, in order to isolate and culture 
mouse ESCs; this is explored in Chapter 4.  Also of significance is what the 
researchers who isolated mESCs, Gail Martin (USA) and Martin Evans (UK), decided 
to do with their new tool.  This chapter argues that science policy and economics 
affected the research directions taken in the USA and the UK by Martin and Evans 
respectively.  This therefore requires some description of the social, political, and 
economic situation of the 1980s in the UK and USA, followed by an investigation of 
how this affected research.  The chapter concludes that, despite the capitalist 
ideologies of the USA, there was more funding to carry out fundamental, or ‘pure’ 
research available to Martin.  In contrast, under Thatcher, Evans needed to 
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demonstrate applicable outcomes for his research, driving him to develop murine 
models of disease in the UK. 
The fifth chapter of this thesis provides an in-depth consideration of a claim 
made by philosopher Michel Morange.  In 2006, Morange wrote a paper 
commemorating the 25th anniversary of the isolation and culture of mESCs in 1981; 
in his paper, Morange compared this event with the isolation and culture of hESCs in 
1998.  Morange claimed that mESCs and hESCs were not equivalent because the 
scientific contexts they were isolated under were different.  This included the 
motivations and goals involved in their isolation and culture.  Chapter 5 therefore 
examines the events which led up to the isolation and culture of hESCs (mESCs were 
described in Chapter 4).  The role of the American biotechnology company Geron is 
considered, since Geron funded the 1990s work of both Thomson and Gearhart.  The 
chapter concludes that Morange was correct in his assertion that the scientific context 
was different between 1981 and 1998, although there were also some parallels 
between the projects of Martin and Evans, and Gearhart and Thomson.  This chapter 
offers a further, complementary addition to Morange’s argument: the political, social, 
legal, and ethical context of the work Thomson and Gearhart carried out were 
different to those same contexts in the late 1970s and 1980s (which was partly 
referred to in Chapter 4).  The chapter concludes that context is important for 
assessing motivations and results of research.  
The last research chapter of this thesis queries the paradigm under which stem 
cells have been studied over the past two centuries, and proposes an alternative 
paradigm for future stem cell research.  To support this claim, some work is required 
to better understand the philosophy of stem cell research.  The first half of Chapter 6 
makes use primarily of the research from philosophers Melinda Fagan and Lucie 
Laplane, who have been the first to carry out any in-depth consideration of stem cell 
philosophy.  Taking the work of Laplane and Fagan as a starting point, Chapter 6 
considers the importance of the definition of stem cells (i.e. the ability to both self-
renew and differentiate), and whether stem cells may be natural kinds.  The chapter 
also discusses the importance of cell fate on our understanding of stem cells.  Cell 
fate, as previously highlighted throughout the thesis as an important factor in the 
concept of the stem cell, and stem cell research, is discussed from the position of the 
niche, embryonic cells, molecular markers, and plasticity.  This last approach 
demonstrates that the current stem cell paradigm is still being used in the laboratory in 
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the twenty-first century: the stem cell entity paradigm.  The examples used in this 
chapter suggest that it may be time for a different approach to understanding stem cell 
biology: ‘stemness’ (i.e. the properties of self-renewal and differentiation) as a ‘state’, 
or phase, that cells can pass through at different times in their life.  This means that 
potentially, any cell has the potential to become a stem cell.  As a way of testing the 
potential of this suggested new paradigm, results of previous stem cell research 
beliefs and experiments are examined.  It is argued in this chapter that results of stem 
cell research in the twentieth and twenty-first centuries support the state view, and 
that perhaps a change in the stem cell concept is required for development of the 
science in the twenty-first century. 
 
Through these chapters, the three overarching research questions of this thesis 
can be answered.  Although specific to stem cell research, some of these responses 
could be extrapolated to cell biology, biomedical science, and even biological science 
in general.   
The first query considers the importance of political and social influence in 
science, evidenced in this thesis as occurring from the nineteenth to the twenty-first 
centuries.  For example, in Chapter 1, the political and social situation in Eastern 
Europe affected the language that ultimately became used in cell biology, which 
affected conceptualisations of various cell types.  The switch in most-used language 
in biological science, from German to English, also occurred due to the political 
situation in Germany and surrounding countries at the beginning of the twentieth 
century; the threat of war led many researchers to move westwards to Britain and the 
USA.  This theme is particularly evident in Chapter 4, which explicitly demonstrates 
that political, social, and economic contexts significantly affect the research that is 
carried out.  Chapter 4 shows that the importance of application of research led to 
Evans’ creation of genetically engineered mice, whereas Martin was able to continue 
with ‘pure’ research.  In Chapter 5, Morange’s claim that motivations and goals 
between mESC and hESC isolation were different, because of the different scientific 
contexts the four researchers - Martin, Evans, Gearhart, and Thomson - were working 
in.  In addition to this, Chapter 5 also demonstrates that the political and social 
context also significantly influenced the work of the four researchers.  The specific 
examples provided in this thesis have not been documented in this manner previously.  
It is useful to expore these particular examples since the isolation and culture of 
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mESCs and hESCs are arguably pivotal moments in stem cell research, and an 
understanding of how social and political factors influence such key research may 
help to influence policy in the future. 
Another question queries the importance of cell fate in stem cell studies.  As 
mentioned in Chapter 1, Haeckel’s Stammzelle concept emerged out of the 
importance of potential: in the fertilised egg was the potential to develop into an 
entire being, including all of the specialised cells, tissues, and organ systems required.  
Cell lineage, or cell fate studies also became a focal point of research in early 
twentieth-century USA, as previously highlighted by Maienschein.   Utilising cell fate 
research to learn more about stem cells also appears through Chapter 2, particularly 
via the discipline of heredity and genetics (see also below).  Chapter 3 in particular 
demonstrates the importance of cell fate studies, not only for ESC studies, but in CSC 
studies as well.  Throughout this chapter, comparisons between normal and abnormal 
cell fate appear in much of the research carried out, ultimately demonstrating the 
influence of identifying parallels between non-pathological and pathological growth 
and development.  This is followed in Chapters 4 and 5, as Martin and Evans utilise 
the ability of ESCs to vary their cell fates in their different research projects through 
the 1980s, and Gearhart’s and Thomson’s knowledge of cell fate directs their 
approach to isolating hESCs in the 1990s.  Lastly, in Chapter 6, the importance of 
differentiation ability, or the ability to change cell fate, becomes particularly 
important for developing our understanding of stem cell properties.  In the late 
twentieth century and early twenty-first century, it has become apparent that cell fate 
is not a one-way street (as proposed, for example, by Conrad Hal Waddington [1905-
1975]).  Instead, it has been shown that cell fate is significantly more flexible than 
previously thought, leading to the distinct possibility that cells can move into and out 
of a stem cell state throughout their lives.  Cell fate and cell fate research have not 
previously been considered in the context of ESC research in this detail.  This thesis 
especially focuses not only on cell fate itself, nor only on cell fate research, but a 
combination of both.  This is important since it demonstrates how theory impacted on 
practice (i.e. how ideas about cell fate impacted on research into cell fate).  The lack 
of current research into the link between cell fate research and ESC research is 
unacceptable, since this thesis shows that each affects the other.  Therefore, a history 
of one is incomplete without a history of the other.  Cell fate is also an important 
INTRODUCTION  38 
 
concept in the development of the stem cell concept, and the impact this has on 
paradigms such research is carried out under (see below). 
Lastly, the thesis asks about the importance of paradigms in ESC research, in 
particular the genetics paradigm and the stem cell entity paradigm.  As the idea of the 
stem cell was evolving in the nineteenth century, it became entwined with the notion 
of potentiality; this was perhaps why Haeckel believed that an additional term was 
required, rather than ‘fertilised egg’.  Haeckel’s Stammzelle was initially the first 
unicellular organism, from which all other life could evolve.  Shortly after, Haeckel 
also referred to the fertilised egg as the Stammzelle, since it had this potential for 
creating an entire organism.  Part of this potential however was to make use of those 
traits inherited from both the mother and father in the creation of an entirely unique 
individual.  Chapter 2 focuses on the genetics paradigm in stem cell research, and 
how both the study of embryology and heredity were developing through the late 
nineteenth and early twentieth centuries, becoming the discipline of genetics in the 
later twentieth century.  As this was occurring, so was the expanding science of stem 
cell research; just as the structure of DNA was becoming understood in the mid-
twentieth century, so were stem cells being isolated and available for experimentation.  
This led to the two disciplines developing together, arguably with the application of 
genetics influencing much of stem cell research through the late-twentieth and into 
the twenty-first centuries.  For example, as in Chapter 4, Evans made use of the 
understanding and application of genetics to his mESCs, resulting in production of 
genetically modified mice; this was considered such an achievement that Evans and 
his colleagues were awarded a Nobel Prize.  Chapter 6 also demonstrates how 
important genetics has become to biological science; a particular section of this 
chapter explores the efforts made by some researchers to find genetic markers of stem 
cells.  Genetics, by the late twentieth century, had become so crucial to biology that 
cells were becoming defined based on their genetic profiles.  It was a natural 
development from this to find such a genetic profile for stem cells then.  Despite the 
efforts of several groups, obtaining a particular genetic profile for stem cells has not 
been achieved.  This failure to obtain what has become so fundamental to our concept 
of cell type has been a contributing factor to our doubting whether stem cells are 
entities at all.  Although the genetics paradigm of the twentieth century has been 
written about several times previously, it has not often been considered specifically in 
the context of embryonic stem cell research (although there are of course links to 
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embryology and development).  It is important to investigate the specific effect of the 
genetics paradigm on stem cell research as arguably, stem cell research is a significant 
discipline of the late twentieth and early twenty-first centuries.  Since so much of the 
experimental design is carried out under the genetics paradigm, its effect on stem cell 
research is essential to explore.  Moreover, the additional exploration of the stem cell 
entity and stem cell state views is also important for future experiment design.  This 
thesis argues that most (if not almost all) stem cell research has been carried out under 
the assumption that stem cells are entities; if, as this thesis argues, stemness is a state, 
it will require scientific researchers to change their appriach to stem cell research, and 
may allow us to learn more, and better understand the properties that can both cause 
us harm (as in cancer), or provide hope for treatment (as in bone marrow transplants). 
 
 As noted above, this thesis begins with an overview of the conceptualisation 
of the stem cell, required to appreciate exactly what a stem cell is and how these ideas 
emerged.  This follows in Chapter 1.	
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CHAPTER 1: 
THE CONCEPTUALISATION OF CELLS, AND THE 
EMBRYONIC STEM CELL 
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1. Introduction 
 The overarching aim of this chapter is to demonstrate how the term ‘stem cell’ 
came about in German (Stammzelle), then English; and in particular, how did the 
concept of an ‘embryonic stem cell’ come to light?  This includes examination of the 
earliest definitions, and contexts of the term’s use.  To achieve this, four smaller goals 
are sought.  Firstly, how biologists came to understand what a ‘cell’ was, and how 
they are created.  Secondly, how biologists connected the cells observed in the early 
embryo to those in the adult.  Once the idea of a ‘stem cell’ was in place, how did this 
concept fit into existing ideas, particularly regarding development?  Lastly, what were 
the different research directions in early-twentieth century USA and Europe, and how 
were these affected or influenced by the concept of an embryonic stem cell? 
 In order to achieve this aim and answer those questions set out above, this 
chapter will begin with a consideration of nineteenth-century European biology, with 
a particular focus on Germany; this includes some examination of the political 
environment of the era, especially how international politics affected the reception of 
work and ideas from various research groups.  Heavily influencing cell biology of the 
nineteenth century, Theodor Schwann’s (1810-1892) Cell Theory will be considered, 
including Schwann’s influences, and the role of Cell Theory in understanding 
multicellular organisms.  Since Schwann’s Cell Theory was refuted relatively soon 
after publication, it is also important to consider why and how the supposed ‘unifying 
theory’ of biology was debunked.  Since this thesis has a focus on embryonic stem 
cells, it is also useful to examine the state of embryology during the nineteenth 
century, and what was understood about early development.  This includes the theory 
that the egg was a cell, and identifying that cells of the early embryo were analogous 
to the cells of the adult. 
 In addition to an examination of nineteenth-century biology, it is also useful to 
consider the use of language and its connotations when querying the origins of ‘stem 
cell’.  The first individual to publish the term Stammzelle was Ernst Haeckel.  
Understanding how Haeckel came up with the term, and how it became the dominant 
term from a pool of other phrases, is also useful in developing an understanding of the 
concept of the stem cell. 
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 Lastly, the chapter will consider what was occurring in early twentieth century 
stem cell research, since there appears to be a difference in research direction 
regarding cell biology of this period, with USA researchers more interested in 
developing an understanding of cell lineages.  In addition, the movement of several 
researchers from Germany and Russia to the USA had a general effect on publication 
language, as well as research interests in different regions.  Examination of this will 
aid in further understanding of the embryonic stem cell concept. 
 
2. Early studies in embryology and development 
2.1 Earliest theories 
 Through the seventeenth century, observations into embryology were made by  
anatomists Hieronymus Fabricius ab Aquapendente (1537-1619) (De formatione 
foetus, 1604), William Harvey (1578-1657) (Exercitationes de generatione 
animalium, 1651), and physician Marcello Malpighi (1628-1694) (De formatione 
pulli in ovo, 1673) for example. 
Italian physician Marcello Malpighi demonstrated that the microscope was 
useful for embryology, anatomy, and physiological studies, greatly extending 
knowledge regarding structure and function of the human body.  Malpighi’s work was 
known not only in Italy, but was popular with the Royal Society in England58.  
Another member of the Royal Society, Robert Hooke (1635-1703), developed his 
microscope in the 1660s, writing a book, Micrographia (1665), based on his 
observations.  Amongst items described in Micrographia is cork, which Hooke 
described as comprising “cells” or “little Boxes”59, comparing them to the ‘cells’ of 
monasteries, where monks would sleep. 
A significant discussion of the seventeenth century was between the ovists and 
spermists.  In 1678, Dutch textile merchant-turned microscopist, Anthoni van 
Leeuwenhoek (1632-1723) identified spermatazoa.  Leeuwenhoek, and those who 
followed his work, believed that the sperm was the germ, considering the egg a nest 
required for ‘hatching’.  The opposing belief was that the egg was the true germ.  The 
ovists (or ovulists) believed that the sperm were relatively insignificant60. 
																																																								
58 Lancaster, 2014 p 29-30 
59 Hooke, 1665. 
60 Harris, 2000. 
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A second discussion point of the period concerned the epigenesists and the 
preformationists.  The epigenesist argument was that the development of an egg or 
embryo was an entirely new construction or creation.  The preformationists argued 
however that embryonic development was akin to a flower bud unfurling: the embryo 
was preformed.  As Harvey remarked in Exercitationes de generatione animalium, 
“the vegetal primordium whence the fœtus is produced...pre-exists”61.  This latter 
approach was favoured by noted microscopists Malpighi and Jan Swammerdam 
(1637-1680), as well as Albrecht von Haller (1708-1777) and Charles Minot (1852-
1914)62. 
 
2.2 Experiments in development (to 1800) 
 Neither the epigenesis/preformation nor ovist/spermist debates were resolved 
in the seventeenth century; little was achieved in the eighteenth either.  It is likely that 
this is due to the lack of experimental progress that was made in embryology, which 
in turn is a demonstration of slow technological progress during this period.  This 
said, some researchers were still concerned with developmental biology, however no 
works really surpassed the excellent studies carried out by Malpighi a century prior.  
One individual who did concern himself with embryology was Haller, who in the 
mid-1700s, carried out dissections on animals post-mating.  Focusing on larger 
mammals, such as sheep, Haller would claim that he could see nothing for the first 
fortnight post-mating, and that only a fluid substance could be observed in the uterus.  
This fluid, Haller claimed, ‘curdled’ (gerinnen)63, forming the embryo.  Haller’s 
conclusions were considered to be plausible and the most reliable explanation, leading 
his theory to be taught in universities across Europe through the late eighteenth 
century64.  There was an opposing theory available however.  In 1797, Scottish 
anatomist William Cumberland Cruikshank (1745-1800) published observations he 
had been making since the 1770s.  Cruikshank dissected rabbits after mating.  He 
reported seeing ova three days post-mating in the oviducts, and four days post-mating 
in the uterus.  Cruikshank made significant numbers of observations which were 
eventually published in the Philosophical Transactions of the Royal Society; Sarton 																																																								
61 Harvey, 1847 p 465. 
62 Harris, 2000. 
63 Translation by Sarton, 1931. 
64 Harris, 2000. 
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suggested however that there was such faith in Haller’s theory that Cruikshank’s work 
was given little consideration65. 
 
2.3 Fertilisation to embryo (1800-1840) 
 Formation of the chick embryo had been studied for centuries; one of the 
earliest works describing such observations is De generatione animalium by Aristotle.  
Despite this, no connection had been made between early embryonic development 
and (what we now understand to be) cells.  So far, there was also no evidence to show 
that there was any correlation between the embryonic development of mammals and 
the development of birds, for example. 
 Jean Louis Prévost (1790-1850) and Jean Baptiste Dumas (1800-1884) 
described the furrowing of frog eggs after treating them with fluid expressed from 
frog testicles66.  For them, the segmentation occurred only after fertilisation.  
Although initially they only appear to describe the changes at the surface, their 
comparison of the dividing egg to a raspberry suggests that Prévost and Dumas 
understood that this was not only a surface phenomenon. 
 Mauro Rusconi (1776-1849), whilst at the University of Pavia, built on the 
work of Prévost and Dumas, describing in detail the ‘segmentation’ of the egg post-
fertilisation.  Rusconi carefully described ‘furrows’ on the surface, which he observed 
to eventually result in division and subdivision, creating ever-smaller units.  
Rusconi’s comprehensive descriptions (and significant experimental detail) indicate 
that he clearly understood the process that was occurring67.  For instance, after these 
first subdivisions, Rusconi described the development of une masse granuleuse.  
Rusconi published his observations in 1834, although he had started his studies in 
1826.  Like Prévost and Dumas, Rusconi also made it clear that he believed 
segmentation occurred post-fertilisation; in Karl Ernst von Baer’s (1792-1876) work 
(which mostly ignored Rusconi’s findings), he theorised that the segmentation 
previously described by Prévost and Dumas occurred before fertilisation.  von Baer 
believed this process occurred in order to give all parts of the egg access to the sperm. 
 
 																																																								
65 Sarton, 1931. 
66 Prévost and Dumas, 1824. 
67 Harris, 2000. 
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2.3.1 Identification of ‘embryonic cells’ 
 English physician Martin Barry (1802-1855) was the first to identify the 
individual cells of the early embryo, comparing them to cells of the adult.  In three 
papers titled Researches in Embryology published in 1838, 1839, and 1840 in the 
Royal Society’s Philosophical Transactions, Barry described the mature egg, 
fertilisation, and the early development of the mammalian embryo in a fashion that 
makes it clear he believed that the subdivision of the fertilised egg was equivalent to 
cells observed and described in adults. 
 In Researches in Embryology: First Series (1838), Barry began with a brief 
history, considering Regnier de Graaf’s (1641-1673) theory that the ovum existed pre-
formed in the ovary, and Haller’s opposition68.  Later, Cruikshank would support de 
Graaf’s theory, but lacked the evidence to be taken particularly seriously.  Evidence 
was collected by Prévost and Dumas, and later von Baer (as noted above).  Barry 
himself went to Germany to work with Johannes Müller (1801-1858) and his students 
to learn about animal development and microscopy (see section 3).  The skills Barry 
learned enabled him to dissect and section mammalian ovaries; the First Series 
described his observations regarding ova development, maturation, structure and size.  
Barry believed that the germinal vesicle was formed first. 
 The Second Series (1839) focused on development of the ovum, tracing the 
early stages of development.  Barry noted that there was still a “dark period” (between 
mating and appearance of vertebrae) in mammalian development - little was 
understood regarding this time, and Barry aimed to shed some light69.  To help him, 
Barry used rabbits (although one of the carefully drawn figures also includes the 
ovum of a tiger!).  Barry claimed to have examined hundreds of ova, both through 
dissections and preserved samples, carefully measuring and drawing what he saw.  
The figures in Barry’s paper clearly reflect this attention to detail. 
																																																								
68 Here, it is likely that Barry is referring to Haller’s earlier views.  As a student, Haller 
followed the teachings of Herman Boerhaave (1668-1738), whose lectures he attended in 
Leiden (1725-1727); Haller therefore supported preformationism, with a bias towards the 
male.  In the 1740s, Haller switched his allegiance, believing that the epigenesis theory was 
the more likely explanation.  Haller changed his mind for a third time however, having 
carried out work on chicken eggs.  For the latter years of his life, Haller became an ovist 
preformationist.  This suggests that Haller would have supported de Graaf’s theory that the 
ovum exists pre-formed in the ovary. (For a more detailed discussion of Haller’s thoughts on 
embryology, see Roe, 1975.) 
69 Barry, 1839 p 307. 
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 Barry described his stages of development in intricate detail alongside his 
figures.  For example, in the sixth stage of development, Barry described the second 
set of cell divisions: 
 
“The centre of this fluid was occupied by four large vesicles. These vesicles were 
spherical, but somewhat flattened…Some of these vesicles presented in their 
interior a minute pellucid space, which may possibly have been a nucleus”70. 
 
A note with the figure suggested that Barry observed a nucleus in all similar vesicles 
he observed.  The seventh and eighth stage resulted in more vesicles, although 
smaller.  By the ninth stage, Barry stated that the small vesicles hung together like a 
“mulberry”71.  At the tenth stage, there were even more vesicles, and within each was 
“an object resembling the ‘germinal vesicle-like nucleus’ observed by Valentin in 
‘globules’ from various parts of the nervous system”72.  Here then, Barry is clearly 
indicating that what he is seeing in the developing embryo can be directly compared 
with the adult cells observed73.  By doing this, Barry is establishing that what he sees 
at the embryonic level is analogous to the ‘subunits’ of adult animals74.  Although 
Barry refered to ‘vesicles’ as opposed to cells, I do not think this is particularly 
significant; the term Zellen only came into common use following publication of 
Theodor Schwann’s (1810-1882) 1839 monograph popularising Cell Theory (see 
below).  Prior to this, ‘vesicle’ was a term used to describe what we would now 
consider to be ‘cells’ (in both plants and animals). 
 Carl Bergmann (1814-1865), whilst working as Rudolf Wagner’s Assistent in 
Göttingen, would also describe furrows in a similar fashion to Prévost and Dumas.  
Bergmann’s work studying the eggs and embryos of newts in the late 1830s and early 
																																																								
70 ibid p 323. 
71 ibid p 324. 
72 ibid p 324-5. 
73 Barry is referring to Gabriel Gustav Valentin (1810-1883), a German physiologist, known 
particularly for his descriptions of cells in nervous tissue. 
74 A further indication that Barry understood the ‘vesicles’ of the early embryo as those which 
would become the ‘vesicles’ of adulthood is in the discussion of methods.  Barry utilised the 
most modern techniques available for his observations, which were primarily histological 
methods.  For example, in the Second Series paper, Barry described using ‘kreosote water’ for 
preserving ova.  This is a solution Müller had shown to Barry, which he used to preserve 
tissues of the nervous system.  Barry must have believed that the ‘substance’ of the ovum 
must be similar to the ‘substance’ of nervous tissue to believe that Müller’s kreosote water 
would be as useful for preserving ova as it was nervous tissue. 
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1840s made him conclude that the ‘furrows’ observed were cell divisions, and that 
these cell divisions gave rise to the cells of the embryo. 
 Shortly after Bergmann’s observations were published, H. Bagge published 
his dissertation75.  In his work, Bagge claimed that the successive segmentation of the 
egg eventually gave rise to the cells of the embryo in nematode worms.  Furthermore, 
Bagge described the division of the nucleus prior to division of the cell in Ascaris.  
Professor of zoology and anatomy at the University of Königsberg, Heinrich Rathke 
(1793-1860), came to similar conclusions as Bagge, although Rathke studied other 
invertebrates.  Rathke’s work was published just a few months later in 1842.  As 
opposed to ‘furrows’, Rathke preferred the term Durchfurchung (‘cleavage’), when 
describing the segregation of the egg.  Such a term suggests that Rathke wanted to 
make clear that this was not only a surface phenomenon.  Likewise, German 
embryologist Adolf Grube (1812-1886) also used the tern Durchfurchung in his 
description of division of the fertilised leech egg76; this has been translated to 
“fissures”, leading to clear division of the fertilised egg into four blastomeres77. 
 
3. Nineteenth century biology: a review 
3.1 The cell as the basic unit of life 
“Give me an organic vesicle endowed with life and I will give you back the whole of 
the organised world.”78 
 
3.1.1 ‘Vital phenomena’ 
 Henri Dutrochet (1776-1847) is known for highlighting two fundamental ideas 
in the life sciences: the search for the identity of the vital phenomena in plants and 
animals, and his particularly materialistic view of the phenomena of life.  In achieving 
these aims, Dutrochet, following German physiologist Kasper Friedrich Wolff (1735-
1794), considered cells as physiological entities, where the most basic biochemistry of 
life occurred.  Dutrochet introduced the ideas of endosmosis and exosmosis, and 
experimental work followed; these were the first steps towards contemporary cell 
																																																								
75 Müller, 1842; Harris, 2000. 
76 Grube, 1844. 
77 Blyakher, 1955 p 520-527. 
78 Raspail, 1833 p 547. 
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physiology79.  It is possible that through his work, Dutrochet was one of the first to 
observe an animal cell, likely to have been a ganglion cell80.  
 In the mid-nineteenth century, many German anatomists were using new 
microscopy techniques to establish the structure and function of the cell.  François-
Vincent Raspail’s (1794-1878) approach however concerned cell chemistry, much as 
Dutrochet’s had done, considering cells as little laboratories.  Raspail was also a 
pioneer in microscopy, developing methods to freeze tissue samples and slice thin 
sections for microscopy; this helped Raspail in his cytochemistry work, only really 
appreciated long after it was carried out.  Harris suggested that this may have been the 
case for three reasons (none of which are related to the quality of his research): firstly, 
Raspail was a French republican, who was imprisoned on more than one occasion.  
For a ten-year period (1853-1863), Raspail lived in exile in Brussels.  In addition to 
his political beliefs being an obstacle to the acceptance of Raspail’s work, Harris 
suggested his work was ignored since Raspail eventually became interested in 
medicine and therapeutics, leaving ‘pure biology’ behind.  Lastly, Harris refered to 
the conflict between the Germans and French of the era - influential German scholars 
failed to appreciate Raspail’s contributions to cell biology and microscopy81.  This is 
an early example of politics affecting scientific belief - a theme that will be returned 
to. 
 
3.1.2 Cell Theory (1839-1855) 
The Breslau School 
 Johann Evangelista Purkyně (1787-1869) was a Czech-born scholar working 
in Germany.  The war between Germanic and Bohemian peoples in the seventeenth 
century had resulted in increasing Germanisation of the Bohemian peoples, including 
the Czechs.  The Bohemian peoples were considered second-class citizens, regardless 
of the continued Germanisation of the region through the eighteenth century.  Such 
Germanisation included academia - the University of Prague, founded in 1348, 
although open to Czechs, Poles, and Germans, was an entirely German-speaking 
establishment by the mid-eighteenth century.  The Kulturkampf of the mid-nineteenth 
century saw the rise of an educated middle-class who identified as Czech - Purkyně 																																																								
79 Harris, 2000 p 28-9. 
80 ibid. 
81 ibid. 
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was one such individual.  Purkyně attended the University of Prague and became 
chair of pathology and physiology at the University of Breslau (Wroclaw) from 1823 
(before returning to Prague in 1859, as professor of anatomy and physiology).  
Purkyně, the Czech, however was given less consideration than his German 
colleagues, due to his ethnic background; Purkyně also occasionally published in 
Czech, greatly reducing the readership for his work.  This said, Purkyně established a 
following - a ‘school’ - at Breslau. 
 Breslau, founded in 1811, was known for its rivalry with the University of 
Berlin, founded a year prior82.  Purkyně’s counterpart at Berlin, Johannes Müller, 
established his own school.  Purkyně was in the midst of nineteenth-century German 
biology, at a university with high-standing, and able to participate in ongoing debates 
with Berlin scientists.  Müller occupied a more dominant position in German biology 
at the time however (given Purkyně’s Bohemian roots), and it was predominately 
Müller’s theories that became popular83. 
More recently, closer study has revealed the importance of Purkyně’s work, 
even if it was only selectively noted by Müller and his students.  Harris suggested that 
in fact it was Purkyně who was the pioneer of Cell Theory84; evidently, Harris was 
not alone.  In his 1828 publication Über Entwickelungsgeschichte der Thiere, von 
Baer concluded that Purkyně had already exhausted the topic85. 
Unlike the prolific publication of Müller and his students, much of Purkyně’s 
school’s works were recorded in theses, reports, and lectures.  Theses of Purkyně’s 
students reveal that Breslau scholars were interested in animal tissue and cell 
structure, made comparisons between animal and plant tissue, and identified the cell 
nucleus.  Purkyně’s term for the cell at the time was Körnchen (i.e., a granule), a term 
that was supposed to draw focus onto the interior of the cell86.  The Breslau school 
were known for their significant contributions to microscopy, leading some to dub 
Purkyně’s laboratory as the ‘cradle of histology’87. 																																																								
82 Although Berlin was known for being an innovative university, it is likely that this is due to 
state pressure, rather than enlightened faculty.  Weindling, 1981. 
83 Harris, 2000. 
84 ibid. 
85 von Baer, 1828. 
86 The slightly later term Zellen, preferred by Schwann and popularised by Schwann’s Cell 
Theory, suggested an empty bag, focusing on the outer membrane and wall of cells.  Schwann 
however identified his Zellen and Purkyně’s Körnchen to mean the same object. 
87 Heidenhain - in Harris, 2000 p 91. 
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 Gabriel Gustav Valentin (1810-1883) was a student of Purkynĕ, whose work 
focused on tissue and cell structure, as much of the work at Breslau did.  Valentin was 
a significant individual, whose work on comparing animal and plant cells pre-dated 
Schwann’s by a few years; the Insitiut de France published Valentin’s first paper on 
the topic in 1834.  Valentin wrote about his observations in greater detail in work 
published in 1836; clearly prior to Schwann’s published monograph of 1839.  Whilst 
Schwann acknowledged Valentin’s work, the comparisons made between plant and 
animals cells were dismissed as brief observations of morphology88 (see below). 
 
The Berlin School 
 Müller, finding himself “somewhat limited” at the university in Bonn, took the 
unusual step of ‘applying’ for a vacant role at the University of Berlin in 1832.  Carl 
Asmund Rudolphi, the professor of anatomy and physiology at Berlin (and, 
incidentally, Purkyně’s father-in-law), had died in November 1832.  Seeing an 
opportunity, Müller wrote to Moritz Seebeck (1805-1884), the minister responsible 
for finding Rudolphi’s replacement89; despite the unusual approach (it was not typical 
for individuals to put themselves forward for such jobs), Müller was deemed a 
suitable candidate and was offered the professorship.  Müller’s situation at Berlin was 
unusual for another reason: he had no physical laboratory.  Instead, he and his 
students would work in small rooms, niches, and guesthouses, either privately owned 
or around the university90.  Despite this hindrance, Müller was fanatical about his 
work, sometimes spending up to ten hours at a time at the microscope, fuelled by 
coffee.  He would have trouble sleeping, and is known to have had at least five 
depressive episodes during his lifetime, and possibly committed suicide91; perhaps the 
hallmarks of a man with bipolar (‘manic’) depression. 
 Müller’s text Handbuch der Physiologie des Menschen (1833) was considered 
to be the ‘go to’ source for human physiology throughout the nineteenth century.  
Müller, as well as being an excellent scholar in his own right, trained a school of 																																																								
88 Harris, 2000. 
89 Since German universities were state-funded, the state made appointments.  Faculties were 
encouraged to make recommendations, but the state had ultimate authority.  Weindling, 1981. 
90 Weindling, 1981; Otis, 2007.  Although the state had a very reasonable budget for 
universities, the ongoing development of institutes and rising student numbers put some 
pressure on university funding.  Many professors believed that their facilities were 
inadequate; Műller perhaps was an individual for whom this gripe was justified! 
91 Otis, 2007. 
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microscopists and experimentalists whose aim appeared to be the mapping of the 
entire human body at the cellular level92.  Jakob Henle (1809-1885) was Müller’s first 
(and possibly favourite) student.  Theodor Schwann was another of Müller’s Berlin 
students, completing his doctoral dissertation in 1834, and becoming assistant to 
Müller until 1839 - the period he was developing his Cell Theory93.  Henle’s work 
under Müller referred occasionally to the work of Purkynĕ, however would highlight 
Purkynĕ’s archaic terminology94. 
 
Körnchen or Zellen? 
 Around the time Schwann was developing his Cell Theory, the Purkynĕ 
school were also developing their theories in cell biology.  Schwann was not the only 
individual at the time who was working towards identification of similarities between 
plant and animal cells.  Publishing Ueber die Analogien in den Struckturelementen 
des Thierischen und Pflanzlichen Organismus in 1840, Purkynĕ described several 
analogies between plant and animal cells.  There was a significant difference between 
the two however, according to Purkynĕ.  When referring to animal cells, Purkynĕ 
used the term Körnchen.  Plant cells however were Zellen.  This implied that Purkynĕ 
did not see plant and animal cells as analogous at all95.  The use of Zellen for plant 
cells suggests Purkynĕ saw them as mostly fluid, although he did describe solid parts 
attached to a more solid cell wall.  This refers to a focus botanists had with the plant 
cell wall at the time.  Conversely, Körnchen were considered to be solid throughout, 
or rather, the term would draw attention to the interior - in animal cells this was 
considered to be more important that than the outer cell membrane.  Furthermore, 
Purkynĕ suggested that in his attempt to find a unifying theory, Schwann relied too 
heavily on Matthias Schleiden’s (1804-1881) plant observations, stating that Schwann 
should not have applied so much of Schleiden’s plant work to animal cells. 
 The most likely reason for Zellen becoming the most popular term (as opposed 
to Purkynĕ’s Körnchen) is the popularity of Schwann’s text.  The popularity of 
Schwann’s monograph meant that it became particularly influential; Purkynĕ’s work 																																																								
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95 This difference between animal and plant cells had been noted significantly earlier; 
Leeuwenhoek for example referred to 'free cells' (those without cell walls), and 'animacules' 
in the 1670s.  Magner, 2002; Lancaster, 2014. 
CHAPTER 1  52 
 
was never likely to be as successful as a German’s work during the nineteenth 
century.  Harris also claimed that Purkynĕ’s work was occasionally misinterpreted.  
For example, Karl Bogislaus Reichert  (1811-1883) (a student of Müller), considering 
Purkynĕ’s Körnchentheorie, mistook Körnchen for ‘nuclei’, leading him to dismiss 
Purkynĕ’s account of cell development96.  Instead, Reichert promoted Schwann’s 
Zellentheorie.  Reichert referred to this again in other papers written during his career, 
particularly in the influential journal Müller’s Archiv, propagating the error and 
encouraging others to follow suit.  As previously noted, Schwann’s work became the 
basis of Cell Theory, whilst Purkynĕ’s theories were considered incorrect and 
insignificant.  There seems to have been little resistance to the use of Zellen to 
describe all cells, since even Purkynĕ’s students are known to have used the term97. 
 
The botanist’s contribution to Cell Theory 
 Matthias Schleiden (1804-1881) is particularly noted for his work that 
contributed to Cell Theory; he is also known to have made some significant 
observations regarding the nucleus and nucleolus.  The attitude Schleiden had, which 
would be unacceptable today, was to not refer to those who had previously made 
similar observations.  For example, in his description of the nucleus, Schleiden noted 
that he is not the first to observe it, but never mentions who influenced his work.  In a 
further example, when Schleiden wrote about the nucleolus of plant cells, he 
neglected to say that Rudolf Wagner (1805-1864) had actually described it three years 
previously98.  Occasionally this has the effect of leaving the reader wondering where 
previous work concluded and where Schleiden’s began. 
 Schleiden’s significant contribution to Cell Theory was regarding the nature of 
the nucleus.  Schleiden, renaming the nucleus the ‘cytoblast’, believed that the role of 
the nucleus was to generate the rest of the cell, and that once this had been achieved, 
the nucleus was dispensable99.  Schlieden described the process of cell generation 
beginning in the Kern, and the membrane of the new cell emerging from the 
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cytoblast; in his Cell Theory, Schwann would also decribe this process in animal 
cells100. 
 
The zoologist’s contribution to Cell Theory	
 Schwann, a loyal Müller-trained scholar of the Berlin school, is well-known 
for his contribution to Cell Theory.  In order to better understand Schwann’s 
contribution to Cell Theory, Ohad Parnes has closely examined the available 
notebooks of Schwann, written between 1836 and 1838.  Although these are not 
complete101, Parnes shows how these notebooks can offer some insight into 
Schwann’s approach.  Regarding Cell Theory, Parnes stated that despite the time 
period over which these notebooks were written, they offer no clear declaration that 
Schwann was embarking on a quest to find any elementary ‘building block’ of both 
animals and plants, despite a perception that this is what Schwann was setting out to 
do102.  Instead, Parnes added, Schwann’s notebooks appear to be “documentation of a 
persistent and consistent attempt to make sense of life in terms of causal agencies”103.  
Instead of using observational techniques (such as microscopy) to simply look for 
similarities between plant and animal life, it should perhaps be the case that Schwann 
should be equally well-known for his contribution to scientific methodology; Parnes 
claimed that Schwann’s late 1830s work was aimed at introducing new experimental 
design into physiological studies.  Through these new methods, the causal relationship 
between the specific agents required to produce specific physiological phenomena 
could be found104.  This prevented ‘vital forces’ being resorted to as an explanation 
for physiological occurrences.  The question we should actually be asking then, 
Parnes highlighted, is not where Schwann conceived of the idea that a cell was a 
fundamental building block, but where did he get his motivation for changing the way 
physiological research was carried out105? 
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 Parnes began his investigation into Schwann’s motivations by claiming that 
Schwann was preoccupied with the “foundations of physiology”106; perhaps this is 
where previous errors have been made, assuming that such a ‘foundation’ was the 
search for unity.  Schwann’s first step appears to have been “banishing the question of 
the seat of the mind from physiology”107; this enabled one to resist any temptation to 
opt for ‘vital phenomena’ as an explanation for physiological phenomena, and 
required instead an account based on causal relationships.  Schwann began this work, 
according to his notebooks, by studying muscle contraction, then stomach digestion; 
each of these projects should, Schwann reasoned, enable him to identify the causal 
agents involved, if he could get the experimental design correct.  For his digestion 
experiments (carried out between 1835 and 1836), Schwann was keen to understand 
the Wesen (essence) of the digestive process; prior to Schwann’s work, whilst the 
process was understood as a chemical reaction, it was belived that a ‘vital 
environment’ was needed for this reaction to occur108.  A few months of experiment 
demonstrated to Schwann that this was not the case; instead, an enzyme was the 
responsible causal agent, which he named ‘pepsin’. 
 These experiments that Schwann carried out in the mid-1830s, are, Parnes 
argued, vastly important for modern experimental research in the life sciences; the 
epistemological step that Schwann took enabled researchers to characterise specific 
physiological causative agents (which could not have been found through previous 
methods, that relied on observation or chemical precipitation, for example)109.  It was 
this approach to work in the life sciences that would elevate biology (to be considered 
alongside other sciences), since it took its methodology from chemistry and physics.  
Again, this “epistemological step”110 is Schwann’s ‘unifying’ achievement in 
physiology, not Cell Theory per se. 
 To really test his new approach to physiology then, Schwann needed to move 
beyond experiments on single systems (such as muscle contraction or stomach 
digestion); Schwann had to show that this methodology could be applied to all 
physiological processes in all creatures.  To this end, he moved onto the study of 																																																								
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respiration, and designed an experiment through which he could demonstrate that 
infusoria (mirco-organisms) required a specific agent in air to be able to respire.  
Schwann heated the air to destroy the agent, and found that the infusoria could not 
live under these conditions111.  Between 1835 and 1837 then, Schwann had carried out 
several experiments that demonstrated the usefulness of his new methodology. 
 In February 1837, Schwann’s notebooks reveal that he was carrying out 
fermentation experiments (showing that yeast was the agent of alcohol fermentation, 
for example).  Schwann identified yeast as a microscopic plant, arguing that the actual 
place where fermentation took place to be within the ‘globules’ (cells); Parnes argued 
that the construction of plants appeared to be made-up of these ‘globules’ was a 
generally accepted view, however Schwann was the first to identify that a 
physiological process was occurring inside such a structure112. 
 In 1879, Schwann claimed that it was Schleiden who inspired his intellectual 
curiosity into cells.  Schlieden, Schwann claimed, was telling him about the role of 
the nucleus in development of plant cells113; it struck him that he had observed similar 
structures in the notochord.  “I grasped the extreme importance that my discovery 
would have if I succeeded in showing that this nucleus plays the same role in the cells 
of the notochord as does the nucleus of plants in the development of plant cells”114.  
Parnes’ reviews of Schwann’s notebooks from the time however suggest that 
Schwann’s recollection of his inspiration may have been written through the rose-
tinted glasses of hindsight.  Instead, Parnes argued that Schwann’s conception of cells 
(as in Cell Theory) was not based solely on simple observation.  Instead, Schwann 
had realised from his conversation with Schleiden that the nucleus might be the 
causative agent of cell generation115.  This would explain why Schwann rejected 
Valentin’s prize-winning work of 1834, suggesting that it was simply observational 
and descriptive; Schwann was looking for something more than similarity of 
morphology.  According to Harris, Schwann argued that such was not good enough to 
aid in the quest for a general law116. 
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 Schwann proceeded to examine how the nucleus was able to generate new 
cells in animals; his tissue of choice was the branchial cartilage of frog larvae.  This 
work was carried out in the first half of 1838 and, Parnes claimed, became the first 
part of Schwann’s volume Mikroskopische Untersuchungen über die 
Übereinstimmung in der Struktur in dem Wachstum der Thiere und Pflanzen, 
published in 1839.  Schwann concluded in his notebook from early 1838 however that 
the observation of cells with nuclei in the frog larvae was not enough; “If rigorous 
proof could be delivered, that in the animal body there exist corpuscles analogous to 
the plant cell, then we could parallel these two and then we could consider the 
generation of animal organisation as nothing other than a modification of plant 
organisation”117.  Schwann continued with this thought: in order for the parallel to be 
confirmed, then he needed to show firstly that the structures he observed in the frog 
larvae were cells, and secondly that the functions, such as “nutrition and growth”, also 
occurred in a similar manner118. 
Following this, Schwann constructed what Parnes referred to as the second 
part of Mikroskopische Untersuchungen, which was drafted in mid-1838.  Here, 
Parnes argued, Schwann begins to move on from observing the similarities between 
plant and animal cells, to describe similarities in processes119.  Again apparently 
inspired from the previous conversation with Schlieden, Schwann’s notebooks reveal 
his investigation into the processes of cell generation, where the membrane of the new 
cell would develop inside the old cell, emerging from the nucleus.  Schwann’s study 
of the process in animal cells provided a functional link between plant and animal 
cells. 
The third and final part of Mikroskopische Untersuchungen, as Parnes 
interpreted Schwann’s work, was carried out at the end of 1838, and in January of 
1839; it also summarised the work Schwann carried out previously, such as the 
muscle contraction and digestion experiments from preceding years.  Now that 
Schwann had shown that cells were the fundamental units of animals (just as they 
were in plants), and that processes were carried out inside these cells (such as the 
yeast metabolism observation), Schwann could now re-interpret the results of his 
previous work in light of his new concept. 																																																								
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“We have seen that all organized bodies are composed of essentially similar parts, 
namely cells; that these cells are formed and grow in accordance with essentially 
similar laws; and, therefore, that these processes must, in every instance, be brought 
about by the same powers.”120 
 
Schwann continued to highlight the ability of cells to change – that is, to differentiate 
and specialise, through ‘chemical alteration’; Parnes interpreted this as making “the 
specific out of the non-specific”.  Through these processes, cells, Schwann argued, 
demonstrated themselves to be the “fundamental, force-exerting principles of life” – a 
series of processes caused by specific agents121. 
 
Response to Cell Theory 
 Following publication of his monograph, Schwann was offered a chair at 
Louvaine, which coincided with a change in his research focus.  There are two 
prominent hypotheses for why Schwann may have stopped working on Cell Theory.  
The first is that it jarred against his Catholic beliefs too much for him to be able to 
reconcile his faith with his research.  God was supposed to have created all life (from 
nothing), yet Schwann’s work had shown that spontaneous generation was not an 
adequate theory for explaining cell formation.  How could Schwann believe in both 
the Catholic doctrine that God created all life, and that cells could not be created 
through spontaneous generation?  Schwann’s uneasiness can be observed in his letters 
to the Archbishop of Malines (the primate of Belgium).  The archbishop replied to 
Schwann’s letter, stating that he had no concerns with his work; we have no record of 
how much this eased Schwann’s conscience however.  The second theory offered by 
Harris suggested that Schwann gave up Cell Theory simply because he knew it was 
incorrect and chose to remain quiet on the topic122!  This would explain how swiftly 
Schwann gave-up his work in cytology and development once he moved to Louvaine.  
It may also explain why Schwann’s Cell Theory was disregarded within a decade of 
Schwann’s Mikroskopische Untersuchungen being published123.  
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 Following the criticisms of Cell Theory after publication of Schwann’s 
Mikroskopische Untersuchungen, Schleiden also became less dogmatic in his own 
works regarding Cell Theory124.  This is not to say that Cell Theory was discounted 
entirely however.  Cell Theory provided Berlin in particular (but cytology in general) 
the opportunity to unite anatomy, physiology, botany, and zoology into the latter 
decades of the nineteenth century, and into the twentieth.  This also maintained the 
organicist view, held particularly in German universities, through the nineteenth 
century.  Professors of this era were concerned with ‘the totality of man’s nature’, and 
believed that the state’s attempts to hire chairs in many specialties undermined the 
organicist approach125. 
 
The end of Schwann’s Cell Theory 
 Harris suggested that Schwann’s Cell Theory caused significant confusion for 
embryologists in the ten years following its publication; embryology became split into 
two schools: those who agreed with Schwann (and who tried to make their 
observations fit with Schwann’s Cell Theory), and those who did not (whose work 
was interpreted to go against Schwann’s doctrine wherever possible)126.  Despite its 
theoretical errors, Schwann’s monograph was still a useful piece of work for its 
histology and admirable aim.  Since at its core the book held the Cell Theory 
however, Schwann’s monograph was eventually considered to be wholly 
misleading127. 
 In 1855, Polish German embryologist Robert Remak (1815-1865) published 
his book on embryology: Untersuchungen über die Entwicklung der Wirbeltiere.  
Remak’s observations clearly showed the egg membrane and what was occurring 
during the first few cell divisions – available through Remak’s pioneering work on 
histological techniques.  Remak identified that all animals consisted of nucleated 
cells, and that each nucleus was descended from the first nucleus (created when the 
egg was fertilised), by cell division128.  Technical advances finally allowed significant 
investigative work to begin tracing the transmission of hereditary characteristics129. 																																																								
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3.2 The egg as a cell 
Although loyal to Schwann, many of the Berlin school were not entirely 
convinced by his Cell Theory.  For example, in Allgemeine Anatomie (1841), Henle 
devoted a significant part of the second section (Die Entstehung der Zellen) to a 
critique of Schleiden and Schwann’s work.  Henle argued that although Schwann had 
attempted to unify plant and animal cells, his model was based on an analogy which 
was, as yet, unestablished.  Henle also disagreed with Schwann’s opinion that the egg 
was a cell (and the germinal vesicle was the nucleus) - Henle instead was of the 
opinion that the germinal vesicle itself was a cell130; such differences of opinion at the 
time made the mode of generation of the egg uncertain. 
 
3.2.1 Carl Gegenbaur 
 Carl Gegenbaur’s (1826-1903) parents had expected him to become a 
physician, and sent him to Würzburg University to study medicine.  However, 
Gegenbaur found himself far more interested in the natural sciences.  Gegenbaur 
became the founder of the ‘Gegenbaur school’ of comparative morphology, initially 
at the University of Jena, and later continuing the tradition at the University of 
Heidelberg131.  Building on current theories of evolution and comparative anatomy 
(previously developed by Müller), Gegenbaur insisted on a systematic approach to 
comparative anatomy: a deviation from the traditional method at the time, which was 
generally based on publishing isolated snippets of observations132. 
In 1861, Gegenbaur produced an influential work in anatomy: the cellular 
nature of the egg (Ueber den Bau und die Entwickelung der Wirbelthier-Eier mit 
partielleer Dotterbildung) in Archiv für Anatomie, Physiologie und wissenschaftliche 
Medicin.  Gegenbaur was the first to identify the egg (of mammals, reptiles, fish and 
birds) as an individual cell.  The cell as the fundamental structural unit, and the basis 
for life science, was emerging as a new approach; one that was closely followed by 
Gegenbaur and Haeckel through their careers133. 
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4. Stammzelle 
4.1 Ernst Haeckel 
 Ernst Haeckel was born in 1834 in Prussia, the second son to Charlotte and 
Carl Haeckel.  Carl and Charlotte encouraged their son’s interest in nature, as did  
Haeckel’s tutor, Karl Gude.  Early in his life, Haeckel read naturalist Lorenz Oken’s 
(1779-1851) Allgemeine Naturgeschichte für alle Stände134.  Oken’s search for a 
system to exemplify the unity of nature ultimately became a concern of Haeckel’s, 
and Oken hinted at a form of Cell Theory: another influence on Haeckel’s later 
work135.  Haeckel also read Matthias Schleiden’s 1848 Die Pflanze und ihr Leben, and 
from this he learned about development (Entwicklung [or as Haeckel elected to spell 
it, Entwickelung]), the origins of life, and the cellular composition of living things136. 
 After completing his secondary education in 1852, Haeckel found himself at 
Berlin studying medicine and natural science.  After a few months at Berlin, Haeckel 
moved to Würzburg University, where he had several fortuitous meetings that would 
influence much of his later life and work.  Firstly, the lecturer Albert Kölliker (1817-
1905), a morphologist and histologist.  Di Gregorio suggested that for Haeckel, 
Kölliker became a mentor, and they stayed in touch for many years, despite their 
differences concerning the correct approach to the natural sciences137.  Secondly, 
Haeckel met another of Kölliker's students, Carl Gegenbaur (eight years Haeckel’s 
senior, and from a similar social background), a significant influence in Haeckel’s 
early professional life.  Whilst at Würzburg, Haeckel also met Rudolf Virchow (1821-
1902)138.  Virchow’s political convictions were reflected in his work on cellular 
pathology, in which he suggested tissues were formed from many individual cells all 
of equal standing139.  Virchow provided the hints of an answer to Oken’s and 
Haeckel’s concerns regarding the unity of nature, since he argued that Cell Theory, 
demonstrating that cells controlled the actions of all living things, provided 
unification for the life sciences.  The cells, in turn, were subject to the laws of 
																																																								
134 These were a series of books on natural science topics, such as botany, and geology.  The 
series were published between the late 1820s and early 1840s. 
135 Di Gregorio, 2005; Richards, 2008. 
136 Wedekind, 1976; Di Gregorio, 2005. 
137 Di Gregorio, 2005. 
138 Pagel, 1931; Pagel, 1945. 
139 Ackerknecht, 1953. 
CHAPTER 1  61 
 
chemistry and physics, representing a further unification140.  Despite Virchow having 
such a significant influence on the life sciences as a whole and on Haeckel’s work 
specifically, Virchow and Haeckel never became friends; Ackerknecht suggested that 
this was simply down to a difference in personality.  Haeckel was insecure yet warm-
hearted, whilst Virchow was over-confident and cold141. 
 In 1854, Haeckel returned to Berlin, where he could attend lectures by 
Johannes Müller, another significant influence.  Di Gregorio observed that Haeckel’s 
earlier works in particular appear based in Müller’s physiology and morphology 
teachings; Haeckel also considered himself a “philosophical scientist”, after his 
lecturer Müller142. 
 Despite taking up a minor academic position at Würzburg in 1856, Haeckel 
returned to Berlin in 1857 to submit his dissertation on crayfish, and was declared 
Doctor of Medicine shortly afterwards.  In 1858, Haeckel set-up a small medical 
practice (which he loathed) in his father’s house, and became engaged to his cousin, 
Anna Sethe143. 
By the late 1850s, Gegenbaur was a well-respected member of the Jena 
faculty, and was able to put into practice his new approach to natural science: 
separation of anatomy and zoology.  Gegenbaur became the chair of anatomy, but 
needed an associate for the work in zoology.  Gegenbaur selected Haeckel for this 
role.  In May 1858, Haeckel first met with Gegenbaur and the university Kurator 
Seebeck to discuss a research trip to Italy.  Gegenbaur fell ill, leaving Haeckel to go 
on his own.  Haeckel’s trip, including the Gulf of Naples and the small island of 
Ischia, formed the basis of his work for many years144.  It also enabled Gegenbaur to 
officially offer Haeckel a post at Jena in 1860145.  Once in his new job, Haeckel was 
able to write-up his experiences in Italy in his first monograph: Radiolaren (1862).  
Another name that appears several times in Radiolaren is that of Thomas Henry 
Huxley (1825-1895), the English naturalist.  Huxley had taken his scientific approach 																																																								
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from the German tradition, and was also concerned with finding natural systems.  
Like his German contemporaries, Huxley was looking for a unifying theory of life, 
approaching the problem using Cell Theory146. 
Together at Jena, Gegenbaur and Haeckel strongly influenced the field of 
developmental biology, encouraging biologists to recognise its relevance to evolution 
(and vice versa); to them it was obvious that understanding ontogeny 
(Entwicklungsgeschichte) was essential to understanding phylogeny 
(Stammesgeschichte)147.  (This became the basis of biogenetic law, which Haeckel 
expressed as ‘ontogeny recapitulates phylogeny’; the hypothesis was that during 
development, the embryo would go through phases that resembled the creature’s 
previous evolutionary phases148.)  Moreover, the concept of homology in anatomy and 
morphology had arisen in the late eighteenth and early nineteenth century, identifying 
similarities (‘sameness’) between structures in various organisms. 
 
4.2 Darwin’s influence: Trees 
 As well as sending a copy to Huxley, Haeckel sent Radiolaren to Charles 
Darwin (1809-1882) in late 1863.  Despite his apparent gratitude, it is likely that 
Darwin never read the book carefully149.  Haeckel however had clearly been 
influenced by Darwin’s work, and explicitly referred to it in Radiolaren, suggesting 
that Darwin’s theory, as outlined in On the origin of species by means of natural 
selection, or the preservation of favoured races in the struggle for life (1859), was an 
opportunity for naturalists to understand “the great law of development”150.  For 
Haeckel, there was one area of deficiency in Darwin’s theory however: the origin of 
the primordial organisms (Urorganismen). 
 According to Haeckel’s own translated copy of Darwin’s Origin, he began 
reading it in the summer of 1860; his annotations however suggest that Haeckel did 
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not read the book in detail until 1864151.  Haeckel’s notes suggest he was particularly 
interested in heredity, external influences on reproduction, and variation; these notes 
indicate that Haeckel believed Darwin’s natural selection explained how heredity and 
adaptation created new life forms.  Haeckel and Darwin’s ideas could co-exist152: 
 
“the natural system is founded on embryology which distinctly reveals the common 
descent…many embryos resemble the common root-form[,] the embryo [is] the 
whole class”153. 
 
Haeckel’s contribution to Gegenbaur’s anatomy reforms at Jena was embryology, 
concluding that the success of these reforms was due to this contribution154. 
 
4.2.1 Stamm 
 As highlighted above, Haeckel was strongly influenced by Müller and 
Virchow, and the developing Cell Theory of Schwann and Schleiden.  A further 
important influence was Gegenbaur’s suggestion that eggs are cells.  From this 
interpretation, Dröscher argued, Haeckel developed his stem trees; he used terms such 
as Stammeltern (progenitors), and Stammorganismen (stem organisms).  Dröscher 
suggested that the German Stamm conjures images of genealogies and origin, as well 
as strength and community155.  Haeckel was not alone in his use of Stamm; the 
philosopher Immanuel Kant (1724-1804), and other biologists such as von Baer and 
Gottfried Treviranus (1776-1837) also used the prefix to conceptualise organic 
organisation.  Dröscher suggested that Haeckel’s Stamm however had a more explicit 
role both linguistically and pictorially, with terms such as Stammform (stem form) 
appearing frequently156. 
 The biological Stamm (phylum) and the concept of the Stammbaum (literally 
‘stem tree’, but used in the context of a genealogical or evolutionary ‘tree’) became 
the linguistic origin of Haeckel’s Stammzelle.  In this context, the stem cell was 
considered as the cell that first gave rise to unicellular and multicellular organisms of 																																																								
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the animal and plant kingdoms.  Stem cells, Haeckel argued, derived from the 
Moneren; clumps of protein that were thought to be the first forms of life.  Monera 
were considered to be the most undifferentiated beings, originated by spontaneous 
generation.  This is different to the way the term is used in Haeckel's later work, 
Anthropogenie (1877), in which the Stammzelle (or Cytula) is the cell that gives rise 
to all other cells of a multicellular organism: the fertilised egg.  This appears to be an 
idea evolved from Gegenbaur and Haeckel’s ‘biogenetic law’: that ontogeny was a 
recapitulation of phylogeny.   
 
“The name “stem cell” seems to me the most simple and appropriate one, because 
all other cells stem from it and because it is in its most literal sense the stem father 
as well as the stem mother of all the countless generations of cells of which later on 
the multicellular organism is composed”.157 
 
Since for Haeckel, each organism moved through each of its previous phylogenic 
states during development, his ontogenetic stem cell (i.e. the fertilised egg) was the 
equivalent of the single-cell organism: the phylogenetic stem cell. 
 
4.3 Stammzelle 
Why though did Haeckel believe that a new term was required?  What was 
wrong with the ‘fertilised egg’ - a concept all biologists would have understood?  
Haeckel did not define Stammzellen in Natürliche Schöpfungsgeschichte; Dröscher 
claimed that he did not need to - that the term was “easily understood as the starting 
point of evolution and as the basis of his stem trees”158.  Maehle furthermore 
suggested that this was Haeckel’s effort to distinguish the fertilised egg from the egg 
cell: the fertilised egg was a combination of mother and father, and represented the 
future offspring159.  This is a more likely explanation; Stammzelle captures the 
essence of great potential far more than ‘fertilised egg’ does. 
 
4.4 Keim and Ur 
 Beginning with Haeckel’s biogenetic law, and the results of Wilhelm Roux’s  
(1850-1924) experiments suggesting that chromosomes were composed of regions 																																																								
157 Haeckel, 1877 (transl. Maehle, 2011). 
158 Dröscher, 2014. 
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distributed amongst daughter cells, August Weismann (1834-1914) developed his 
model of heredity and development (see also Chapter 2).  Following Haeckel, 
Weismann linked embryology with evolution and heredity; Dröscher suggested that 
this approach provided a plausible account of the material basis, and conceptual 
explanation of development160.  This included theory relevant to stem cells: 
Weismann suggested that germ cells developed separately to somatic cells, and it was 
only these germ cells that would pass on hereditary material.  Just as Haeckel had 
utilised the prefix Stamm, Weismann introduced Keim (‘germ’).  The germ cells, as 
carriers of inheritance, possessed all material needed to create the next generation in 
the Keimplasma (germ plasm), and these germ cells developed along the Keimbahn 
(germ track).  The somatic cells did not contain all of the Keimplasma; instead each 
cell division resulted in division of the Keimplasma, resulting in irreversible 
differentiation and specialisation.  It was the nucleoplasm, Weismann argued, that 
contained the “hereditary tendencies” of each cell type; the first ectoderm cell would 
divide unequally, creating a cell containing the nucleoplasm required for the nervous 
system, and another containing the nucleoplasm needed for the skin161.  The germ 
cells however needed the entire nucleoplasm.  Weismann believed this was the route 
of inheritance and development until the 1890s, when he saw that Roux’s frog 
embryo experiments offered a different explanation (see section 5.1).  Weismann re-
imagined the transmission of information from one cell to the next in the early 1890s: 
“…the hereditary substance of the egg-cell, which contains all the hereditary 
tendencies of the species, does not transmit them in toto to the segregation cells, but 
separate them into various combinations, and transmits these groups to the cells”162.  
Accordingly, Weismann placed the Urzelle at the start of development; it was the 
Urzelle that contained the potential to become an entire organism.  Weismann’s cell 
trees then provided a causal explanation of development as well as a description of it. 
 Weismann never used Haeckel’s term Stammzelle, preferring Urzelle; the 
meaning appears similar: a cell that has great potential, a cell that is the ancestral 
remnant and the beginning of ontogenesis.  Weismann’s Urzelle however seems to be 
a more specific idea than Haeckel’s Stammzelle.  Weismann described the method of 
increasing differentiation (either as decreasing complexity or composition) via the 																																																								
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nucleoplasm.  Haeckel also suggested that there were more external forces at work 
during development, whereas Weismann placed more emphasis on intracellular 
events.  On this basis then, it is interesting that Stammzelle is the phrase that has 
remained, when Urzelle appears to more accurately describe our current 
understanding of stem cell biology. 
 
4.5 Stem Cell 
 Jan Sapp suggested three tenets of Cell Theory: 1) that all plants and animals 
are made of cells; 2) cells possess all of the attributes of life; 3) all cells arise from 
division of pre-existing cells163.  Staffan Müller-Wille suggested a fourth: that the cell 
can be regarded as a ‘unit of life’164.  These observations are crucial, Müller-Wille 
argued, in allowing biologists to conceive cell populations as a succession of 
generations.  This was crucial for emerging nineteenth-century ideas regarding 
heredity.  In the early twentieth century, the requirement for a unifying approach to 
biology was falling away again.  Cytology, useful to a large array of disciplines, was 
becoming too large for anyone to comprehend it in its entirety.  For this reason, 
although American biologist Edmund Beecher Wilson’s The Cell in development and 
inheritance (1896) covered three decades of changes in the field (the third edition 
being published in 1926), it was the last work in cytology to have been all-inclusive 
whilst written by a single author165. 
As well as becoming a known phrase in English (see below), Stammzelle was 
establishing its context in German.  For example, Berlin anatomist Richard 
Weissenberg (1882-1974), previous assistant of Oscar Hertwig (1849-1922), used the 
term to refer specifically to precursors of egg cells and sperm cells166. 
 In 1892, Valentin Haecker  (1864-1927), then an assistant of Weismann at the 
University of Freiburg, used Stammzelle with reference to a cell that becomes 
internalised during embryonic cell migration in crustacean development - the 
daughter cells of this progenitor give rise to the mesoderm and germ cells167.  (It has 
been suggested that as Haecker did not use the term more widely in his publications, 																																																								
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164 Müller-Wille, 2010 p 225.  Here Müller-Wille is not repeating the second tenet suggested 
by Sapp, but is instead referring to the single cell stage of life that all organisms pass through. 
165 Maienschein, 1991. 
166 Weissenberg, 1926; Maehle, 2011. 
167 Haecker, 1892; Maehle, 2011. 
CHAPTER 1  67 
 
it is possible that he ‘borrowed’ the term from elsewhere168.)  Theodor Boveri (1862-
1915) (then working under Richard Hertwig (1850-1937)169 at the University of 
Munich) also used the term in a similar way to Haecker170.  In a lecture given to the 
Munich Society for Morphology and Physiology on the horse roundworm, Boveri 
described the cells derived from the fertilised egg that would eventually become the 
primordial germ cells as Stammzellen. 
Despite the growing popularity of Haeckel’s Stammzellen, Dröscher suggested 
that the term was “too speculative in its evolutionary part, and too generic in its 
embryological part, to find followers among the experimental biologists”171 (although 
this did not take into consideration the relationship of Boveri and Wilson172).  This is 
not to say that Haeckel’s concept had no influence at all however; Stammzelle 
enhanced the previously rebuffed Schleiden and Schwann Cell Theory.  The initial 
focus on cell walls, membranes, and the nucleus was diverted somewhat to the 
protoplasm and the behaviour of chromosomes.  Just after Haeckel’s Natürliche 
Schöpfungsgeschichte was published, Oscar and Richard Hertwig described in detail 
the merging of the maternal and paternal nuclei during fertilisation, and began 
investigations into the actions of chromosomes. 
The term ‘stem cell’ was not popularised in English until the publication of 
Wilson’s The Cell, in which Wilson reviewed the work of Haecker and Boveri; in 
fact, Boveri’s cell lineage diagrams and drawings were featured in Wilson’s text.  
Boveri and Wilson had previously worked together in the early 1890s at the 
Zoological Institute in Munich, and had remained friends173.  Wilson began writing 
the 1896 edition of The Cell between 1892 and 1893, based on lectures given at 
Columbia University in New York.  Initially, Wilson claimed that the book was 
simply going to be a book of his lectures for a general university student audience; 
this aim shifted slightly following the publication of Oscar Hertwig’s book (Zelle und 
Gewebe, 1893) and his research project investigating the history of centrosome 
function in fertilisation174.  This appears to have delayed the publication of The Cell 																																																								
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slightly, as Wilson was clearly keen to ensure that the information contained within 
was as up-to-date as possible.  There are only a couple of references to the stem cell 
in the 1896 version of The Cell.  These appear in the chapter on Origin and growth of 
the germ-cells.   On pages 110 and 111, Wilson wrote “Haecker has recently traced 
very carefully the origin of the primordial germ-cells in Cyclops from a “stem-cell” 
(Fig. 56) clearly distinguishable from surrounding cells by the early blastula stage, not 
only by its size, but also by its large nuclei rich in chromatin, and by its peculiar mode 
of mitosis, as described beyond”.  Figure 56 is from Haecker’s work; the figure 
legend reads: “A. Young embryo, showing stem-cell (st).  B. The stem-cell has 
divided into two, giving rise to the primordial germ-cell (g).  C. Later stage, in 
section; the primordial germ-cell has migrated into the interior and divided into two; 
two groups of chromosomes in each”175.  In The Cell then, ‘stem cell’ clearly referred 
to the progenitor of germ cells, as in Boveri’s work.  This is diagrammatically 
explained in Figure 55 (from Boveri), where Wilson’s legend reads: “A. Two-cell 
stage dividing; s. stem-cell, from which arise the germ-cells”176.  Wilson continued 
his explanation by stating that at the 4-cell stage, there are two stem cells and two 
somatic cells; the stem cells are larger, and are richer in chromatin.  These cells 
continue to divide eventually resulting in the primordial germ cells, which then only 
give rise to germ cells.  “Through this remarkable process it comes to pass that in this 
animal [Ascaris] only the germ-cells receive the sum total of the egg-chromatin 
handed down from the parent.  All of the somatic cells contain only a portion of the 
original germ substance” [original emphasis]177.  Citing Boveri, Wilson went on to 
explain the function of the stem cell further: “The original nuclear constitution of the 
fertilized egg is transmitted, as if by a law of primogeniture, only to one daughter-cell, 
and by this again to one, and so on; while the other daughter-cells, the chromatin in 
part degenerates, in part is transformed, so that all of the descendants of these side-
branches receive small reduced nuclei” (p 437 in Boveri, 1891)178. 
There is very little change to Wilson’s use of ‘stem cell’ in the 1900 edition of 
The Cell, where the term still appears in reference to Boveri’s and Haecker’s work, 
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and assumes that the stem cell is a primordial germ cell179.  This second edition was 
reprinted several times until at least 1911.  After a relatively significant gap, Wilson 
published the third edition (‘with corrections’), in 1925, which also included a subtle 
title change to The cell in development and heredity.  In this version, the original 
account of stem cells changes very little; the term is still used alongside images and 
text from Haecker and Boveri.  In addition however, Wilson included his own 
diagram, referring specifically to the cell lineage of the early Ascaris embryo.  The 
zygote itself is referred to as a stem cell, as are three further cells from the first three 
cell divisions.  These divisions are asymmetrical, so the first cell divisions result in 
the embryo comprising three somatic cells and one stem cell.  The stem cell then no 
longer produces somatic cells when it divides, but only germ cell progenitors (and 
eventually germ cells).  The somatic cells continue to divide to produce the rest of the 
cells required by the developing embryo.  “[T]he germ-line may be followed without 
a break back to a stem-cell that is distinguishable as such already in the 2-cell stage of 
the embryo, and in each succeeding cleavage.  This cell differs from the somatic cells 
at every stage in the fact that it alone retains the sum-total of the nuclear substance, 
while every somatic nucleus has cast out a portion of its chromatin”180.  
The popularity of The Cell could have been partly due to the distinguished 
positions Wilson had held at Columbia University181; at the time of publication of the 
first edition, Wilson was professor of invertebrate zoology (having previously held 
the position of professor of biology).  Following publication of his monograph, 
Wilson became praised as the world’s leading cytologist; such was the influence of 
The Cell, many have argued that it paved the way for acceptance of Mendelian ideas 
of heredity, and that TH Morgan’s opinions on chromosomes in inheritance were 
revised according to work following on from Wilson’s textbook182. 
 Wilson considered the cell as the fundamental unit of development, and 
therefore organisation (since, for Wilson, these two problems were inseparable)183.  
As previously mentioned, Cell Theory was to establish biology as a scientific 
discipline, and united several fields of research (including, for example, physiology, 
microscopy, and natural history).  The influence of The Cell can be seen in other texts 																																																								
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that were produced in the years that followed; for example, then University of 
Michigan assistant professor of zoology, Robert William Hegner (1880-1942), also 
used Wilson’s phrasing and Boveri’s diagrams in The germ-cell cycle in animals 
(1914). 
 Wilson’s use of ‘stem cell’ (to mean a progenitor of germ cells) appears 
elsewhere in the early twentieth century, following publication of The Cell.  For 
example, SJ Holmes’ paper Early cleavage and formation of the mesoderm of 
Serpulorbis squamigerus, describing research carried out in the 1890s under Charles 
Otis Whitman (1842-1910) at Chicago, was clearly written in the style of cell lineage 
studies (see section 5.2).  The use of the term ‘stem cell’ in this paper is not defined in 
any way, and makes a single appearance.  This makes it somewhat difficult to know 
exactly which cell Holmes is referring to as the stem cell, and why.  Holmes appears 
to be referring to a cell from which the mesoderm layer originates (from which the 
germ cells will eventually emerge), at around the 24-cell stage184. 
 In 1907, at the Seventh Zoological Congress, JP Munson included the term 
‘stem cell’ in his paper Generation and degeneration of sex cells, which desribed the 
development of the butterfly Papilio rutulus. Again Munson’s ‘stem cell’ appears to 
be similar to that of Boveri and Wilson; the cell from which germ cells develop. The 
origin of sperm cells, Munson claimed, was the “grandmother stem cell”, or “the 
original germ cell”185.  This stem cell had a large nucleus, and long “protoplasmic 
processes or strands”, at the end of which were cells also rich in chromatin; Munson 
refered to these cells as “mother branch cells”, which divided asymmetrically, one of 
which remained near the stem cell, and the other eventually becoming a sperm cell186.  
A similar set-up may be seen in the female, and had also been observed in the 
tortoise. 
 A paper published in 1918, Oogenesis and early embryology of Ascaris, still 
described the stem cell as the cell responsible for the eventual creation of germ cells.  
AC Walton referred to asymmetric division soon after fertilisation, resulting in a 
particular cell lineage moving towards germ cells.  “These observations, while scanty, 																																																								
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laden cell, lying obliquely above the larger stem cell in such a way as the indicate that the 
division was laeotropic.  This cell corresponds exactly as regards its time and mode of origin 
with the primary mesoblast cell of other molluscks”.  Holmes, 1900 p 118. 
185 Munson, 1907 p 327. 
186 ibid. 
CHAPTER 1  71 
 
go to prove that Ascaris canis agrees with Ascaris megalocephala (Boveri, ’99), in 
that there are five stem cells which give rise to a soma cell and a stem cell, the sixth 
stem cell giving rise only to pure propagation cells.  Each of these five soma cells, or 
its immediate daughter cells, undergoes the process of ‘chromatin diminution’”187.  It 
appears that Walton also believed that the amount of material in the cells that would 
not become germ cells reduced following each division (hence the term ‘diminution’). 
 This use of the term ‘stem cell’ is narrower than the term as its used by Vera 
Danchakoff (1879-1950) in her work.  In her research, published in English after 
1910, Danchakoff instead referred to a cell that is not only the progenitor of germ 
cells, but of other tissues as well; in particular, Danchakoff’s research focused on 
haematopoiesis.  Thus far, Danchakoff’s working model of the stem cell appears far 
more similar to the definition we would use today, than the narrower definition 
popular in the work of Wilson (and others). 
The economic climate (particularly in Germany) following the end of the First 
World War saw a reduction in stem cell research in Europe, and an increase in 
America (which also led to a change in the publication language from German to 
English).  The Russian Vera Danchakoff, for example, began her career at Moscow 
University, before continuing her research in New York (at Columbia University, The 
Rockefeller Institute and The Wistar Institute, where she moved to prior to 1916).  
Whilst in America, Danchakoff observed that most (haematopoietic) stem cell 
research was still being carried out in Europe, but her publications and lectures 
suggest that ‘stem cell’ was a term also familiar to an American audience188. 
The meaning of ‘stem cell’ appears relatively precise in Danchakoff’s work, 
although it is in a different context to the use described above (by Wilson, for 
example).  Although the term ‘stem cell’ is occasionally interspersed with ‘mother 
cell’ (a term also used elsewhere), it is Danchakoff who provides an explicit 
description of a stem cell that would be recognisable today189: 																																																								
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“In the early development of the blood cells …many similar features may be noticed 
during the simultaneous differentiation of the granuloblasts and erythroblasts from a 
morphologically and genetically identical mother-cell.  This stem-cell maintains its 
own existence by uninterrupted multiplication, on the one hand, and on the other it 
differentiates…”190. 
 
Other terms were also used for the ‘progenitor cells’ of the haematopoietic system, 
such as ‘haemoblast’.  Despite this variation, Danchakoff described some features of 
stem cells that are still considered essential characteristics today: that a stem cell may 
last for the entire life of the organism, retaining its potential for self-renewal and 
differentiation191.  Danchakoff appears to have been the first researcher to use the 
term ‘stem cell’ in English to refer to precursor cells of tissues other than gametes.  
This may have been because she had recently moved from Eastern Europe however, 
since the term ‘Stammzelle’ had been used to refer to progenitor cells of the 
haematopoietic system prior.  For example, Artur Papenheim (1870-1916) would state 
that the precursor of blood cells was the Stammzelle192.  Pappenheim also referenced 
works that refered to stem cells as precursors of gametes (as above), as well as 
sensory cells, ganglion cells, neuroglia cells, and connective tissue193.  For 
Pappenheim then, the Stammzelle was an embryonic cell that was the ancestral cell of 
any tissue type.  Pappenheim was not the only researcher to use ‘Stammzelle’ in this 
fashion; for example Alexander Maximow (1874-1928) would also tell the Berlin 
Haematological Society in 1909 “the ‘lymphocyte’ was ‘the common stem cell’ of all 
tyhpes of blood cells, both during embryonic devlopment and in the adult life of 
mammals”194.  These views then were all commited to the concept of a single ancestor 
cell of the entire haematopoietic system195. 
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5. Embryonic stem cells 
5.1 Experimental embryology of late nineteenth century Europe 
In the late 1880s, Wilhelm Roux began ‘pricking experiments’ using two-cell 
frog (Rana esculenta) embryos.  Using a fine, hot needle, Roux would puncture one 
of the cells (with the aim of killing it, and rendering it no longer capable of 
contributing to development), whilst leaving the second cell to develop normally.  
Roux observed that the usual result of the experiment was that half an embryo would 
develop from the cell left intact.  Therefore, Roux argued, the material for 
development of one half of the embryo was contained in one of the cells at the two-
cell stage204.  
 A few years later, Hans Driesch (1867-1941) experimented with early sea 
urchin (Echinus microtuberculatus205) embryos, separating cells by shaking them in 
sea water.  This experiment was important, since it demonstrated that Roux’s findings 
were not as a result of any effect from the pricked cell206 (i.e. the death of one cell at 
the two-cell stage).  Instead of observing half-embryos as Roux had, Driesch’s sea 
urchins were notably smaller, but nevertheless formed fully developed larvae.  The 
same occurred after separating cells at the four-cell stage, and, occasionally, the eight-
cell stage (also refered to as “¼ blastomeres”207)208. 
 
“The isolated half-cells did in fact cleave as if they were still connected with their 
sisters, and formed half-cleavage stages resembling half of a hollow ball.  However, 
this then closed to a small whole ball, and I obtained on occasion, quite contrary to 
my expectations, a dwarf pluteus”209. 
 
Driesch also considered whether the same results would be found using amphibian 
embryos, however claimed that he was not skilful enough to make this experiment a 
success210. 
 Such new observations required new experimental protocols to examine the 
changing ideas about developmental biology (see above).  Swiss anatomist Wilhelm 																																																								
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His (1831-1904) demanded that developmental biology needed to describe the 
structure and function of the fertilised egg as it developed, and that these descriptions 
should be derived from mechanical explanations and direct causal relationships, 
allowing each step to be understood as a consequence of the proceeding one211.  For 
emerging developmental biology, it was considered important to track the fates of the 
early embryonic cells, still believed to relive their phylogenies.  August Rauber 
(1841-1917) also took His’ approach, and set to work carefully observing cleavage 
events in order to better understand the importance of geometrics in morphogenesis.  
Weismann was part of another investigative strand of His’ developmental biology, 
concerning himself with the carriers and passage of hereditary material. 
 
5.2 American cell lineage studies 
Development of evolutionary theory after the publication of Darwin’s Origin 
(1859) meant that the development of individual organisms could no longer be 
adequately explained by referring back to conformity of species type – these ‘types’ 
no longer existed (if species were changing all of the time).  The emerging ideas 
about evolution suggested that individuals could inherit from distant as well as recent 
ancestors212; this was captured in Haeckel’s biogenetic law, however it was attracting 
criticism.  Gegenbaur’s ideas (basically rejection of Haeckel’s ‘phylogenies beget 
ontogenies’ beliefs) were particularly influential in American embryology of the era, 
especially influencing a new school of study: cell lineage.  This was the study of 
exactly what happened to each cell of the developing fertilised egg over the course of 
the first few cell divisions of the early embryo213.  In particular, Mainenschein has 
highlighted that there were six members of this school (in addition to students or the 
occasional visitor); in her account, the school began and ended with these researchers.  
The six researchers included EB Wilson (see above), CO Whitman, Edwin Grant 
Conklin (1863-1952), Aaron L Treadwell (1866-1947), AD Mead (1869-?), and Frank 
Rattray Lillie (1870-1947)214.  For Wilson, Whitman, Conklin, Treadwell, Mead, and 
Lillie, examination of the earliest stages of development would shed light on 
fundamental biological processes, taking a more modern approach to interpreting 																																																								
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Haeckel’s biogenetic law.  They accepted that ontogeny and phylogeny were likely 
related; however, they saw that although phylogenies of adult forms may have 
similarities to ancestral ontogeny, there was no causal relationship215.  The section 
below will briefly highlight the contributions of Conklin, Lillie, and Wilson, since 
Conklin’s and Wilson’s interpretations of results were so different to the extent of 
almost opposing each other, whereas Lillie’s, although more like Conklin’s, were 
more moderate216.   
Two centres became crucial for cell lineage study in the US: the University of 
Chicago, and the Marine Biological Laboratory (MBL) at Woods Hole, 
Massachusetts (where Conklin was the first director, from 1888).  In 1894, at an MBL 
Friday Evening Lecture, Wilson noted that “no-one believes that ontogeny is actually 
a true and complete record of phylogeny”217.  Wilson and Gegenbaur appeared to 
have similar views: that homology could only be accurately assessed using 
comparative anatomy and morphology218.  (The search for homologies also became a 
key concept for cell lineagists, who used this approach to help understand body plans 
and variation, for example219.)  The aim of the cell lineage researchers was to first, 
learn the extent to which an individual embryo is a product of its distant ancestors, 
and secondly, to learn how the individual embryo is affected by external pressures 
(perhaps resulting in adaptation and change).  This fit well with the proposed 
Darwinian theory of natural selection; it should also shed light on whether changes 
due to selective pressures occurred in the past, or whether they were still occurring220.  
Maienschein claimed that although not the priority of cell lineage studies, it was the 
clarification provided on the relationship between ontogeny and phylogeny that 
enabled later study of development221.  Gross goes as far as to say that the cell lineage 
studies were successful as they could be carried out “largely free of preoccupation 
with phylogeny”, enabling the researchers to demonstrate the somewhat superficial 
nature of Haeckel’s style of embryology; without such shackles, a new way of 
studying the developing form of the embryo could emerge222. 																																																								
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 Wilson’s contemporary and, Maienachein claimed, “inspirational leader” of 
the cell lineage group, Conklin, concluded that the germ layer was not the best place 
to start looking for homologies223.  Instead, Conklin preferred to study the cleavage 
patterns of of blastomeres.  This would also help Conklin learn more about the 
various factors which he believed had an influence on evolution, including growth, 
differentiation, variation, metabolism, and inheritance, for example224.  From his 
studies on blastomeres, Conklin could examine any phylogenic significance of early 
cleavages without the many extra factors at play that affected cleavage in later 
development.  Conklin saw development as an expression of internal or intrinsic 
factors alone, believing from his results that the cleavage and cell divisions were all 
precisely inherited functions (i.e. unaffected by any external influence).  For Conklin 
then, understanding early ontogeny was the key to understanding evolution225.  
Conklin therefore rejected Haeckel’s biogenetic law.  Conklin’s approach was 
historical; he explained that whilst cleavages were morphogenetic, this did not fit with 
recapitulation theory226.  Laublichler and Maienschein highlight the difficulties with 
such studies however; although the practicalities of such experiments were difficult 
enough, there were also issues with disseminating results.  It was expensive to publish 
the results of such observational studies, since so many figures and plates were 
required to adequately describe the processes occurring227.   
 Lillie’s cell lineage work began around a decade after Conklin’s, after 
attending an 1892 session at the MBL, then working with Whitman there.  Lillie 
completed his PhD under Whitman in 1894.  Lillie worked with Unio (a fresh-water 
mussel), receiving acclaim for providing impressive insight in his 1895 paper The 
embryology of Unionadae229.  Lillie believed that the cleavage options of the fertilised 
egg were limited by information inherited from the parents, and the orientation of its 
cytoplasm.  External pressures would not affect any adaptation at this stage, however 
could come into play on the organism as a whole; like Conklin then, Lillie believed 
that ontogeny was influenced only by internal factors. 
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 Wilson began his cell lineage work in the 1870s, whilst still studying under 
William Keith Brooks at Johns Hopkins University.  Wilson’s early papers, published 
in the late 1870s and early 1880s, trace the early developmental stages of various 
invertebrae230.  Wilson interpreted his observations as showing that each cell of the 4-
cell embryo developed into a different part of the body.  He also learned that cleavage 
for cell division occurred in a specific way, so that new cells always developed at a 
slight angle, resulting in what became known as ‘spiral cleavage’231.  As his research 
continued, he found that he became less and less convinced by Haeckel’s biogenetic 
law, having rejected most of it by the early 1890s.  Guralnick claimed that Wilson’s 
Nereis (a polychate worm) work from 1892 in particular demonstrated that a different 
approach from Haeckel’s version of recapitulation was needed, as Wilson launched a 
“vitriolic” attack on Haeckelian methods in his MBL lecture of 1894232.  Instead, 
Wilson believed that ontogeny was actually a series of organogenies – each organ 
appeared to develop from a single cell (a blastomere).  To achieve this, the egg 
divides depending on the role the new cell will later have, so the morphology and 
location or pattern of cleavage and division was regulated to achieve this.  This 
regulation may have been affected by both internal and external (such as 
environmental) factors.  The impact of external factors meant that although early 
embryos may have the same cleavage events and cell divisions, and the resulting new 
cells all be arranged in the same way, they may eventually have different 
morphologies.  Each cell was influenced by its inherited factors, whilst the whole 
embryo was also influenced by its immediate environment233, a belief that most cell 
lineagists would agree with234.  This appeared to set Wilson’s next goal: to elucidate 
how external factors could affect internal functions, resulting in differences to adult 
homologies; yet again, cell lineage studies were useful here, but were not the only 
way to learn more about embryology235.  Eventually, by the beginning of the 
twentieth century, Wilson had also accepted cell homology, and summed up the work 
of cell lineagists by noting the similarities revealed by studies on molluscs and 
																																																								
230 Maienschein, 1978. 
231 Guralnick, 2002 p 541. 
232 ibid p 544; Wilson, 1894 p 104. 
233 Wilson, 1892; Maienschein, 1978. 
234 Guralnick, 2002. 
235 Maienschein, 1978. 
CHAPTER 1  78 
 
annelids, and other such creatures as all basically following the same general plan of 
development236. 
 The cell lineage studies of the late nineteenth and early twentieth centuries 
resulted, claimed Gross, in the modern approach to studying embryonic development.  
Gross argued that embryology had been viewed as an especially useful discipline 
through which evolution could be studied; by the end of the nineteenth century 
however, embryology had begun to be seen as a discipline in its own right (see also 
Chapter 2)237.  The question of inheritance versus adaptation was important in the 
latter half of the nineteenth century, and cell lineage studies were able to begin 
investigating this, eventually showing that both internal and external factors were 
influential238.  In the 1890s, cell lineage work was mainly based on observation.  This 
is a different methodological approach to the emerging experimental embryology of 
researchers such as Roux in Europe (see Chapter 2).  Whilst observation was of 
course initially useful, the experimental embryologists argued that observation alone 
could not provide explanation for developmental phenomenon (Grualnick has argued 
however that Wilson’s Nereis work supported mechanistic explanations of cleavage 
patterns239).  The experimental embryologists, making use of similar creatures for 
their work as the cell lineagists, demonstrated that the early cleavage events could be 
disrupted without affecting the embryo’s capacity to continue normal development240; 
observation alone could not have achieved such understanding.  Arguably, cell 
lineage studies had helped to elevate the field of embryology from its study under the 
paradigm of Haeckel’s biogenetic law.  The study of the embryo and embryogenesis 
could potentially reveal much more about multicellular life than the study of 
recapitulation theory241.  Potentially, this may have also been a significant factor in 
the end of cell lineage studies in the early twentieth century; as highlighted by 
Guralnick, published accounts of new cell lineage studies had stopped by 1907242.  
Guralnick offered a potential explanation for the decline of cell lineage studies: that 
researchers stopped carrying them out because the general patterns of cleavage 																																																								
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observed were relatively similar, whilst simultaneously, specific cell divisions of 
embryos showed too much variation243.  Although significant amounts of data had 
been produced by this time, no-one really knew how to process it all into a theory of 
embryonic development.  It was only through experimental embryology, particularly 
as it developed in the early twentieth century, that biologists such as Hans Spemann 
(1869-1941) became capable of assimilating and evaluating the observations 
produced regarding cell lineage studies, utilising the data alongside experimental 
results.  In 1915 for instance, Spemann noted the significant influence of the 
homology theme of cell lineage work, claiming that it was useful to link the causal-
analytical and historical approaches of previous embryological studies244. 
 
6. Conclusions 
 There was significant growth in cell biology studies through nineteenth-
century Germany, for which several factors were responsible.  Firstly, there were 
significant funds available through the state for university appointments and research.  
Secondly, the academics employed, and trained in new techniques of systematic 
observation and experiment, also had access to dyes and microscopes (for example, 
Paul Ehrlich’s [1853-1915] influence on the use of dyes in microscopy in the late 
nineteenth century249).  Organicism drove the search for the cell, and then its structure 
and function.  In Germany in particular, this was aligned with idealistic views of the 
state; Haeckel, for example, compared cells to good citizens of the Kulturstaat, which 
could only flourish by the division of labour.  Different political views would be 
manifested in different theories on ‘the cell state’.  Eventually, social concepts such as 
‘colonies’, ‘migration’, and ‘culture’ would remain in the cytology that developed250. 
 Henri Dutrochet’s idea of the vital phenomena that allowed all life to flourish, 
and the translation of his thoughts to experimentation, took the first steps towards 
modernising cell physiology.  So great were Dutrochet’s microscopic skills, that he 
was one of the first to observe a somatic cell.  Experimentation was also taken up by 																																																								
243 These variations, Guralnick argues, are not addressed in the cell lineage papers published.  
In part, this may have been because there was no easy way (at the time) of analysing the mass 
of data produced on such variation in any meaningful or quantitative manner.  Guralnick, 
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Raspail, now considered important for the development of the discipline of 
cytochemistry.  Franco-German politics however diminished  the reception of 
Raspail’s work, and the initial impact it had in Europe. 
 A further example of such political influences on scientific endeavour, that of 
Purkynĕ’s contemporary at Berlin, Müller, being far more influential, since he was 
German as opposed to Czech.  Although Purkynĕ’s student Valentin was one of the 
first to publish comparisons between animal and plant cells in the 1830s, his efforts 
were dismissed by the popular Müller student Schwann, when he published 
Mikroskopische Untersuchungen in 1839. 
 Although the details of Schwann’s Cell Theory were repudiated within a 
relatively short amount of time, the basis of Cell Theory (i.e. that all organisms were 
made-up of cells) was influential in biology for much longer; the ideal of unifying the 
disciplines of zoology, botany, anatomy, and physiology, strengthened by German 
organicism, would influence the type and structure of research in the biological 
sciences well into the twentieth century. 
 This had an effect on the developing discipline of embryology.  Although 
there had been an interest in development throughout history, it was the development 
of the microscope and staining that gave scientists the first opportunities to take a 
closer look at early mammalian development.  Fuelled by debates concerning 
epigenesis, evolution, and preformation, pre-nineteenth century studies focused on 
dissection and microscopy.  Following the initial boost of information provided by 
microscopy in the late 1600s, little technological development in microscopy through 
the 1700s stymied progress.  Late eighteenth-century dissections were of some use, 
but the popular conclusions drawn by Haller distracted some research avenues as 
other theories were dismissed. 
 It was not until 1861 that Gegenbaur clearly argued that the egg itself was a 
cell.  I would argue that this is an important point in embryonic stem cell history - 
without identifying the unfertilised egg as a cell, it would be difficult to consider the 
first ‘products’ of the fertilised egg as cells too.  The first influential observations on 
fertilised eggs were made in the early nineteenth century.  Prévost and Dumas 
described how ‘furrows’ would appear in the hours following fertilisation in the rabbit 
egg.  Rusconi followed suit, going further than Prévost and Dumas by declaring that 
the furrowing was not only a surface phenomenon - in fact there was segmentation 
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occurring throughout the fertilised egg, resulting in division and subdivision of the 
egg. 
 Soon after Rusconi published his observations, Barry published the first of 
three papers that would describe his studies on egg development and maturity, 
fertilisation, and early embryonic development in detail.  In the second paper (1839), 
Barry described segmentation like Rusconi, referring to division of vesicles with 
nuclei.  Barry compared the vesicles he observed with globules identified in the 
nervous system by Valentin.  This, I argue, is the first time cells of the newly-forming 
embryo were compared with the cells observed in an adult. 
 Barry’s and Rusconi’s observations were confirmed by others working with 
invertebrates.  The theory was strengthened by the publication of Remak’s book on 
embryology.  Remak claimed that the nuclei in cells of the adult were all produced 
from the first nucleus created at fertilisation.  This again shows that the preformation / 
epigenesis and ovist / spermist debates of previous centuries still required 
conclusions; Remak’s work seems likely to have been influenced by this, given the 
conclusions provided. 
 It is important to consider how the works of Remak, Barry, and others 
influenced stem cell biology.  Since Haeckel initially coined the term Stammzelle, it is 
prudent to understand how and why, and in what context.  Haeckel was influenced 
early on in life and education by botany and botanists.  Haeckel’s time at Würzburg 
and Berlin where he met Müller, Kölliker, and Gegenbaur (amongst others) was 
important, since this influenced Haeckel’s interests and career path.  Dröscher argued 
similarly - that Haeckel’s exposure to Cell Theory, Müller, Virchow, Darwin, and 
Gegenbaur allowed him to conceive his ‘stem tree’ idea, from which influences 
Haeckel would develop Stammeltern and Stammorganismen.  The use of Stamm 
appears to follow from the works of others in similar disciplines of study.  Stammzelle 
seems to alter its meaning in Haeckel’s works, dependent on context.  Stammzellen 
were derived from Moneren, giving rise to the first unicellular and multicellular 
organisms.  In Anthropogenie, Stammzelle referred to a fertilised egg.  This concept of 
the stem cell intergrated well with Haeckel’s idea that ontogeny begets phylogeny - 
the ontogenic stem cell being both the fertilised egg of multicellular organisms, and 
the equivalent of a unicellular organism.  Stammzelle also appeared to capture the 
essence of the great potential the cell had for life. 
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 Across the Atlantic, American biology was taking a slightly different research 
direction.  Wilson’s The Cell has been referred to as the last comprehensive text in 
cytology; during the early decades of the twentieth century the discipline was 
becoming too complex for a single textbook to explain all of its nuances.  Its 
popularity was significant for stem cell history - it included the first time ‘stem cell’ 
was used in English.  The term was becoming popular in the two most influential 
languages of biology at the beginning of the twentieth century - German and English. 
 Experimental techniques had been improving to the point that early embryos 
of some species could be cultured in the laboratory.  In particular, frogs, sea urchins, 
and similar creatures proved useful as experimental animals for observing and testing 
embryonic development.  The term Stammzelle or stem cell would be used in various 
contexts in the first three decades of the twentieth century, both in America and 
Europe. 
 Cell lineage studies were the most popular use of new experimentation 
techniques in the USA, particularly as Haeckel’s biogenetic law was reducing in 
popularity251.  Cell lineage studies were considered a useful way of learning about 
fundamental biological processes; Conklin was particularly influential in this area of 
study.  Meanwhile in Europe, a reduction of stem cell research in Europe (due to 
political disruption and, eventually, the outbreak of war) resulted in a small exodus of 
researchers to the USA252.  Vera Danchakoff was one such emigrant.  Danchakoff’s 
focus was haematopoiesis, however still produced works important for general stem 
cell biology. 
 Having explored the history of the stem cell concept, another concept now 
needs to be surveyed to aid further understanding of the development of genetics, and 
its role in ESC research.  The following chapter considers the role of the nucleus, and 
the relationship between heredity, genetics, development, and embryology. 
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CHAPTER 2: 
GENETICS UNDER THE EMBRYOLOGY PARADIGM: 
FANTASTICAL EXPERIMENTS 
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1. Introduction 
In 1985, Garland Allen wrote a paper proposing that since embryology and 
heredity were so closely conceptually and historically related, that heredity research 
initially developed under the paradigm of embryology.  Allen’s paper begins with the 
early relationship between genetics and embryology (from the end of the nineteenth 
century and into the first years of the twentieth).  The paper then discusses the 
developing divergence between genetics and embryology up to 1940, and Thomas 
Hunt Morgan’s  (1866-1945) role in this.  Initially, Allen argued, the study of heredity 
emerged in the latter half of the nineteenth century, as part of studies of embryology, 
since these areas were conceptually linked.  For example, researchers such as August 
Weismann and Ernst Haeckel proposed that information was ‘transmitted’ to 
offspring from parents, then ‘translated’ into traits seen in the offspring.  Towards the 
end of the nineteenth century however, newer generations of researchers wanted a 
shift in scientific methodology, preferring experiment and testable hypotheses – 
Morgan was one such researcher.  These researchers made use of embryology (and in 
particular experimental embryology) to test their hypotheses about heredity, however 
discovered that this was difficult.  Whilst theoretically it made sense to consider 
development and heredity together, practically it was more useful to separate them.  
Allen argued in his 1985 paper that there was therefore a separation of the study of 
‘transmission’ (genetics) and ‘translation’ (embryology) in the early twentieth 
century; therefore, it was after developing into the field of genetics, Allen suggested 
that heredity was able to distance itself from embryology.  Morgan’s work in 
particular is used by Allen to illustrate and support this claim.  This chapter aims to 
develop Allen’s ideas, which were focused on the early decades of the twentieth 
century, and apply them to research into heredity, genetics, embryology, and 
development later in the twentieth century; in particular, this will be explored by 
considering the experiments carried out which would yield chimeras, hybrids, and 
clones. 
This chapter will demonstrate that there is a difference between the 
chronological development and conceptual development of research fields.  Initially, 
the conceptualisation of the cell nucleus needs to be considered, including recognition 
of its structure and its function in heredity.  This includes discussion concerning 
several individuals who were influential in the field, such as van Leeuwenhoek, 
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Scottish botanist Robert Brown (1773-1858), Purkyně, and Weismann (see also 
Chapter 1).  Each of these men were individually important in identifying and naming 
the cell nucleus, and suggesting a function for it. 
In addition, this chapter will also give a brief history of experimental 
embryology, selecting examples from the early, mid-, and late twentieth century.  The 
work in the early twentieth century is exemplified by the research of Nobel Prize 
winner Hans Spemann in particular.  It was Spemann who proposed the ‘fantastical 
experiments’ referred to in the title of this chapter: these would be experiments that 
examined the role of the nucleus by transferring it between cells at early stages of 
development.  Decades after Spemann’s experiments, Robert Briggs (1911-1983) and 
Thomas King (1921-2000) worked towards achieving the fantastical experiments, 
swapping nuclei between fertilised frog eggs, and achieving continued development 
of the recipient eggs.  Following the successes of Briggs and King, John Gurdon 
(1933-) was able to achieve live births following his nuclear transfer work, again 
using frogs.  In 1962, Gurdon published his initial findings, including a photograph of 
the first mature adult vertebrate created using nuclear transfer.  Moving on from frogs 
and into the latter decades of the twentieth century, this chapter will consider the work 
of Karl Illmensee (1939-), who began attempting to clone Drosophila in the late 
1970s.  Although this feat was not achieved until much later (and not by Illmensee), it 
was another hint that nuclear transfer was a technique being utilised throughout 
Europe and North America to learn more about development and heredity.  In the 
1980s, Ilmensee claimed that he had used nuclear transfer to create mice, however 
later accusations of fraud impacted the trust individuals had concerning his earlier 
work cloning mammals. 
The chapter will then move on to consider the history of theories concerning 
genetics and embryology.  As mentioned above, this will focus on the interpretation 
made by Allen: that the field of genetics developed initially under the paradigm of 
embryology, before Thomas Hunt Morgan initiated a split of the disciplines.  In order 
to more closely examine Allen’s claims, a brief review of Morgan’s contribution will 
be given, including a critique of Allen’s claims by philosopher of biology Robert 
Meunier, who suggested that Allen’s claims are too Morgan-centric.  In an effort to 
look at Allen's claims from another angle, the chapter considers historian Gregory 
Radick’s account of Raphael Weldon’s (1860-1906) explanation of heredity. 
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Lastly, this chapter will conclude that Allen was correct to observe the 
development of genetics under the paradigm of embryology.  Using Meunier’s 
critique, Radick’s Weldonian genetics, and examples of nuclear transfer research 
through the twentieth century, this chapter will also demonstrate that there was no 
definitive split of disciplines, but that the fields of genetics and embryology are still 
closely linked with each other late into the twentieth century. 
 
2. Conceptualisation of the cell nucleus 
 It is valuable to consider the conceptualisation of the nucleus, since 
elucidation of its structure and function are relevant to the way the nucleus’ role was 
understood.  This section will distinguish between the initial identification of the cell 
nucleus in plants and animals, including the language used to distinguish it from other 
organelles.  The section will then move on chronologically and conceptually to 
consider how function of the nucleus was established.  This links back to theories 
expressed as part of Cell Theory (see Chapter 1), and the first observations and 
experimental procedures that were carried out in order to identify a function for the 
nucleus.  Again, this is relevant since the framing of nucleus’ function would affect 
the experimental design of later work carried out in the field. 
 
2.1 Identification of the cell nucleus 
 It has been suggested that the first to see the cell nucleus was the Dutch  
merchant Antoni van Leeuwenhoek; in a letter to English microscopist Robert Hooke  
dated 3 March 1682, van Leeuwenhoek described the blood cells of fish: “…I came to 
observe the blood of a cod and of a salmon, which I also found to consist of hardly 
anything but oval figures…it seemed to me that some of them enclosed in a small 
space a little round body or globule…”253.  The editors of Leeuwenhoek’s 
correspondence note that this is the ‘Discovery of cellular nucleus’; others are more 
tentative about what Leeuwenhoek is describing.  For example, in The birth of the 
cell, biologist Henry Harris (1925-2014) concluded that “Leeuwenhoek saw globules 
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most other cells, having a central ‘dip’; this is to increase surface area for gaseous exchange.  
To further increase opportunity for gaseous exchange, erythrocytes have no nucleus or other 
organelles; these cells therefore do not circulate for longer than a few months, before being 
replaced by new erythrocytes. 
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everywhere”254; a particular criticism is that Leeuwenhoek is describing small fish 
blood cells (erythrocytes).  When Leeuwenhoek described the equivalent, larger 
erythrocytes of frogs, he did not refer to any globules, but instead to a central 
shadowing, which is typical of mature erythrocytes. 
 It was Italian biologist Felice Fontana (1730-1805) who was probably the first 
to describe the nucleus.  Fontana observed the skin of eels, and his illustrations 
suggest that the epithelial cells he saw contained nuclei, placed at different points in 
each cell - these were referred to as globules.  Inside each of these globules was a 
central body255.  Unbeknownst to Fontana at the time, epithelial cells would have been 
a much more appropriate choice for observing cell structures than erythrocytes.  In 
comparison to the erythrocyte, the epithelial cell is naturally flattened, making the 
nucleus more prominent.  This would have been especially useful for early 
microscopy.  Thin, single-cell thick layers of epithelium can be easily extracted from 
the skin of many animals for viewing under the microscope. 
 Unsurprisingly, the nucleus of the plant cell was also observed following 
introduction of the microscope.  Franz Andreas (later Francis) Bauer (1758-1840) was 
an Austrian botanical draughtsman who had links with other botanists in England; his 
drawings of plants were known to the Fellows of the Royal Society of the late 
eighteenth and early nineteenth century.   In 1802, Bauer made a sketch of the stigma 
and stigmatic surface of Bletia tankervilleae (an orchid), in which he described seeing 
“one, two or three granular, more opaque greenish yellow specks, looking like young 
seeds of an Orchis”256; the rest of the sketch showed these same structures in almost 
every cell, suggesting Bauer regarded the greenish yellow specks as a regular feature.  
Despite Bauer’s illustrations not being published until the late 1830s, they were well-
known by Robert Brown. 
 Scottish botanist Robert Brown is considered to be the individual who 
introduced the term ‘nucleus’ into common parlance (Brown is also known for his 
observation of Brownian motion).  In a paper read to the Linnean Society on 1 and 15 
November 1831, Brown described the nucleus of the cell in plants, which included a 
detailed discussion of Bauer’s drawings and notes257.  Brown suggested that he had 																																																								
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seen this nucleus in a variety of plant types, describing it as “distinctly granular”, 
“slightly convex”, and having “no regularity as to its place in the cell”258, describing 
many tissues where nuclei could be observed, and its presence in other plant species.  
Brown did not claim to have discovered the structure, referring to previous work not 
only by Bauer, but also by Franz Meyen (1804-1840), Purkyně, and Adolphe-
Theodore Brogniart (1801-1876) (although, Brown claimed, his predecessors appear 
to have attached little importance to the structure, sometimes not even referring to it 
in figure descriptions259); Brown’s work is still considered important for his naming 
of the structure however.  Through his paper, Brown actually uses two terms 
interchangeably - nucleus, and areola.  Harris suggested that there is little reason why 
nucleus came to be the preferred term for the structure, except perhaps that the Latin 
translation conceived a nucleus as a solid structure, as opposed to the open space 
implied by ‘areola’260.  The problem with this explanation however is that, in the 
1830s, it had not yet been demonstrated whether the nucleus was solid or not.  A 
further explanation may be the influence of the German nomenclature, where the 
nucleus was referred to as the Kern (kernel)261. 
 Whist the influence of Bauer and Brown was relevant for plant biology, we 
need to return to Purkyně for early nineteenth-century influence in animal biology.  In 
1825, Purkyně observed the vescula germinativa in the hen’s egg.  The role of the 
nucleus was initially considered based on its observation in eggs, which is further 
linked to identification of the nucleolus.  Although it is possible that the early 
nineteenth-century microscopists may have observed the nucleolus as a darker region 
of the nucleus, it is generally accepted that the nucleoli were first described by Rudolf 
Wagner in 1835262.  Wagner’s work examining Graafian follicles of sheep allowed 
him to observe Purkyně’s vescula germinativa, inside which Wagner described seeing 
a dark spot.  Wagner claimed that he was drawn to this spot, since he had also noticed 
it in other animals.  He named it the macula germanitiva (germinative spot), and 																																																								
258 ibid p 710. 
259 ibid p 713. 
260 Harris, 2000 p 80. 
261 As highlighted in Chapter 1, Purkyně’s term for animal cells was Körnchen, implying 
either that animal cells were more solid than plant cells (Zellen), or to draw attention to the 
cell interior.  Furthermore, a student of Müller, Karl Reichert, misunderstood Purkyně’s use 
of the term Körnchen, believing that the term was referring to the nucleus, not the entire cell. 
262 The nucleolus was also identified independently by physiologist Gabriel Valentin the 
following year. 
CHAPTER 2  89 
 
suggested that it was a structure important in development.  The context in which the 
nucleus and nucleolus is described then is particularly influential - Wagner’s study of 
the germinative spot had evolved from his observations of the Graafian follicle; with 
these studies in mind, Wagner surmised that the germinative spot had a role in 
development, concluding that the presence of the spot was the first sign of the 
embryo, having seen the first germinal layer arising from this spot. 
 Purkyně, despite the general use of microscopy during the nineteenth century, 
elected to carry out his studies of the hen’s egg with a hand lens.  Purkyně’s studies 
on the germinal vesicle were published in 1825, in a volume prepared by the Breslau 
medical school to mark the fiftieth anniversary of the graduation of the German 
naturalist Johann Friedrich Blumenbach (1752-1840).  Purkyně’s contribution, De 
evolutione vesiculae germinativae (Keimbläschen), described Purkyně’s attempts to 
isolate the delicate germinal vesicle from the hen egg.  Purkyně’s work on the 
germinal vesicle was influential and highly regarded; von Baer for example 
announced that Purkyně had virtually exhausted the topic, and had little to add on the 
subject of the germinal vesicle in 1828263. 
 Purkyně however did not consider the germinal vesicle as a cell nucleus; 
instead, Purkyně believed that this vesicle may be another whole cell.  Purkyně may 
have been persuaded otherwise later on - a Polish student of Purkyně’s, Adolph 
Bernhardt (1801-1870), submitted a doctoral thesis considering the existence of a 
structure not dissimilar to the vesicle Purkyně described, within the mammalian 
ovum.  Harris believed that Bernhardt’s thesis of 1834 then suggested that it was no 
longer feasible to consider that the structure described by Purkyně was not the cell 
nucleus of the egg264.  Through examination of the later work of Purkyně’s students, it 
becomes apparent that the delivery of a Plossl (Vienna) compound microscope in 
1832, and another new microscope constructed by Pistor and Schiek (Berlin) in 1836, 
heavily influenced the theses of Purkyně’s students265.  Czech histologist František 
Karel Studnička (1870-1955), in his work considering the doctoral theses produced by 
Purkyně’s students266, noted several theses that refer to a cell nucleus.  These include 
Alphons Wendt (1833), whose thesis described the structure of human skin.  Wendt’s 																																																								
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illustrations showed the presence of granules (textura granulosa) in the various skin 
layers, which themselves contained smaller granules. Later, Wendt described these 
granules as existing in all tissues.   Another student, Carolus Deutsch, described 
corpuscles (Knochen-Körperchen) in bone (in a similar manner to Purkyně’s work 
describing corpuscles in cartilage)267.  With hints of Cell Theory to come, Purkyně’s 
student Isacus Raschkow made a specific comparison between plant and animal cells 
in his thesis (1835).  Raschkow’s doctoral research was focused on mammalian tooth 
development, and, describing the Körnchen he saw in the epithelium of the dental 
papilla, suggested that these were similar to the cells of the parenchyma of plants 
(“paranchyma plant arum cellulis simillimum”)268. 
 
2.2 Function of the cell nucleus 
 The work of van Leeuwenhoek, Fontana, Bauer, Purkyně and his students may 
have described a structure we now recognise to be the nucleus, however they did not 
suggest any possible role or significance to it.  This said, it was the first structure 
identified as an organelle, with other cellular components eventually being described 
over the following century; these are reviewed in Edmund Beecher Wilson’s 1926 
edition of The Cell. 
 Conceiving a function for the nucleus was a somewhat different endeavour, 
however developed from the structure’s identification in many cells in both animals 
and plants.  In his Cell Theory, Schleiden proposed that that the plant cell nucleus had 
a role in generating new cells, referring to it as the cytoblast. Schwann, focusing on 
animal cells, had also observed the nucleus; after conversing with Schleiden about 
these structures, Schwann wanted to demonstrate that the nucleus in the animal cell 
was also responsible for the creation of new cells269.  Schwann’s research led him to 
argue that both plant and animal cells contained cell membranes, cytoplasm, nuclei, 
and nucleoli; it was the presence of the nucleus that characterised true cells in plant 
and animal tissues270. Remak’s following work demonstrated the problems with 
several of the incorrect assumptions incorporated into Schwann’s Cell Theory, 																																																								
267 Deutsch’s work on bone was referenced by one of Johannes Müller’s students, Jacob 
Henle.  The references to Deutsch and Purkyně’s work in Henle’s 1841 textbook Allgemeine 
Anatomie demonstrate that the Berlin school were aware of the Breslau school’s useful 
contributions to the field.  Harris, 2000. 
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including the role of the nucleus in cell division.  Remak studied the developing frog 
embryo, and observed that the nucleus would divide prior to the rest of the cell271.  
Further clarification that Remak was observing cell division came from his study of 
the haematopoetic system of the developing chick.  From his research, Remak 
concluded that cell number would increase by cell division. Virchow accepted 
Remak’s version of events, and popularised this with the declaration of omnis cellula 
e cellula.  This idea was supported by the findings of Prévost and Dumas, Rusconi, 
and Barry in the 1820s and 1830s - fertilised eggs would undergo cleavage events that 
led to an increasing number of cells in the early embryo (see Chapter 1). 
 So it became understood then that the nucleus was present in almost all cells, 
and would divide prior to the rest of the cell during cell division.  What then would 
this information lead researchers to believe the function of the structure was?  It was 
later in the nineteenth century that the function of the nucleus with regards to heredity 
was considered.  Lois N Magner suggested that this way of thinking developed 
through the work of cytologists attempting to link their work to theories of heredity 
and evolution272.  Microscopy techniques had developed through the nineteenth 
century which now allowed some staining of tissues prior to observation; such 
staining suggested to cytologists that the nucleus was different in both form and 
function to the cytoplasm273.  Some stains were even capable of highlighting 
chromosomes. 
 August Weismann carried out influential work at the end of the nineteenth 
century that resulted in a new framework for thinking about development and 
heredity, in which the nucleus had a central role274.  Weismann had, up until the mid-
nineteenth century, made use of the microscope and the techniques that went with it 
for his research; in 1864 however, he developed a disorder which made microscopy 
and experimental work painful for him.  Weismann then moved into developing  his 
theoretical work - Magner argued that Weismann made his most valuable 
contributions as a theoretician275.  Weismann agreed with Charles Darwin’s idea that 
adaptions are generally made through small, subtle changes; Darwin had described a 
mechanism through which evolution could occur, and biologists needed to describe 																																																								
271 For Remak’s overview of his own work in this area, see Remak, 1862. 
272 Magner, 2002 p 395. 
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the mechanism through which inheritance could occur.  Weismann concluded that 
although looking at evolving populations was useful, it was important to understand 
how cells and individuals were involved in inheritance between generations first276.  
Weismann therefore developed his germ plasm (Das Keimplasma) theory, which 
dictated that there is a continuous line of descent from one generation of cells to the 
next, beginning with the germ cells. 
The germ plasm theory of 1892 stated that differentiation was controlled by 
‘determinants’, which controlled ‘elementary vital functions’277.  Therefore, each cell 
type’s structure and function would be controlled by its determinants.  Determinants 
were derived during mitosis (i.e. a process which does not occur in germ cells) and 
separation of the ‘ids’ (roughly translated to the genome278). 
 
“In the first cell division every id divides into two halves, each of which contains only 
half of the entire number of determinants, and this process of disintegration is 
repeated at every subsequent cell division, so that the ids of the following 
ontogenetic stages gradually become poorer as regards the diversity of their 
determinants, until they finally contain only a single kind”.279 
 
Germ cells retained the entire ‘idioplasm’. Wihelm Roux’s late 1880s work 
apparently supported this theory (see below). 
 
3. History of experimental biology 
As previously noted at the beginning of the previous section, the understanding 
of nucleus function was relevant to the way experiments were designed.  In this 
section, those experiments will be considered in more detail.  This section will move 
chronologically, beginning in the late nineteenth century with the work of Wilhelm 
Roux and Yves Delage, moving into the twentieth, particularly looking at the 
contribution of Hans Spemann.  Spemann’s work in experimental embryology was 																																																								
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highly influential, and won him a Nobel Prize in 1962.  What Spemann was interested 
in particularly was how the early developing embryo would organise itself, leading to 
many useful experiments being carried out to this end.  It also led Spemann to claim 
that much could be learned from a ‘fantastical experiment’ - the transfer of nuclei 
between cells in order to observe their influence.  In the mid-twentieth century, 
Robert Briggs and Thomas King were able to continue Spemann’s work by carrying 
out nuclear transfer in frogs, and were ultimately able to do this successfully, with 
eggs developing, though not to the embryo stage.  It would be another decade after 
Briggs and King began their work that an adult frog would result from nuclear 
transfer; this would be achieved by Cambridge researcher, John Gurdon. 
 After Gurdon’s success, attempts were made to clone other animals in the 
latter decades of the twentieth century.  To examine this, this chapter will consider the 
work carried out by Karl Illmensee; this is not to suggest that Illmensee’s work was 
carried out in isolation.  On the contrary, Illmensee’s network included several other 
influential biologists from the fields of cell biology and development, including Leroy 
Stevens and Beatrice Mintz, for example.  Focusing on Illmensee’s contributions 
highlight where late twentieth century researchers were using embryological methods 
to learn about genetics and where genetics was being used as data support for 
developmental biology theories. 
 
3.1 Fantastical experiments I: Late nineteenth and early twentieth century 
In his 1938 text, Spemann suggested that it was Weismann’s Das Keimplasma 
and anatomist His’ Über unsere Körperform (1874) that kick-started the work in 
experimental development.  During the latter half of the nineteenth century, Spemann 
reported that the science of morphology was thriving in Germany280.  His made the 
study of chick embryos his work, in an attempt to elucidate the formation of layers 
and their folding in the developing embryo.  Roux made advances in developmental 
embryology using experimentation to determine the direction of development (as 
proposed by the germ plasm theory), and what caused these.  Whereas Roux felt that 
he could demonstrate that ‘internal forces’ were the only controlling mechanisms of 
development (as in the germ plasm theory), another physiologist, Eduard Friedrich 
Wilhelm Pflüger (1829-1910), believed that external forces could also have an effect 																																																								
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(in a similar way that gravity appeared to have an effect on the growth of plants)281.  
Roux discounted Pflüger’s theory by continually changing the position of the 
developing fertilised egg, and demonstrating no deviances from normal 
development282.  Spemann went on to recall Roux’s following ‘pricking experiments’, 
“which exercised an enormously stimulating influence on future research”283 (see also 
Chapter 1).  In 1907, Michael Guyer (1874-1959) (whilst at the University of 
Cincinnati) used a very similar technique (pricking one cell with a fine capillary 
containing blood cells).  Many eggs developed to the blastulae and gastrulae stage, 
and two became swimming tadpoles284.  Guyer accredited this to the injected 
leukocytes, stating his belief that the female pronucleus took no part in 
proliferation285.  Cell biologist Robert McKinnell suggested this experiment (and it’s 
results) were particularly important for two reasons: firstly, it suggested that at least 
some cells from adult organisms retained developmental potential; secondly, this was 
the type of ‘fantastical experiment’ Spemann referred to286. 
In the late 1880s, Roux began his pricking experiments using two-cell frog 
(Rana esculenta) embryos.  Using a fine, hot needle, Roux would puncture one of the 
cells (with the aim of killing it, rendering it unable to contribute to development), 
whilst leaving the second cell to develop normally.  Roux observed that the usual 
result of the experiment was that half an embryo would develop from the cell left 
intact.  Therefore, Roux argued, the material for development of one half of the 
embryo was contained in one of the cells at the two-cell stage.  Later (during the 
1890s), Roux decided that since the remaining half appeared to be developing 
normally, there is no need for the second half of the egg.  The ‘causal topographical 
conception’ as Roux called it, stated that as long as the living half of the fertilised egg 
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had all of the conditions required to develop (e.g. oxygen, heat, etc.), the remaining 
half could continue its development normally287. 
Similar work (with similar results) was carried out by Laurent Chabry (1855-
1893) (using a glass needle) at the same time as Roux, using early Ascida (sea squirt) 
embryos.  A few years later, Hans Driesch experimented with early sea urchin 
(Echinus microtuberculatus) embryos, separating cells by shaking them in sea water.  
This experiment was important (according to Spemann), since it demonstrated that 
Roux’s findings were not as a result of any effect from the pricked cell288.  Instead of 
observing half-embryos as Chabry and Roux initially had, Driesch’s sea urchins were 
notably smaller, but nevertheless fully developed larvae. 
Hermann Endres (1895) and Spemann (1901) were both able to repeat Driesch’s 
experiments in urodele embryos, whilst Albert Brachet (1904) and later GA Schmidt 
(1933) repeated the work using anuran eggs.  It was noted that if the “gray crescent 
material” was distributed evenly between separated blastomeres (using hair-loop 
constriction289), two normal (but small) embryos would develop290.  Boveri would 
comment on these experiments in the early twentieth century, interpreting the results 
as demonstrating that if the nucleus was in-tact when “fragments” were taken from 
the early embryo, then such a fragment could “give rise to normal dwarf [smaller than 
average] embryos”291.  Much later, similar work was carried out in mammals (with 
single blastomeres implanted into the oviducts of pseudopregnant females), 
specifically rabbits292 and mice293. 
 It has been argued that prior to the published work of Spemann in the late 
1930s, the French biologist Yves Delage (1854-1920) proposed nuclear transfer294.  In 
1895, Delage published La Structure du Protoplasma, les théories sur l’Hérédité et 
les grands problèmes de la Biologie géneralé, in which he suggested that 
differentiation occurred due to differences in the cytoplasm between daughter cells.  
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This then caused changes in the nucleus.  Delage proposed an experiment that would 
demonstrate this:  
 
“…if, without any deterioration, the egg nucleus could be replaced by the nucleus 
of an ordinary embryonic cell, we should probably see this egg developing without 
changes.”295 
 
It can convincingly be argued then that the original aim of nuclear transfer was 
to test Weismann’s germ plasm theory (part of which stated that differentiation 
occurred as a consequence of unequal nuclear division throughout embryonic 
development)296.  The theory suggested that the differences in the nuclei that resulted 
during cell division would determine (differentiated) cell type.  The first attempts to 
experimentally test this theory were probably made by August Rauber (1841-1917) in 
the late 1880s.  During this period, Rauber was the Head of the Institute of Anatomy, 
Histology and Embryology at the University of Tartu (Dorpat) in Estonia297.  
Amongst many other experiments utilising early embryos and fertilised eggs, Rauber 
exchanged the nuclei of frog and toad eggs one hour after fertilisation; neither egg 
developed, possibly as a result of ‘rough treatment’298.  It appeared however that 
nuclear transfer did not demonstrate clearly Rauber’s hypothesis (that the nucleus and 
cytoplasm together transmit hereditary traits to the offspring)299.  Roux was 
apparently well aware of Rauber’s work, although Driesch probably did not earlier 																																																								
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on300.  Later, Driesch referred to Rauber’s work, but only briefly, since Rauber “failed 
to get any results at all”301. 
Oscar Emile Schotté (1895-1941) obtained his doctorate under Emile Guyénot 
(1885-1963) at the University of Geneva in 1925, before moving to Freiburg and 
Spemann’s group with a Rockefeller Foundation Fellowship in 1928.  At the time, 
Spemann and his group were concerned with the interaction of tissues in embryonic 
development; Schotté’s contribution would highlight the role of genetic transmission 
in embryonic development302.  In Freiburg, Schotté carried out xenotransplantations 
between frog and salamander embryos.  Transferring the ventral ectoderm of a frog 
gastrula to a salamander gastrula mouth region would result in developing salamander 
larvae with jaws and suckers of a frog.  The reciprocal transplant would result in 
tadpoles with balancing rods and dentine teeth of salamanders303. 
Hans Spemann was the first embryologist to win a Nobel Prize for work in 
developmental biology304.  Spemann believed that the nucleus of the morula provided 
the genetic information required to produce an entire embryo.  To demonstrate this, 
over approximately 15 years, Spemann devised a method to introduce a morula 
nucleus into an egg which had had its nucleus removed.  Spemann also believed that 
it would have been a useful experiment to inject the nucleus of a more differentiated 
cell into an enucleated egg, whilst conceding that a failure to develop would not 
necessarily be as a result of transplantation of an incomplete genome; in his 1938 text, 
Spemann stated that “genes may be lost or become ineffective in other ways besides 
that of elimination out of the cell”305. 
When talking about this work in the Silliman Lectures (delivered at Yale 
University in 1936), Spemann suggested that the main problem in furthering this work 
was obtaining a denucleated egg.  If this could be achieved, he argued, it might 																																																								
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demonstrate that the nuclei of differentiated cells could initiate normal development 
in the correct environment (i.e. the oocyte cytoplasm)306.  This suggests that Spemann 
could see the importance of the argument that the oocyte cytoplasm was essential to 
development, and also his anticipation into somatic cell nuclear transfer or cloning.  
Maienschein has suggested that Spemann’s foresight into the possibilities of nuclear 
transfer was due to Spemann’s interest in transplanting “just about anything 
experimentally”307. 
 
3.2 Fantastical experiments II: Mid-twentieth century 
This chapter has already briefly considered the work in heredity that was 
occurring under the embryology paradigm at the beginning of the twentieth century, 
which is probably most well-known for Spemann’s conceiving of a ‘fantastical 
experiment’, where genetic transmission could be studied as part of embryological 
development (by nuclear transfer).  In the mid-twentieth century, such fantastical 
experiments became possible, again perhaps highlighting a role for the study of 
heredity under the embryological paradigm. 
Robert William (“Bob”) Briggs was born in Massachusetts in 1911, moving to 
be raised by his grandparents at the age of 2 (after his mother and brother died of 
tuberculosis).  Briggs stated that he had a happy, stable childhood, surrounded by 
aunts and uncles.  Although his lifelong love of music was encouraged by his family, 
his passion for biology was stirred by a high school teacher; Briggs spent his time 
collecting small animals and plants and examining them under magnifying glasses or 
the school’s microscope.  After completing his schooling, Briggs went to Boston 
University, working nights to fund himself.  After completing his first degree, Briggs 
was convinced that his future was in biology, and went to graduate school at Harvard, 
receiving his Ph.D. in 1938 for a project investigating metabolic changes during frog 
development308.  Continuing with amphibian research, Briggs became a fellow at 
McGill University before moving to the Lakenau Hospital Research Institute in 
Philadelphia309, where he continued research using frog embryos310. 																																																								
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Thomas Joseph King Jr was born in New York in 1921.  King’s mother died in 
childbirth, and so King was raised by his aunt.  King earned his B.S. from Fordham 
University in 1943, after which he served as an army instructor for the Army Medical 
Technicians School in Georgia.  Leaving the army three years later, King returned to 
New York to New York University, earning a Masters degree for his work on tumours 
in R. pipens.  It was during this period that King trained in microsurgery; this skill 
encouraged Briggs to recruit King to his laboratory in Philadelphia in 1950 as a 
research fellow311.  McKinnell claimed that Briggs and King carried out “the first 
successful experiments involving the introduction of a living, undamaged embryonic 
nucleus into an activated and enucleated recipient egg” in 1952312. 
 
It has been reported that Briggs applied for several grants before the research 
could begin with funding from the National Institutes for Health313.  Briggs and King 
were ultimately successful however, and were able to fund their research taking the 
nuclei of donor cells from R. catesbeiana (the bullfrog) and inserting them into eggs 
of R. pipens (northern leopard frog).  This resulted in development to the blastula 
stage314.  Donor blastulae were produced by inseminating R. pipens eggs with R. 
catesbeiana sperm.  The egg nucleus was removed, producing androgenic haploid 
hybrids.  Other eggs fertilised in the same way were allowed to develop to diploid 
hybrids.  After 18 hours, all of the fertilised eggs had developed to the mid- to late 
blastula stage, and their nuclei harvested for transplantation.  A useful control 
mechanism is important here: R. pipens and R. catesbeina hybrids do not survive past 
the mid-blastulae stage.  Approximately half of the enucleated eggs which received 
donor nuclei developed to the late blastulae stage before arresting.  Many displayed 
abnormalities related to cell division, and some had chromosomal abnormalities 
(presumably due to earlier irregular division).  This said, Briggs and King considered 
development to this stage a success (since the cells could not have been R. pipens x R. 
catesbeina hybrids if the eggs developed to this late stage).  In the conclusions of their 
publication, Briggs and King suggested that successful development of the nuclear 
transfer method would be particularly important in studying nuclear differentiation.  It 																																																								
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may also have other uses, such as testing the impact on variously treated nuclei, or 
developing an optimal nuclear medium (something which should have “real 
importance for future studies of nuclear biochemistry”)315.  McKinnell praised the 
authors for their convincing argument that the enucleated egg cytoplasm was the ideal 
‘test site’ for a variety of nuclear tests (also referring to Briggs, Green and King, 
1951)316.  Later, Briggs and King would be able to develop these nuclear-transferred 
eggs to the larval stage317. 
In order to contribute to the debate over the contribution of male and female 
pronuclei/cytoplasm, Briggs and King also carried out experiments to investigate the 
importance of cytoplasm.  At the end of the 1950s, Briggs and King announced their 
findings that endoderm cytoplasm (by itself) could not elicit or alter cleavage or 
differentiation on enucleated or nucleated eggs318.  By the late 1970s, further work 
had been carried out in this field (such as work by DiBerardino), leading McKinnell 
to conclude that “The elucidation of the molecular events by which the cytoplasm 
effects a reprogramming of inserted nuclei is perhaps the most exciting area in cell 
biology today”319. 
The donor nuclei used by Briggs and King were from blastula-stage cells only, 
not more differentiated cells (as Spemann and Delage had suggested); development 
after transplantation of nuclei from cells cultured to a later stage was not 
successful320.  However, for their pioneering work on nuclear transplantation, Briggs 
and King would be awarded the Charles-Leopold Mayer Prize by the French 
Academy of Sciences in 1972; the first Americans to receive the award321.  
Maienschein has observed that Briggs and King considered nuclear transfer to be the 
starting point for research into heredity and development322, perhaps again indicating 
that, despite the separation of heredity and genetics as disciplines, heredity studies 
were still carried out under embryological paradigms. 
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Notwithstanding John Gurdon’s apparent lack of expertise after becoming 
aquainted with biology for the first time as a teenager323, he was offered a place at 
Oxford to study Zoology324, and allowed an extra year to make up for the learning he 
had not been able to do at school.  After failing at his first attempt at applying for 
graduate work, Gurdon was “fortunately accepted” to work under Michail Fischberg 
in 1956, then the embryology lecturer at Oxford325.  This gave Gurdon a pedigree 
which would lead back to Hans Spemann and Theodore Boveri326; Fischberg had also 
worked under CH Waddington in Edinburgh327. 
Following the methods of Briggs and King, injecting nuclei into eggs, Fischberg 
encouraged Gurdon to carry out similar work, in an attempt to achieve nuclear 
transplantation in Xenopus (clawed frogs).  Following the work of Weismann (1892), 
Spemann (1928) and later Briggs and King (1952), Fischberg was aware of the 
importance of genetics in studying development.  In addition, Gurdon claimed that 
Fischberg had selected Xenopus as his experimental model of choice since it would 
grow to maturity within a few months, produced eggs all year round, and could be 
easily kept in the laboratory.  Initially, Gurdon was frustrated by the protective jelly 
of Xenopus eggs.  Fischberg’s newly-obtained UV microscope was purchased in order 
to eradicate egg chromosomes (resulting in enucleated eggs, ready to accept a donor 
nucleus), however Gurdon also found that very low wave lengths were also useful in 
dissolving the frustrating jelly.  Gurdon reported that a second piece of good luck was 
the discovery of an individual frog that would produce single-nucleolated diploid 
embryos328, making it a very useful genetic marker of nuclear transplantation – there 
was no need to carry out enucleation in the donor eggs, so any embryos produced 
would have to have been a result of successful nuclear transfer.  Gurdon’s further 
research would eventually result in the first cloned adults (Figure 1). 																																																								
323 Gurdon quotes part of his teacher’s report after he had been studying biology for a term in 
the late 1940s: “I believe Gurdon has ideas about becoming a scientist; on this present 
showing this is quite ridiculous; if he can’t learn simple biological facts he would have no 
chance of doing the work of a specialist, and it would be a sheer waste of time, both on his 
part and of those who would have to teach him”.  Gurdon, 2006 p 2. 
324 Gurdon modestly suggests that he gained a place at Oxford University since “at that time, 
the universities were short of applications”.  Gurdon, 2006 p 2. 
325 Gurdon, 2006 p 2. 
326 Buscaglia and Duboule, 2002. 
327 Gurdon, 2006. 
328 These were eggs with only a single set of ribosomal genes, which provided a useful 
marker.  This is described in greater detail in Elsdale, Fischberg, and Smith, 1958; Brown and 
Gurdon, 1964; Wallace and Birnstiel, 1966. 
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Figure 1: The first mature adult vertebrate produced using nuclear 
transplantation.  From Gurdon, 1962a. 
 
As Briggs and King reported in 1957, Gurdon also concluded that as cells 
differentiate, the nuclei become less able to allow development of enucleated eggs.  
That said, Gurdon then observed that nuclei from differentiated cells of the tadpole 
intestine were also capable of producing (fertile) adult frogs329.  This led Gurdon to 
conclude that even in differentiated cells, the genome was stable.  This was not, 
Gurdon confessed, generally accepted, particularly by more senior researchers.  
Eventually Gurdon went on to further demonstrate his theory, by transferring nuclei 
from other differentiated cells, including muscle, lung, skin and kidney330. 
In addition to showing what differentiated and undifferentiated cells were 
capable of genetically, these experiments also demonstrated the “remarkable powers” 
of egg cytoplasm331.  Gurdon went on to continue working with this in mind through 
the late 1950s and 1960s. 
 
3.3 Fantastical experiments III: Late twentieth century 
As a student of Briggs in the mid-1970s, Maienschein has described Briggs’ 
surprise that the public was not more interested in this type of work and the cloning 
possibilities it presented332.  It was not only the public that missed Briggs and King’s 
work: Maienschein has suggested that genetic determinists have often ignored the role 
of the cytoplasm too.  It has not been ignored by developmental biologists however, 																																																								
329 Gurdon, Elsdale, and Fischberg, 1958; Gurdon, 1962b. 
330 Laskey and Gurdon, 1970; Gurdon, Laskey, and Reeves, 1975; Gurdon et al., 1984. 
331 Gurdon, 2006 p 4. 
332 Maienschein, 2003 p 120. 
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who appreciated the importance of the zygote’s organelles333.    As late as the 1980s, 
some scientists remained sceptical of the benefits of cloning and developmental 
genetics (for research if not therapeutics); in their 1983 textbook Recombinant DNA: 
A Short Course, James Watson, John Tooze and David Kurtz wrote: 
 
“In the immediate future there is little likelihood of nuclear transplantation being 
attempted with any other mammalian species…If the efficiency and reproducibility 
can be improved, the method may, however, find a place in animal breeding.  In 
theory, it could be attempted with human eggs and embryonic cells, but for what 
reason?  There is no practical application.”334 
 
* * * 
The Austrian Karl Oskar Illmensee was born in Lindau in 1939.  He moved to 
Ludwig Maximilian University in Munich to study chemistry and biology, receiving 
his doctorate in 1970335.  During the period of Illmensee’s education, reproductive 
biology studies in mammals had established an artificial insemination method, which 
was soon used in standard practice (and was a huge boost to, for example, dairy farms 
of the period)336.  In 1965, George Pincus had published his book The Control of 
Fertility, which was intended for a wider audience, despite the scientific details and 
data it contained337.  Maienschein described the era as a time when learning and 
talking about sex and reproduction became more socially acceptable, and a “great 
deal” had been learned from developmental studies carried out on animal embryos338.  
It was during the 1960s when the Cambridge physiologist Robert Edwards (1925-
2013) began studying the cells of the pre-implantation embryo339 and Richard 
Gardner (1943-) produced a chimaeric embryo by inserting cultured embryonic stem 
cells into murine blastocoels340 (producing a mouse which had cells developed from 
																																																								
333 ibid, p 31, 256.  Karl Illmensee by this definition then would be a ‘developmental 
biologist’ as opposed to a ‘geneticist’, since his research included work on the cytoplasm and 
the effect it had on embryonic cells. 
334 Watson, Tooze and Kurtz, 1983 p 207-208. 
335 Karberg, 2007. 
336 Maienschein, 2003 p 140-1; McCarry, 1999. 
337 Maienschein, 2003 p 141-2. 
338 ibid p 141-2. 
339 Edwards has commented that his work on stem cells had to be placed on the ‘back burner’ 
as the demands of his work on in vitro fertilisation with Patrick Steptoe were greater.  
Edwards, 2001b. 
340 The hollow area inside a developing embryo. 
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both the original and the donor cells)341.  Edwards has written that by this time 
“…‘ES’ [embryonic stem] cells became a familiar term [to scientists], reflecting their 
immense potential in colonizing chimaeras”342. 
llmensee’s first publication, written whilst in Munich, described the 
transplantation of embryonic nuclei into unfertilised eggs in Drosophila melanogaster 
(fruit flies)343.  Following his own interests in cloning, Illmensee had moved to 
Indiana University in the early 1970s, into the Department of Zoology.  Later 
Illmensee would claim that he believed that since cloning had been carried out in 
frogs, why not try it in insects344?  Furthermore, Drosophila had been used for several 
decades by this point345, which included some studies on chromosomes and genetics 
(see below)346.  Also using fruit flies, Illmensee eventually managed to remove the 
nuclei of more differentiated cells and insert them into enucleated eggs, with 1% 
developing to the larval stage (and one example almost to the pupae stage)347.  
Illmensee continued his work using Drosophila348 alongside his colleague Anthony 
Mahowald349.  It had previously been demonstrated that primordial germ cells (PGCs) 
of D. melanogaster form at the posterior tip of the developing embryo at the 
preblastoderm stage (the phase following fertilisation of the egg).  Illmensee and 
Mahowald set out to determine whether the formation of PGCs could be induced from 
the posterior polar plasm (i.e. the cytoplasm at the posterior tip of the developing 
blastocyst) at the preblastoderm stage; in the introduction to the paper, Illmensee and 
Mahowald referred to Boveri’s 1887 work in Ascaris, describing cytoplasmic 
determinants in the formation of germ cells, although not to Schotté’s earlier work 
transplanting various sections of embryos between frogs and salamanders.  Illmensee 																																																								
341 Gardner, 1968. 
342 Edwards, 2001a p 349. 
343 Illmensee, 1968. 
344 Karberg, 2007. 
345 For example, Thomas Hunt Morgan made use of fruit flies during his time at Columbia 
University in the first decades of the twentieth century.  Morgan, in a paper referring to rat 
breeding, preferred using Drosophila as they were a wild species, and study of evolution 
should be carried out on non-domesticated creatures.  Morgan, 1909; Kohler, 1994 p 1, 42-3. 
346 Rudkin and Schultz, 1956. 
347 Boveri, 1887; Illmensee, 1968. 
348 At the time there was no tool appropriate for handling the microscopic fly eggs.  During 
the first year of his Ph.D., Illmensee spent much of his time designing a small glass pipette 
and other implements required for manipulation of the eggs and nuclei (Karberg, 2007).  
Earlier glass microneedles and pipettes had initially been created for amoeba work in the 
1930s (Comandon and de Fonbrune, 1932; de Fonbrune, 1934). 
349 Illmensee and Mahowald, 1974. 
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continued working with Mahowald on manipulation of fruit fly cytoplasm during 
1975-6350.  This work demonstrated that the cytoplasm contained germ cell 
determinants and the effect this had on early embryo cells.  
 His intricate work on the manipulation of fruit fly eggs earned Illmensee the 
reputation of having ‘blessed hands’ (despite his failure to produce a cloned fly351).  It 
was after his move to the Institute for Cancer Research in Philadelphia in 1974/5 that 
Illmensee met and worked with Beatrice Mintz (1921-) on mosaic mice produced by 
using malignant teratocarcinoma cells352.  Following his work on fruit flies, Illmensee 
learned to manipulate the oocytes of mice.  The first of the two papers published by 
Illmensee and Mintz described the process by which ECCs (with a normal karyotype) 
were taken from embryoid bodies353 (cultured as ascites tumours for 8 years) and 
injected into blastocysts (see also Chapter 3).  Illmensee and Mintz stated that their 
intention was to test the reversibility of malignancy, developmental capacity and 
‘genetic constitution’ of the ECCs. 
 
“The most rigorous test possible for developmental totipotency would be significant 
contributions of the carcinoma cells to the normal differentiation of virtually all 
tissues of the mouse.  For this to occur, the initially malignant cells would 
presumably have to be brought into association with early embryo cells so that the 
latter could provide an organizational framework appropriate for normal 
development.”355 
 
The ascites tumour used was, like most others, obtained from Leroy Stevens’ 
laboratory, and had been maintained in inbred strain 129 mice.  This was useful as it 
allowed those carrying out similar work to compare their results more directly.  The 
blastocyst injection technique was used to create the mosaic mice: blastocysts from a 
different inbred strain of mouse (named C57) were each injected with 5 ECCs356 near 
to the inner cell mass.  Following this procedure the blastocysts were incubated for 
four hours at 37ºC before being transferred to the uteri of pseudopregnant albino 
female mice.  Of the fourteen foetuses and postnatal mice analysed, three were found 																																																								
350 Mahowald, Illmensee and Turner, 1976; Illmensee and Mahowald, 1976. 
351 Only in 2004, after 820 trials, were five live Drosophila clones produced by a group in 
Canada (Haigh, MacDonald and Lloyd, 2005). 
352 Mintz and Illmensee, 1975; Illmensee and Mintz, 1976. 
353 Stevens, 1960. 
355 Mintz and Illmensee, 1975 p 3585. 
356 These cells were from the ‘core’ of the embryoid bodies, after the removal of the yolk sac 
‘rinds’ (Mintz and Illmensee, 1975).  This is illustrated in Figure 2. 
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to be mosaic mice, labelled as mosaic mouse no.1, no. 2 and no. 3 (the remaining 
eleven had developed from C57 cells only).  The published paper described the 
cellular composition of each mouse in detail. 
 
 
 
Figure 2: The eight-year history of the mosaic mice created by Mintz and Illmensee 
using teratocarcinoma cells.  From Mintz and Illmensee, 1975. 
 
Evidence of the contribution of the teratocarcinoma cells to the normal 
development of the mice could easily be observed by differences in coat colour, 
where, for example, agouti and non-agouti hair could be observed in the same 
mouse357.  Further tests carried out on the mosaic mice demonstrated that the 
circulating blood cells were predominantly typical of strain 129 mice, although some 
C57-type blood cells were also observed in mosaic mouse no. 1, whilst no strain 129 
blood cells were observed in no. 2.  Gel electrophoresis was used to further establish 
that the liver of no. 1 contained cells derived from the original C57 blastocyst and the 
strain 129 teratocarcinoma donor cells.  No. 2 contained cells of strain 129 origin in 
her kidneys and thymus.  Morphogenically, her reproductive tract was normal, 
																																																								
357 In the male mosaic mouse no. 1, the agouti coat of the strain 129 derived cells and the non-
agouti of the C57 cells could be observed as ‘stripes’ across the animal.  Mintz and Illmensee, 
1975 p 3586. 
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although some XY cells from the strain 129 cells were observed358.  Likewise, male 
no. 3 also had strain 129 cell contribution to the liver (33%), spleen (20%) and 
kidneys (33%).  This mouse was culled at 3 days of age, so was not bred from.   
The initial results of this experiment were presented at a meeting by Mintz, 
much to the surprise of Stevens, who had provided the original ascites teratoma359.  It 
was only at this meeting that Stevens became aware of these experiments, although he 
personally communicated with Mintz and Illmensee prior to the publication of this 
1975 paper.  Stevens had answered a query from Mintz and Illmensee, regarding a 
coat colour gene named steel, which was also evident in no. 1.  Stevens had 
confirmed that the mother of the mouse from which the original teratoma had been 
taken had a steel allele360.  Don Varnum, a technician in Stevens’ laboratory at the 
time, spent a few years working with strain 129 mice.  He reported that by adding the 
gene steel to the strain 129 mice, teratoma formation in males increased to 10%, 
increasing the number of teratomas available for research361.  
Mintz and Illmensee continued their work by mating no. 1 with C57 females; 
the 61 offspring produced were all normal, and demonstrated that the sperm from no. 
1 were from the 129 strain (some progeny had inherited the steel gene). 
Importantly, this study demonstrated that teratocarcinoma cells were capable 
of contributing to normal development (i.e. differentiation and proliferation in a 
controlled manner).  Mintz and Illmensee also demonstrated that the core cells of the 
embryoid bodies remained tumourigenic; when tested by subcutaneous inoculation, 
this resulted in teratoma formation.  The transplanted cells were also capable of 
normal differentiation.  The range of cell types derived from the original 5 cells 
transplanted also suggested that these cells had already partially committed to a line 																																																								
358 Although female, no. 2 was still found to have XY cells derived from the original (male) 
XY strain 129 cells injected into the blastocyst. 
359 Mintz had been a visitor to Stevens’ laboratory, there to learn mouse embryology 
techniques.  By this time, Stevens had been maintaining teratoma-derived cells (using serial 
transplants) for eight years.  Stevens’ daughter, Anne Wheeler, suggested that the reason her 
father was so surprised when Mintz presented her results was that he had mentioned the 
experiment to her as work he was considering carrying out.  Mintz, with a larger laboratory 
and more research funding, had produced the chimeric mice first.  Wheeler recalled her father 
suggesting that this was the end of an era where researchers shared their ideas and helped 
each other.  Instead, research became more secretive and information would not be so freely 
shared.  Lewis, 2001 p 136. 
360 This is a relatively important question that suggests Illmensee’s good attention to detail – 
particularly with reference to possible inherited genes.  This is contrasted by his apparent 
complacency later on, leading to accusations of fraud (see below). 
361 Lewis, 2001 p 132-5. 
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of differentiation and were multipotent, not pluripotent.  Furthermore, this suggested 
that an entire embryo could not be created using only ECCs. 
In addition to this paper, Mintz and Illmensee published for the second time 
only five months later; this paper described in further detail analysis of other mosaic 
mice and the contribution of the strain 129 cells to each organ362.  It was also possible 
to inject only one 129 cell into a blastocyst and for mosaic mice to be created.  It was 
shown that despite the demonstrated tumourigenicy of the cells used, only one of the 
21 mice developed cancer (a pancreatic adenocarcinoma, shown to have developed 
from strain 129 cells).  None of the animals gave any indication of teratoma 
development, however as a note added in proof, Illmensee and Mintz highlighted a 
paper published by Virginia Papaioannou et al. (1975) in which several mosaic mice 
(created by a similar method) developed tumours363. 
In late 1977, alongside Peter Hoppe at Jackson Laboratories (JAX – see 
Chapter 3), Illmensee published a paper describing what was essentially the cloning 
of mice; the title of the paper referred to these clones as “homozygous-diploid 
uniparental mice”364.  Shortly after being fertilised, one of two pronuclei of the eggs 
was removed, leaving the haploid egg.  These were first cultured in media which 
allowed nuclear division but not cytokinesis (this technique allowed the remaining 
pronucleus to become diploid) before being transferred to media which would allow 
normal cell growth and division.  These early embryos were then transplanted into 
pseudopregnant females; of the 93 transplants, 7 live births resulted, all female.  Five 
of these offspring were derived from the maternal genome (gynogenesis) whilst two 
mice had inherited the paternal genes (androgenesis)365.  Homozygosity was shown 
across several different genetic loci in all of the mice.  Six of the seven mice born had 
a normal diploid karyotype (including two X chromosomes) and were shown to be 
fertile.  In this publication, Hoppe and Illmensee mentioned the previous work of 
Oxford University zoologist CF Graham, who had also created ‘uniparental’ 
																																																								
362 It was also noted here that of 161 blastocysts injected with strain 129 cells and surgically 
transferred, 71 survived (44%).  Of the 71 animals born, 30% were shown to contain strain 
129 strain cells in at least one tissue.  Illmensee and Mintz, 1976. 
363 Papaioannou et al., 1975.  See also Chapter 3. 
364 Hoppe and Illmensee, 1977. 
365 This occurred as either the maternal or paternal pronucleus had been removed during the 
first phase of the experiment, leaving some fertilised eggs with the maternal pronucleus and 
some with the paternal pronucleus. 
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embryos366.  In the acknowledgements, Stevens is thanked for his “generous 
support”367.  As with Evans’ work on developing an embryonic stem cell line (see 
Chapter 4), Hoppe and Illmensee’s comments in this paper suggested that these mice 
could be used as a tool in further research (for example, “studying gene action during 
mammalian embryogenesis”368), and not simply as an end in itself.  In a later review, 
Illmensee also saw the ‘uniparental’ mouse model as useful in the study of X 
chromosome inactivation and as a way of comparing paternal and maternal gene 
activity during development369.  This perspective appears to have changed somewhat 
in later years, as mammalian cloning began to be recognised as useful for many 
applications, and Illmensee felt his early contribution to the field had not been 
sufficiently appreciated.  This was likely due to the claims of fraud against Illmensee 
and this work (see below).  In addition, Illmensee was prevented from carrying out 
work on cloning for several years due to problems in attracting funding – again as a 
result of the fraud accusations.  More recently, Illmensee has been involved in cloning 
as a useful application in infertility treatment; although funded, this work is still 
controversial and illegal in some countries. 
In 1964, Lewis J Kleinsmith and G Barry Pierce had demonstrated that 
teratocarcinoma cells remain pluripotent (by showing that they can clonally give rise 
to various tissue types typical of teratocarcinomas)370; when injected into mouse 
blastocysts, normal development had been observed371.  In 1978, alongside Hoppe 
and Carlo Croce (at the Wistar Institute, Pennsylvania), Illmensee reported that he had 
produced chimaeric mice from mouse teratocarcinoma cells and human fibrosarcoma 
cells372 (see Figure 3).  The mouse-human hybrid cells initially produced were 
injected into mouse blastocysts.  The resulting mice were shown to retain at least one 
human chromosome (17) in resulting mosaic organs (although human gene products 
were only weakly identified in two of the mosaic tissues – heart and kidney).  																																																								
366 Graham, 1974. 
367 Hoppe and Illmensee, 1977 p 5660. 
368 ibid p 5657. 
369 Illmensee, 1982.  This type of work eventually came to fruition, with later publications by 
Illmensee.  For example, in 1987, Illmensee published a paper describing the expression of 
phosphoglycerate kinase (PGK-1), an X-linked enzyme, in early mouse embryos (Fundele et 
al., 1987). 
370 Kleinsmith and Pierce, 1964. 
371 Brinster, 1974; Mintz and Illmensee, 1975; Illmensee and Mintz, 1976; Papaioannou et al., 
1975.  See also Chapter 3. 
372 Illmensee, Hoppe and Croce, 1978. 
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Illmensee considered this comparable to the results published with Mintz in 1976.  
Illmensee, Hoppe and Croce suggested that this might be a useful technique for 
studying human gene expression during differentiation. 
 
 
 
Figure 3: This is the mouse pictured in Illmensee, Hoppe and Croce, 1978.  
However, during the 1980s, the origins of this mouse were questioned, particularly 
as the origin of the white patches of fur could not be explained.  Joachim Huarte, a 
graduate student in Illmensee’s laboratory, claimed that this mouse did not originate 
from the described experiment.  Illmensee later conceded that he had confused this 
mouse with another, arising from a testicular cancer cell implanted into an 
embryo373. 
 
In the discussion of the 1978 paper, Illmensee explained the unexpected white 
markings on the coat of the mouse.  The teratocarcinoma cell line used was 
heterozygous for the steel gene, and had previously exhibited an agouti phenotype374.  
Illmensee suggested that the human-mouse hybrid cells may have become 
hemizygous for steel (i.e. phenotypically white) since a small deletion on 
chromosome 10 carried the wild-type allele.  Spontaneous mutation on chromosome 7 
at the albino locus could also have caused this change in coat colour.  Later, Illmensee 
wrote about the fate of the human insulin gene in transgenic mice, suggesting that he 
																																																								
373 Image from Illmensee, Hoppe and Croce, 1978.  The allegations of forgery were reiterated 
in New Scientist (31 May 1984).  New Scientist writer MacKenzie claimed that this mouse 
was produced when ‘a tumour cell from a mouse ovary was implanted into a mouse embryo 
at the very early blastocyst stage’ (p 3).  However, the original paper stated that this mouse 
developed from a mouse blastocyst injected with a human-mouse hybrid cell.  The white 
patches observed were said to have been derived from the injected hybrid cell (approximately 
20% of the total coat) (Illmensee, Hoppe and Croce, 1978 p 1916). 
374 Described in Mintz and Illmensee, 1975. 
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(or at least those working for him) continued work on human-mouse hybrids375.  This 
may be considered as a ‘fore-runner’ to Martin Evans’ work in creating mouse models 
of human disease, which was first proposed by Evans’ research group in 1987376. 
In his 1978 textbook on amphibian cloning, McKinnell wrote an interesting 
summary of where cloning research was at the time: 
 
“It would be nice to conclude…by stating that the old questions posed half a 
century or more ago are now resolved.  They are not.  We still do not know how 
many cell types (if any) in the adult are totipotent.  There is controversy concerning 
the results obtained by nuclear exchange…There is good reason to believe that egg 
cytoplasm has the capacity to order a somatic nucleus to mimic a zygote nucleus.  
…[H]opefully [the rest of this book], will reduce some of the misunderstanding of the 
results of cloning studies.”377 
 
In 1979, Illmensee and Croce published together describing the creation of 
chimaeric mice from rat-mouse hybrid cells; the murine cells were teratocarcinoma 
cells, and the rat cells were hepatoma cells.  Although no visible coat mosaicism was 
observed, the chimaeric mice were positive for rat-specific liver enzymes.  This work 
was described as more successful than the previous human-mouse hybrid attempts by 
Illmensee and Croce, and was followed up by a second publication in 1982378.  This 
paper examined the protein synthesis of rat-mouse hybrid cells in chimaeric organs.  
The first author of this paper was Denis Duboule, a PhD student. 
Illmensee was clearly interested in teratocarcinomas, and published (alongside 
Stevens) a substantial review (“Teratomas and chimeras”) in Scientific American in 
1979.  The paper described what teratomas were, and illustrated the differentiation of 
these tumours into a variety of tissues.  It also described the strain 129 mice, as 
established by Stevens, as well as the embryoid bodies and ECCs.  Illmensee and 
Stevens reviewed the work by Kleinsmith and Pierce (1964) as well as Brinster, 
Gardner and Papaioannou, who created chimaeras from teratocarcinomas and 
achieved live births379.  The review ended with some of the work carried out by 
Illmensee with Croce and Hoppe, in creating hybrid cells and chimaeric mice. 
																																																								
375 van der Putten, Botteri and Illmensee, 1984. 
376 Kuehn et al., 1987; Evans, 1989.  See also Chapter 3. 
377 McKinnell, 1978 p 20. 
378 Duboule et al., 1982. 
379 Papaioannou et al., 1978; Brinster, 1976. 
CHAPTER 2  112 
 
Following his own hybrid and chimaera work, Illmensee published a series of 
three papers on the formation of the cytoskeleton during embryogenesis380.  These 
appear to be papers produced from the work of Illmensee’s laboratory workers and 
students, one of which was Kurt Bürki.  Again these papers appear to indicate that 
Illmensee, similarly to Martin Evans, saw manipulation of the mouse embryo as a tool 
for further experimentation, such as creating mouse models or investigating genetics 
during cell differentiation. 
Illmensee and Hoppe continued working together, publishing an important 
joint paper in the journal Cell in 1981.  In the introduction to this work, Illmensee and 
Hoppe suggested that this research might answer questions such as whether changes 
in gene expression during differentiation restrict the totipotency of the zygote’s 
nucleus.  Illmensee and Hoppe described a procedure whereby the nuclear genome of 
a fertilised mouse egg was replaced by that of an embryonic cell.  This was carried 
out in 363 eggs, of which 48 embryos survived to the pre-implantation stage.  Sixteen 
were transferred into pseudopregnant females, and three mice were born (two female 
and one male [see Figure 4]).  When bred from, these mice produced offspring which 
also had the nuclear donor phenotype.  Illmensee and Hoppe referred back to the 
experiments carried out by Briggs and King three decades earlier, reporting successful 
nuclear transfers in frogs (Illmensee and Hoppe also observed however that to date a 
live adult frog had not been produced derived from the transplanted nucleus of a 
differentiated adult cell)381.  Illmensee himself had also previously carried out similar 
work in fruit flies, also without producing adults382.  It was reported in The New York 
Times in 1981 that Illmensee and Hoppe had achieved the first scientifically 
acknowledged cloning of a mammal, and that they would attempt to clone other 
mammals383.  A similar report appeared in The Wall Street Journal384. 																																																								
380 Jackson et al., 1980; Jackson et al., 1981; Krietsch et al., 1982. 
381 Illmensee and Hoppe, 1981 p 9.  Previously, John Gurdon had attempted cloning of 
Xenopus laevis, and demonstrated that nuclei from the intestinal lining of tadpoles could 
support development of adult frogs (Gurdon, 1962a).  However, after being unable to 
reproduce this work, a student of Robert Briggs, Dennis Smith, suggested that Gurdon had 
not isolated intestinal cells, but primordial germ cells, which migrate through the gut during 
development.  Gurdon eventually elected to repeat his experiment using keratinised skin cells, 
the results of which were published in 1975 (Gurdon, Laskey and Reeves, 1975).  Gurdon had 
succeeded in using an adult donor to support larval development and larval donor to support 
adult development, but not an adult nucleus to support adult development  (i.e. cloning) 
(Lewis, 2001 p 162-3). 
382 Illmensee and Mahowald, 1974. 
383 Sullivan, 1981. 
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Figure 4: Experimental scheme of nuclear transplantation in the mouse, resulting in 
a clone.  From Illmensee and Hoppe, 1981. 
 
This was followed in 1982385 by another paper describing the transplantation of 
parthenogenetic embryonic nuclei into fertilised mouse eggs, also resulting in live 
births386.  Diploid parthenogenically activated oocytes from mice, which cleaved 
spontaneously387, developed into blastocysts but died within a few days of 
implantation388.  Hoppe and Illmensee transplanted the nuclei of these cells (once they 
had reached the blastocyst stage) into fertilised eggs (which had had their pronuclei 
removed).  When injected with nuclei of cells from the trophectoderm, growth 
arrested at the morula stage.  However, when nuclei of cells from the inner cell mass 
were injected, live births were achieved.  All four female mice born were of the same 
genotype as the original parthenogenic oocyte, and one was fertile (transmitting the 
partheonogenic genome to her offspring). 																																																																																																																																																														
384 Unknown author, 1981. 
385 Hoppe and Illmensee, 1982. 
386 Parthenogenesis, usually associated with invertebrates and some fish, birds and reptiles, 
also occurs in approximately 10% of an inbred mouse strain named LT; unfertilised eggs 
cleave and develop into diploid blastocysts.  Even after transplantation into pseudopregnant 
females, these early stage blastocysts die and develop no further. 
387 This spontaneous parthenogenic activation occurred only in the LT inbred strain of mouse 
(in which approximately 50% of females develop ovarian teratomas).  The development of 
the LT strain of mice and the incidence of ovarian teratomas are described in Stevens and 
Varnum, 1974. 
388 Witkowska, 1973; Tarkowski, 1975. 
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3.3.1 Claims of fraud 
“Good science…presupposed an attitude that one might describe as professional 
integrity.  A scientist should not cheat or falsify data or quote out of context or do 
any other thing that is intellectually dishonest.  Of course, as always, some 
individuals fail; but science as a whole disapproves of such actions.  Indeed, when 
transgressors are detected, they are usually expelled from the community.  Science 
depends on honesty in the realm of ideas.  One may cheat on one’s taxes; one may 
not fiddle the data.”389 
 
The results of Illmensee’s and Hoppe’s 1981 and 1982 papers were questioned 
following the claims of fraud made against Illmensee in May 1983.  On 2 June 1983, 
New Scientist reported that Illmensee, by then Professor at the University of Geneva, 
was under investigation for fraud regarding experiments transplanting murine 
teratocarcinoma nuclei into fertilised mouse eggs.  The vice-rector of the university 
suggested that either there had been negligence in Illmensee’s record keeping, or 
‘intellectual falsification’.  The report also claimed that it was a worker in Illmensee’s 
own laboratory who first questioned the results of his research, claiming that they 
corresponded ‘too closely’ to the predicted outcomes.  Importantly, this research had 
not been published.  This was swiftly followed by a report in Science (3 June 1983) 
describing the same situation, and the withholding of Illmensee’s $70000 research 
grant from the National Cancer Institute (NCI).  According to Clement Markert (an 
embryologist at Yale University), reproduction of these experiments had ‘proved 
difficult’390.  This news reached the US national press by 4 June; The New York Times 
reported that an internal committee at the University of Geneva had found no 
evidence of systematic fraud, although an external review was in progress391.  In 
addition, another investigation was carried out by a committee at JAX, since Hoppe 
was an employee of this facility392.  The New York Times stated that Hoppe was sure 
that the experiments were carried out as described, although he could not exclude the 
possibility that the embryos had been switched prior to transplantation.  The report 
from Bar Harbor suggested that Hoppe and Illmensee should repeat their experiments, 
particularly since no other groups had been able to replicate their results.  In 																																																								
389 Ruse, 1982 p 74 (original emphasis). 
390 Marx, 1983. 
391 Schmeck Jr, 1983. 
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defending Hoppe and Illmensee, the JAX report suggested that this might be the case 
because no other had the microsurgery skills of Illmensee393.  Amidst this 
controversy, James McGrath and Davor Solter published a paper in Science 
describing a different method for nuclear transfer (17 June, 1983).  McGrath and 
Solter referred to Hoppe and Illmensee’s work, suggesting that many embryos were 
lost due to disruption of the plasma membrane.  Instead, McGrath and Solter 
described a technique which did not require penetration of the plasma membrane, 
therefore increasing the success rate394.  Interestingly this result did not appear to 
evoke any adverse reaction, despite the high success rate recorded and the forerunner 
of Illmensee’s work still being debated; writing in The New York Times, Sullivan even 
described McGrath and Solter’s methods as ‘refinement’ of Illmensee’s work395.   
A report (New Scientist, 28 July 1983) published after apparent conversations 
with Illmensee, stated that the charges were based on five experiments carried out in 
July 1982; the earlier Science report suggested that the University of Geneva vice-
rector had received a request from Illmensee to review his previous work (such as that 
reported in Cell in 1981).  However, Illmensee had started to produce reasons why the 
experiments could no longer be repeated, such as changes which would have taken 
place in the cancer cells whilst frozen. 
A commission of enquiry, setup by the University of Geneva in August 
1983396, had found ‘no compelling evidence of falsification of data’, however did find 
‘numerous corrections, errors and discrepancies’ in the experimental records 
Illmensee had kept.  The commission recommended repetition of the experiments 
with an outside collaborator.  On 23 February 1984, Peter Newmark reported in 
Nature that the fraud charges were unproven.  As well as reprimanding Illmensee for 
his errors (which were clear, even if they did not amount to fraud), the commission 
noted Illmensee’s accusers should have had more documentation to support their 
accusations, and should have had more rigorously assessed their evidence397.  It 
appears that after July 1984 little was published regarding the issue in the mainstream 
media.  The case, however, did appear to continually influence the media’s response 																																																								
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to other work in the field, even years later.  For example, a report in The Wall Street 
Journal titled “Science: How Do We Know Dolly Isn’t A Hoax?” suggested that the 
accusations of fraud at the hands of Illmensee should ensure that serious questions 
would be asked about the validity of such results398. 
 Following the claims of fraud, Illmensee submitted his resignation from his 
professorship at the University of Geneva in 1985, which came into effect on 30 
September 1987 (when his contract expired).  Illmensee however expressed his hope 
that he would be able to repeat the 1982 experiments involving teratocarcinomas 
(despite the difficulties in re-establishing the cell cultures required) and, if possible, 
the 1977 experiments, producing live homozygous diploid mice399. 
The papers published in Naturwissenschaft (1989)400 and Development 
(1990)401 described the transfer of nuclei from teratocarcinoma cells to oocytes and 
eggs, and their developmental potential.  In collaboration with international 
researchers, Illmensee had repeated the work he had carried out almost a decade 
earlier, as requested by the commission, with international collaboration.  Both 
Richard Gardner and Anne McLaren both believed that these papers explained that 
the research in question had been reproduced (albeit using a different cell line).  
Gardner and McLaren wrote to the University of Geneva in 1991 stating their view 
that the University should formally advise the scientific community that the 
controversial findings had been confirmed, as set out by the commission.  However, 
the University had not responded to this request several years later, as highlighted in 
Nature in 1997402. 
 
4. History of heredity and embryology 
 In order to examine whether genetics did indeed develop under the paradigm 
of embryology, and if it did, when it became a separate discipline, we need to look at 
reasons why this was proposed, and its critics.  This section will give an overview of 
Allen’s proposition that genetics developed under the paradigm of embryology 
initially, before Morgan’s work began to divide the disciplines in the early twentieth 
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century.  This section aims to consider why Allen made such a proposal, and a 
particular critique of the theory, by Robert Meunier.  One of Meunier’s claims is that 
Allen's theory is too Morgan-centric; to examine this, a brief overview of Morgan’s 
relevant work is provided.  This section will also include another example, which I 
claim is useful for looking at Allen’s proposal: Weldonian genetics.  Greg Radick has 
provided a history of genetics from the perspective of Raphael Weldon, which I 
believe is useful here; Weldonian genetics, also developed at the beginning of the 
twentieth century, offers a view of how genetics, heredity, and development was 
thought about by some biologists.  This should help to determine whether Allen’s 
proposal is too Morgan-centric, as argued by Meunier, and whether, in the light of 
twentieth century ESC research (examined above), Allen’s proposal stands. 
 
4.1 Garland Allen’s history of heredity, genetics, and embryology 
Initially, as the field of heredity was developing the latter half of the nineteenth 
century, it emerged under the paradigm of embryology, since the two were “so closely 
related conceptually and historically”424.  Late nineteenth and early twentieth century 
biologists followed the influential work of naturalist Charles Darwin to construct 
theories of heredity; this was generally done in relation to embryonic development. 
Weismann and Haeckel were two such individuals who proposed two methods of 
heredity: firstly, ‘transmission’ from parent to offspring, and ‘translation’ of that 
inherited into traits observed in the adult; both were equally important, and, Allen 
suggested, Weismann and Haeckel made no distinction between genotype and 
phenotype.  Similarly, there was a belief that the cell nucleus and cytoplasm should 
also be considered as a whole (as alluded to by Weldon [see below]).  This wholist 
attitude to heredity and embryonic development worked well alongside developing 
theories of evolution.  This led Müller-Wille and Rheinberger (for example) to 
suggest that all heredity theories up to 1900 were closely tied to theories of evolution, 
or development, or both425.  By the turn of the century however, expansion of ideas in 
philosophy of science and development of the scientific method, meant that younger 
biologists were keen to develop testable hypotheses – this was important for a new 
generation who were keen to put biology on an equal footing with the hard sciences of 
physics and chemistry.  Allen observed that Morgan was one of the newer generation 																																																								
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of researchers keen to identify more rigourous methods for biology426.  Despite this, 
the new generation held onto the idea of a unified heredity theory, including genetic 
transmission and embryogenesis; alongside Morgan, for example, EG Conklin agreed 
that the problem of heredity was a significant problem in biology: 
 
“Heredity is today the central problem of biology...but the mechanism of heredity 
can be studied best by the investigation of the germ cells and their 
development.”427 
 
For the likes of Morgan and Conklin then, the most appropriate approach to heredity 
research was through embryology.  For instance, learning about transmission between 
parents and offspring lacked value if it was not considered alongside the development 
of this trait in the adult.  Morgan in particular however began to feel that it was 
becoming increasingly difficult to maintain this position when it came to experimental 
testing of hypotheses.  Theoretically, it made sense to consider heredity and 
development together; experimentally, it was more fruitful to separate the two. 
Allen opted to look at the separation of transmission (genetics) studies from 
translation (embryology) through the career of Morgan, who, between around 1910 
and 1924, appeared to change his mind about how heredity should be studied428.  As 
highlighted above, Morgan initially conceived the study of heredity to involve both 
transmission and translation together; although this was a useful way of 
conceptualising heredity, it was less useful for its practical study.  Allen identified 
five factors that not only influenced Morgan, but other biologists of the time to begin 
studying genetics – a removal of the consideration of heredity under the embryology 
paradigm: 
 
1) A commitment from biologists of the early twentieth century to the analytic 
methods of mechanistic materialism (in order to separate complex problems 
into smaller, testable, components). 
2) The growing distinction being made between genotype and phenotype (this, 
Allen proposed, was highly influenced by Wilhelm Johannsen’s work 
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published in 1911), and the comparable distinction between genetics and 
embryology. 
3) The research carried out using D. melanogaster that had demonstrated 
chromosomal transmission. 
4) The emerging competition developing between fields of study, which, at the 
time, was advantageous (for obtaining funding and students, for example). 
5) The importance of the agricultural context.  Late nineteenth-century and 
early twentieth-century USA was becoming a victim of food shortages, as 
increasing industrialisation moved workers out of the farms and into the 
factories.  The developing fields of heredity and genetics were harnessed by 
the agricultural industry as an area where permanent improvements could be 
made to crops that would improve yield (and profit), leading to significant 
investment into agricultural genetics (i.e. not embryology) 429. 
 
These claims are also explored in The cultural history of heredity by Müller-Wille and 
Rheinberger; in addition, these authors consider in more detail the social, cultural, and 
economic factors that heralded the formation of genetics as a discipline.  Although 
social, economic and cultural factors are not a focus of this chapter, it is valuable to 
note that once again, there was an important contextual influence in the direction of 
life sciences research430. 
 
4.2 Thomas Hunt Morgan’s separation of genetics and embryology 
Concerning the argument that eventually genetics and embryology would 
separate from each other, there is a different view that the disciplines were never able 
to split since they were never a singular discipline in the first place.  This latter view 
is supported by Robert Meunier, as a counter-argument to the narrative supplied 
predominantly by Gar Allen, and supported by Scott F Gilbert.  Meunier argued that 
the separation theory is too “Morgan-centric”, and instead suggested that genetics and 
embryology developed out of different research traditions431.   
 In his 1910 publication Chromosomes and Heredity, Morgan claimed that: 																																																								
429 Allen, 1985. 
430 Müller-Wille and Rheinberger, 2012.  In particular, see Chapter 6, ‘Disciplining Heredity’ 
(pp 127-160). 
431 Meunier, 2015. 
CHAPTER 2  120 
 
 
“We have come to look upon the problem of heredity as identical with the problem 
of development.  The word heredity stands for those properties of the germ-cells 
that find their expression in the developing and developed organism.  When we 
speak of the transmission of characters from parent to offspring we are speaking 
metaphorically; for we now realize that it is not characters that are transmitted to the 
child from the body of the parent, but that the parent carries over the material 
common to both parent and offspring.  This point of view is so generally accepted 
to-day that I hesitate to re-state it”.432 
 
It is useful, in the analysis of the movement of genetics away from the 
embryology paradigm, to look closely at what Morgan claimed in this opening 
paragraph.  Firstly, Morgan stated that “the problem of heredity [is] identical with the 
problem of development”.  At the turn of the twentieth century then, Morgan is 
declaring that there is a relationship between the study of heredity, and the study of 
development, to the point where they are “identical”.  This has also been highlighted 
by James Griesemar, who suggested that heredity and development were considered 
together under the discipline of ‘reproduction’433. Meunier however argued that 
through this opening paragraph, Morgan is explicitly moving away from an older, 
literal view of character transmission, and towards a metaphorical interpretation434, 
supporting his claim that genetics and embryology were never a single discipline.  As 
Morgan stated that “heredity stands for those properties of the germ-cells that find 
their expression in the developing and developed organism”, Meunier claimed that 
here, Morgan is separating himself from the ‘transmission of characters’ theory of the 
older, literal interpretation, where characters were transmitted and developed.  By 
rejecting this literal view concerning characteristics then, Morgan has highlighted the 
distinction between transmission of hereditary material and its expression - 
transmission only concerns the “properties” of germ cells435 (i.e. constituents of 
parent germs cells and characteristics of the offspring are not the same thing).  
Morgan reserved the term “heredity” for this transmission process; an interpretation 
of the original legal metaphor of transferring ownership, goods, or property. 
 Morgan here then is again signalling that he considered heredity and 
development as separate processes, which was distinct from the older view of 																																																								
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transmission/translation (or heredity/development) being considered as parallel, or at 
least overlapping, processes436.  By 1917, Morgan had developed this idea further: 
 
“…it seems desirable in the present condition of genetics and embryology to 
recognise that the mechanism of distribution of the hereditary units or genes is a 
process of an entirely different kind from the effects that the genes produce through 
the agency of the cytoplasm of the embryo”.437 
 
Here Morgan clearly delineated the distinction between transmission 
(“mechanism of distribution of the hereditary units or genes”) and the manner in 
which genes affect development, i.e., ‘characters’.  Those who argue it was Morgan 
who separated heredity and development, such as Allen and Gilbert, suggest that 
Morgan abandoned developmental explanations, retaining a view that the presence of 
characters are explained via genes.  This opinion led Gilbert to suggest that studies of 
inheritance became the discipline of genetics (as defined by Morgan’s 1926 accounts 
of a discipline concerned with transmission of genes)438.  I prefer the view supported 
by Meunier, which argued that Morgan actually separated heredity from ‘characters’, 
leaving explanation of characteristics to the discipline of development.  In The theory 
of the gene, Morgan wrote that “The modern theory of heredity is…primarily 
concerned with the distribution of units between successive generations of 
individuals”439; ‘units’ are genes, whilst characters are considered data.  Morgan’s 
theory of heredity is therefore concerned with the distribution of genes to successive 
generations.  By excluding characters from heredity, Morgan separated development 
from heredity440 (not genetics from embryology). 
 As previously mentioned, Meunier has argued that the separation narrative is 
too Morgan-centric.  Meunier is not the only researcher to make this claim; in The 
cultural history of heredity, Müller-Wille and Rheinberger also state that the 
establishment of genetics “cannot be reduced to the relatively narrow realm of pure 
transmission genetics in the style of Morgan”441.  Meunier’s alternative explanation is 
that genetics and embryology developed from different research traditions.  To 																																																								
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support his claim, Meunier developed Rasmus Winther’s theory of the two styles of 
thought in biology: formal (with a focus on mathematical laws and models) and 
compositional (focusing on parts and wholes, and respective functions)442.  Winther 
claimed that developmental biology would be an example of biology in the 
compositional style, whilst genetics follows the formal.  Meunier developed 
Winther’s idea in his PhD thesis by contrasting Winther’s ‘compositional style’ with 
his own ‘differential’ way of thinking: in the compositional style, the whole is 
separated into its constitutive parts.  Meunier’s differential style instead noted that 
such parts may be considered as separate, but may be classed together443. 
 
4.3 Weldonian Genetics 
Greg Radick has been concerned with a query regarding heredity and genetics, 
particularly the Mendelian paradigm and its dominance in the teaching and thinking 
of genetics.  Rediscovered in 1900, Mendel’s studies on wrinkled peas and petal 
colour have shaped the teaching of heredity throughout the twentieth century, with 
Mendelian genetics dictating that eye colour or hair colour could be explained simply 
through the inheritance of dominant or recessive characteristics.  As geneticists have 
learned more about the way genes and DNA functions through the latter half of the 
twentieth century, it became clearer that the Mendelian view of genetics is 
oversimplified to the point that it is incorrect for anyone requiring any more than a 
basic understanding of heredity.  One of the first to observe this, as Radick points out, 
was Walter Frank Raphael Weldon (1861-1906), a zoology graduate of Cambridge 
University.  After Mendel’s work was rediscovered in 1900, Weldon set-about writing 
a critique of Mendel’s theories of inheritance, which was published in early 1902.  
Weldon identified that Mendel’s results oversimplified the inheritance of hereditary 
factors (genes), which he noted from observing ‘errors’ that would crop-up in 
Mendel’s theories.  A typical example, as given in Weldon’s 1902 paper, is that peas 
can not be easily separated by colour - although there are green and yellow peas (as 
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Mendel claimed), there were also peas that were greenish-yellow, or yellowish-green; 
there was a continuum of colours444 (Figure 5).   
 
 
Figure 5: Photographic plate taken by Weldon to demonstrate that not all peas 
easily fit into a category of ‘yellow’ or ‘green’.  From Weldon, 1902. 
 
Radick argued that for Weldon, it was noting those results that were not 
expected, and checking on what could have caused them, that generated ‘good 
science’445.  Following publication of his critique of Mendelism, Weldon spent the 
next four years formulating an alternative explanation.  Radick noted that Weldon’s 
work would approach the study of genetics in two ways: firstly, using statistics, and 
secondly, using experimental embryology.  Statistical analysis was useful to Weldon, 
since it would highlight those outlying results that may otherwise be ignored, and 
could give clues as to actual underlying mechanisms.  Weldon’s selection of 
experimental embryology to study genetics is, according to Radick, surprising; this 
despite experimental embryology being “one of the premier sciences in biology in the 
late nineteenth century”446.  Prior to his untimely death, Weldon was preparing a book 
which detailed an alternative way of explaining heredity (and genetics), which made 																																																								
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important use of experimental embryology.  Radick highlighted one such case, where 
embryos were dissected into three sections, and each section was capable of 
regrowing and again forming another complete embryo.  Such experiments, Radick 
argued, demonstrated to Weldon that dominance or recessiveness could not be 
something permanently expressed in tissues (as proposed by Mendelism), but 
something that could be influenced by environmental or otherwise external factors - 
gene expression was “fundamentally context dependent”447.  Throughout his 
unfinished book, Weldon built a picture of the expressive capacities of hereditary 
factors that depended on interaction with each other (for example, that characteristics 
like eye colour were not dependent on the expression of a single gene) and their 
environment. 
 In the early twenty-first century, we accept this to be the case - genetic 
inheritance is not as simple as Mendelian genetics suggests, and in fact interactions 
between genes, proteins, and other external factors has a significant impact on the 
characteristics observed.  Radick argued that Weldon’s premature death allowed his 
nemesis William Bateson (1861-1926), a firm believer in Mendelian genetics, the 
opportunity to propagate his own views, and his influence ensured Mendelian 
genetics would be the way genetics has been taught into the current century448.  This 
chapter is not concerned with this point in particular, but it is important that Weldon 
elected embryology as a way of demonstrating his own theories of inheritance and 
mechanisms of genetics, whereas Mendel and Bateson did not.  It appears that only in 
the latter decades of the twentieth century, when the complexity of inheritance and the 
mechanisms of genetics were becoming clearer, that Weldon’s ideas, collected in part 
using embryology, began to appear more accurate than Mendelism.  This chapter has 
previously been looking at how (or whether) the disciplines separated, and how they 
developed alongside each other; what Radick’s work considering Mendelian versus 
Weldonian genetics shows is that without embryology, a clearer notion of the 
complexity of genetic mechanisms could not be demonstrated.  Early genetics needed 
embryology to demonstrate not only how genes were transmitted, but that genes 
should not be considered single ‘hereditary units’, where each characteristic was 
‘coded for’ by a single gene, inherited from one’s parents.  Embryology demonstrated 
that phenotype expression was more complex than this, with gene translation alone 																																																								
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being unable to account for development and phenotype.  Weldonian genetics needed 
the embryological paradigm to demonstrate that Mendelian genetics was 
oversimplified, and that a much more complex explanation was required. 
 
5. Conclusions 
 What can the ‘fantastical experiments’ described above tell us about genetics 
under an embryological paradigm?  And why is this relevant to the history of 
embryonic stem cell research?  This chapter has shown that nuclear transfer 
experiments demonstrate that a form of experimental embryology was still very 
relevant to genetics throughout the twentieth century. 
 This chapter began with an overview of conceptualisation of the cell nucleus, 
since elucidation of its structure and function is relevant to the way a role for the 
nucleus (and its content) was understood.  I use August Weismann’s work as an 
example here to demonstrate that concepts of structure and function of the nucleus 
were relevant for theoretical work in heredity (and genetics); Weismann’s germ plasm 
theory made use of previous observations on the cell nucleus and heredity to propose 
that ‘id’ distribution was important in embryonic development.  Here is an important 
link then with the history of ESC research: in the late nineteenth century, Weismann 
was combining ideas about heredity, cell biology, and embryology to create a theory 
concerning the importance of heredity as a mechanism in evolution, and for 
successful embryological development (this of course is also an important moment in 
evodevo449).  What developed from Weismann’s theorising was the field of 
experimental embryology - a way of testing hypotheses such as those set out in the 
germ plasm theory.  For ESC research, the methods of experimental embryology 
arguably produced the first experimental insights into embryo development at the 
cellular level (as opposed to the observational work carried out in the earlier 
nineteenth century, as described in Chapter 1).  The earliest work in experimental 
embryology demonstrated that individual cells of the early embryo were capable of 
generating new, entire creatures (such as that demonstrated by Hans Driesch), or that 
the position of certain cells in the embryo would have significant effects on 
development (Weldon, Spemann, and Mangold). 
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 Initially, experimental embryology was technically challenging, leading 
Spemann to, for example, resort to using his young son’s fine hair as a tool to separate 
embryonic cells from each other.  Spemann famously suggested that much more could 
be learned about embryonic development and heredity by transferring the nucleus 
from one cell to another; an idea previously suggested by Yves Delage.  The tools that 
would be required to successfully transfer nuclei between cells was not available to 
Delage or Spemann, but the idea for the ‘fantastical experiment’ was clearly around in 
early twentieth-century biology.  Both Delage and Spemann consider that it would be 
a useful exercise to transfer the nuclei of one fertilised egg into an enucleated 
fertilised egg of another species; why?  I argue that the proposition of nuclear transfer 
suggests that Delage, Spemann, and possibly others in the field, had an understanding 
that the nucleus had two linked functions: a way for information to be passed on from 
parents to offspring (heredity), and to hold the information required to develop all the 
different cells needed in a multicellular organism (genetics); this was also a factor 
considered by Weldon.  How were Delage, Spemann et al. suggesting that this 
understanding of nuclear function could be tested?  Via embryology.  Here then is a 
clear example of the discipline of genetics developing under the paradigm of 
embryology (as suggested by Allen).  This approach is relevant for this thesis, since 
the experiments carried out were on the early embryonic cells - those which we now 
understand to be pluripotent or totipotent.  Such totipotency was clearly demonstrated 
by early experiments (such as by Driesch); although the primary aim of this work was 
not to explicitly learn more about ESCs, it certainly contributed to the field which 
would develop later in the twentieth century. 
 Allen argued that genetics split from its embryological paradigm following the 
work of TH Morgan in the 1920s.  This hypothesis is contested by Müller-Wille and 
Rheinberger, and by Meunier, who argued that the splitting view is focused too much 
on Morgan; I am inclined to agree (although Meunier also argued that genetics and 
embryology were separate disciplines from their inception; this I disagree with).  In 
support of the claim that genetics and embryology did not split, I demonstrate that the 
fantastical experiments proposed by Delage and Spemann continued throughout the 
twentieth century.  Although of course these are not the only experiments that are 
being used to learn more about genetic capability of cells, I believe that nuclear 
transfer experiments demonstrate that a form of experimental embryology was still 
very relevant to genetics through the twentieth century; furthermore, as experimental 
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embryology methods were still being used to learn about genetics, it can be argued 
that genetics was still, to an extent, under the embryology paradigm.  The experiments 
I refer to as examples in this chapter are those carried out by Briggs and King, and 
Gurdon in the mid-twentieth century, and by Illmensee in the latter decades.  Briggs 
and King began by demonstrating that the fantastical experiment was possible in 
principle; Gurdon demonstrated that it was an actual possibility, reporting in the early 
1960s that frogs created by nuclear transfer had reached adulthood.  In the late 
twentieth century, nuclear transfer methods were being used in mammalian 
embryology, a focus of Illmensee’s work.  As highlighted in their published papers, 
Briggs, King, Gurdon, and Illmensee all utilised nuclear transfer as a way of not only 
learning more about embryology, but making use of established embryological 
techniques to learn more about genetics (it also demonstrated that Weldon was correct 
to suggest that gene expression was dependent on context). 
 This chapter then has demonstrated, by carefully selecting examples of 
twentieth-century nuclear transfer experiments, that Allen was incorrect to suggest 
that the field of genetics split from embryology in the early twentieth century.  
Instead, I argue that genetics continued to be studied via embryological techniques 
(such as nuclear transfer), and, as further demonstration, that Weldonian genetics 
required the experimental results provided by embryology to demonstrate the 
complexity of genetic mechanisms.  This is relevant to the history of ESC research 
since, as researchers were looking to embryological techniques to examine genetics, 
they also highlighted the important features of ESCs - i.e. the ability to multiply (and 
generate all the cells of an entire new organism), and the ability to generate all of the 
different cell types required (by an entire new organism). 
 Having now considered in detail the background to stem cell research in the 
late nineteenth and early twentieth centuries, the thesis now turns to studies that 
shaped ESC research in the twentieth century.  In the following chapter, a brief 
history of cancer theory is required, before the discussion can move on to discuss 
parallels between cancer and stem cell studies through the 1900s. 
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1. Introduction  
 Recently, and in particular since the turn of the twenty-first century, several 
researchers have drawn attention to the historical links between cancer research and 
developmental biology, in particular that which occurred in the latter half of the 
twentieth century.  For example, Alison Kraft (2009, 2011) and Melinda Fagan (2007, 
2010) have highlighted the post-World War II history of haematopoietic stem cell 
research and bone marrow transplantation.  There are few accounts that have 
generated a comprehensive overview of the link between cancer research and stem 
cell research, particularly that which goes back further than the mid-twentieth century.  
Philosopher of science Lucie Laplane has made some steps towards this with her 
recently published book (2016) on the cancer stem cell theory, however, the focus on 
philosophy of science is key to this text, and historical context is only provided in the 
early sections of the book.   
This chapter then intends to move towards a more comprehensive history of 
the links between cancer and embryonic development, with a focus on stem cell 
research.  This will begin with a brief overview of the history of cancer theory, 
focusing on the nineteenth-century development of the embryonic rest theory.  This 
theory, or, more correctly, cluster of theories, is a key moment in the comparison of 
embryonic (non-pathological) and tumour (pathological) development.  It is possible 
that the embryonic rest theories were so highly regarded because they highlighted that 
embryonic cells possessed the “essential factors” of tumour growth450.  These 
comparisons are clearest when embryonic development is compared with the 
development of teratomas – those tumours that, like embryos, contain various tissues 
originating from all three germ layers. 
Teratomas are tumours that can contain several different cell types, including 
(but not limited to) nervous tissue, skin, bone, and glandular tissue, for example.  
These types of tumour are believed to form from either germ or embryonal cells (i.e. 
pluripotent cells), and can grow in almost any region of the body.  Since teratomas 
can arise from germ cells, they are often observed in either the testes or ovaries of 
adults or children.  It is now, according to the journal Nature, “clear” that some 
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tumours are sustained by a population of stem cells – cancer stem cells (CSCs)451.  
Just as other stem cells have the ability to divide asymmetrically, so do CSCs, 
perpetuating and growing tumours with each division.  The concept of a cancer stem 
cell is not a recent idea; in the early twentieth century for example, Boveri interpreted 
the results of his experiments452 as demonstrating that tumours “go back to common 
ancestors…If one extrapolates further, one is bound to conclude that, in general, every 
tumour has its origin in a single cell”453.  Boveri referred to this as the ‘primordial 
tumorigenic cell’454.  Teratoma formation in vivo is a useful (and widely used) 
approach to determine the pluripotent potential of stem cells (such as ESCs), since it 
enables the cells to demonstrate their ability to differentiate into cell types of all three 
germ layers.  For example, when transplanted into immunodeficient mice, pluripotent 
stem cells are able to form differentiated teratomas, containing a variety of tissues. 
The section of the chapter that discusses teratomas will describe the work of 
pioneers in mid-twentieth century teratoma research, in particular Leroy Stevens and 
Barry Pierce.  As Stevens and Pierce carried out their experiments, more was learned 
about the origins of teratomas, and perhaps all cancers (as theorised in the embryonic 
rest theory, and the later CSC theory).  Although in the mid-twentieth century 
researchers like Pierce and Stevens did not often use terms such as ‘embryonic’ or 
‘cancer stem cell’, this changed following the work of Gail Martin and Martin Evans, 
who were able to isolate and culture the stem cells of teratomas.  (This is discussed in 
Chapter 4.) 
Following the narrative of teratoma research in the mid-twentieth century, this 
chapter then explicitly explores the parallels between cancer and embryonic 
development as currently understood, including, for example, consideration of gene 
expression and cell biochemistry. 
Bringing together the historical conceptualisations of cancer (as explored in 
this chapter) with the conceptualisation of the embryonic stem cell (as examined in 
Chapter 1), this chapter concludes with an examination of similar properties and 
functions between cancer and embryonic development that have been considered 
throughout history, and how this is relevant to the history of ESC research. 																																																								
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2. History of cancer theory 
As observed by Pamela Sanders-Goebel in her reflections on surgical 
interventions in cancer, throughout history, cancer treatment has been based on the 
then prevailing hypotheses, and results following treatment interpreted in light of the 
popular hypotheses of the time.  Treatment also needed to correspond to the personal 
beliefs of the cancer patient455.  Lay understanding of cancer by the early twentieth 
century appreciated cancer as growth, however clinicians and researchers were keen 
to highlight that there was a difference between normal and pathological (cancerous) 
growth, and this could be seen most easily in the comparison between embryonic 
development and cancer456. 
 
2.1 Ancient 
Cancer has been known of for thousands of years and its causes have been 
debated many times over the course of history.  Prehistoric and ancient peoples 
believed that cancer was caused by supernatural events, such as the alignment of the 
planets or evil spirits for example.  Religious beliefs also played a part, with ancient 
Greek, Roman and Hebrew writings suggesting that sin and wrath of gods caused 
cancer.  Some scholars have noted that relatively little appears to have been written 
about cancer at this time, possibly due to its generally incurable nature457. 
Greek-Roman physician Galen (c. AD 129-216) also wrote about various 
cancers.  Cancer [karkinos], Galen claimed, developed from accumulation and 
thickening of the black bile.  This theory appeared to be based on Galen’s observation 
that cancer occurred more often in women after cessation of menses, and that rectal 
cancer was associated with haemorrhoids.  Unlike those before him however, Galen 
proposed treatment for internal, hidden cancers, as well as excision and cauterisation 
of superficial cancers; Galen had become an active surgeon during his time as 
physician to the gladiators at Pergamum (AD 158-161), and there is evidence that this 
practice continued at least into the 180s, and perhaps 190s458. 
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2.2 Middle Ages 
After the collapse of the Roman Empire following the fall of Rome in AD 
476, the remaining Eastern Roman (or Byzantine Empire) retained some medical 
knowledge from its predecessor (which was not the case to the same extent for the 
remaining Western Roman Empire)459.  For example, physician Paulus Ægineta (c. 
625-690) followed Galen’s teachings with regards to the description and treatment of 
cancer.  In addition, Ægineta advocated the removal of nearby lymph nodes460.  
Further eastwards, Christian scholars of the Near and Middle East ensured Galen’s 
writings were preserved in churches and monasteries.  Some Arabic caliphs 
encouraged adoption of Greek thought, resulting in translation of Greek medical texts 
into Arabic, and their use by Arabic physicians.  Some such physicians included 
additional descriptions of cancer and its treatment, such as Avenzoar (1094-1162), 
who gave descriptions of oseophageal and stomach cancer, and proposed treatments 
(including feeding via enema).  Avenzoar’s work became part of standard teaching at 
several influential medical schools in Europe, including the universities at Padua, 
Montpellier, and Bologna, by the end of the fourteenth century461. 
 
2.3 Early Modern and Modern 
American pathologist James Ewing (1866-1943) claimed that the first to 
criticise Galen on the causes of cancer was the Swiss physician Paracelsus (1493-
1541).  Instead of humoural imbalance, Paracelsus suggested that substances such as 
salt of sulphur and arsenic could cause cancer if these accumulated in the blood – 
perhaps building on the previous inclusion of chemical agents in therapeutics. The 
French surgeon Ambroise Paré (1510-1590) also believed that cancer could be caused 
by depositing of toxic substances in the blood, which, if overheated, could cause the 
ulceration observed in some cancers.  Such ideas were elaborated on into the 
seventeenth century, where cancer came to be explained in the context of newly 
identified anatomical structures or chemistry462. 
The reintroduction of dissection during the sixteenth century aided diagnosis 
and demonstrated the tumours and ulcers that typify cancer; prior to this point, 																																																								
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internalised tumours were either unknown or considered untreatable.  Alongside this, 
the discovery of blood circulation (in 1628), the lymphatic system (in 1656), and red 
blood cells (in 1661) suggested fermentation and/or coagulation of the blood and 
lymph could cause cancer (lymph theory)463.  Lymph theory suggested that a 
cancerous lump could be caused by coagulation, resulting from obstructed flow 
around the lymphatic system - where obstruction was in the lymph nodes themselves, 
coagulation here could also form cancers (and a build-up of acid in these lumps could 
cause ulceration)464.  By the early 1700s, many considered the cause of cancer to be 
stagnation and coagulation of blood, particularly if the blood was contaminated with 
poisonous substances.  
In 1775, the surgeon Percival Pott (1714-1788) suggested that chimney 
sweeps were susceptible to cancer due to the accumulation of soot on the skin465.  
Prior to Pott, it may have been Bernadino Ramazzini (1633-1714) who had first 
suggested that cancer may be linked with occupations, behaviour, environment.  
Working particularly in Modena (1700) and Padua (1713), Ramazzini studied the 
incidence of cancer in nuns revealing that, compared with the general population, 
there was a lower risk of cervical cancer, but a higher risk of breast cancer466.  In 
1761, botanist and physician John Hill (1714?-1775) would also link tobacco snuff 
and cancer467. Surgeons believed that the most effective treatment was immediate 
excision of the ulcer or tumour; physicians however did not agree468. 
With the cause, nature, and treatment of cancer still provoking a variety of 
theories and practices, the Academy of Lyon in France offered a prize in 1773 for the 
most enlightening report on Qu’ est ce que le cancer?.  The competition was won by 
French surgeon Bernard Peyrilhe’s (1735-1805) doctoral thesis, published in 1776469.  
In his book, Peyrilhe suggested that cancer was caused by a toxin, and resulted in 
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‘virus’ formation470, although the precise causative agent was unknown.  It was 
Peyrilhe’s experimental approach that was particularly novel – Peyrilhe proposed 
injecting samples from cancers underneath the skin of other mammals471.  Peyrilhe 
also considered why relapses occurred after surgery, suggesting that the cancer had 
spread unseen through blood or lymph, or that the entire tumour was not removed by 
the surgical procedure472. 
Meanwhile, the introduction of improved microscopy was allowing more 
detailed observational records of cancer to be made.  For example, Giovanni 
Morgagni (1682-1771) contributed to the understanding of cancer pathology via his 
book On the seats and causes of diseases as investigated by anatomy (1761), which 
included careful descriptions of autopsies including many who died of cancer473. 
In the early nineteenth century, there re-emerged the concept that cancer was 
like a parasite474, mirroring earlier ideas of cancer eating the flesh of the patient, 
clinging to it with claws like a crab.  This parasitic view of cancer suggested that a 
tumour could live an autonomous existence in the body of the patient. 
Cell Theory of the nineteenth century therefore had a significant effect on 
cancer theory.  As pathologists began applying cell theory to cancer, they began 
suggesting that cancer cells existed.  In 1845, anatomist Hermann Lebert (1813-1878) 
described ‘cancer cells’ when referring to surgical removal of a breast cancer 
tumour475.  Lebert, an influential clinical pathologist, had previously also asserted that 
cancers may contain “heterologous” elements (i.e. that tumours contained cells that 
were not typical of the tissue of cancer origin) – an idea that became popular 
(especially in France) in the mid-nineteenth century476.  Professor of anatomy and 
physiology, and later pathology, at Utrecht, Jacobus Coenraad Schroeder van der 
Kolk (1797-1862) also subscribed to the cancer cell theory, claiming in 1853 that 
cancer cells could be present in the body far removed from the original tumour477.  
William Halsted (1852-1922), an American surgeon, proposed that cancer could arise 																																																								
470 Peyrilhe’s reference to a ‘virus’ uses a historic definition of ‘virus’, similar to a poison.  It 
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from a single proliferating cell, which would result in cancerous cells spreading 
throughout other tissues in the region; surgery was one option to remove all of the 
cancer cells from an area, regardless of which tissues they had become present in.  
The cancer became inoperable when the tumour cells spread beyond the locality478.  
In addition, development of Cell Theory and understanding of cytology led to the 
view that cancer was not generally caused by any type of infection by micro-
organisms (with the exception of the virus found to cause some sarcomas)479.  It was 
also during the nineteenth century that French physician Joseph Claude Anthelme 
Recamier (1774-1852) coined the term ‘metastasis’480. 
A further theory that gained in popularity during the nineteenth century was 
the proposal that cancer risk could be inherited.  One such physician who noted the 
greater incidence of cancers in some families was the physician Sir James Paget 
(1814-1899); many who took this view also believed that the cause of cancers may 
have been inherited due to an “underlying constitutional defect”481.  Paget suggested 
that previously undetected (developmental) defects in organs may also leave the 
affected susceptible to malignancy482.  Boveri would help later researchers 
demonstrate a link between genetics and cancer through the results of his experiments 
on the artificial fertilisation of sea urchins.  Boveri observed that when he fertilised a 
single sea urchin egg with two spermatozoa, the resulting fertilised egg often had 
more chromosomes than normal, and would multiply to form not embryos, but 
unorganised masses of tissue483.  From such experiments, Boveri would conclude that 
tumours may be the consequence of “a certain abnormal chromosome constitution”, 
although was aware that during the first decades of the twentieth century, his ideas 
were often met with scepticism484. 
Between the 1920s and 1960s, radiation treatment became increasingly 
popular, particularly after research had demonstrated how radiation could kill cancer 
cells485.  In the context of studies on the effects of radiation, James Till and Ernest 
McCulloch of the Ontario Cancer Institute developed (accidentally) the first 																																																								
478 ibid. 
479 Simonds, 1935. 
480 Faguet, 2015a. 
481 ibid p 2029. 
482 Ewing, 1919. 
483 Calgins and Boveri, 1914; Baltzer, 1967; Faguet, 2015a. 
484 Boveri, 1914 (transl. Harris, 2008) p 5. 
485 Sanders-Groebel, 1991. 
CHAPTER 3  136 
 
qualitative assay for generating haematopoietic cells (from haematopoietic stem 
cells).  They did this by irradiating mice to kill all bone marrow cells (mirroring 
radiation poisoning), before attempting to re-populate the bone marrow.  Some of the 
injected cells would create a ‘colony-forming unit’ in the spleen, effectively creating 
tumours from single cells486. 
 
2.3.1 Embryonic rest theories 
 The embryonic rest theory suggests that cancer can develop from residual 
embryonic cells.  It is a theory that has been proposed since the early 1800s; the 
pathologist Jean Frederic Lobstein (1777-1835) and Recamier both compared the 
growth of tumours to embryonic growth in the 1820s.  In particular, Lobstein noted 
the similarity of tumour growth with embryonic tissue, conceiving that neoplastic 
growths were tissues that were no longer under the control of the organism487.  Paget 
also suggested that ‘invisible defects’ in organ formation may be prone to 
malignancy.  As noted in Chapter 1, in the early nineteenth century, Schwann 
proposed that cells were formed from the cytoblastema.  Schwann’s mentor Müller, in 
his work On the fine structure and forms of morbid tumors (1839), agreed that cells 
would form from condensation of the cytoblastema, and that cancer had a similar 
origin: cancer would develop from crystallisation of semen morbi (germ of disease) of 
the cytoblastema488 – i.e. the cancer ‘germ’ was in the cytoblastema, and cancerous 
cells would develop out of this diseased cytoblastema (although Müller did not see 
evidence for this from the microscopical studies carried out)489.  Remak refuted 
Schwann’s theory however, suggesting instead in the mid-nineteenth century that 
cells divide (forming two cells where there was once one), as opposed to any 
spontaneous generation theory490.  Tumour cells, therefore, must also arise in this 
fashion491.  As an alternative to Müller’s suggestion that cancer cells emerge from the 
cytoblastema, Adolf Hannover (1814-1894) suggested that tumours would arise from 
a specific cancer cell [cellula cancrosa], which was morphologically distinct from 
other non-pathological cells.  The anatomist and surgeon Alfred Armand Louis Marie 																																																								
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Velpeau (1795-1867) also proposed that a cancer cell existed, but that it was not the 
cause of the cancer; instead Velpeau suggested that there must be “some more 
intimate element” that caused cancer492.  Virchow was also unable to find evidence of 
the cellula cancrosa493.  Initially, in Die krankhaften Geschwülste, Virchow proposed 
that cancer occurred due to changes in the connective tissue (see below), rejecting 
Remak’s suggestion that cells multiplied by division.  It did not take long for Virchow 
to reverse his decision however, making use of Raspail’s phrase omnis cellula e 
cellula494.  Virchow would also disagree that cancers could be heterologous, since 
there was no analogy for this in the healthy body (see below for Virchow’s reasons 
for finding equivalents in pathological and non-pathological tissues)495. 
Professor of Surgery at the University of Rome, Francesco Durante (1844-
1934), was likely to be one of the first to clearly state that all tumours arise from 
embryonal cells in 1874496.  This said, it was the German pathologist Julius Friedrich 
Cohnheim (1839-1884) who popularised the theory (possibly through his influence as 
a biologist497, presumably having more scientific influence than Durante as a 
surgeon).  Ewing (1919) has also remarked on the comprehensive nature of 
Cohnheim’s theory, which would increase its appeal.  In addition, Durante’s papers 
and books were published only in Italian498, which is likely to have restricted his 
readership.  Cohnheim worked at several universities in Germany, including Berlin, 
where he studied under Virchow.  Although this theory was not his most famous 
work, Cohnheim is often credited with the ‘embryonic rest’ theory of cancer – i.e., 
that cancers form from embryonic cells which had not migrated to the appropriate 
region of the body.  The model for this theory was the teratoma, which could contain 
tissues from all three germ layers, as found in the developing embryo (see section 3). 
Hugo Ribbert (1855-1920) was a German pathologist who agreed with most of 
the ‘embryonic rest’ theory, but attempted to update it in light of some criticisms (for 
example, that adult cells were also capable of forming tumours under appropriate 
circumstances).  Ribbert believed that cancer could arise from cells which ‘had a 
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disturbed relationship with their neighbours’499, causing them to grow and divide 
abnormally. 
 In 1854, Remak had proposed what Laplane has referred to as the 
‘delocalised’ embryonic rest theory.  Remak’s view was inspired by Virchow’s 
detailed description (above), in an effort to explain why a tumour of ectoderm origin 
appeared in tissue of mesodermal origin.  Remak’s explanation was that the tumour 
had arisen from an ectodermal embryonic cell, which had become ‘delocalised’ 
during the early stages of embryogenesis500 – hence Laplane’s terminology.  This was 
not intended to be a general theory of cancer development, but was intended to 
explain how a tumour of a different tissue type to the organ of origin could emerge.  
For example, Remak would also note that cancer could emerge from islands of 
epithelial cells, in tissues that would not normally contain epithelia501.  Louis Bard 
(1829-1894) expanded Remak’s work, by identifying a method by which different 
cell types could arise: differentiation.  Bard proposed that normal cells would divide 
and then mature into different functional cell types.  In cancer development, defects in 
the cells would result in tumour formation instead of non-pathological mature cell 
types502. 
 Virchow himself had a different view however, proposing what Laplane 
referred to as the ‘connective tissue’ theory503.  Virchow believed that all new cells 
came from division of cells in connective tissue, therefore connective tissue cells 
could generate cells of all three germ layers, both normal and pathological.  Virchow 
was convinced that the underlying goal of Cell Theory was correct – that it was a 
unifying theory, explaining that all cells originated from inside the body, including 
pathological cells.  Virchow rejected any ontological pathologist view that the entity 
of a disease was outside the patient’s body; likewise, the tumour was always part of a 
patient’s body (and subject to the same ‘laws of biology’).  Virchow believed that the 
cell was the seat of physiological processes, pathological and non-pathological, and 
that Cell Theory could be preserved if he could show that tumour cells emerged from 
non-pathological tissue504.  Unlike Remak’s theory, Virchow believed that this theory 																																																								
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could be applied to all cancers.  Virchow’s connective tissue theory certainly had its 
critics however. 
In January 1861, the British Medical Journal published detailed reviews of 
Virchow's Cellular Pathology, which had been translated into English, and published 
in 1860.   In addition to refuting Schleiden and Schwann's Cell Theory to concur 
(unreferenced) with Remak’s views, Virchow suggested how morbid growths were 
generated.  Virchow proposed that cancer cells must arise from pre-existing cancer 
cells; since cancer could develop in any tissue, Virchow formulated the ‘histological 
substitution’ argument, stating that it was possible “to find one tissue at a certain fixed 
point of the body replaced by an analogous one belonging to the same group, or, in 
other words, by an histological equivalent” (original emphasis)505.  The BMJ reviewer 
was not wholly impressed by Virchow’s histological equivalent theory, concluding 
that obvious failures in Virchow’s initial theory of cancer generation were too easily 
explained by a claim that tissues could be mixed up506.  Considering the connective 
tissue theory, the BMJ reviewer first noted that the term ‘connective tissue’ is not 
particularly specific, since collectively, German anatomists referred to many fibrous 
tissues, including ligaments, as connective tissue507.  The reviewer called into 
question Virchow’s assertion that the connective tissue had “the common stock of 
germs (Keimstock) of the body, and [it is possible to] directly trace to it, as the general 
source, the development of new formations”508, including benign and malignant 
morbid growths509.  The reviewer stated that the evidence Virchow supplied for this 
was “very unsatisfactory”, and that “Nowhere have we seen any evidence that 
tubercule forms within fibre-cells, and still less cancer”, despite the frequency with 
which such diseases occur510. 
 A further type of embryonic rest theory, proposed by Julius Cohnheim, has 
been referred to as the ‘superabundant rest’ theory511.  Cohnheim’s theory can be seen 
as an adaptation of Remak’s idea – in contrast to the restrictions Remak placed on the 
types of cancers caused by embryonic rests, Cohnheim believed that the theory could 
explain the development of all cancers.  In addition to applying the theory to all 																																																								
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cancers, Cohnheim proposed that the cancerous cells were not just those that had 
become ‘detached’ (like Remak), but also those that the organism did not require for 
development  (i.e. ‘superabundant’).  Instead of focusing on the displacement of 
embryonic cells in the causation of cancer, Cohnheim gave more weight to the 
“inherent disposition” (the developmental ability intrinsic to the cell) to explain 
potential tumour development.  In addition, the cell may have the potential to become 
cancerous, but cancer would not develop without other developmental factors512. 
 Cohnheim was the individual whose name became attached to the embryonic 
rest theory in general - for example, in his 1935 review of cancer, Northwestern 
University’s professor of pathology James Simonds refered to the potential for 
hereditary causes of cancer: “In the development of the human embryo certain faults 
in reproducing the normal pattern may occur.  Some of these faults, such as 
Cohnheim’s embryonic rests, may be a factor in the later occurrence of cancer”513.  
Ewing, in 1919, described Cohnheim’s theory as ‘modern’, and highlighted the details 
of the theory: that tumours develop from masses of tissue misplaced during 
embryonal development, or from ‘small groups of superfluous cells’, which retained 
their embryonic characteristics (and were not necessarily misplaced).  The ‘embryonal 
character’ of the cells however was central to the theory.  Cohnheim believed that 
these cells were the result of overproduction of the germ layers prior to organ 
formation.  These cells were then distributed throughout the body, with a tendency to 
gather in certain regions.  Sudden development of these cells occurred due to changes 
in blood supply514.  Ewing stated that “the present support of Cohnheim’s theory is 
extensive”, since it explained the presence of different tissue types in tumours; this is 
most obvious in teratomas (see below)515. 
 Anatomist Ernest Krebs (1911-1996) suggested that the embryonic rest theory 
was a “logical consequence” of German physiologist Wolff’s theory of epigenesis516.  
Epigenesis, as opposed to preformationism, proported that multicellular organisms 
develop from seeds or eggs through a sequence of development and differentiation.  
Initially, Wolff’s eighteenth-century proposal struggled for popularity, since it 																																																								
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suggested that development required the gradual formation of organised parts from 
unorganised matter517.  This surpassed theories which suggested that the baby was 
pre-formed in either the egg or sperm prior to conception.  It also suggested that an 
organism would develop as different parts were added.  As Krebs observed, 
epigenesis enabled embryonic rest theory; if, as the creationists or preformationists 
asserted, offspring were already fully developed in the germ cell, then there would be 
no opportunity for cells of this embryo to become misplaced.  In epigenesis however, 
embryos were not pre-formed in the germ cell, and were generated anew; this opened 
up the possibility for newly emerging cells to become misplaced in the embryo, and 
later develop into cancers in the adult.  Krebs used the metaphor of a house, being 
assembled brick-by-brick, then posing the question: “[What if] some of these “bricks” 
be misplaced in the process of building?”518.  Similarly, Spemann, in experiments 
carried out in the late nineteenth century, demonstrated that when regions of the 
embryo (which have not yet differentiated into a specific organ) are transplanted to 
another ‘organ field’, the transplanted piece begins to conform to the ‘morphological 
pattern’ of the host region519.  More differentiated tissue does not conform in the same 
way.  This could account for ‘embryonic rests’, but probably suggests the possibility 
that embryonic cells are capable of conforming to a new environment, and that 
therefore there would be no ‘rests’. 
Krebs also reported French pathologist Charles Oberling’s (1895-1960) view 
opposing the embryonic rest theory: Oberling argued that although embryonic cells 
and cancer cells do somewhat resemble each other, embryonic cells all eventually lose 
their proliferative potential and differentiate.  Malignant cancer cells however 
continue to multiply520.  This said, Spemann’s and Oberling’s theories were restricted 
to embryos; Oberling stated that in the body of an adult, embryonal cells may behave 
differently.  Boveri also stated in the early twentieth century that he was sceptical of 
the “embryonale Reste” theory, claiming that “tumours are often found in 
circumstances that make one think that they may have arisen from arrested embryonic 
cells, but in most cases a connection of this sort can be excluded”521.  In addition, 
although Ewing initially praised Cohnheim’s theory, he stated that experiments 																																																								
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testing the isolation of these cell groups were not always followed by tumour 
formation.  In fact, tumour formation was one of five possible outcomes (no changes, 
cyst formation, limited growth, or normal development then atrophy may also 
occur)522.  It is also likely, Ewing claimed, that tumours grew where no embryonic 
cells existed523. 
 
3. Teratomas 
“We killed it, and looked at the testes, and they had strange things inside.”524 
 
3.1 History of teratomas 
 As early as the Roman period, tumours of the testes were known.  For 
example, Galen described seven types of scrotal tumours, and prescribed their 
surgical removal525. 
 In the eighteenth century, Pott was credited amongst his contemporaries for 
his understanding of cystic disease, which we would refer to today as teratomas of the 
testes (with cysts); Pott understood that these tumours could be malignant; this is in 
contrast with Pott’s contemporary Sir Astley Cooper (1768-1841), a surgeon and 
anatomist, who believed that testicular teratomas were benign.  Cooper authored one 
of the first books solely on the topic of testicular cancer (Observations on the 
structure and diseases of the testis), published in 1830526.  Dr Samuel Gross also 
described several types of testicular tumour, including the teratoma, in his 1857 book, 
Elements of pathological anatomy527. 
 According to Melinda Cooper, teratomas were first described in 1822 by 
Étienne Geoffroy Saint-Hilaire (1772-1844) in the second edition of Philosophie 
Anatomique528, although he did not use the term ‘teratoma’.  It was his son Isidore529 																																																								
522 Ewing, 1919. 
523 Ewing’s chapter on ‘Theories and Nature of Cancer’ also highlighted other important 
factors required for tumour formation, which may hint at the possibility of a cancer stem cell.  
For example, “The period of isolation of the cells is an important factor.  The earlier its 
occurrence the less is the differentiation and the greater the capacity for growth.  Early 
embryonal rests when starting to grow meet conditions which do not favor normal 
development” (Ewing, 1919 p 97). 
524 Don Varnum, speaking to Ricki Lewis; Lewis, 2001 p 132. 
525 Toledo-Pereyra, 1973 p 373-374. 
526 Young, 2005. 
527 ibid. 
528 Étienne Geoffroy Saint-Hilaire was a French naturalist, completing Philosophie 
Anatomique whilst Professor of Zoology at the University of Paris. 
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(1805-1861) who extended his father’s work and used the term ‘teratology’ to 
describe the study of ‘monstrosity’ in anatomy530.  The pair had also unsuccessfully 
attempted to reproduce ‘monstrosities’ by manipulating fertilised chicken eggs.  
Cooper claimed that the first to successfully induce teratomas was Camille Dareste 
(1822-1899)531, as described in 1871532.  Cooper noted that Dareste realised the 
potential of such work in studying evolution and development: 
 
“[My research] demonstrates in the most complete manner the possibility of 
modifying, by the action of external physical causes, the evolution of a fertilised 
germ.  The demonstration of this fact is of interest not only for the production of 
monsters but also for biology in its entirety.  In effect, if it is possible to produce 
monstrosities by modifying the evolution of a fertilised germ, we must consider it 
possible to produce simple varieties, in other words slight deviations from the 
specific type, which are compatible with life and the generative functions.”533 
 
 In Neoplastic Diseases (1919), Ewing devoted a chapter to ovarian teratomas.  
Previous observations were described in detail, particularly with regard to the 
different structures and cell types observed.  In addition, there were also several 
images of dissected tumours.  With regards to the etiology, Ewing stated that many 
currently believed the origin of ovarian teratomas to be the ovum: 
 
“The essentially tridermal character of these tumors requires that the originating 
material be totipotent.  Only two possible sources of such material have been 
seriously considered, the isolated blastomere of Marchand-Bonnet, and the 
primitive unfertilized ovum.”534 
 
Ewing stated that the blastomere theory535 was not generally accepted since the 
frequency of tumours was too high, and these tumours had also been observed in 																																																																																																																																																														
529 Isidore Geoffroy Saint-Hilaire was appointed assistant naturalist to his father at the 
University of Paris in 1824, after completing studies in natural history and medicine.   
530 Cooper, 2004. 
531 Dareste was a French zoologist and specialist in embryology, holding doctoral degrees in 
both medicine and science. 
532 Dareste’s Recherches sur la Production Artificielle des Monstruosités ou, Essais de 
Tératogénie Expérimentale also used the term ‘teratogeny’ to describe the ‘experimental 
counterpart’ of teratology.  Cooper, 2004. 
533 Dareste, 1891; in Cooper, 2004. 
534 Ewing, 1919 p 603. 
535 Felix Marchand (1846-1928, Professor of pathology at Marburg) and the Greifswald 
anatomist Robert Bonnet (1851-1921) developed the ‘blastomere theory’, which stated that 
tumours could arise from misplaced embryonic cells that had become separated from the rest 
CHAPTER 3  144 
 
testes.  Support for these tumours originating from the unfertilised ovum came from 
the frequent observation of multiple dermoid cysts, the totipotent nature of ova, and 
the fact that teratomas occured during the fertile period in a woman’s life. 
 In 1939, the French histologist Félix Albert Peyron (1884-1947) described the 
histology of the teratoma, including embryoid bodies; Peyron’s contribution to 
teratoma histology would total more than 17 papers, including further descriptions of 
embryoid bodies and polyembryomas536.  Peyron was sent his first sample of a 
testicular tumour (including embryoid bodies) from Professeur Limousin, a former 
colleague of Peyron’s from the Institut Pasteur.  The polyembryoma, described by 
Peyron in 1936, is a neoplasm comprising embryoid bodies; this was a topic of 
particular fascination for Peyron, having started his research on polyembryomas in 
1919, and publishing his last paper on the topic in 1941537.  All of Peyron's 
contributions were published in French; the first English description of the 
polyembryoma was written by uropathologist Meyer Melicow (1894-1983) in 1940, 
describing a fatal case538.  Of all of the polyembryoma cases described during the first 
half of the twentieth century, none were pure, often having a teratoma or mixed germ 
cell element associated with them539.  More recent thoughts on the polyembyroma 
tumours described by Peyron and others suggest that these tumours may be primitive 
forms of teratoma, since the embryoid body (and presence of embryonal epithelium) 
are characteristic of both polyembryomas and immature teratomas540. 
 Drs Nathan B Friedman (1912-2009) and Robert A Moore published their 
work on testicular teratomas in 1946; this was a collection of 922 cases collected by 
the Armed Forces Institute of Pathology in the early 1940s.  Friedman was working 
with the Institute at the time, whilst Moore held the Chair in Pathology at Washington 																																																																																																																																																														
of the developing embryo prior to the blastocyst stage.  These cells did not develop normally, 
and therefore had the potential to become cancerous later on.  Marchand had also 
hypothesised that tumours (and in particular perhaps teratomas) may develop from polar 
bodies.  Ewing, 1919; Marchand, 1898; Bonnet, 1901; Maehle, 2011. 
536 Young, 2005. 
537 In 1942, Peyron was sacked from the Institut Pasteur; this is likely to be because of the 
conflict between Peyron and the Minister of National Education, as the Vichy Government 
requested Peyron’s dismissal.  Peyron however found another position, studying syphilis at 
the Institut Prophylactique Arthur Vernes; this may explain why no further papers on 
testicular tumours or polyembryonas were forthcoming.  Service des Archives de l’Institut 
Pasteur, n.d.; Young, Stall, and Sevestre, 2016. 
538 Young, Stall, and Sevestre, 2016. 
539 ibid. 
540 ibid p 95; Friedman and Moore, 1946. 
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University School of Medicine.  The military was a useful resource for testicular 
tumours, because of the age range of the men in the armed forces.  Friedman and 
Moore suggested four classifications of testicular tumour: seminoma, embryonal 
carcinoma, teratoma, and teratocarcinoma541. 
 The case studies collated by the Armed Forces Institute of Pathology was 
revisited by Moore alongside University of Pittsburgh researcher Frank J Dixon 
(1920-2008) in the early 1950s.  Pathologist Robert H Young noted that the 1950s 
Cancer papers by Dixon and Moore were more clinical in nature than the previously 
published work, such as that in the Armed Forces Institute of Pathology journal542.  In 
the late 1950s, Barry Pierce (see section 3.3) would work alongside Dixon to 
demonstrate the similarities between developing teratomas and early embryos.  In his 
review of cancer research from 1959, Charles Oberling quoted from recent research 
into gonadal tumours, reporting that testicular tumours could be ‘female’543 - a result 
of the tumour arising from germ cells, which have either an X or Y chromosome.  
This was part of another aspect of cancer research growing in the 1950s - cell 
culture544.  For example, Alice E Moore of the Sloan-Kettering Institute for Cancer 
Research at Cornell University, published research results regarding the culture of 
cells in the laboratory - it was possible for non-cancerous cells in culture to develop 
chromosomal abnormalities545.  Critically however, the reason cells in culture became 
cancerous remained elusive546. 
 Whilst Moore, Friedman, and Dixon were developing their classifications of 
testicular tumours in America, a British group were working on the same problem.  In 
1964, the British Testicular Tumour Panel published their suggestions in a 
supplement to the British Journal of Urology; the British team also identified four 
classifications: teratoma differentiated, malignant teratoma intermediate, malignant 
teratoma anaplastic, and malignant teratoma trophoblastic.  This work, claimed 
Young, was easily comparable to the classifications suggested by Friedman and 
																																																								
541 Young, 2005. 
542 ibid. 
543 Sohval and Gaines, 1955; Oberling, 1959. 
544 In his 1959 review, Oberling updated the reader on several results from cell culture 
studies, including behaviour of the cell membrane, studies on invasiveness, and the role of 
some hormones on metastases. 
545 Moore, 1957; Oberling, 1959. 
546 Oberling, 1959. 
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Moore547.  Eventually, the World Health Organization (WHO) would publish their 
own testicular tumour classification system; the gaps between the American, British, 
and WHO classification systems were in part due to WHO initially also classifying 
ovarian tumours, in an effort to standardise terminology and classification of tumours 
common to both ovaries and testes.  The WHO system, based mainly on the 
suggestions of the American classification system, was published in 1976548. 
  
3.2 Stevens’ contribution 
3.2.1 JAX history 
 The Roscoe B Jackson Memorial Laboratory (known as “Jackson 
Laboratories” or “JAX”) was founded in 1929 by Clarence Cook Little (1888-1971), 
upon leaving the presidency of the University of Michigan549.  Throughout his 
academic career, Little had been interested in mammalian, and in particular murine 
genetics, and had many years experience in creating inbred strains of Mus 
musculus550.  This was an aim of JAX – to create ‘pure’ mouse lines for research – 
particularly for cancer research, as was Little’s interest at the time551.  The difficult 
economic situation of the period made it necessary for JAX to sell inbred mice for 
research elsewhere552; it now annually provides around 2.5 million mice to 
laboratories worldwide553.  By the 1950s, JAX was already considered to be the 
supplier of the ‘ultimate’ laboratory mouse554; this would also have created an 
environment where purity of strain and successful upkeep of substantial numbers of 
mice was paramount.  The drive of research into the genetic causes of cancer was 
championed by Little, and this provided Stevens (see below) with the ideal 
																																																								
547 Young, 2005. 
548 ibid. 
549 Griesemer and Gerson, 2006.  Jackson Laboratories was named after Roscoe Jackson, 
founder of the Hudson Motor Car Company of Detroit, who supplied a great proportion of the 
funding needed in order to found the laboratory. 
550 For a biography of Little detailing his work with mice before, during and after his time at 
JAX, see Rader, 2004. 
551 This was followed after WWII by interest in the effect of radiation damage, giving further 
use to the inbred laboratory mouse.  Rader, 2004, Kraft, 2009 and Lancaster, 2009. 
552 Rader, 2004. 
553 The Jackson Laboratory, 2016. 
554 In 1941, ‘JAX Mice’ were registered with the US Patent Office.  Griesemer and Gerson, 
2006. 
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environment for research following his identification of testicular teratomas in strain 
129 mice555. 
 
3.2.2 Stevens’ introduction to teratomas 
“Today, it is widely held that Stevens’s lucky break and all his science thereafter 
went a long way toward launching the field of stem cell biology.”556 
 
Leroy Stevens (known as Roy to his colleagues) graduated with a biology 
degree from Cornell University in 1942.  The same year, he married and joined the 
army.  Stevens began his research career with a PhD in experimental embryology at 
the University of Rochester, under the supervision of embryologist J Holtfreter; Barry 
Pierce has highlighted that this makes Stevens a ‘scientific descendant’ of Hans 
Spemann557.  Later the same year as completing his PhD (1952), Stevens began as a 
postdoctoral assistant to Little558.  Stevens remained at JAX until he retired in 1989. 
Stevens was working with mice at JAX, particularly strain 129 mice.  These 
were inbred mice maintained through brother and sister matings559.  Six months into 
his work, Stevens observed a single mouse with an abnormal testis.  Through 
histological examination, JAX histological stalwarts Elizabeth Fekete and Katherine P 
Hummel identified a teratoma; Stevens recalled that this piqued his interest as no 
murine testicular teratomas had been previously described560.  Stevens also recalled 
that he had the freedom to pursue such interests: “I felt perfectly free to do anything I 
wanted, and didn’t have to account to anybody”561.  It was another six months before 
another testicular teratoma was observed in the same mouse strain, then a third was 
found two months later.  Stevens would have been accustomed to visually scanning 
mice, and would have probably been swift to observe these abnormalities562.  At the 																																																								
555 First described in Stevens and Little, 1954. 
556 Parson, 2004 p 26. 
557 In ‘An Appreciation’ of Stevens presented in 1987, Barry Pierce highlighted Stevens’ 
military career, stating that he served in Italy, Africa and Sicily, and landed on the Normandy 
beaches on D-Day.  Pierce stated that despite being decorated twice during his time in the 
army, Stevens was more keen to discuss how he graduated from Cornell with more demerits 
than anyone else (Pierce, 1988).  
558 Parson, 2004; Pierce, 1988. 
559 For more details of the genetic background of these mice, see Stevens and Little, 1954. 
560 Stevens, 1984. 
561 Stevens, 1986. 
562 Ricki Lewis suggested that at this time, embryologists would spend many hours scanning 
“dozens, hundreds or even thousands of animals”, instantly alert when one “stood out from 
the crowd”.  Lewis, 2001 p 132. 
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time, Stevens was testing different cigarette components on mice, which he did not 
find particularly interesting, so was pleased when he saw the teratoma: “I was pretty 
good at reading slides”, Stevens boasted in 1990563.  This prompted an investigation 
into the genetic susceptibility of strain 129 mice to testicular teratomas, resulting in 
publication of Stevens’ first paper in 1954564.  It has been suggested that Stevens 
appreciated the resemblance of teratomas to embryos, due to his previous experience 
as a PhD student565. 
 
“I very slowly got this thing off the ground. I mean, what do you do when you find 
something as rare as that!”566 
 
In Stevens’ first publication on the subject, a short review indicated the 
research into teratomas Stevens and Little were familiar with567.  Spontaneous murine 
testicular teratomas had not previously been reported, although ovarian teratomas had.  
One such publication was by Fekete and Ferrigno, also working on inbred mice at 
JAX (see above)568.  A spontaneously occurring ovarian tumor was described in 
which differentiated cells and tissues where observed as well as “undifferentiated 
embryonal cells”569.  Serial transplantation into other mice demonstrated a pluripotent 																																																								
563 Lewis, 2001 p 132. 
564 Stevens and Little, 1954. 
565 Parson, 2004. 
566 (original emphasis) Stevens in Parson, 2004 p 25. 
567 Stevens and Little, 1954. 
568 Fekete and Ferrigno, 1952.  As Pierce and Dixon observe, the first ascites tumours of 
teratomas were produced using a ‘Fekete’s teratoma’ (Pierce and Dixon, 1959b, referring to 
Leighton, 1954).  If this was a development useful to research (as it later proved to be), why 
was Fekete’s teratoma ascites ignored in favour of developing another ascites tumour from 
strain 129 teratomas?  Was this because of popularity of Stevens’ publications in comparison?  
Was it that Stevens encouraged others (like Barry Pierce and Beatrice Mintz) into his 
laboratory to learn from him?  Undoubtedly, the work carried out by Pierce was essential in 
allowing strain 129 teratomas to be used in research elsewhere, but if research into or using 
teratomas was considered so important, why were Fekete’s teratomas, with ascites available 
(as produced by Leighton) years prior to 129 teratomas, not more widely utilised?  This is 
probably due to Elizabeth Fekete’s retirement in 1956 (Hummel, 1980).  Since Fekete retired 
as the importance of teratomas was only just being realised, her work was less likely to be 
recognised in favour of her more ‘current’ colleague, Roy Stevens. 
569 This paper appears to be the model on which Stevens and Little based their publication on 
testicular teratomas two years later.  However, on the whole this contribution appears to have 
been largely ignored by later researchers, with only a handful of citations compared to the 320 
citations of Stevens’ and Little’s 1954 publication (estimated by Google Scholar; available at: 
http://scholar.google.co.uk/scholar?hl=en&lr=&cites=16851338284840483051&um=1&ie=U
TF-8&sa=X&ei=i26OUKLRKKjL0QWtt4G4CA&ved=0CCUQzgIwAA [Accessed 
September 2016]). 
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element, from which many other cell types could arise whilst maintaining growth of 
the tumour.  Testicular teratomas had been described in both humans and horses; 
studies had shown that some similarities in tissue type had been identified.  Both 
embryonic and adult tissues which were not usually observed in the testis were 
observed in these tumors.  Furthermore, Stevens and Little highlighted a few studies 
in inducing teratomas, which usually involved injecting an inorganic compound in 
fowl or autografting different regions of a newborn rodent to the testes. 
 
3.3 Barry Pierce 
3.3.1 Barry Pierce’s introduction to teratomas 
Gordon Barry Pierce was born in 1925 in Alberta, Canada.  He was raised on a 
remote farm, and stated that it was his experiences regarding his ill father (Pierce 
describes him as a ‘cardiac invalid’) that made him want to train as a physician.  After 
serving in the Canadian Army during World War II, Pierce completed a BSc in 
biology, MSc in anatomy and an MD at the University of Alberta570.  Whilst at 
medical school, Pierce became particularly interested in medical science.  So much 
so, Pierce took a year out to work in a research laboratory – the project he was 
assigned was related to breast cancer.  Pierce described this as “one of the most 
wonderful years of my life”571.  After graduating and during his two year pathology 
residency, Pierce remembered treating a young boy with testicular cancer.  Pierce 
recalled that “He died, which was terrible, but what disturbed me was our ignorance 
of testicular cancer.  It bothered me that we did not even know the diagnosis of the 
tumor that killed him.  So, I decided then that I was going to be a scientist and work 
on testicular cancer”572. 
This led Pierce to Frank Dixon, who had written about testicular cancer for the 
Armed Forces Institute of Pathology573.  By this time, Dixon was Professor of 
Pathology at the University of Pittsburgh, and Pierce joined him in 1955.  Dixon 
believed that teratomas had a multipotential embryonal carcinoma precursor cell, but 
Pierce admitted that this was not a widely accepted idea at the time, particularly in 
Britain.  Pierce claimed that his late 1950s work with Frank Dixon made him realise 																																																								
570 Pierce, 1993. 
571 ibid p 8. 
572 ibid p 8. 
573 Dixon and Moore, 1952. 
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he needed a better understanding of embryology574.  To this end, Pierce went to work 
with Stevens575.  Pierce learned the technique of producing embryoid bodies; an 
important technique Pierce felt, since it allowed mass production of the ascites 
variant576 of the solid tumour577.  Pierce was excited to tell Stevens of this technique, 
and when Stevens published a paper about such work months later578, Pierce said 
“[Stevens] was very gracious to me, and we became very close friends”579. 
 
3.3.2 Ascites tumours and cancer cell differentiation 
“The remarkable manner in which early embryonic life is recapitulated in neoplasia 
surely is one of the most stunning examples of the numerous fascinating aspects of 
microscopy which on a daily basis provides interesting images…”580 
 
 Embryoid bodies are rounded structures that, histologically, become clear in 
sections because of the dark staining of ectodermal cells, which form a disc.  This disc 
is associated with a thin layer of yolk sac epithelium, and a cavity (similar to the 
amniotic sac), lined by flattened endodermal epithelium.  Human embryoid bodies 
also stain for human chorionic gonadotrophin and α-fetoprotein.  Usually, the 
embryoid bodies are singular (i.e. do not usually form in pairs or in greater numbers), 
but can be found in large groups, with each embryoid body separate from others.  
Where a cancer has metastasised, embryoid bodies may be observed at the secondary 
site.  Polyembryomas, as mentioned previously, include blastocysts and embryoid 
bodies similar to day 17 or 18 embryos581. 
The pathologist Max Askanazy (1865-1940), professor at Geneva, was an 
expert in teratomas working in the early twentieth century, and his experiments were 																																																								
574 Pierce, 1993. 
575 Pierce states that he started working with ‘the Fekete ovarian teratocarcinoma’ in 1956, 
before moving onto Stevens’ strain 129 testicular teratomas.  Pierce, 1993 p 9. 
576 Embryoid bodies form from teratoma cells transplanted into the ascitic fluid; these are so-
called since, morphologically, they appear similar to early embryos – there forms a layer of 
cells on the outside, and a mass of cells on the inside.  Embryoid bodies differ from embryos 
however as the endoderm, normally part of the inside mass of the developing embryo, 
becomes part of the outer layer of cells on the embryoid body.  Effectively, the embryoid 
body looks like an embryo, however those cells on the inside of the normal embryo are on the 
outside of the embryoid body, and vice versa.  The embryoid body is also referred to as the 
‘ascitic form’ of the solid tumour, since it develops in ascitic fluid. 
577 Pierce, 1993 p 9. 
578 Stevens, 1960. 
579 Pierce, 1993 p 9. 
580 Young, Stall, and Sevestre, 2016 p 104. 
581 ibid. 
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the beginning of a series of similar experiments that would begin again in the mid-
twentieth century.  In 1907, Askanazy gave an overview lecture on the topic to the 
German Pathological Society, which has become a highly cited source for 
understanding of the teratoma in the early twentieth century.  In this lecture, 
Askanazy suggested that teratomas arise from an eiwertige [egg equivalent] stem cell 
remaining in the adult body.  To demonstrate that the embryonic rest theory was 
correct, Askanazy would inject embryonic tissue into the peritoneal cavity of rats.  
The experiments (as far as Askanazy was concerned) were successful – teratoma-like 
tumours would develop from the injected embryonic tissue582. 
 In 1954, a paper describing the conversion of a murine ovarian teratoma to an 
ascitic form was published583.  This was part of a research project with the aim of 
determining to which extent different tumours produced aggregates of cells584.  The 
ascites form was later shown to lose more differentiated tissues and remain as a small 
cluster of cells, or monocellular carcinoma585.  Those cells remaining then must be, 
argued Pierce, highly malignant.  Pierce and Dixon observed that these tumours 
would be especially useful in determining whether malignant teratoma cells were 
capable of successfully differentiating into “adult forms” (as proposed by Askanazy in 
1907)586. 
In two papers published in 1959 (see below), Pierce and Dixon demonstrated 
that ascites tumours could be made from Stevens’ strain 129 teratomas, and that the 
undifferentiated cells obtained using this method could form other teratomas 
(including several differentiated cell types).  What Pierce and Dixon demonstrated 
was that embryonal carcinoma cells (ECCs) were multipotent, and that these cells 
were similar to those of the preimplantation embryo587.  Pierce submitted his paper to 
Cancer – a clinically-oriented journal, in keeping with Pierce’s background in 
pathology.  Pierce said he received the card to state that his paper had been received 
by the journal, but it was under review for six months – a long time.  Eventually an 
associate editor of Cancer telephoned Pierce, and he was immediately told that there 
was nothing wrong with the data presented.  Pierce claimed he was relieved, however 																																																								
582 Maehle, 2011. 
583 This was the ovarian teratoma described by Fekete and Ferrigno (1952), and referred to by 
Leighton as the ‘Fekete teratoma’. 
584 Leighton, 1954. 
585 Goldie, 1956; Klein and Klein, 1956. 
586 Pierce and Dixon, 1959b p 584. 
587 Pierce and Dixon, 1959a. 
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was then told that the paper could not be published.  Pierce enquired as to why, and 
was told that “everyone knows that cancer cells can’t differentiate”.  Pierce protested, 
stating that if the data was sound, and the data showed that cancer cells could 
differentiate, then presumably they could.  After a pause, the assistant editor agreed to 
publish the paper with a change to the title.  Pierce agreed.  The original 
“Teratocarcinogenesis by differentiation of multipotential cells” (described by Pierce 
as ‘a jawbreaker’) became “Teratocarcinogenesis by metamorphosis of multipotential 
cells”588. 
In this paper, eventually published in 1959, Pierce and Dixon showed that 
murine teratomas developed from undifferentiated cells.  This had already been 
postulated by other groups, however Pierce and Dixon were the first to publish 
experimental data to support the claim.  Pierce and Dixon minced solid 
teratocarcinomas and injected the resulting thick suspension into the peritoneal cavity 
of weanling mice (i.e. infant mice that had recently begun feeding independently of 
their mother).  After a period averaging 35 days, with their bellies distended, the mice 
were killed and an incision made into the peritoneal space.  The fluid was aspirated 
and stained.  Pierce and Dixon observed distinct growths in this fluid, including cysts 
and free-growing tumour cells.  Teratocarcinomas were also observed.  These 
tumours contained tissues differentiated from all three germ layers, as well as 
undifferentiated tissue.  This elegant experiment then showed that minced 
teratocarcinomas were capable of producing other teratocarcinomas with 
differentiated tissues from all three germ layers.  The ‘stem cells’ of these tumours 
then had to be multipotent (or pluripotent, to use current terminology).  However, the 
concept of cancer cells which were capable of differentiation was not particularly well 
received (see above). 
In order to refute the argument he was continually faced with (i.e. that 
differentiation does not occur in cancer cells), Pierce demonstrated that differentiation 
occurred not only in teratocarcinomas, but in other cancers as well.  In addition, 
Pierce continued to work on demonstrating the multipotentiality (pluripotency) of 
teratocarcinoma cells specifically.  In 1964, Pierce published a paper with Lewis 
Kleinsmith, a Cancer Research Fellow student.  Taking the 1959 work a step further, 
Kleinsmith and Pierce isolated single cells from embryoid bodies (from ascites 																																																								
588 Pierce, 1993 p 10. 
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tumours of teratocarcinomas), and transplanted these into mice589.  Those mice which 
developed tumours were killed, and 44 clonal cell lines obtained from these tumours.  
Kleinsmith and Pierce reported that between four and eleven different tissue types 
were observed from each clonal line over five generations.  This then very clearly 
demonstrated that single teratocarcinoma cells were capable of producing many 
different cell types590.  As a result of this work, Pierce suggested an appropriate future 
therapy for cancer may be differentiation therapy – a therapy which would force the 
cancer cells to differentiate, and become benign, reducing the growth rate591. 
 
3.4 Primordial germ cells – ‘stem cells of teratomas’ 
 Stevens’ first paper in 1954, co-authored with Little, followed several months 
work with strain 129 mice by Stevens, who observed their susceptibility to testicular 
teratoma formation (see above).  Testicular teratomas occurred spontaneously in 
approximately 1% of strain 129 males, and contained “undifferentiated embryonic 
tissue”, glandular tissue, cysts, nodules of bone (with marrow) and/or cartilage, 
cuboidal epithelium, fat and nervous tissue; the larger the teratoma, the more tissue 
types were observed592.  Stevens transplanted fifteen of these teratomas into other 
mice and whilst all grafts took, only one developed into a “rapidly growing 
transplantable tumor”, which contained undifferentiated cells593.  Stevens and Little 
ascribed the maintenance of the transplanted teratoma to “pluripotent embryonal 
cells”; this concurred with Dixon and Moore’s previous suggestion that totipotent, 
undifferentiated cells of germ cell origin had the potential to become embryonal 
carcinomas594, and Stevens and Little considered their own findings were in accord 
with this theory, stating this in their 1954 paper. 
 In 1964, Stevens published a paper summarising his experimental work 
producing testicular teratomas in mice, and how these results supported the theory 																																																								
589 In 2000, the generation of human embryoid bodies in vitro was achieved by removing 
pluripotent stem cells from the feeder layer of the suspension culture.  Itskovitz-Eldor et al., 
2000. 
590 For example, see Pierce and Wallace, 1971. 
591 The beginning of this research was already underway, with Niu, Cordova and Niu 
demonstrating that ectopic ribonucleic acid induced differentiation in ascites tumours (Niu, 
Cordova and Niu, 1961). 
592 Stevens and Little, 1954.  Not all tissue types were observed in all teratomas examined. 
593 Those which did not grow remained as small nodules of highly differentiated cells, which 
had the growth characteristics of homogenised 13-14 day foetal tissue, injected 
subcutaneously (Stevens and Little, 1954). 
594 Dixon and Moore, 1952. 
CHAPTER 3  154 
 
that testicular teratomas were derived from primordial germ cells (PGCs)595.  In order 
to demonstrate this, Stevens investigated the induction of teratoma formation from 
transplanted genital ridges of mice.  The optimal time for this transplant was at twelve 
days after conception, where the genital ridges were transplanted out of the foetus, 
and grafted onto either the spleen or testes of adult mice.  Approximately 80% of 
testicular grafts developed teratomas, identical to spontaneous teratomas; Stevens 
suggested that this development was via PGCs.  The grafts into the spleen however 
were less successful.  Where teratomas developed in the spleen (ten times less 
frequently than testicular grafts), the tumours were smaller and simpler; Stevens 
suggested that the spleen provided an environment that promoted differentiation of 
the “undifferentiated embryonal cells”, which were described as “the stem cells of 
these tumors”596. 
 Following repetition of the 1964 experiment, John T Aldrich (also at JAX) and 
Stevens described the effect of 5-Fluorouracil (FU), an anticancer agent used in 
chemotherapy, on murine testicular teratomas597.  The paper championed the use of 
their induced testicular teratomas in cancer studies, noting that the system was unique; 
the “carcinogenetic process” was known to take place within 24 hours of grafting, and 
no other factors were required to induce tumour formation598. 
As well as continuing work on teratoma development, Stevens continued 
testing chemotherapies on induced teratomas with other researchers599.  Using 
Stevens’ induced teratoma model meant that drugs could be administered at a precise 
stage in tumor development; again, a particularly useful research tool.  Aldrich and 
Stevens suggested that two types of cell were potentially exposed to the effects of FU: 
the “teratomatous tissue” contained in the grafted genital ridges, and the normal cells 
																																																								
595 Stevens, 1964.  Boveri had originally named primordial germ cells in 1892, suggesting that 
these cells may be directly descended from the fertilised egg, and retain the ‘character’ of the 
spermatozoa or egg in its chromatin.  PGCs, which would then differentiate into either egg or 
sperm cells of the new organism, would then retain the ‘character’ of the offspring’s parents 
in the offspring’s germ cells, and so on.  Baltzer, 1967; Maehle, 2011. 
596 Stevens, 1964 p 659. 
597 FU functions as an antimetabolite for uracil in nucleic acid synthesis.  It therefore affects 
rapidly proliferating cells. 
598 In continued use of strain 129 mice for this work, histocompatibility was also not an issue 
(since the mice were inbred), which may have been a problem for other researchers (Aldrich 
and Stevens, 1967 p 945). 
599 For example, see Mount, Stevens, and Whitmore, 1970. 
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of the grafted genital ridge600.  Aldrich and Stevens noted that other studies had 
shown that teratomas could arise from a single cell: the PGC601. Stevens was 
confident enough to agree: 
 
“This influence [of the testicular environment] results in the initiation of development 
of male primordial germ cells.  They proliferate and give rise to undifferentiated 
embryonic cells which in turn give rise to the primary germ layers.  The primary germ 
layers differentiate into disorganized mixtures of many kinds of tissues characteristic 
of teratomas.”602 
 
Stevens’ 1968 paper described the use of grafted fertilised eggs (instead of 
genital ridges) to induce testicular teratomas.  Where undifferentiated cells were 
observed, Stevens attributed this to their environment: the influence of sex hormones 
and the disorganised nature of the tumour603.  Alternatively, Stevens suggested that 
“undifferentiated cells may have arisen from cells with characteristics of primordial 
germ cells”604, although which cells these could be (if not PGCs) is unclear.  Serial 
transplantation highlighted a sub-set of cells which were capable of proliferating and 
remaining undifferentiated for 165 days.  Stevens suggested that as these cells were 
able to divide asymmetrically and had a high proliferative potential, they were likely 
to be the “stem cells of teratomas”605. 
Earlier examination of grafted eggs showed that early development was very 
similar to normal embryogenesis, including development of extra-embryonal cells.  
This was the case for grafts up to 14 days post-grafting, when some regions of the 
tumour started to become disorganised.  Tumours examined at later stages of growth 
showed increasingly differentiated cells alongside some undifferentiated embryonic 
cells, demonstrating that differentiation of some cells “may be delayed for remarkably 																																																								
600 Aldrich and Stevens, 1967 p 946.  I believe this implies that, as highly proliferative cells 
are susceptible to FU, the cells in genital ridges are stem cells; Aldrich and Stevens make no 
explicit note of this however.  More recently, it has been suggested that primordial germ cells 
colonise the genital ridge (for example, see Sutton, 2000), as implied by the work carried out 
by Stevens in the 1960s. 
601 In particular Pierce, Dixon, and Verney, (1960) and Kleinsmith and Pierce (1964). 
602 Stevens, 1968 p 329. 
603 Later, Stevens further investigated the effect of environment by culturing genital ridges at 
either 32°C or 37°C prior to transplantation.  One observation was that ridges cultured at 
32°C induced many more teratomas following transplantation than those cultured at 37°C, 
confirming that environment did have a role in teratocarcinogenesis (Friedrich, Regenaas, and 
Stevens, 1983). 
604 Stevens, 1968 p 330. 
605 ibid p 332. 
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long periods of time”606.  As well as this, Stevens suggested that these cells “…give 
rise to differentiated tissues and to more undifferentiated proliferating cells like 
themselves”607.  Note the similarity here to current definitions of stem cells – capable 
of proliferation and differentiation.  Stevens suggested that these cells were 
indistinguishable from the pluripotent “stem cells of teratocarcinomas” described 
separately by both Pierce and Stevens in 1967.  Stevens noted the relevance of the 
“misplaced blastomere” theory in his research, which suggested that teratomas 
developed from “embryonic totipotent cells”, which were no longer influenced by 
“embryonic organizers”608.  However, Stevens preferred to believe that teratomas 
developed from PGCs, citing his previous work609.  Stevens explained that the results 
of his study (i.e. that teratomas can develop from eggs at the two-cell stage) 
demonstrated that teratomas derive from cells destined to become PGCs, or from 
disruption of normal cell-cell relationships610. 
Later, Stevens described the induction of teratomas from more developed 
embryos, at 3 and 6 days following fertilisation.  Some grafts contained 
undifferentiated cells which remained pluripotent and proliferated indefinitely 
through several serial transplants.  Stevens now had an altered view on the cells from 
which teratomas develop.  Spontaneous teratomas, Stevens still believed, were 
derived from PGCs, however teratoma development could be induced in the 
laboratory by grafting embryos/fertilised eggs611.  The term “undifferentiated stem 
cells” also seems to replace “undifferentiated embryonic cells” in this paper612, which 
also contained Stevens’ first reference to an “embryonic stem cell”613.  Stevens 
however does not appear to use this phrase any differently to similar phrases used 
throughout previous publications; the ‘undifferentiated embryonic stem cell’ is the 
cell responsible for the continued growth observed following serial transplantation of 
tumours – the theory that such a cell existed had been mooted many times previously.  
The ‘embryonic stem cell’ is not referred to again in this paper.  The shift in 
terminology may be a reflection of the general shift in terminology for such cells, 																																																								
606 ibid p 336. 
607 ibid p 337. 
608 ibid p 338. 
609 For example, Stevens 1967b. 
610 Stevens, 1968. 
611 Stevens, 1970. 
612 For example, Stevens, 1970 p 375. 
613 Stevens, 1970 p 380. 
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with a greater number of researchers understanding the concept of an embryonic stem 
cell in the context of Stevens’ work. 
 
4. Parallels between development and cancer 
Several approaches have been taken to examine the parallels between normal 
development and cancer development in mammals.  Referring to the study of 
developmental biology in the context of regenerative medicine, John Gurdon (see 
Chapter 2) stated that “As we get older, the normal processes of cell renewal...may 
become uncontrolled, leading to cancer”614.  Here Gurdon is asserting that the usual 
processes of development and regeneration are ‘hijacked’ by cancer; better 
understanding of one should therefore aid in better understanding of the other.  
Immune tolerance, invasiveness, and proliferative mechanisms that are essential in 
pregnancy and early development are exploited by malignancies to evade the host’s 
immune response to spread, and to grow615. 
Some of the earliest investigations in this area were carried out in the early 
twentieth century, and made use of the increasingly precise measurement of cellular 
components available; this led to several researchers examining the biochemistry and 
metabolism of both developing embryos and cancers.  Other research has been 
concerned with what determined cell fate (a continuation perhaps of the early 
twentieth century interest in cell lineage studies in the USA [see Chapter 1]).  As 
demonstrated by nuclear transfer in the mid-twentieth century (see Chapter 2), the 
genome is stable, and no changes are made during development.  What changes, 
however, are the genes that are expressed at any one time.  This consistency is key, 
argued Gurdon, since it ensured that by changing the pattern of gene expression, any 
cell type could become any other cell type (see also Chapter 6)616. 
 
4.1 Biochemistry 
In a report from 1972, W Eugene Knox, then Professor of Biological 
Chemistry at Harvard Medical School, summarised the findings of his own 
experiments and those of others, who had compared cancer and foetal cells of various 
organs, and quantified their similarities.  Biochemistry was utilised as an approach to 																																																								
614 Gurdon, 1999. 
615 Holtan et al, 2009. 
616 Gurdon, 1999. 
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determine those substances (such as proteins) present in the cytoplasm of various cell 
types; this, Knox argued, would enable detailed examination of both gene products 
and their rates of degradation in the cell.  He admitted however that such information 
would only be a snapshot of the cell’s cytoplasm at a particular moment in time, and 
that the components of the cytoplasm would be affected by factors such as age, and 
stress, for example.  Such research was not necessarily part of any “ambitious quests” 
to identify either the cause or the cure of cancer, Knox noted, preferring that the 
research he and others were carrying out be considered as “defining…the relation 
between normal animal tissues and their neoplasms”617; a further indication that 
parallels between cancer and normal tissue were becoming appreciated and, to an 
extent, exploited. 
Making use of various cell types of the rat, Knox (and others) isolated and 
quantified the components of each cell type, in particular normal adult tissues, foetal 
tissues, and neoplastic tissues (especially kidney, liver, and brain).  In 1947, the 
biochemist JP Greenstein had published similar research, concluding that tumours 
from various tissues resembled each other more closely than their tissue of origin; 
this, Knox suggested, presented a paradox: experts knew that “the outstanding 
characteristic of tumors was not their uniformity but their diversity in nature and 
behavior”618.  Instead, Greenstein’s results suggested that tumours were rather similar 
to each other.  Perhaps, Knox argued, noting that Greenstein would have tested 
undifferentiated tumours, tumours would be less similar to each other in highly 
differentiated tumours.  Knox’s own research agreed with Greenstein’s results, and 
furthermore, showed that foetal tissues were more similar to each other than the adult 
tissues they would develop into.  There was a parallel emerging; foetal tissue was 
more similar to other foetal tissue than its differentiated adult state.  Similarly, 
undifferentiated tumour tissue was more similar to other undifferentiated tumour 
tissue, than the tissue it had arisen in.  (More differentiated tumours however were 
more similar to the tissue of origin than undifferentiated tumours.)  These results led 
Knox to ponder over whether tumour cells became undifferentiated through (genetic) 
change, or whether normal development was reversed, resulting in 
																																																								
617 Knox, 1972 p 480. 
618 Knox, 1972 p 485. 
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dedifferentiation619.  Why was such work useful?  Because, suggested Knox, 
“Neoplasms become less mysterious as they are recognized to be similar to a familiar 
type of normal tissue and as they become susceptible to some logic”620.  This 
contrasts with some of the earlier descriptions and explanations of cancer (see section 
2), conceptualising cancers as crab-like monsters, eating away at their victims.  Knox 
is suggesting here that in the laboratory, experimental work on neoplastic tissue 
should be carried out in a similar fashion to those experiments on normal tissue.  In 
addition, Knox is proposing that cancer perhaps should not be considered as 
something abnormal or alien, but should be considered as a regular function of cell 
fate (through either undifferentiation or dedifferentiation).  Is this then an indication 
of the normalisation of cancer, as it became more prevalent through the twentieth 
century?   
In the 1920s, biochemists began investigating metabolism in organisms and, 
eventually, individual tissues and cells.  Nobel prize winner Otto Heinrich Warburg 
(1883-1970), for example, described the aerobic glycolysis621 that cancer cells used to 
generate energy in the form of ATP (adenosine triphosphate) (now referred to as the 
Warburg Effect622).  Cells other than cancer cells have also been shown to create ATP 
in this less efficient way: rapidly proliferating cells, such as those in the pre-
implantation embryo623.  It has been suggested that one reason for this may be that the 
blastocyst requires a lot of ATP, since the cells are rapidly dividing; much of the ATP 
requirement is met through the regular glycolysis pathway in the mitochondria (via 
the tricarboxylic acid, or TCA, cycle), however extra ATP can be generated in the 
cytoplasm.  As mentioned prior, the aerobic glycolysis cycle is less efficient at 
generating ATP from glucose than the TCA cycle, leading biologists to enquire as to 																																																								
619 ibid p 486.  Knox also proposed the term “fetalism” to describe the resemblance of 
undifferentiated tumours to foetal tissue (p 487). 
620 ibid p 487. 
621 Normally, mammalian cells prefer to generate energy by glycolysis in the mitochondria – 
the cell’s ‘power station’.  In cancer cells, however, glycolysis occurs in the cytoplasm, which 
results in a build-up of lactic acid (or lactate). This process normally only occurs when there 
is a lack of oxygen available (for example, after exercise), and is not a metabolic pathway that 
is designed to continue for extended periods of time (due to its inefficiency, and the build-up 
of acid in and around the cell). 
622 This is the Warburg Effect as it refers to oncology.  Warburg’s research was not limited to 
animal biochemistry however, and there is also a Warburg Effect that refers to plant 
physiology, and the decreased rate of photosynthesis in environments containing a high 
concentration of oxygen.  For example, see Turner and Brittain, 1962. 
623 Fridhandler, 1961. 
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why cancer cells, or the early embryo, generate a significant proportion of their ATP 
using this method.  It has been suggested that the different pathways, with different 
products (or intermediates), may be useful to the cancer cells or embryo.  Below, two 
such examples are given: the products of lactic acid, and glucose-6-phosphate624. 
In cancer, aerobic glycolysis occurs regardless of the amount of oxygen 
available (i.e. through vascularisation), and cannot be accounted for by mitochondrial 
defects625.  It has been suggested that the cancer cells may actually thrive in the highly 
acidic environment created by this glycolytic pathway, giving cancer cells an 
advantage over surrounding non-cancer cells, which would find the increased acidity 
toxic.  For example, the localised acidosis may result in the breakdown of junctions 
between cells, and of the extracellular matrix reinforcing tissue structure; this may 
enable the invasion and metastasis of cancer cells, resulting in cancer spreading and 
secondary tumours626. 
 In the blastocyst, like in cancer, aerobic glycolysis also results in the 
production of lactic acid, and the acidosis of the local environment.  It has been 
suggested that just as the increased acidity of the local environment aids in the 
invasion and metastases of cancer, the increased acidity of the local environment 
around the pre-implantation embryo may enable implantation, mirroring tumour 
invasion627. 
 The aerobic glycolysis pathway produces another intermediate not generated 
by the TCA cycle: glucose-6-phosphate.  Glucose-6-phosphate can be utilised in a 
further metabolic pathway: the pentose phosphate pathway (PPP).  The PPP is 
important for rapidly dividing cells, as it increases the amount of carbon available to 
cells where there may otherwise be a shortfall.  The PPP generates ribose for nucleic 
acid synthesis, and NADPH (nicotinamide adenine dinucleotide phosphate), essential 
for lipid (and therefore membrane) synthesis628.  NADPH is also important for 
																																																								
624 There are several other examples available in addition to lactic acid and glucose-6-
phosphate.  For example, there is increased production of glutamine in cancer cells and the 
early embryo, which is useful in generation of ATP.  For a review, see Smith and Sturmey, 
2013. 
625 Genetic defects of mitochondrial proteins only occurs in a few cancers, however almost all 
cancers make use of the alternate glycolysis pathway.  Smith and Sturmey, 2013.  
626 ibid. 
627 Gatenby and Gilles, 2004; Smith and Sturmey, 2013. 
628 Vander Heiden, Cantley, and Thompson, 2009; Smith and Sturmey, 2013. 
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antioxidant production, and therefore maintaining the redox status629 of cells630 – 
particularly important since, as established above, cancer cells and the early embryo 
are generating a lot of lactic acid.  There is an increase in the amount of glucose in the 
PPP cycle from 7% in the cleavage-stage embryo, to around 20% in the blastocyst631. 
The above examples demonstrate the similarities between cancer cell and early 
embryo metabolism; there are further parallels observed between cancer cell and 
embryo regulation.  The example of pyruvate kinase will be used to highlight this. 
 In the final step of the TCA cycle, pyruvate (and ATP) is produced from the 
action of an enzyme, pyruvate kinase (PK), on phosphoenolpyruvate (PEP).  A 
different isoform of the pyruvate kinase enzyme, named PKM2, is expressed in both 
cancer cells632 and early embryos (at the cleavage stage).  The dimeric form of PKM2 
(induced by interaction of PKM2 with some oncoproteins) is less active than PK, 
resulting in the production of less pyruvate from PEP633.  An alternative reaction then 
takes place, due to the increased amount of PEP in the cell.  Independently of PK, 
PEP acts as a phosphate donor (to the enzyme phosphoglycerate mutase 1 [PGAM1]), 
which also results in PEP becoming pyruvate634.  This action, side-stepping the usual 
TCA cycle pathway, reduces the amount of ATP produced, but generates more 
pyruvate for the PPP, which, as noted above, is important in rapidly proliferating 
cells. 
 In addition to its cytoplasmic function, PKM2 has a role in the nucleus, where 
it acts as a transcription factor.  In this role, PKM2 functions as a regulator in histone 
modification635 and epigenetic regulation.  In particular, the PKM2-dependent histone 
modification affects genes involved in tumourigenesis and proliferation636.  PKM2 
has been shown to function as a transcription factor on genes that have roles in the 																																																								
629 ‘Redox’ is the term given to chemical reactions that involve both reduction (gain of 
electrons) and oxidation (loss of electrons).  The TCA cycle is an example of redox reaction 
in the cell.  Other such redox reactions can result in the production of ‘free radicals’, or 
electrons, which attach to other molecules almost instantly after their production.  For some 
molecules, this can be harmful, reducing or preventing their function altogether.  Other 
molecules, such as NADPH, function as antioxidants, which free radicals can attach to 
without causing harm. 
630 Leese, 2012. 
631 Javed and Wright, 1991. 
632 The amount of the dimeric form of PKM2 in tumour cells correlates with the degree of 
malignancy.  Eigenbrodt et al., 1992. 
633 Mazurek et al., 2005; Cortés-Cros et al., 2013. 
634 Vander Heiden et al., 2010. 
635 Histones are proteins that ‘package’ and organise the DNA inside the cell nucleus. 
636 Yang et al., 2012. 
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progression of cancers, and many that are needed for normal embryonic 
development637. 
 
4.2 Cell fate 
 As demonstrated by the success of nuclear transfer experiments in the mid-
twentieth century (see Chapter 2) and the generation of induced pluripotent stem cells 
(iPSCs) in the early twenty-first century (see Chapter 6), every cell contains exactly 
the same DNA638; what causes one to be muscle and one to be brain (for example) are 
the genes that are being expressed.  Differentiated cells are encoded by <10% of the 
total number of genes in nuclear DNA639.  Gurdon has argued then that cell fate 
cannot be determined by genetics, but must instead be influenced by the cell’s 
environment.  Cell lineage studies have demonstrated that there is no simple linear 
relationship between the position of a particular cell in the early embryo, and the fate 
of its descendants.  Removal of any such cell in the embryo would simply require a 
compensatory action of the neighbouring cell640. 
 A useful example of the sort of cell lineage changes that Gurdon refers to is in 
epithelial and mesenchymal cells of the early embryo.  During organogenesis, 
epithelial and mesenchymal cells switch phenotypes depending on their function at 
the time.  This is referred to as epithelial-mesenchymal transition (EMT) or 
mesenchymal-epithelial transition (MET), both of which are required for complex 
tissue patterning and morphogenesis641.  The plasticity afforded to epithelial cells via 
EMT is essential for development, such as enabling cell migration during 
embryogenesis (in particular, for example, morphogenesis of the mammary gland) 
and for cancer (in particular, invasiveness).  Once the epithelial cells have migrated 
and no longer require their mesenchymal characteristics, MET returns the cells to a 
completely epithelial state642.  In cancer, epithelial cancer cells acquire some 
mesenchymal features in order to metastasise; for example, EMT results in 																																																								
637 These genes include Oct4, Myc, KRAS, HIF, TFAM, SLC2A1, STAT3, and p53.  Luo and 
Semenza, 2012; Smith and Sturmey, 2013.  It is also of interest to note that both Oct4 and c-
Myc are two of four genes (the others being Sox2 and Klf4) required to dedifferentiate somatic 
cells into iPSCs (induced pluripotent stem cells).  Takahashi and Yamanaka, 2006. 
638 The exception of course being erythrocytes (red blood cells), which do not contain any 
nuclear DNA. 
639 Gurdon, 1999. 
640 ibid. 
641 Micalizzi, Farabaugh, and Ford, 2010. 
642 ibid; Nieto, 2013. 
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delamination of the primary tumour, a first step required for metatstasis643.  The genes 
expressed during EMT in development include those that are also expressed in cancer, 
their expression correlating with poor clinical outcomes644.  Comparing 
developmental processes with their parallels in cancer provides targets for 
therapeutics. 
 
4.2.1 The niche 
 Large organisms contain many microenvironments referred to as niches; in 
particular, these are regions where stem cells reside, and retain their potential for both 
self-renewal and differentiation (see Chapter 6).  Another such niche is the 
microenvironment created by the early embryo during implantation – the developing 
placenta creates a microenvironment that supports immunological privilege (i.e. the 
immune system of the host/mother, will not attack the invader/preimplantation 
embryo)645. 
 So whilst the embryo generates a microenvironment or niche, so do adult stem 
cells, residing in niches around the body (such as the intestinal crypts or the hair 
follicle bulge).  The microenvironment of adult stem cells again permits asymmetric 
division, enabling regeneration (such as wound repair).  The microenvironment has 
also been seen to affect the developmental path of ESCs and iPSCs; non-pathological 
ESCs and iPSCs transplanted into the peritoneal cavity of immunodeficient (‘nude’) 
mice develop into teratomas646. 
This extrinsic determinant of cell fate has not gone unnoticed by those who 
propose that there are populations of cells that give rise to cancer cells, whilst also 
being able to self-renew; these are referred to as CSCs, and are also thought to 
generate their own niches, a microenvironment that determines cell fate, proliferation, 
migration, and vascularisation (for example)647.  The CSC concept is described in 
detail below. 
 
																																																								
643 ibid. 
644 Micalizzi, Farabaugh, and Ford, 2010 p 117. 
645 Holtan et al., 2009. 
646 For example, Hanna et al., 2009. 
647 Ruiz-Vela, Aguilar-Gallado, and Simón, 2009. 
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5. Comparison of CSC and ESC properties and functions 
5.1 The CSC concept 
“As differentiated normal and cancer cells can reenter an undifferentiated stemlike 
state, another level of cell plasticity has become apparent”.648 
 
CSC theory has evolved from research such as that highlighted previously in 
this chapter.  Currently, it is a popular theory – it works for both for practical 
experimentation and as an explanation for successful or unsuccessful theories.  
Recently, Laplane has published a book on the CSC theory, examining its roots and 
explaining, using philosophy of science, how the theory has become practically useful 
for biologists and clinicians. 
In her book, Laplane noted that the first international meeting specifically 
addressing the topic of CSC theory was held in 2006 by the American Association for 
Cancer Research.  At this meeting, a functional definition of the CSC was decided on: 
 
“[A CSC is] a cell within a tumor that possesses the capacity to self-renew and to 
cause the heterogeneous lineage of cancer cells that comprise the tumor”649 
 
Laplane unpacked the definition provided, highlighting the four propositions implied: 
1) CSCs are capable of self-renewal 
2) CSCs are capable of differentiation 
3) CSCs represent a small subpopulation of cells (these are distinct, and 
therefore can potentially be isolated) 
4) CSCs initiate cancers650. 
These propositions however are burdened with currently-held assumptions about stem 
cells and cancer.  In an attempt to circumnavigate this problem, Laplane separated the 
propositions.  Propositions 1) and 2) refer to stem cell properties – stem cells are cells 
that have the ability to both self-renew and differentiate (see Chapter 1, Chapter 6).  
Proposition 3) is a relational property; CSCs are only distinct if compared with other 
																																																								
648 Nieto, 2013. 
649 Clarke et al., 2006 p 9340; in Laplane, 2016 p 28. 
650 Laplane, 2016 p 28. 
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non-CSCs (i.e. those without the ability to self-renew and differentiate).  This 
proposition is required to show that not all cancer cells are CSCs651. 
 Although Laplane’s work on CSCs is useful, it does not explain where CSCs 
arise: from normal adult stem cells that “run amok”, or somatic cells that 
dedifferentiate652?  Such questions are important for the goal of treating cancer: which 
cells need to be eliminated?  One possible explanation is that there are several 
changes required in any cell (leading to mis-controlled differentiation and growth) 
prior to oncogenesis, and the first of these events is likely to occur in stem cells (since 
these cells undergo sufficient numbers of cell divisions to acquire oncogenetic 
changes)653. 
 Furthermore, the CSC theory may not be as clear as Laplane’s work (and in 
particular the four propositions) suggests.  In 2008, Quintana et al. reported that, far 
from the low numbers of CSCs purported to be present in each tumour (0.0001-0.1%), 
one in four tumour cells, when implanted into immunodeficient mice, were capable of 
initiating a further tumour.  One possible explanation for this involves the cell’s 
microenvironment, such as ECM-rich areas (where increased levels of ECM 
components, like laminin, improve tumour-cell viability)654. 
 
5.2 The ESC concept 
 The history of the ESC concept was discussed in Chapter 1, however relevant 
aspects of the ESC concept will also be briefly included here for clarity. 
 The growth in cell biology studies that led up to development of the ESC 
concept began in nineteenth-century Germany, where there was funding and 
microscopy tools available.  At Berlin, Schwann published his Cell Theory; although 
soon repudiated, the attempt to unify several disciplines would continue to influence 
how biological sciences studies were carried out well into the twentieth century. 
 In the first decades of the nineteenth century, Barry concluded that the first 
divisions observed in the fertilised egg were actually the generation of the first cells 																																																								
651 This is an important distinction to make.  The ‘classical’, or ‘stochastic’ model of cancer 
looks at the properties of all the cancer cells as a whole.  Based on this, some of these cells 
(although they are not distinct) must be able to contribute to tumour growth and secondary 
tumour formation / metastases.  Only in the CSC model are these cells conceptualised as 
separate to other cancer cells (non-CSCs).  Laplane, 2016. 
652 Passegué, 2006 p 754; Krivtsov et al., 2006. 
653 Eaves, 2008. 
654 Quintana et al., 2008; Eaves, 2008 p 582. 
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of the new organism – embryonic cells.  Around twenty years later, Haeckel would 
use the term Stammzelle, influenced by Darwin’s ‘stem trees’, initially to refer to the 
earliest (single-celled) organisms that arose from Moneren, the ancestors of 
multicellular organisms – i.e., a phylogenic, evolutionary developmental context.  
Later, Stammzelle would also refer to the fertilised egg.  In 1892, Boveri suggested 
that it was not only the fertilised egg that should be considered as a stem cell, but the 
daughter cells of the next few cell divisions as well. 
 In the USA, Wilson translated Haeckel’s Stammzelle into the English ‘stem 
cell’, and make use of this term in his popular book The Cell, which was produced in 
several editions well into the twentieth century.  The popularity of The Cell meant that 
the idea of stem cells became habitual in relevant discourses (particularly referring to 
the embryo) throughout the twentieth century.  Meanwhile, experimental techniques 
had improved, enabling embryos of some species to be created and observed in the 
laboratory. 
 As highlighted by Stevens’ infrequent use of the phrase ‘embryonic stem cell’, 
it was perhaps still not a concept many were comfortable with, in regard to a 
definition.  Stem cells had been defined previously, however the ESC had not – it is 
possible that even by the mid-twentieth century, some researchers were not confident 
to claim knowledge of the lineage of each cell, as it comes into existence, in the early 
embryo.  The concept of an ESC then needed to wait until more experimental work 
could be carried out to demonstrate the stem cell properties of embryonic cells (see 
Chapter 4). 
 
5.3 Comparison of CSC and ESC concepts 
The nineteenth century was a significant period for research comparing 
pathological and non-pathological development, as parallels were drawn between 
tumour growth and embryonic growth.   In the late 1820s, both Recamier and 
Lobstein compared the growth of tumours to the growth of the embryo, with Lobstein 
suggesting that tumours occurred when the organism lost control of tissue growth.  It 
appears that the ability of tumours to grow so quickly, and apparently separately from 
the rest of the organism, that led to the comparison with embryonic development. 
As discussed in Chapter 1, Barry’s work in the first half of the nineteenth 
century clearly showed that he appreciated that the continuous matter between the 
embryo and the adult were cells, and Cell Theory would have supported Barry’s 
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ideas.  It would also renew conversations about the origins or causes of cancer.  For 
some, such as van der Kolk, the explanation of tumours as clumps of cells would 
enable the suggestion that metastases could arise from the movement of cancer cells 
around the body.  The ancient view that any surgical treatment should remove the 
entire tumour, leaving nothing behind, was reinvigorated with the suggestion that 
tumours were made-up of cells, and that leaving any cancer cells behind would result 
in tumour re-growth (as Lebert advised in 1845). 
 Cell Theory would also suggest how cells would arise in the first place: that 
both non-pathological and pathological cells arise from the cytoblastema (in the 
adult).   For Virchow in particular, the tumour needed to be considered as part of the 
body (even though it was pathological), refuting the view that tumours could originate 
from a source separate from the body.  Remak would also agree that tumour cells 
must arise from other (non-pathological) cells. 
 Where the comparison of tumour and embryonic growth appeared again in the 
later nineteenth century, Italian surgeon Durante would suggest that all tumours arise 
from embryonic cells.  This idea then takes the premise of Cell Theory and omnis 
cellula e cellula, together with the older observation that tumour growth mimics the 
speed and individuality of embryonic growth, to generate direct comparisons between 
pathological and non-pathological development. 
In 1895, Durante published a paper explaining how he worked out this idea; 
he observed two cases where he would surgically remove dermoid cysts, only for 
secondary tumours to reappear later.  He then examined other similar tumours that 
had been removed, and saw that these tumours contained various, disorganised 
tissues.  When considering how all of the tumours he examined contained both mature 
and embryonic tissue, he was led into consideration of development, and in particular 
pubertal development.  During puberty, Durante reasoned, some tissues that had been 
dormant in an otherwise adult body, would spring into life.  Durante suggested that an 
external stimulus may then be responsible for other dormant embryonic cells to 
become active, becoming cancerous growths657. 
As suggested by Eyre, the other embryonic rest theories that followed, were a 
variation on Durante’s initial ideas. The notion that tumour growth was like 
																																																								
657 Durante, 1895 (transl. Eyre, 1896). 
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embryonic growth – so much so that the latter could induce the former – was not at 
issue. 
 In 1947, Krebs claimed that modern embryology had ‘disposed’ of the 
embryonic rest theory of cancer.  There was an individual who would later suggest an 
alternative to the embryonic rest theory – Charles Oberling.  Oberling did not agree 
that embryonic cells remaining in the adult may suddenly lose control of their growth 
and become cancerous.  Oberling’s view is projected in discourses currently occurring 
in the philosophy of stem cell biology, such as Fagan’s argument that stem cells are 
capable of either proliferating or differentiating, but not both at the same time660.  
Oberling observed that both embryonic and cancer cells were morphologically 
similar.  However, Oberling argued that for tumour growth, cancer cells needed to 
continue to multiply.  Embryonic cells, Oberling said, did not have this continuing 
proliferative potential, instead becoming differentiated cells661. 
 
“It is true that embryonal cells do somewhat resemble cancer cells in appearance, 
but the two are entirely different in nature.  For whereas the proliferative vigor of the 
former gradually flags as they differentiate to form normal tissues, their malignant 
prototypes continue to multiply indefinitely and end at last in anarchy and ruin. 
But, it may be said, in the embryo growth is restricted by controlling and directing 
influence; in the body of the adult, where these are missing, the embryonal cells 
behave quite differently.  Experiment does not confirm this objection.  Embryonal 
tissues in all stages of development have been inoculated into countless adult 
animals, and always with the same outcome; they never changed their character, but 
continued to act as they do in the embryo, growing for a time but ending as mature 
tissue”.662 
 
 Oberling’s consideration that malignant cells did not stop proliferating, and 
embryonic cells did, was supported by the experimental results suggesting that 
transplanted embryonic tissue would not result in tumour formation.  For Oberling, 
this was conclusive – no resting embryonic cells were the cause of malignancy in the 
adult. 
 In the latter half of the twentieth century, an updated version of the embryonic 
rest theory emerged – the concept of the cancer stem cell.  Through the twentieth 
century, it became clear that stem cells could not be restricted to the embryo, as the 																																																								
660 Fagan, 2013a. 
661 Oberling, 1944. 
662 Oberling, 1944 p 31. 
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adult body would also need a means of repairing and regenerating – stem cells must 
also be required in the adult body.  If stem cells continued to exist in the adult, then 
‘embryonic rests’ were no longer needed to explain how tumours emerged, even if 
their tissues were different to that of the tissue of origin.  The cancer stem cell then 
was the stem cell that was ‘went rogue’, and became the stem cell of the tumour.  
Laplane’s recent exploration of the CSC concept highlights its practical use for 
clinicians and researchers: it offers an explanation for whether certain therapies are 
either successful or not664. 
 In comparison, the original ESC theory was theoretical.  Developed from the 
early nineteenth century onwards, the ESC theory developed through microscopical 
observations and attempts to explain how a single fertilised egg could develop into an 
enormous, organised, multicellular organism.  Although the term Stammzelle or stem 
cell became used throughout Europe and North America in the late nineteenth and 
early twentieth centuries, its application in embryonic discourses appears lacking.  For 
example, as noted previously in this chapter, Stevens only used the term once as late 
as 1970.  Practically then, ESCs were not as immediately popular as its CSC 
counterpart.  Further evidence for this is the increasing popularity of the term after the 
experimental (i.e. practical) work of Martin and Evans; a search on PubMed for 
“embryonic stem cell” reveals no papers were published containing this term until the 
early 1970s (demonstrating that Stevens’ use of the term was an early example).  In 
the twenty years following the publication of Evans and Kaufman, and Martin’s work 
isolating mESCs, the use of the term increases drastically, with hundreds of papers 
published on the topic (in the twenty-first century, this number increased into the 
thousands). 
 
6. Conclusions 
The aim of this chapter was to explore the parallels between cancer and 
embryonic development, with a focus on the nineteenth and twentieth centuries.  This 
began with a brief history of concepts of cancer, narrating the influence of 
Hippocratic thinking (via Galen) in Ancient Europe, and the importance of Christian 
and Islamic scholars in the upkeep on these ideas about cancer and its treatment into 
the Middle Ages.  It was not until the early modern period that the humoural theory of 																																																								
664 Laplane, 2016. 
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health and wellbeing in general (including cancer) became to be questioned; the 
cultural and technological changes of Renaissance Europe further enabled the creation 
and dissemination of alternative ideas.  The discovery of blood circulation (in 1628), 
the lymphatic system (in 1656), and red blood cells (in 1661) suggested fermentation 
and/or coagulation of the blood and lymph could cause cancer, and resulted in the 
lymph theory in the latter half of the seventeenth century.  Other potential causes of 
cancer came to light in the eighteenth century, such as Pott’s observation that cancer 
could be caused by the accumulation of soot on the skin, and Ramazzini’s study 
regarding the incidence of different cancers in nuns. 
 Re-emerging concerns about the parasitic nature of cancer in the early 
nineteenth century were refuted by those believing in the unifying ideas of Cell 
Theory, maintaining that all organisms were made up of cells, which can only arise 
from the division of other cells.  This idea included both pathological and non-
pathological cells, encouraging researchers such as Virchow to argue against extenal 
causes of cancer, and focus on the possibility that cancer cells could arise from non-
pathological cells or tissues. 
 Durante was possibly the first to suggest that cells from the embryo may 
remain in the adult, suddenly emerging from a dormant state, and initiating tumour 
formation and growth.  A variety of European researchers would agree with the 
concept of left-over cells from the embryo (‘embryonic rests’) being able to cause 
cancerous growths, several theories developed from this theme, including those of 
Ribbert, Remak, Virchow, and Cohnheim.  The embryonic rest theory, or a version of 
it, would survive well into the twentieth century.  Oberling was a vocal opponent to 
the theory in the mid-twentieth century, citing experiments that demonstrated 
transplanting embryonic tissue into an adult did not result in tumour formation. 
 At this time, through the studies beginning with Stevens at JAX, teratomas 
became a useful research tool for the study of cancer origin and, later, development 
(see Chapter 4).  Stevens was not the first to describe testicular teratomas, however 
developed a strain of mice with a high incidence, which could be easily maintained 
and stocks sent to various laboratories around the world; this popularised the strain 
129 mice as the model of study for teratoma research.  Barry Pierce became interested 
in teratoma research from his experiences as a clinician, and in particular the lack of 
understanding regarding human testicular tumours in the mid-twentieth century.  His 
studies with Frank Dixon demonstrated that human teratomas, like their murine 
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counterparts, would differentiate into a variety of tissue types from all three germ 
layers.  Pierce worked with Stevens precisely to gain a better understanding of 
embryology, and how this compared with the teratomas he had observed.  Pierce was 
amongst the first to controversially conceive that some cancer cells were capable of 
differentiation in the late 1950s; this idea was only slowly accepted following the 
publication of results by researchers like Stevens and Pierce, clearly showing that this 
was the only explanation for tumour growth and cell differentiation in the tumour. 
 Throughout the late 1950s and 1960s, Stevens also worked to elucidate the 
cause of teratomas, carrying out experiments to test his hypothesis that PGCs were 
responsible.  This would, apparently unknown to the current generation of researchers 
(as it was not mentioned in their publications), mirror the suggestion made by Beard 
in 1902 that the trophoblast cell (a precursor to germ cells) could be the misplaced 
‘embryonic rest’ that could initiate cancer generation in the adult. 
 After closely narrating the important work of Stevens, Pierce, and others in 
describing the nature and origin of mammalian teratomas, parallels between 
development and cancer have been discussed in this chapter.  Several approaches 
have previously been taken comparing development and cancer, such as Gurdon’s 
reflections cumulating in the claim that the processes of normal renewal become 
uncontrolled, leading to cancer.  Some of the earliest investigations comparing non-
pathological and pathological development were carried out at the beginning of the 
twentieth century, including, for instance, scrutiny of the cellular biochemistry of 
cancerous and non-cancerous cells.  Another research avenue was the examination of 
cell fate, possibly as an off-shoot of the concern with cell lineage studies in the USA 
during this period.   
In a further attempt to characterise cancer cells, Greenstein and Knox (for 
example) carried out a series of biochemistry experiments in the mid-twentieth 
century.  In 1947, Greenstein’s published results suggested that biochemically, cancer 
cells were more similar to each other than the tissues they arose in.  Knox suggested 
that this presented  a paradox, since up to this point, tumours had been characterised 
by their diversity.  Knox repeated Greenstein’s experiments and observed the same 
results; furthermore, Knox also showed that foetal cells were more similar to each 
other than the organs they would differentiate into.  This led Knox to ponder whether 
tumour cells became undifferentiated, or dedifferentiated, in order for tumours to 
grow.  Knox also advocated further study of cancer, since the less mysterious cancer 
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was, the more susceptible to logic (for treatment) it became.  In fact, Knox went a step 
further to suggest that cancerous tissue should be “recognized to be similar to a 
familiar type of normal tissue”665; a clear further indication that in the twentieth 
century, parallels between pathological and non-pathological tissue were sought out.  
In the case of Knox, the clear aim was to improve understanding.  More recent work 
into cell metabolisms and pathways has provided further information regarding the 
ATP (energy) generation of pathological cells (in comparison to non-pathological), 
and how the preference for various pathways results in the production of 
intermediates, useful for cancer growth and invasion.  Interestingly, these same 
pathways and intermediates also appear to be responsible for growth and implantation 
of the early embryo.  There are further similarities in the genes expressed, and by the 
creation of niches, by cancer and embryonic cells in vivo.  It is noteworthy that at this 
time there is still no clear, defined origin of the CSC (unlike the fertilised egg origin 
of the ESC). 
 The apparent ability of cancer cells to self-renew and differentiate was not lost 
on the research community, and, possibly aided by the clear biochemical and 
metabolic similarities between cancer cells and ESCs, a concept of the CSC emerged.  
In her recent book, Laplane linked the history of the CSC concept to the embryonic 
rest theories of the nineteenth century.  Her focus is on the practical uses of the CSC 
theory for research and therapies, and to do this, she noted four premises of CSCs for 
their definition: CSCs are capable of self-renewal and differentiation; they represent a 
small subpopulation of cells (these are distinct, and therefore can potentially be 
isolated), and CSCs initiate cancers.  The capability of self-renewal and 
differentiation are, of course, properties that CSCs have in common with all other 
stem cells (including ESCs).  Although more is becoming understood regarding the 
properties of CSCs, there is still no clearly defined origin of CSCs. 
 Lastly, comparison of CSC and ESC concepts explains that the nineteenth 
century was a key period for the development of comparative links between normal 
and pathological development.  Influential researches included Barry’s initial work 
suggesting that the cells of the embryo were equivalents of cells in the adult; 
Virchow’s interpretation of Cell Theory (and omnis cellula e cellula) requiring that 
pathological and non-pathological tissues must arise from inside the body, (although 																																																								
665 Knox, 1972 p 487. 
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there is no precise definition of pathological origin); Durante’s idea that misplaced 
embryonic cells might lie dormant in the adult, before suddenly beginning to 
proliferate (and differentiate) uncontrollably, forming a tumour; further variations on 
the embryonic rest theory; Oberling’s rebuttal; and eventually the observation that 
PGCs were able to initiate teratomas in mammals. 
Initially, the ESC concept was theoretical in nature, relying on the 
observations and interpretations of microscopists in the nineteenth century.  
Experimentally (or practically), the ESC concept was initially of little use, and 
perhaps stalled its acceptance into embryological and developmental research.  (The 
ESC concept became populariased in the 1980s and beyond by the research carried 
out by Gail Martin and Martin Evans [see Chapter 4].)  Alternatively, the CSC 
concept appears to have been born out of practical requirements for explaining results 
of research and therapeutics. ESC theory provided an explanation of how ESCs could 
arise, and their specific origin.  CSC theory in contrast does not specifically address 
the problem of how CSCs arise, or define their origin. 
I argue that the CSC theory developed from embryonic rest theories through 
the practical work carried out in the mid-twentieth century.    This practical work was 
only possible because of the theoretical background provided by ESC concepts in the 
late nineteenth and early twentieth centuries.  The ESC concept suggested that cells in 
the early embryo were capable of two functions: self-renewal, and differentiation.  
This explained how an entire multicellular organism could arise from a zygote – self-
renewal enabled physical growth, whilst differentiation enabled a multitude of 
specialised tissues to be created.  Parallels were seen with tumour development – 
tumours could physically enlarge (showing that self-renewal was required), and 
include a range of tissue types (demonstrating differentiation potential).  Embryonic 
rest theories were then, generally, an attempt to explain how: 
1) the unifying nature of Cell Theory could be applied to pathological as well as 
non-pathological tissues (and there was a continuum); 
2) tumours could contain various tissues (possibly different to the tissue of 
origin); 
3) stem cells (or cells with the ability to both proliferate and differentiate) could 
exist in the adult. 
This would also encompass Beard’s later trophoblast theory of cancer origin.  
Experimental attempts to test the embryonic rest hypotheses emerged in the early 
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twentieth century, with researchers transplanting sections of embryonic tissue into 
other organs, and examining the results.  These experiments demonstrated that 
‘misplaced’ or ‘reactivated’ embryonic cells were not responsible for tumour 
formation.  As addressed by Oberling, if embryonic cells, with their properties of 
proliferation and differentiation, were not responsible for tumour formation, it implied 
that other cells with these properties were.  This inferred that CSCs existed, however 
gave no suggestion as to their origin.  The embryonic rest theory had implied that 
cells with the properties of self-renewal and differentiation (i.e. stem cells) were 
present in the adult, and that a subset of these cells were capable of causing cancer.  
Tumours, with their ability to grow uncontrollably, and contain both undifferentiated 
and differentiated tissues, were the clear result of the stem cell ‘running amok’.  The 
definition of CSCs currently in use, and helpfully unpacked by Laplane, shows that 
CSC theory emerged from embryonic rest theories, and therefore from the ESC 
concept.  The diffence between ESCs and CSCs however is that whilst the origin of 
ESCs are firmly defined, the CSC origin is not. 
 This chapter concluded with the work of researchers in the mid-twentieth 
century comparing pathological and non-pathological cytology.  The following 
chapter continues chronologically, demonstrating how the use of teratomas became 
essential for the isolation and culture of mESCs. 
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CHAPTER 4: 
AN EXAMINATION OF BRITISH AND AMERICAN 
SCIENCE IN THE 1970S AND 1980S: CASE STUDIES OF 
EMBRYONIC STEM CELL RESEARCH 
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1. Introduction 
 Following on from the teratoma research discussed in Chapter 3, the 
teratocarinomas and their cells identified in the 1950s and 1960s were recognised as 
promising models for both embryo development and cancer research.  The early 
embryonic stem cell work that started in the 1970s began particularly by taking 
methods and techniques from cancer research.  Throughout the twentieth century, 
techniques for embryo culture and in vitro manipulation were improving, and the 
early embryonic cell researchers took full advantage of this. 
 In the 1970s and 1980s, two prominent researchers, Gail R Martin, and Martin 
J Evans, began working to develop a line of embryonic stem cells that could be used 
in the laboratory.  Martin and Evans worked together during the 1970s, developing a 
line of embryonal carcinoma cells.  By the mid-1970s, it had also been shown that 
mouse embryos could complete some of their development ex utero.  In the early 
1980s, Martin and Evans’ continuing work individually resulted in the first isolation 
of embryonic stem cells, both researchers independently publishing methods for 
isolation and culture of murine embryonic stem cells: Martin in the USA, and Evans 
in the UK.  This milestone in stem cell research, and in particular ESC research, 
therefore requires particular attention in this thesis.  Although Martin’s and Evans’ 
work in isolating mESCs has been noted previously, there as yet has been little 
consideration of the reasons or motivations for Evans or Martin to isolate mESCs in 
the first place.  This prompted the selection of these case studies for this chapter, 
particularly as an opportunity to demonstrate the role of social, political, and 
economic factors on what may generally considered to be such ‘milestone’ research.  
This is an interesting time period for looking at potential effects on science by social, 
economic, and political factors, since the 1980s in particular were a time of change – 
changes in social attitudes and priorities (such as high unemployment), political 
changes (with the election of Margaret Thatcher in Britain and Ronald Reagan in the 
USA), and changes in economics, as the downturn hit.  This period also matches one 
of the key timepoints in stem cell history – isolation of mESCs.  Instead of simply 
reiterating the history of Evans’ and Martin’s achievements, this chapter utilises these 
well-known experiments in stem cell history as a way of examining the effects of 
changing social, political, amd economic factors on research in this field. 
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 The research directions Martin and Evans elected to pursue were rather 
different.  Evans, in the UK, concentrated his research on the more clinical and 
therapeutic applications of the stem cells he had cultured in the laboratory.  Half a 
world away on the west coast of the USA, Martin used her stem cells to learn more 
about animal development.  It is unlikely that these selections were arbitrary choices 
on the part of Martin and Evans.  This chapter therefore examines what encouraged or 
discouraged the research directions of Martin and Evans through the 1980s in the 
USA and UK.  This will include global and national economics and politics, as well 
as the research traditions Evans and Martin were working in at their respective 
universities.  Although it is expected that the capitalist ideologies in late twentieth 
century USA would encourage more applied research than the UK, this chapter 
demonstrates that in the 1980s, this was not the case.  Instead, Evans, in the UK, was 
encouraged to find more practical applications for mESCs, whereas Martin in the 
USA could focus on fundamental research into development. 
 Biologist Chris Graham claimed that from the mid-1960s onwards there was a 
strong sense of international collaboration in the fields of fertility and developmental 
biology research, making it “impossible to isolate a uniquely British contribution to 
the field”666.  In this chapter, I seek to demonstrate that this is not necessarily the case.  
I agree that there is more movement and collaboration of individuals and groups 
between Europe, Britain, and North America through the latter half of the twentieth 
century than there had been previously; however, I will also demonstrate that such 
influence and collaboration has not completely merged European and American 
research into a single ‘Western pool’.  Instead, I intend to show that whilst 
collaboration and travel were important and influential, other factors determined how 
embryonic stem cell biology developed separately on each side of the Atlantic. 
 
1.1 Science in the UK and USA: 1970-1981 
 As early as the 1970s, UK and US governments began to reduce their 
monetary support for scientific research.  This said, the biomedical sciences were 
spared from the worst of this initial austerity – their clear application to public health 
and wellbeing was too important.  Eventually, funding in this sector too would be 
scaled back by British Prime Minister Margaret Thatcher (1925-2013) and US 																																																								
666 Graham, 2000 p 51. 
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President Ronald Reagan (1911-2004) (see below)667.  At this time however, 
biomedical sciences were increasing their demand for resources – new areas of 
research (such as genetic sequencing and molecular biology) meant an increase in 
requirements for equipment and specialists, that would provide further improvements 
in medicine and new ways to generate knowledge.  The increased requirements and 
decreasing funds led to biomedical science becoming a highly competitive field. 
 Political scientist Dietmar Braun reported that there were large increases in the 
number of scientists and academics working in the biomedical sciences through the 
1970s and 1980s.  In Great Britain for example, Braun reported a 30% increase in 
senior lecturers, readers, and professors between 1972 and 1980668. 
 As demonstrated below, there was some public disenchantment with science 
in the 1970s UK and USA; coupled with growing economic difficulties throughout 
the decade, the US and UK government budgets on scientific research in general was 
squeezed669. 
 
1.1.1 UK science: 1970-1981 
 Following World War II, it was becoming more obvious that there was a 
developing relationship between scientific and technological progress and power; this 
relationship continued into the late twentieth century, becoming inexorably linked 
with the Cold War.  Science could no longer be considered “value-free”670.  Polish 
bacteriologist and political commentator Ludwig Fleck (1896-1961) had suggested 
this as early as 1935, warning that Western power was too great, and scientific 
discoveries were becoming dependent on social framing (e.g. networks, prestige)671. 
During the 1960s, the general public became much more aware of research 
science, and were developing strong opinions on what procedures or experiments 
should and should not be carried out.  As predicted by Fleck, science was becoming 
implicated in social and political interests672.  This was further emphasised since the 
state funded most biomedical science research in Britain673.  This can be seen in the 
debates concerning animal experimentation and in vitro fertilisation, used here as 																																																								
667 Braun, 1993. 
668 ibid p 269. 
669 ibid. 
670 Jacob, 1992 p 488. 
671 Fleck, 1979 (1935); Jacob, 1992. 
672 Jacob, 1992 p 488. 
673 Johnson et al., 2010. 
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examples to demonstrate the increasingly complex interactions between science and 
the public in the late twentieth century. 
 
Animal experimentation  
 By the end of the 1960s and through the first half of the 1970s in particular, 
animal experimentation was becoming increasingly contested by the general public.  
Letters to the Home Office concerning vivisection increased ten-fold between 1972 
and 1975674.  Growing public concern became political concern, with both the House 
of Commons and the House of Lords meeting to bring in more restrictive legislation 
on animal testing.  Several pressure groups and societies were formed, keen to 
promote the abolition of vivisection in particular and animal experimentation in 
general; most wanted to highlight the advances made in tissue culture to show that it 
was a viable alternative to animal testing.  In 1977, British Prime Minister James 
Callaghan (1912-2005) announced that it was his Labour government’s policy to 
encourage research to move away from animal experimentation as soon as possible675.  
The announcement was generally welcomed by animal welfare groups and the public; 
however, only two years later, with a general election looming, animal welfare 
disappeared from political debate.  The global economic downturn and strikes 
dominated discussion on the run up to the election, with Margaret Thatcher 
(Conservative) being elected as Prime Minister on the back of her promises to 
decrease union powers and improve the economy. 
 
In vitro Fertilisation 
 There was a significant increase in interest in medical and biomedical ethics 
from the late 1960s onwards, with publications contributing to influential journals 
such as the New England Journal of Medicine and the British Medical Journal.  The 
reproductive sciences, which had previously fallen between the divisions of other 
disciplines (such as agriculture and medicine), were also beginning to establish 
themselves as legitimate fields in their own right676.  One area of research that 
concerned many interested in bioethics was that being carried out by obstetrician and 
gynaecologist Patrick Steptoe (1913-1988) and physiologist Robert Edwards (1925-																																																								
674 Wilson, 2011 p 85. 
675 ibid p 87. 
676 Johnson et al., 2010. 
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2013), researchers who were attempting to work on a method of carrying out human 
fertilisation in vitro.  Although fertility research was not looked on unfavourably by 
the UK research councils, it was not a priority.  Instead, as concerns regarding the 
effects of radiation were fading in popularity, this was replaced by another increasing 
concern: over-population.  Infertility was considered to be a relatively low priority in 
comparison with research into contraceptive methods and birth control677.  Steptoe 
and Edwards had failed to obtain funding from the Medical Research Council (MRC) 
(who, Jon Turney suggests, had therefore tacitly proscribed the research), but had 
obtained money for their work from private American funding678. 
In a paper detailing why the MRC did not fund Edwards and Steptoe’s work, it 
is again made clear that social and political agendas affected scientific funding and 
therefore research direction.  The MRC were positive about Edwards’ proposal at 
first; at the beginning of the 1970s they had significant amounts of money to spend on 
establishing specific research institutes, and Edwards was invited to participate.  
Edwards preferred to carry out the work at the University of Cambridge however.  
Furthermore, given the research priorities on over-population, infertility was 
considered a low priority.  This was not only a British consideration, but one which 
had warranted the establishment of the United Nations Fund for Population Activities 
in 1968, and the population control-focused Human Reproduction Programme of the 
World Health Organization in 1972679. 
As Edwards and Steptoe continued their work with American funding, it was 
becoming clear that there was very little legislation concerning their work in the UK, 
again highlighting the need for ethical, legal, and philosophical discussion concerning 
embryo research.  The British legal system was relatively slow with regards to 
creating and implementing new legislation, so, in the meantime, the Warnock 
Committee was set-up to look carefully at research on embryos in the UK680.  Again, 
since legislation was slow, their recommendation for licensing research appeared to 
be the most viable option. 																																																								
677 Graham, 2000; Johnson et al., 2010. 
678 Turney, 1998 p 175. 
679 Johnson et al., 2010. 
680 The report by the Committee of Inquiry into Human Fertilisation and Embryology (also 
known as the Warnock Report, after its Chair Mary Warnock [1924-]) led to the Human 
Fertilisation and Embryology Act 1990, and the establishment of the Human Fertilisation and 
Embryology Authority.  For more on the ethics of the Human Fertilisation and Embryology 
Authority, and bioethics in general in twentieth century Britain, see Wilson, 2014. 
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As demonstrated by these two brief examples, scientific endeavor was being 
bound by the goals and interests of politics; the effect on scientific research was going 
to be significant, since the governmental funding of research was vital in British 
universities.  Similar agendas could be observed in American politics and science. 
 
1.1.2 USA science: 1970-1981 
 The increased concern for the welfare of laboratory animals and the ethical 
debates concerning embryo experimentation were not limited to the UK; in the USA, 
similar discussions were appearing from the late 1960s through the 1970s.  This led to 
some areas of biomedical research becoming particularly politicised.  The USA would 
react slightly faster to new technological capabilities; for example, in October 1971 
the Federal Government deliberated human experimentation, with a particular focus 
on research carried out on the foetus or embryo.  Linked with the abortion debate, 
particularly after elective abortions became legal in 1973, the American government 
was keen to show that such a step was not taken in order to encourage abortion681; this 
led to the Department for Health, Education and Welfare (later the Department of 
Health and Human Services) releasing a statement, advising that there should be no 
attempt to implant a human ova fertilised in vitro until further guidelines had been 
developed.  Initially, this was a moratorium, only made obligatory in 1974, and even 
then only for a year.  In 1974, Congress established the National Commission for the 
Protection of Human Subjects of Biomedical and Behavioural Research, who 
recommended that an ethical board be put in place682.  In 1975, the Ethics Advisory 
Board was set-up, however did not approve any research until after the birth of the 
first IVF baby, Louise Brown, born in Britain, in 1978.  Newspaper reports from the 
time suggest that there was some resentment amongst American researchers, since 
research in the USA could not benefit from those achievements made in embryology 
elsewhere683. 
From 1973, federal funding was not available for research on embryos; the 
private sector however could fund whatever research they wished; since the 
seventeenth century, free enterprise has been a cornerstone of American values, 																																																								
681 Wertz, 2002. 
682 ibid. 
683 Turney, 1998 p 182. 
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preventing the government from legislating against such companies pursuing their 
own goals684.  The Ethics Advisory Board would only eventually approve research 
funding for basic research - not therapeutic or infertility research.  This continued 
until the Ethics Advisory Board charter expired in 1980.  It was never replaced, 
technically leaving no lawful body to approve (or disapprove) embryo research685. 
  
2. Embryoid carcinoma cells to embryonic stem cells: 1970-1981 
 The period 1945-1965 in biology is particularly noted for establishing the 
mouse as an experimental model686.  The era was also defined for its research into the 
effects of radiation (see Chapter 3).  Other research interests were catered for 
however; in Britain, for example, the Marshall School of Reproductive Physiology in 
Cambridge and Waddington’s Institute of Animal Genetics in Edinburgh were also 
well-funded at the time.  By the late 1960s, mammalian physiology, genetics, and 
embryology had been linked with clear applications – Graham refers to this as “a 
powerful cocktail”687.  In Britain, this would lead to the mouse being adopted as the 
animal model for developmental biology; in the USA, Drosophila was the preferred 
model, due to the better understanding of its genetics at the time688. 
 
2.1 Martin J Evans 
 Sir Martin J Evans (1941-) is probably most well known as the winner of the 
2007 Nobel Prize in Physiology or Medicine (alongside Mario R Capecchi and Oliver 
Smithies)689.  Evans, Capecchi and Smithies were awarded the Nobel Prize “for their 
discoveries of principles for introducing specific gene modifications in mice by the 
use of embryonic stem cells”690.  Much of Evans’ life has been well documented, 
particularly since being awarded the Nobel Prize.  Evans’ recollections of his 
childhood and early university career suggest his constant interest in biology, and 
some fortunate instances which led him to meet and/or work with influential 
scientists. 																																																								
684 Wertz, 2002 p 143. 
685 ibid. 
686 For example, see Myelnikov, 2015. 
687 Graham, 2000 p 51. 
688 ibid. 
689 Nobel Foundation, 2007. 
690 ibid. 
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 Evans was born on 1st January 1941 near Gloucestershire, and soon moved to 
Hertfordshire, where Evans recalls his ‘first experiment’: mixing sand cement with 
water, because he could not understand how the mixture could become solid.  After 
suffering from a burst appendix on what should have been his first day of school, 
Evans remembers being treated with one of the first antimicrobial drugs (M&B 693), 
without which he may not have survived; this said, Evans then went on to suffer from 
several other childhood infections, such as mumps691.  Evans suggested that 
recollecting on the time spent in bed at home as a child, reading, playing with his 
chemistry set and electric experiment set, he was ‘naturally’ a scientist692.  After 
electing to study Chemistry, Zoology and Botany at sixth form, Evans won a 
scholarship to Christ’s College, Cambridge, where he found the Natural Sciences 
options tempting, giving him an opportunity to elect courses he enjoyed; this included 
biochemistry (taught by noted plant biologists David Coombe (1927-1999), Malcolm 
Dixon (1899-1985) and Don Northcote (1921-2004)693) and molecular genetics.  In 
the academic year 1962-63, Evans recalled a series of lectures by Jacques Monod 
(1910-1976)694 and Sidney Brenner (1927-)695 about mRNA; from this point Evans 
claimed he was resolved to work in either developmental biology or plant 
biochemistry696.  Evans never had the opportunity to sit his final exams however, 
becoming ill with glandular fever697.  Although disappointed at the lack of 
opportunity to embark on a postgraduate research career at the time, Evans considerd 
himself fortunate to have been employed as a research assistant with Elizabeth 
Deuchar at University College London (where he was also able to complete his PhD).  
Evans described the atmosphere as somewhat relaxed, stating that Deuchar 
encouraged but did not direct, allowing Evans the freedom to experiment, innovate, 
develop techniques and learn a wide range of skills, whilst working on Xenopus 
development. 
																																																								
691 ibid. 
692 ibid. 
693 Evans, 2001. 
694 Monod was to win the Nobel Prize in 1965 for work on genetic control of virus synthesis. 
695 Brenner was another future Nobel Prize winner (2002), and one of the first to see Watson 
and Crick’s 1953 model of DNA. 
696 Evans, 2001. 
697 Nobel Foundation, 2007; Evans, 2001. 
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 During this time, Evans was attempting to isolate developmentally controlled 
mRNA698.  Evans was able to use blastula and gastrula ectoderm, providing an early 
insight into embryo biology.  Evans observed that there were two limiting factors for 
his research: lack of foreseeable genetics, and difficulty in obtaining enough material 
for research699.  This latter Evans discussed with colleague Robin Weiss (1940-), who 
suggested using mouse teratocarcinomas, following the 1966 publications by Stevens 
and Pierce (see Chapter 3).  Evans noted that Stevens had presented these rapidly 
dividing cells which could divide asymmetrically, whilst Pierce had demonstrated 
their clonality.  Stevens sent Evans stocks of mice from JAX, and Evans was taught 
the tissue culture techniques required by Weiss and Pavel Vesely (visiting from 
Prague)700. 
 
2.2 Gail R Martin 
 Gail Martin (née Zuckman) was born in New York, USA, in 1944, and went to 
the University of Wisconsin before beginning her research career at the University of 
California at Berkeley.  She obtained her PhD in 1971.  Martin then moved to 
England with her English husband Steven Martin (also a biologist), after he had been 
offered a job there.  Martin herself found work in Martin Evans’ biochemistry group 
at University College London (UCL), where she credited Robin Weiss with 
introducing her to teratocarcinomas701.  Martin was not the only American at the time 
to visit the UK and Europe after completing a PhD; the National Institutes of Health 
(NIH) and March of Dimes provided funding for fellowships.  In fact Graham 
estimated that such funding doubled the research in mammalian developmental 
biology in the UK between 1960 and 1980702.  Martin returned to the USA in 1976 to 
work at the University of California at San Francisco (UCSF), where she has 
remained until the present.  Martin is currently Emeritus Professor in the Department 
of Anatomy, working particularly on development and organogenesis in mice and 
chickens.  Martin was also President of the Society for Developmental Biology in 
2006-2007 after winning the Edwin Grant Conklin Medal from the Society in 2002.  																																																								
698 Nobel Foundation, 2007. 
699 ibid. 
700 ibid. 
701 Robin Weiss was working in a shared laboratory alongside Steven Martin at the Imperial 
Cancer Research Fund’s Laboratories in London in 1971.  It was Robin Weiss (whose 
primary interest was retroviral biology) who introduced Gail Martin and Martin Evans. 
702 Graham, 2000. 
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In 2007, Martin received the Pearl Meister Greengard prize (along with Beatrice 
Mintz and Elizabeth Robertson), celebrating women in science.  She is also a member 
of the American Academy of Art and Sciences and the National Academy of Sciences 
(cellular and developmental biology), and in 2015 was elected to be a Foreign 
Member of the Royal Society. 
 Gail Martin began her research career investigating collagen, in particular its 
use in laboratory tissue culture and its cross-linking properties703.  It was likely to be 
this experience in cell culture and associated techniques which made Martin a 
promising postdoctoral addition to Evans’ laboratory at UCL. 
 
2.3 The SIKR Cell Line 
 Publications from Evans’ laboratory suggest that the group were spending 
almost all of their time and resources on mouse work, including their ongoing studies 
into teratocarcinomas.  However, if one is to believe Graham’s interpretation of the 
era, this was relatively unheard of.  Graham instead proposes that few groups invested 
in mammalian developmental biology full-time, instead preferring to top-up funding 
for their mouse work with other areas of research in the 1970s704.  It is possible that 
Evans, who was only beginning to establish his own small group in the early 1970s, 
could garner enough funding for his laboratory to concentrate solely on murine cell 
biology. 
In 1972, Evans published “The isolation and properties of a clonal tissue 
culture strain of pluripotent mouse teratoma cells” in the Journal of Embryology and 
Experimental Morphology.  In this paper, Evans described a clonal culture of cells 
isolated from a teratoma of strain 129 mice, obtained from Stevens.  Evans made it 
clear that tissue culture work using mouse teratoma cells was already well underway, 
citing the work by Stevens and Little (1954), Stevens (1964, 1967, 1968 and 1970) 
and Kleinsmith and Pierce (1964).  In 1970, two further groups had demonstrated that 
teratomas had a single cell origin (Kahan and Ephrussi, 1970; Rosenthal, Wishnow 
and Sato, 1970705).  Evans differentiated his work from his predecessors by stating 
that his paper demonstrated the ‘isolation of pluripotent stem cells from a solid 																																																								
703 For example, The nature of the collagen synthesized by cultured human fibroblasts and the 
review Recent progress in collagen research, both published in 1971. 
704 Graham, 2000. 
705 These papers had described homozygous teratocarcinoma lines, whereas Gail Martin and 
Martin Evans described a heterozygous cell line. 
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teratocarcinoma derived from the implantation of an early embryo into the adult 
testis’706.  This then is continuing a trend highlighted previously – the comparison of 
cancerous growth and normal development (i.e. that teratomas arise from initially 
non-pathological cells), and studying their parallels.  The paper described the nature 
of “SIKR” cells707 (see Figure 6), which were capable of producing teratomas in mice 
when reintroduced (demonstrating differentiation into ten tissue types). 
 
 
Figure 6: Isolation, culture and tumourigenicity testing of Evans’ SIKR cell line.  
Constructed using information in Evans, 1972. 
 
In culture, two sub-clones were isolated: C-type (tumourigenic, pluripotent and 
comparable to SIKR cells in differentiation range) and E-type (non-tumourigenic and 
with lower differentiation capacity).  C cells grew as monolayers on E cells; C cells 
were unaffected by colony density, whereas E cells would not proliferate once the 
culture had reached a certain density.  The C cells were considered to be more 
primitive than E cells; E cells alone were not tumourigenic, but could become so 
																																																								
706 Evans, 1972 p 164. 
707 “SIKR” appears to be a shortened version of the longer name given to the cell line, OTT 
5568S/1/KR; OTT 5568 was a transplantable tumour obtained from Stevens in May 1969.  
The tumours were maintained by continuous transplantation, with the slowest growing 
tumours selected for Evans’ project.  These were named OTT 5568S.  One particular clone of 
OTT 5568S, OTT 5568S/1/KR, grew well in vitro, and demonstrated good differentiation in 
vivo. This was selected for use by Evans, and the name shortened to SIKR.  See Evans, 1972. 
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following spontaneous transformation in vitro.  C and E cells were also pluripotent708.  
The ratio of C and E cells in culture could also be manipulated by seeding the cells at 
different densities.  When mentioning previous reports of teratocarcinoma cell line 
establishment, Martin and Evans suggested that: 
 
“These reports primarily have been concerned with demonstrating that these in vitro 
teratocarcinoma lines are pluripotent.  This evidence was obtained by reinjecting the 
cells of these in vitro lines into mice and making a histological examination of the 
tumors formed.  There has, however, as yet been no detailed description of the 
characteristics in vitro of these cell lines.”709 
 
Martin and Evans also suggested that in vitro cell lines would be useful as a 
research tool, as large numbers of these cells could be cultured in controlled 
environments.  This would allow more detailed study, and an understanding of the 
“biological and biochemical characteristics of pluripotency” to be established710.  
What Martin and Evans had done was to produce a heterogenous teratocarcinoma cell 
line, unlike homogeneous lines described by Kahan and Ephrussi (1970) and Jakob et 
al. (1973)711.  Importantly, Martin and Evans concluded that the C cells were ‘the 
stem cell line of teratocarcinomata’; this was supported by evidence including 
morphological examination and molecular biology techniques (in this case, 
experiments testing alkaline phosphatase levels)712.  The cells were described as 
having large clear nuclei with prominent nucleoli, and a minimal, dark cytoplasm.  In 
culture, these cells formed small, tight colonies.  In bacteriological dishes (where the 
cells had no opportunity to adhere to the plastic base of the plate), embryoid bodies 
developed, noted as morphologically similar to early post-implantation embryos713.   
Martin and Evans also concluded that C cells gave rise to E cells and that this process 																																																								
708 Martin and Evans, 1974. 
709 ibid p 163. 
710 ibid p 163. 
711 BW Kahan was at the Department of Zoology, University of Wisconsin and Boris 
Ephrussi, a Russian geneticist was at Laboratoire de Génétique physiologique, Gif-sur-
Yvette, France, in 1970.  The Jakob et al. group were based in France; H Jakob was at the 
Institut Pasteur, Paris.   
712 Martin and Evans (1974) suggest that these homogeneous cultures consisted of only C 
cells.  In 1973, a group working across the UK, USA and France published a paper 
specifically describing alkaline phosphatase activity in murine teratomas (Bernstine et al., 
1973).  This publication demonstrated that a correlation between alkaline phosphatase activity 
and embryonal carcinoma cells (the stem cells of teratomas) had been established. 
713 Martin and Evans, 1974; Martin and Evans 1975a; Martin and Evans 1975b; Martin, 1975. 
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was not reversible; this was identified as a possible route to studying cell 
determination (although this was difficult in vivo with E cells as they were not 
malignant). 
 To follow this, Martin and Evans published another paper less than twelve 
months later, describing the nature of SIKR subclones714.  Where C cells were 
subcloned, the cultures were homogeneous, consisting of only embryonal carcinoma 
cells.  When injected into strain 129 mice, these cells gave rise to teratocarcinomas 
with differentiated tissues present, such as nervous tissue, cartilage and epithelium.  
With appropriate cell culture techniques, the C cell colonies could be induced to 
differentiate in vitro.  The first stage of this was the development of aggregates of 
cells which produced an endodermal outer layer – these formations were found to be 
identical to the embryoid bodies observed in the ascites fluid of mice with 
intraperitoneal teratocarcinomas715 (and also similar to developmental events which 
had been shown to occur during normal murine embryogenesis716).  If allowed to 
continue growing for several weeks in vitro, a variety of cell types could be observed, 
including keratinising epithelium, cartilage, endodermal cysts, neural cells, muscle, 
fibroblasts and pigmented cells.  Martin and Evans had identified that the early 
differentiation processes of teratocarcinoma cells that occurred in vitro were identical 
to those which occurred in vivo717.  In addition, this process was shown to be highly 
organised, and paralleled early development of the mouse embryo; in their 
conclusions however, Martin and Evans did not suggest that this would be a useful 
tool for studying the early stages of embryogenesis.  Three months later, Martin 
published a review describing how teratocarcinomas might be useful for studying 
embryogenesis and neoplasia.  This detailed paper described teratomas, embryoid 
bodies, embryogenesis, embryonal carcinoma cells, and the development of derived 
cell lines.  Here then, Martin seems to be highlighting herself the parallels between 
normal and pathological development718.  Martin also described techniques used to 
learn more about these cell lines, including morphology, karyotyping, the biochemical 																																																								
714 These subclones were produced by culturing colonies from a single cell of the original 
SIKR cell line. 
715 As described by Teresky et al., 1974. 
716 This was described byTarkowski and Wroblewska in 1967; this is the reference Martin and 
Evans refer to in their description of the process. 
717 This is further investigated and published in a separate paper: Martin and Evans, 1975b. 
718 Since Martin appears aware of the significance of the parallels in the 1970s, this 
observation may have driven her focus towards development, as seen in her later work. 
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marker alkaline phosphatase, immunological properties and some genetics, focusing 
on the T locus719.  A section was also devoted to describing the similarities between 
embryonal carcinoma cells and normal embryonal cells: 
 
“No significant differences have yet been detected among embryonal carcinoma 
cells found in tumors from different sources…There are at least two possible ways in 
which embryonal carcinoma cells could arise from their progenitor cell types.  First, 
some malignant change occurs in the progenitor cell types.  Second, that embryonal 
carcinoma cells are normal undifferentiated embryonic cells (or primordial germ 
cells) which behave abnormally because they are not in their normal 
environment”720. 
 
Martin commented that this latter hypothesis was first suggested by Cohnheim and 
Ribbert in the nineteenth century (see Chapter 3).  Ivan Damjanov and Davor Solter  
also discussed this embryonic theory in two papers published in 1974.  It was an 
attractive theory as the genetic and chromosomal stability of embryonal carcinoma 
cells was demonstrated over many generations both in vitro and in vivo; tumours also 
developed from early embryos transferred to extra-uterine sites, suggesting that 
malignancy would occur readily in this situation.  Martin then reasoned that if 
embryonal carcinoma cells were normal pluripotent embryo cells (and if pluripotent 
embryo cells could be cultured from early embryos), then these cells should have the 
same characteristics of embryonal carcinoma cells in vitro, and should form 
teratocarcinomas in vivo.  Martin highlighted however that Michael Sherman (at the 
Roche Institute of Molecular Biology, New Jersey) had so far been the only 
researcher to produce cell lines from mouse embryos, and these cells appeared 																																																								
719 Mutations at this locus had been previously shown to affect mouse embryogenesis and the 
antigen expression of spermatozoa.  Artzt, Bennett and Jacob (at Laboratoire de Genetique 
Cellulaire, Institut Pasteur et College de France, Paris) (1974) reasoned that this could 
therefore also affect the antigen expression of early embryos and embryonal carcinoma cells.  
In addition to this, in a paper published in late 1975, Peter Stern (at the Neuroimmunology 
Unit at University College London) alongside Martin and Evans, described the investigation 
of the antigens expressed by teratocarcinoma cells.  As the cells differentiated, their surface 
antigen profile changed.  In the conclusions, there were hints that the importance of such 
work would be eventually realised in developmental biology, if cell determination could be 
identified by changes in cell surface antigen expression.  This suggests that Martin may not 
have been the only researcher at the time to have recognised the significance of the parallels 
between pathological and non-pathological development, and the importance of this for a 
variety of research projects. 
720 Martin, 1975 p 240.  This could be seen as a development of earlier work by Knox, 
although Martin does not reference this previous research, so it is unknown whether she was 
aware of it or not. 
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somatic, not pluripotent, and in no way similar to embryonal carcinoma cells721.  
Evans and Matthew Kaufman (see below) would later develop a method to improve 
on Sherman’s results. 
 
2.4 Embryonal carcinoma stem cells 
 Martin’s next set of experiments revealed that there were common proteins in 
both embryonic carcinoma cells and the embryonic ectoderm (which were not 
observed in other cell types)722.  Furthermore, it appeared unlikely that embryonic 
carcinoma cells and preimplantation embryonic cells were homologous.  This led the 
group to suggest that whereas embryonic carcinoma cells begin to differentiate by 
developing an endoderm outer layer, they were more biochemically similar to normal 
embryonic cells which had already developed this layer – i.e. these embryoid bodies 
were developing ‘inside-out’.  It was therefore suggested that the embryonic 
carcinoma cells were a better model system for studying the embryonic ectoderm than 
earlier embryonic development (since it was more easily accessible)723.  In addition, 
later 1970s work studied the expression of a protein in both embryonic carcinoma cell 
lines and cells isolated from the ICM (inner cell mass) of the blastula at 4 days post-
conception.  The protein investigated (large external transformation-sensitive protein, 
or LETS protein) was expressed correlating with differentiation.  A comparable result 
was observed – that teratocarcinoma cells were similar to the embryonic ectoderm724. 
 This work led Martin to write another, updated, review comparing 
teratocarcinomas and embryogenesis, again highlighting the importance of the 
parallels between abnormal development and embryogenesis for researchers in this 
field. 
 
“There is…some uncertainty about the normal embryonic equivalent of embryonal 
carcinoma cells, and whether pluripotent embryonal carcinoma cells isolated from 
different tumors are all derived from the same embryonic cell type.  Nevertheless, 
these tumor cells, particularly those cell lines that synchronously form embryoid 																																																								
721 Sherman, 1975.  Sherman had developed a culture medium which promoted the hatching 
of mouse blastocysts; the free cells would then adhere to the culture dish.  These cells would 
swiftly differentiate however. In 1978, Mintz, Cronmiller, and Custer also published a paper 
describing the potentially somatic cell origin of teratocarcinomas. 
722 Martin, Smith and Epstein, 1978. 
723 ibid. 
724 Zetter and Martin, 1978. 
CHAPTER 4  191 
 
bodies, can provide a model system for studying differentiation during the early 
postimplantation period”725. 
 
Martin explained that such a model was useful because this is a period in time when 
the embryo is least accessible.  This is also the time when the most important steps in 
cell determination and differentiation are occurring.  For Martin then, the parallels 
between the normal and abnormal were essential for this research. 
 Evans’ and Martin’s work on ECCs initiated a trend amongst developmental 
biologists, who also elected to use ECCs; for example, Virginia Papaioannou and 
Richard Gardner both attempted to generate germ cell lines from ECCs (this line of 
research was not successful).  What became clear however was that it was possible to 
manipulate ECCs in culture, then combine them with a developing blastocyst, to 
generate a chimeric mouse726. 
 
* * * 
 
 After becoming lecturer at UCL, and approaching the salary bar from lecturer 
to senior lecturer, Evans applied for a post in the Genetics Department at Cambridge 
University; eventually he was offered the post (and began working there in 1978)727.  
During his interview for the Cambridge post, Evans stated that his aim was to use 
mouse teratocarcinoma cells as a vector for the study of mouse genetics728.  As early 
as 1972, Evans suggested how useful isolated (and easily cultured) pluripotent cells 
could be: 
 
“It would be very useful if this process could be experimentally manipulated.  Cell 
lines of this type should prove extremely useful in the studies of the control of 
cellular determination and differentiation.”729 
 																																																								
725 Martin, 1980 p 769-70. 
726 Graham, 2000. 
727 Evans, 2001. 
728 Evans had the opportunity to make his point when in 1983, a collaboration between 
researchers at the Clinical Research Centre in Harrow, the Laboratory of Human Molecular 
Genetics in London and Evans at the Department of Genetics at the University of Cambridge 
led to a publication describing the use of immunoblotting to study glycoprotein production in 
differentiating cells.  The cells used included several different EC and EK cell lines (Childs et 
al., 1983; Stacey and Evans, 1984). 
729 Evans, 1972 p 176. 
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This proved to be a useful move for Evans’ goal as he met Matthew Kaufman, who 
showed Evans how to use delayed blastocysts, a technique that was then used to 
isolate ESCs (see below).   
 Once at Cambridge, Evans’ interest in the use of biochemical markers to 
identify points of differentiation in ECCs continued.  Evans’ first work was with Ten 
Feizi, with whom Evans demonstrated that the main surface antigen on ECCs were 
carbohydrate epitopes of glycohalix730.  Meanwhile, Peter Stern had moved to 
Brenner’s laboratory (also at Cambridge), and produced an antibody against another 
cell surface glycolipid (named the Forssman antigen731).  Evans saw the potential of 
this and used the antibody on ECCs and early embryos for comparison732.  This 
complimented further work by Evans’ PhD student Robin H Lovell-Badge (1953-), 
who established that many changes in protein synthesis occurred in the 12 hour period 
following embryoid body formation733.  Lovell-Badge and Evans used two-
dimensional electrophoresis to ascertain protein expression and post-translational 
modifications, which was important for two reasons: firstly, the method is capable of 
resolving large numbers of proteins at once, allowing very precise changes to be 
noted without first needing to identify which proteins to specifically observe.  
Secondly, this was a change from identifying differentiating cell types 
morphologically734. 
 
“…2D electrophoresis would seem to be a valid means of establishing homologies 
amongst different cells.  Theoretically, it should be better than techniques that rely 
on morphology, histochemistry, or the detection of individual cell products, as it is 
monitoring a significant fraction of the genetic and epigenetic activity of the cells 
under comparison.”735 
 
This meant that differentiation could be identified far earlier in the process than had 
been achieved previously, and monitored in comparison to normal cells.  Lovell-
Badge and Evans used mouse ICM (inner cell mass) cells as controls.  Since the 2D 																																																								
730 Kapadia, Feizi and Evans, 1981. 
731 Stern et al., 1978. 
732 Stinnakre et al., 1981. 
733 Lovell-Badge and Evans, 1980. 
734 Histology was still being used to identify cell types in teratomas.  It was late in Stevens’ 
career for example when he was an author on a published paper describing the usefulness of 
creating biochemical profiles of teratomas (Blüthmann et al. 1983). 
735 Lovell-Badge and Evans, 1980 p 202 (likely to have been written to justify the use of a 
new technique). 
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electrophoresis method was relatively new (first described in 1975736 and modified by 
Lovell-Badge in 1978), few proteins had been specifically identified by the spot 
pattern produced. 
 
 
Figure 7: A 2D electrophoresis pattern from EC cells at 12 h post embryoid body 
formation, and a key to the numbers assigned to different spots.  From Lovell-Badge 
and Evans, 1980. 
 
This meant that few specific proteins were identified from this work (one example 
however was α-foetoprotein, tentatively identified as spot 1 in Figure 7).  What the 
2D electrophoresis could show however were differences in the protein profiles 
between cell types.  Many proteins, required for regular cell function, will be 
expressed by all cells; some cells however have specialist functions which require 
production of specialist proteins.  The differences in the proteins created by each cell 
type could be observed using the 2D electrophoresis technique.  Therefore, as cells 
differentiated, slightly different protein profiles would result737. 																																																								
736 O’Farrell, 1975. 
737 Lovell-Badge and Evans continued to describe the results by noting changes in spot 
appearance or movement between cell lines and times.  It was also clear that there were few 
protein spots that appeared to change even between cell types – for example, Lovell-Badge 
and Evans also analysed fibroblasts using 2D electrophoresis, and when compared to ECCs, 
only approximately 5% of the detectible proteins differed between these cell types.  (This 
said, Lovell-Badge and Evans noted that if a 2D gel resolves 1000 polypeptide spots of 
mostly ‘abundant’ and ‘intermediate’ proteins, extrapolation of the 5% may be as many as 
400 proteins when post-translational modifications were considered.)  It was also observed 
that the EC cells used may not be differentiated enough, as differences of approximately 25% 
had been noted between adult organ-specific cells and embryonic cells (Klose and Von 
Wallenberg-Pachaly, 1976). 
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 In 1981, Evans published his first paper with Matthew Kaufman, who was 
working in the Anatomy Department at Cambridge.  This was an extremely influential 
paper, published in Nature, describing the isolation and culture of pluripotent murine 
embryonic cells738.  These were named ‘EK’ cells (after ‘Evans’ and ‘Kaufman’).  
Early embryos were removed from mice pre-implantation, and cells from the 
blastocyst isolated and cultured, using Kaufman’s ‘delayed blastocyst’ technique 
(Figure 8):  removal of the ICM cells of the blastocyst before they developed to the 
egg cylinder stage.  The ICM cells could then be disaggregated, separating the cells, 
prior to culture739.  What Kaufman had done was to take a phenomenon that occurred 
normally in rodents, and develop this into an in vitro technique740.   
 
 
Figure 8: A sketch from Evans’ laboratory notebook showing the isolation and 
culture of ESCs.  From Evans’ Nobel Lecture, 2007.  Evans shows the removal of the 
ICM, their in vitro culture, and their re-aggregation and differentiation into an 
embryoid body. 
 
																																																								
738 Evans and Kaufman, 1981.  According to Google Scholar, this paper has been cited 7159 
times (up to 8 September 2015). 
739 Kaufman et al., 1983. 
740 In vivo, this is referred to as diapause, allowing rodents to generate a new litter of fertilised 
eggs whilst remaining pregnant with a previously conceived litter.  The newer batch arrest 
development at the blastocyst stage until the previous litter is born; the ‘delayed blastocysts’ 
can then implant and continue their development. 
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 EK cells, obtained by this method, were defined as ‘pluripotential embryo-
derived’ cells741, and Evans and Kaufman claimed them to be more simple to use than 
ECCs; they could be grown entirely in vitro, and were capable of participating to 
normal development in chimaeric mice742 (Figure 9).  The cells had normal 
karyotypes, and could form embryoid bodies (a technique learned from ECC cells).  It 
was hoped that further work may elucidate how teratocarcinoma cells could be 
‘transformed’ into normal embryonic cells and tissues743.  Arguably, this is a further 
example of the importance of the parallels between normal and tumerigenic 
development for research; techniques used in the fields of both developmental and 
cancer biology to demonstrate the properties of both. 
 
 
Figure 9: Notes on growth of EK cells in culture, including a note on “Martin’s Magic 
Mix” for culturing cells, and dates of media changes and passages (from July 1980).  
From Evans’ Nobel Lecture, 2007. 
 
																																																								
741 Kaufman et al., 1984 p 75.  Evans later suggested that these were the same cells described 
by Martin as embryonic stem cells (Evans, 2001). 
742 Unpublished observations by Robertson, Kaufman and Bradley, as described in Kaufman 
et al., 1984.  These observations were published as Evans et al., 1985. 
743 Kaufman et al., 1984. 
CHAPTER 4  196 
 
 Gail Martin was also continuing her work on ECCs in San Francisco.  Just as 
Martin had been one of many American early career researchers to move to Europe 
for research experience in the early 1970s, she also followed the trend of many 
researchers in Britain moving to North America, which began only a few years later.  
Martin may have been one such researcher; however, her husband’s work in England 
would have also had a significant effect on her decision to move.  This general 
movement, Graham suggests, was due to lack of adequate funding, and something of 
a bottleneck in career progression.  UK mammalian biologists moved to North 
America and continental Europe, following the potential of funding for their research.  
Those staying in the UK found that research priorities were moving away from 
development, and more towards care for an aging population744 (following on from 
practical concerns regarding over-population). 
In December 1981, Martin published a paper describing the development of a 
teratocarcinoma cell line which, when injected into an adult mouse, gave rise to a 
teratoma.  When injected into a blastocyst, the cells contributed to normal 
development of a mouse (Figure 10). 
																																																								
744 Graham, 2000. 
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Figure 10: The relationship between normal embryos and teratocarcinoma stem 
cells.  From Martin, 1981.  Here, Martin shows how teratocarcinomas and the 
teratocarcinoma cell lines were utilised in several ways, creating differentiated cells 
(in vitro and in situ), and their ability to contribute to normal development after 
injection into blastocysts. 
 
Martin referred to the important publication by Evans and Kaufman, published earlier 
the same year.  Evans and Kaufman had used the same strain 129 mice as in Stevens’ 
experiments.  Martin created her own cell line by using a feeder layer745 and 
conditioned media for the first five passages, naming these cells embryonic stem cells 
(ESCs) to denote their embryonic origin.  The cells were also genetically tested to 
ensure that they had not been contaminated by ECCs (as the two appeared to be 
morphologically similar).  The ESCs were able to produce teratomas (containing all 
three germ layers) when implanted into mice, and could produce clones (although this 
ability was reduced to only around 10% of that observed in ECCs).  These clones 
could become teratocarcinomas when implanted, again differentiating into several cell 																																																								
745 ‘Feeder layers’ are cells (such as fibroblasts) that are cultured alongside other cells.  These 
fibroblasts (often irradiated to prevent proliferation) produce proteins which ‘condition’ the 
media, providing the co-cultured cells with, for example, cytokines essential for growth. 
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types, demonstrating the pluripotency of these cells.  Differentiation could also be 
induced in vitro and protein markers of stem cells were shown to be present.  Martin 
highlighted that the method she described, as well as the alternative described by 
Evans and Kaufman (1981), negated the requirement for producing a tumour from an 
embryo in vivo to isolate pluripotent stem cells.  Furthermore, Martin noted that the 
development of this method would allow for production of mESC lines with specific 
genetic alterations, providing an additional research tool for mammalian biologists, in 
particular those interested in development. 
 Importantly, both Martin (1981) and Evans and Kaufman (1981) described 
methods for the culture of ESCs which no longer required tumour induction.  It is 
possible that this is indicative of research moving on from the parallel paradigm in the 
laboratory.  Martin highlighted that ESCs would now be available for genetic 
manipulation, something also mentioned by Evans and Kaufman.  In his discussion 
published in 2006, the immunologist Davor Solter concluded that the isolation and 
culture of ESCs in the early 1980s was most widely perceived as a new tool for gene 
function analysis.  Solter continued to suggest that the application of ESCs for 
therapeutics and regenerative medicine had not yet been realised; it was only once this 
happened that a wider scientific community and the general public became aware of 
these cells746.  As previously mentioned, Evans was aware of the usefulness of ECCs 
in the study of embryonic development as early as 1972747; it seems realistic that 
Evans would also have realised the same potential for ESCs.  He may not however 
have realised the potential therapeutic benefits of such cells just yet.  In part, this may 
have been because Evans is a scientist as opposed to a clinician, or that he did not 
have any significant links with clinical research, which may have made him more 
aware of potential therapeutic benefits. 
 
3. Science in the UK and USA: 1982-1989 
 As previously hinted at, there was an economic slow-down in the later 1970s; 
this peaked at the turn of the decade, and had significant global impact.  Both British 
PM Thatcher and US President Reagan needed to reduce government expenditure.  
This set the tone for science in the UK and USA over the next decade. 																																																								
746 Solter, 2006. 
747 Evans, 1972. 
CHAPTER 4  199 
 
 
3.1 UK science: 1982-1989 
 In the UK, Thatcher did not explicitly state that science funding would be cut; 
science funding did however fall into a category of government-supported activities 
that would be financially affected by a global recession.  Such activities were 
supported by 40% of gross domestic product (GDP) in 1981, falling to 29% by 
1988748.  Regarding scientific endeavor specifically, Thatcher would comment – 
being a trained chemist herself, this is unsurprising:  Thatcher stated that scientists 
needed to contribute to social and economic needs.  Any funding for research had to 
represent value for money, meaning that research grants were now more often handed 
out to those with specific applied outcomes.  This did not mean that there was no 
money for other research at all however; some of the deficit was made-up by other 
sources of funding, including charities and industry.  There was a catch here though: 
unlike government grants, such funding would not provide new or improved research 
facilities749.  A more politicised perspective of science was developing in the UK.  
Developmental biologists had learned to describe their work in this framework by, for 
example, deferring to the breakthroughs of IVF, and highlighting the increasing 
importance of understanding congenital abnormalities.  As Graham described it, 
“mammalian developmental biologists had learned to explain themselves”750.  Such a 
skill was key under a Thatcher government keen to emphasise science links with 
industry and economic output. 
 The decline of funding for scientific research in the 1980s led to concerns in 
the scientific community - how would this affect the country’s future prosperity, and, 
more immediately, would they be able to keep working as research scientists751.  In 
response to this, a group of researchers thought an advertisement in The Times might 
help to alert the general public to the plight of science.  In order to pay for this 
advertisement, the small group solicited scientists from around Britain to contribute, 
and contribute they did.  On 13 January 1986, a half-page advertisement appeared in 
The Times asking readers to encourage their MPs to ‘save British science’ (Figure 
11).  The generosity of the scientific community not only paid for this advertisement 																																																								
748 Braun, 1993 p 270. 
749 ibid. 
750 Graham, 2000 p 54. 
751 Weir, 2014. 
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and a press-conference752, but the founding of a ‘Save British Science’ (SBS) 
movement753.  Politicians of the time claimed that the movement became useful for 
them in understanding research and establishing scientific policy; the SBS movement 
were not simply a group of ‘whinging scientists’, but were persuasive and 
informative754. 
 
 
 
Figure 11: The ‘Save British Science’ advertisement from The Times, 13 January 
1986. 
 
 Thatcher’s neo-liberal government of the 1980s also made some steps towards 
allowing professions more economic freedom; this included looking more carefully at 
market lines and resulted in many professions becoming more accountable to the ‘end 
user’.  With regard to tissue culture for example, some patients were becoming wise 
to the idea that their doctors may be removing tissue, culturing it in the laboratory, 
then selling it on.  The Thatcher government in fact encouraged such commercial 
incentives.  From this point of view then, it can be argued that the Thatcher 																																																								
752 Much to the organiser’s frustration, coverage of the press conference was relatively muted; 
on the same day, Michael Heseltine resigned from his position in the Cabinet, a story that 
trumped saving British science. 
753 Weir, 2014. 
754 Weir, 2014.  In 2005, SBS became CaSE (Campaign for Science and Engineering), which 
continues to be an influential communication group between scientists and politicians. 
CHAPTER 4  201 
 
government determinedly introduced austerity measures concerning science funding.  
This deliberate policy decision was made in order to encourage a particular type of 
research: that which would contribute to economic growth755. 
 Despite this, and all of the concern over biotechnology advances through the 
1970s, by the late 1980s there was still relatively little legislation concerning tissue 
from living donors (which, in part, included embryos), since the 1961 Human Tissue 
Act did not cover these issues756.  Faced with this, entrepreneurial doctors were 
advised to get signed consent forms from their patients prior to removing tissue which 
may later be cultured in the laboratory757.  In 1990, professor of law, Douglas J 
Cusine, claimed that researchers had been working almost in ‘legal darkness’ for 
several years, with a potential for several more; although the Warnock Committee’s 
advice regarding licensing was deemed appropriate, Cusine highlighted that it not 
only needed to be in place, but it must be clearly shown to be operating.  Time and 
interest in such matters for parliament was also thought to be a problem, which again 
reduced the probability of providing up-to-date legislation concerning recent 
developments in biotechnology. 
 It has been argued that the Thatcher government policies of the 1980s had 
greater impact on the biomedical sciences than those of the Reagan administration.  It 
is possible that this was due to Thatcher’s attempt to re-distribute research funding, 
making less available generally.  This, the government would argue, would increase 
competitiveness, but therefore also increase selectivity, encouraging funds to be 
distributed more into applied than pure research.  This change was not so profound in 
the USA, where the move towards support for applied research was more subtle.  
Essentially, the UK biomedical researcher had to adapt to an entirely different funding 
approach, whereas American researchers only needed to work with fewer 
resources758. 
 In contrast to the significant amount of funding US universities obtained from 
the NIH (see below), the British equivalent, the MRC, provided around 12% of 
funding in 1985/6.  Another 15% was provided by the Universities Funding Council 
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(UFC), which provided block grants to universities to administer how they wished759.  
The UFC faced stagnation of its funds through the 1980s.  The MRC was less 
affected, however was unable to make up for the UFC shortfall.  In addition, no 
indirect costs could be paid for out of MRC grants, placing more strain on a 
university’s UFC income.  Research facilities became insufficient (based on the 
swiftly expanding technologies and techniques available to biomedical researchers), 
and the MRC was therefore rejecting funding applications based on sub-par facilities. 
 The MRC was under pressure concerning what grants to approve from two 
external groups – the government providing the money, and the researchers applying 
for it.  The highlighted government policy on scientific research strongly encouraged 
grants which would result in practical outcomes for economic growth.  Not all 
researchers however would apply for funding based on this principle.  Researchers 
and Research Councils were not autonomous enough to resist the political pressure.  
Unable to avoid government policy, UK Research Councils concentrated their 
resources into selected groups and laboratories.  This resulted in a significant 
competitiveness that was introduced into British research science760. 
 In Britain, the results of austerity measures taken through the 1980s resulted in 
researchers working more in larger teams (rather than individually), which often 
meant researchers working on projects not of their own design or interest, and 
becoming more interdisciplinary761. 
 
3.2 USA science: 1982-1989 
 It was not only in the UK where there were concerns over research funding; 
the recession that had hit the UK in the late 1970s and early 1980s was also apparent 
in the USA.  Initially, the USA appeared to suffer less from funding reduction than 
the UK.  Basic research, particularly anything related to defence, was still relatively 
well-funded until the mid-1980s.  Reagan made an attempt to reduce spending in 
biomedical research, but, being a favourite of Congress, funding remained.  In fact, 
federal funding for biomedical science increased by, on average, 3% per annum 
between 1981 and 1987762.  As previously mentioned however, the demands of 																																																								
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biomedical science were increasing, and federal funding was still insufficient.  
Reagan took similar views to Thatcher concerning promoting economic growth, and 
also encouraged marketisation of professions with a look towards impressing the end 
user.  Federal scientific funding was significantly less than researchers would have 
wanted.  This had the effect of providing private funders with greater influence, as 
well as giving researchers somewhere to obtain funding from if they wished to work 
in an area of research not funded by federal money.  Biomedical sciences did not tend 
to be in this group however; the NIH funded a significant amount of biomedical 
research in the 1980s – 75% of federal grants for biomedical research were made 
through the NIH763.  This was very important, since the NIH allowed indirect costs to 
be built into grant applications (for example, building maintenance, heating costs).  
Post-World War II, many US universities were reliant on such grants for their indirect 
costs; indirect costs came to 21% of total costs in 1970; by 1988 this had increased to 
31%764.  The average size of research grants (at constant prices) between 1980 and 
1989 increased from $97800 to $113900765.   
Despite some restraints on the amount of funding the NIH was able to provide, 
it did manage to retain funding for a significant number of projects designed out of 
intellectual curiosity – in fact the number of such projects funded from the NIH’s total 
was 44% in 1970, increasing to more than 60% in 1987766.  The NIH reduced the 
amount of funding it made available elsewhere (such as for training) to remain able to 
fund such basic research.  This is a stark contrast to British research that particularly 
struggled to obtain funding for anything that did not immediately appear to have a 
practical outcome. 
Through the 1980s, the Department of Health and Human Services continued 
to withhold approval for any therapeutic research making use of foetal tissue or cells, 
even though the NIH had proposals submitted that suggested carrying out such work.  
In response, the NIH established the Human Fetal Tissue Transplantation Research 
Panel in 1988, which voted to allow federal funding of therapeutic research 18 votes 
to 3.  The Secretary for the Department of Health and Human Services, Louis Wade 
Sullivan (1933-), however agreed with the three panel members that believed such a 																																																								
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move would encourage abortion.  With this decision, Sullivan extended the 
moratorium on federal funding for embryo research767. 
 In April 1991, the American Association for the Advancement of Science 
(AAAS) held a conference to determine what had happened to funding during the 
previous decade, and to discuss what the Bush administration could do in response. It 
appeared that a significant amount of the discussion highlighted mistrust between 
scientists and the government, and vice versa.  Scientists believed they did not have 
the opportunity to apply for appropriate funding for their research, whilst politicians 
believed that the scientific community were incapable of spending limited federal 
funds responsibly.  Increasing numbers of fraud stories had been highlighted in the 
press, and in particular the misconduct of David Baltimore and Thereza Imanishi-Kari 
were considered damaging768.  This was not to say that there were no advancements 
made in 1980s America; for example, the Human Genome Project was funded by 
Congress in 1986, initially with James Watson (1928-) as Director. 
 Concerns regarding animal welfare were also apparent in the USA.  The first 
Animal Welfare Act was enacted in 1966, with amendments in the 1970s; in 1985 
however, the Act included the Improved Standards for Laboratory Animals Act.  Prior 
to this, Congress had discussed animal testing, and highlighted that: 1) some animal 
experimentation was necessary for research and education advancing knowledge and 
treatment for human and animal disease; 2) that alternative methods were continuing 
to be developed; 3) that measures should be taken to eliminate or minimise the 
unnecessary duplication of animal experiments (resulting in more productive use of 
federal funds); and 4) that measures should be taken to help meet the public concern 
for the welfare of laboratory animals whilst allowing research to progress769.  Such an 
Act had implications for biomedical research and pushed new technologies towards 
finding alternatives to animal testing; this was particularly the case regarding federal 
																																																								
767 Wertz, 2002. 
768 Abelson, 1991.  Specifically on the case of Baltimore and Imanishi-Kari, see Kevles, 2000.  
Imanishi-Kari had been accused of misconduct when another researcher, Margot O’Toole, 
was unable to replicate her results.  Baltimore was Imanishi-Kari’s superior and co-author, 
and it was suggested that Baltimore should have supervised Imanishi-Kari’s work more 
closely, particularly if he was listed as an author on her publications.  Since Imanishi-Kari’s 
work had been funded by the NIH, the case was discussed by the United States Congress, 
gaining worldwide attention. 
769 United States Department of Agriculture, n.d. 
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funding, such as through the NIH; the NIH provided $3423 million in grants in 1980, 
which had increased to $7145 million by 1989770. 
 The American biomedical scientist, like their British counterpart in the 1980s, 
had to deal with increased competitiveness for funding.  Many secured funding by 
opting to propose topics known to be favoured, and those where results could be 
produced in a relatively short amount of time771. 
 
The continuous struggle to obtain grant moneys for research had a significant 
effect in the UK and USA through the 1980s.  Not only were researchers forced into 
proposing research that fit into government policy frameworks, they were also forced 
to compete on a much higher level than before.  Such competition led to rivalry, 
jealousy, and mistrust between research groups, peer reviewers, assessors, and 
referees.  This inevitably led to a reduction in range and quality of scientific 
endeavor772.  Reduction of grant money availability occurred across all research 
sectors, including developmental biology.  This therefore would have affected the 
type of grant proposals submitted for ESC research, and increased the rivalry between 
competing researchers.  
 
4. UK: Using embryonic cells to create genetically engineered 
mouse models of disease (GEMMD) 
 After establishing the germline potential of his EK cells, Evans considered 
options for their mutagenesis.  In 1983, Richard Mann, Richard Mulligan and David 
Baltimore at the Whitehead Institute for Biomedical Research (Massachusetts) and 
the Center for Cancer Research at MIT, published a paper describing the use of 
retroviral vectors for such work773.  Inspired by this, Evans organised a visit to 
Mulligan’s laboratory for a month in October 1985774.  Despite several attempts by 
other scientists to tempt him away from the bench, Evans made a concession for only 
one: Oliver Smithies775.  Smithies had just published work describing gene targeting 
by homologous recombination in vitro; interested, Evans took samples of his EK cell 																																																								
770 National Institutes of Health, Office of Budget, n.d. 
771 Braun, 1993. 
772 ibid. 
773 Mann, Mulligan and Baltimore, 1983. 
774 Evans, 2001. 
775 Nobel Foundation, 2007. 
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cultures to Smithies in Wisconsin for a weekend.  Smithies introduced Evans to PCR 
(polymerase chain reaction) and his thermal cycling machine776.  Mario Capecchi, 
then at the University of Utah, visited Evans for a week at his laboratory in 
Cambridge, with the aim of collecting cells and learning the associated techniques777.  
Evans conceded that PCR often now only warranted a few lines in experimental 
genetics papers, but it allowed almost any mouse mutation to be specifically 
targetable, leading to work in experimental genetics “illuminating our understanding 
of the mammalian genome physiology and human function in health and disease”778. 
 In 1989, Evans published a review describing the use of ECCs and chimaeric 
animals in the context of rising technologies of genetic manipulation.  Evans 
highlighted that “new genetic technology is likely to have a major impact both in 
genetic studies and, especially if it can be extended to larger mammalian species, in 
practical applications”779.  These ‘larger species’ appeared to extend rapidly to pigs, 
as pluripotent ECCs were isolated and cultured, described in a paper published in 
1990 by Evans’ group at Cambridge.  Such methods appear to have been at the 
forefront of Evans’ work, since he also published new methods and ‘technical tips’780; 
only a year later Evans’ group described isolation and culture of sheep ECC lines781.  
In the 1990s then, ECCs (i.e. tumourigenic cells) were considered useful enough to 
warrant the research into larger mammals – apparently parallels between 
tumourigenic and normal cells was still in place. 
It was later in 1991 that Evans moved department, after helping to secure 
funding and set up the Wellcome/CRC Institute for Cancer and Developmental 
Biology at the University of Cambridge782.  The Institute had been set up in 1989 to 
‘promote research in the areas of developmental biology and cancer biology’, 
allowing researchers to integrate and share information and expertise783.  Such 
potential appears to have been realised: later in 1991 a group of researchers from the 
MRC National Institute for Medical Research, Imperial College, and the University of 																																																								
776 This interest eventually even led Evans into becoming a co-founder of the biotechnology 
company Animal Biotechnology Cambridge Ltd.. Nobel Foundation, 2007. 
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Cambridge (including Evans) published work describing activation of specific genes 
in mice during ECC differentiation in vivo and in vitro784. 
 Importantly to Evans, such work could have practical uses; the first hints of 
such research for medical application began to appear.  Kuehn et al. (1989) (a group 
including Evans at Cambridge) published a paper in Nature describing the 
development of a mouse model for the human neurological disorder Lesch-Nyhan 
syndrome785.  Using genetic manipulation, ESCs were modified and chimeric mice 
produced from these cells.  Some gave rise to germ cell chimeras, allowing mutant 
mice to be bred, and a murine model of Lesch-Nyhan syndrome to be developed.  
Later, in collaboration with the Department of Biochemistry and Molecular Genetics 
at St Mary’s Hospital Medical School, a group led by Evans at the Wellcome/CRC 
Institute established that the cystic fibrosis transmembrane conductance regulator 
gene (cftr) could be disrupted in ESCs using gene targeting.  At the time, no animal 
model of cystic fibrosis was available, despite it being the most common autosomal 
recessive genetic disorder (affecting 1 in 2000 of the Caucasian population)786.  The 
group were able to disrupt the gene in ESCs, and produce chimeras from these cells.  
In summary, the group announced their intention to continue their work in order to 
produce a cystic fibrosis mouse model, to enable further research into the 
pathophysiology of the condition, as well as make use of the model as a further way 
of testing potential new therapeutic drugs.  This research was a collaboration between 																																																								
784 Poirier et al., 1991. 
785 Although Martin has referred to her isolated calls as embryonic stem cells (or ESCs) from 
her initial publication in 1981, Evans appears to have resisted this.  Papers published by 
Evans through the early and mid-1980s still refer to EK cells – the term coined in Evans and 
Kaufman 1981.  The ‘EK cells’ term can be seen in, for example, Influence of injected 
pluripotential (EK) cells on haploid and diploid parthenogenetic development (1984), and 
The ability of EK cells to form chimeras after selection of clones in G418 and some 
observations on the integration of retroviral vector proviral DNA into EK cells (1985).  By 
the late 1980s, Evans had started to refer to these cells as ESCs.  We can identify that in these 
later publications, Evans is referring to the same cells despite the change in terminology.  For 
example, in Expression of v-src induces aberrant development and twinning in chimaeric 
mice (1989), the following phrase is included: “In order for this approach to be successful, the 
v-src gene must be introduced and expressed in vivo both efficiently and reproducibly, and 
consequently we have chosen to use embryonic stem (ES) cells (Evans and Kaufman, 1981; 
Martin, 1981) as a means of effecting ectopic expression in the embryo. ES cells provide a 
powerful tool for analyzing mouse development, since they are developmentally pluripotent, 
capable of contributing to many cell lineages, including the germ cells, on their introduction 
into the embryo…and are  amenable to genetic manipulation in culture” (Boulter et al., 1991, 
p 358.).  This then demonstrates that the EK cells referred to in the earlier 1980s, were the 
same as the ESCs referred to later on. 
786 Ratcliff et al., 1992. 
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biological and clinical researchers, showing that whilst individuals tended to remain 
either as biologists or clinicians, collaborative research enabled applied biology to be 
directly applicable to medicine.  In 1995, alongside the research group leader from St 
Mary’s Hospital Medical School, WH Colledge, Evans published a review of gene 
therapy for cystic fibrosis.  The publication reviewed the current thoughts and 
possibilities for suitable vectors and gene delivery mechanisms, and the first results 
from clinical trials787. 
 In 1980s UK then, there was a definite move in research direction towards 
practical application; those involved in ESC research had to look towards potential 
medical application for their work by clinical collaboration.  This affected the way 
ESC research was promoted and funded, with an emphasis on the practical, medical 
application, as opposed to pure biology (‘fact-finding’) research.  Evans possibly 
ensured funding by collaborating with cinical researchers, clearly showing the 
practical applications of his work. 
  
5. USA: Using embryonic cells for developmental biology 
 An examination of the papers published by Gail Martin and her laboratory at 
the UCSF between 1981 and 1989 reveals how Martin began utilising ECCs and 
ESCs for research into mammalian development.  This selection of research direction 
can be seen soon after Martin returned to the USA. 
 In 1982, Martin and co-workers published a paper concerning a lethal 
mutation at the t-locus, which is known to cause death at approximately 9 days post-
fertilisation (this is due to morphological problems in the ectoderm)788.  The authors 
noted that previously, lethal t-mutations had been difficult to study due to the lack of 
available material; the method Martin described in her 1981 paper however allowed 
the authors to establish “pluripotent stem cell cultures” from murine blastocysts789.  
Using careful breeding, the authors were then able to use Martin’s method to create 
cell lines from mice that were homozygous and heterozygous for the lethal mutation 
(tw5).  That the authors were able to establish a cell line immediately indicated that 
tw5/tw5 alone did not result in general lethality.  The creation of the tw5/tw5 cell line 
using Martin’s method demonstrated the importance of the technique; it allowed new 																																																								
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approaches to be investigated concerning the role of lethal and mutant alleles on 
development. 
 This did not mean that Martin abandoned her use of teratocarcinomas 
altogether however, and still made use of them throughout the 1980s.  Observing ECC 
aggregate differentiation, Martin and her co-authors examined the expression of 
factors known to be associated with embryonic development.  Applying inhibitors to 
the cell aggregates caused changes in the differentiation process, enabling the authors 
to understand the role of a particular factor (N-asparagine-linked glycoproteins) in the 
formation of endoderm layers in the developing embryo790.  This is another clear 
example of results observed from pathological cells being applied to normal 
development. 
 Furthermore, Martin would make use of her teratocarcinoma stem cells to 
create chimeras - mouse embryos that would develop from a mixture of ‘normal’ 
embryonal cells and ECCs.  Martin’s preliminary work on chimeras established that 
they could be created and live births achieved, but a significant number of normal 
cells needed to be present for this to occur.  Larger numbers of embryonal carcinoma 
cells present in the chimera were unable to support normal development.  Martin 
hoped that such work would eventually lead to better understanding of the differences 
between ECCs and ESCs791, although this work again also clearly showed that there 
were some recognised similarities between normal and abnormal cells. 
 Martin also shrewdly used her cells and techniques to examine the similarities 
between murine and human development.  In 1985, Martin’s laboratory published a 
paper comparing the human homeo-box (Hu1) and the mouse homeo-box (Mu1) 
genes (these sections of DNA had previously been demonstrated to have a 4kb 90% 
homologous region)792.  Martin’s laboratory differentiated human teratocarcinoma 
cells in vitro, and observed that levels of Hu1 expressed increased.  Using the same 
experimental conditions for the murine teratocarcinoma cells did not result in a 
similar increase however.  Instead Mu1 expression was observed to increase in 
embryos, between 10 and 17 days post-fertilisation.  This type of research, Martin 
claimed, was useful in helping to understand the role of homeo-box genes during 
embryogenesis.  Martin’s laboratory also carried out similar work observing 																																																								
790 Grabel and Martin, 1983. 
791 Fujii and Martin, 1983. 
792 Hauser et al., 1985. 
CHAPTER 4  210 
 
expression of two similar genes, called engrailed.  Again, engrailed was observed to 
have a role during mouse embryogenesis, which had been previously shown to be the 
case in Drosophila793.  As with Mu1 and engrailed, Martin’s laboratory examined the 
role of another gene during embryogenesis, utilising teratocarcinoma cells.  N-myc 
had been shown to be expressed in neuroblastomas, however Martin’s laboratory also 
demonstrated that N-myc was expressed in teratocarcinoma cells and normal embryo 
cells during development794. 
 Returning to her work on the t-locus, the Martin laboratory carried out more 
research on other t-mutations, establishing that some alleles were important for 
survival of the early mesoderm, whilst others were lethal.  Martin commented that 
“The results of this study are useful…in providing a unique source of experimental 
material…The technique of ESC isolation from mutant homozygous embryos 
provides a means of circumventing the difficulties inherent in accumulating sufficient 
numbers of mutant embryos for experimental studies.  The cell lines obtained provide 
an essentially unlimited source of mutant homozygous DNA, as well as an abundant 
source of proteins and mRNAs”795. 
 Although Martin (and Kaufman and Evans) had provided techniques for 
creating embryonic cell lines in 1981, the extract above from the last paragraph in a 
1987 paper has a tone indicating Martin is still having to sell the idea of using such 
cell lines to other researchers.  In the midst of 1980s pressure to reduce the number of 
laboratory animals in the UK and USA, Martin’s demonstration that cell lines were 
particularly useful where animal models were difficult to obtain (or, in the case of a 
lethal genetic mutation, would not exist) seems particularly valid.  In particular, many 
of Martin’s publications through the 1980s indicate that her laboratory was funded in 
part by the NIH; such funding may not have been as forthcoming if Martin had 
decided to rely only on animals for her developmental research; likewise, Martin 
would not have made the knowledge advances (such as those highlighted here) if she 
had not made use of cell lines and relied on mouse embryos. 
 
6. Influences on stem cell research: UK and USA, 1970-1989 
 Historian of biology Jane Maienschien has argued that cell biology and 																																																								
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embryology in 1970s and 1980s America had some emphasis on ‘engineering’; a 
focus that had been in place since the early twentieth century, particularly following 
the work of physiologist Jacques Loeb (1859-1924).  Experimental work, claimed 
Maienschein, “focussed on research first, and applications later”796.  I agree that 
research directions that formed in the earlier decades of the twentieth century in the 
USA had an effect on research carried out towards the end of the century. 
 As mentioned in Chapter 1, there was a clear goal in early twentieth-century 
American cell biology in the elucidation of cell lineage.  Prominent biologists such as 
Edmund Beecher Wilson and Edwin Grant Conklin believed that examination of cell 
lineage during embryogenesis would help with establishing understanding of 
fundamental biological processes.  Conklin in particular began his studies at the early 
stages of embryo development, studying cleavage patterns of blastomeres.  As well as 
being technically complex, there were difficulties disseminating the data produced 
(since many diagrams and plates needed to be included to show what was 
happening)797.  Similarly, Wilson played his part in cell lineage studies by looking at 
cell structure (Chapter 1).  The middle decades of the twentieth century saw 
significant improvements in methods to identify and differentiate between cell types 
(such as improved microscopy and techniques in genetics), and new tools for use in 
cell biology798.  Both embryology and cell aging were important areas of research in 
the 1960s, following on from the cell lineage studies established decades earlier.  
“The major difference”, Maienschein argued, “between 1981 [isolation of murine 
embryonic stem cells] and 1998 [isolation of human embryonic stem cells] was not 
the extension of the techniques to human cells, but the advances in understanding the 
underlying genetic basis for development”799.  From the work carried out in the USA 
by Martin, it is clear that she is part of this tradition.  Similarly, Michael Morange has 
noted that human embryonic stem cells and murine embryonic stem cells are not 
equivalent considering the “motivations and goals attendant on their creation”800.  
(This will be examined in detail in Chapter 5.) 
 It is also important to consider the financial support available.  As noted on 
Martin’s publications, much of her work in the 1970s and 1980s was funded by the 																																																								
796 Maienschein, 2014 p 176. 
797 Laublicher and Maienschein, 2003. 
798 Maienschein, 2014. 
799 ibid p 208. 
800 Morange, 2006 p 540. 
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NIH and the American Cancer Society.  As historian of biology Christina Brandt has 
highlighted, there was significant funding available in the 1970s for cancer research, 
although the mouse model that was used for much of this also had uses in 
developmental biology, genetics, embryology, and cell differentiation studies through 
the 1970s as well.  The earliest ESC work that began in the 1970s was a result of 
improved techniques in embryo and cell culture and manipulation, and cancer 
research801.  Teratocarcinomas were the cells that would bridge the gap between 
cancer and embryology; Martin was aware of this as early as the mid-1970s, when she 
wrote that embryonal carcinoma cells could be used for comparison with embryonic 
cells, and in the creation of chimaeras802; Ralph Brinster was also starting to create 
chimeras with teratocarcinoma cells at this time803. 
 It can also be argued that there was a shift in stem cell studies between the 
early and late twentieth century.  Late nineteenth and early twentieth century studies 
(as described in Chapter 1) were preoccupied with establishing the ‘natural history’ of 
cells and organisms, looking for the cells from which organisms could arise, and how 
this would support (or not) evolutionary theory, ontogeny and phylogeny.  By the 
latter decades of the twentieth century however, less concern was given to the origins 
of stem cells, but their potential.  There appears to be a shift in research focus, looking 
at what stem cells were capable of moving forwards in time (i.e., development, 
differentiation potential, etc.), as opposed to using stem cells to look backwards. 
 This chapter has not only demonstrated that the 1970s and 1980s were a 
changing era for biomedical science; it also shows the outcome of a debate occurring 
in the philosophy of science from the same time.  In the 1970s and 1980s, some 
philosophers of science were split into two camps: the internalists and the externalists.  
By the mid-1980s, it has been argued that most philosophers of science were more 
convinced by the externalist argument804.  Whilst internalists agreed that science 
existed within frameworks of social convention and political institutions, what was 
found was only that which could be seen in nature.  The externalists showed that far 
from only existing in social and political frameworks, science and its constructions 
were actively influenced by it.  Researchers learned to describe their research in 																																																								
801 Brandt, 2012. 
802 Martin, 1975. 
803 Brinster, 1974. 
804 Jacob, 1992. 
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particular ways, and refer to outcomes (or expected outcomes) using terminology that 
would explicitly hint at potential economic or therapeutic application.  This chapter 
has shown that the work by Martin and Evans (and others) was directly affected by, 
for example, governmental and institutional policy, funding availability, and 
discipline genealogies.  What was reported as outcomes (or potential outcomes) had 
clear, practical uses in knowledge creation in medical research (Evans) and biological 
research (Martin). 
 
7. Conclusions 
 This chapter has examined the direction of life sciences research in the UK 
and USA through the 1970s and 1980s via the work of two prominent stem cell 
researchers: Martin J Evans and Gail R Martin.  In particular, it has asked what 
encouraged and discouraged the work of Martin Evans (in his creation of GEMMD) 
and Gail Martin (research on development).  The chapter has argued that research 
traditions, as well as global and local politics and economics has had a role.  
Evans remained in the UK throughout the period covered by this chapter, 
concerning himself firstly with how newly-isolated teratocarcinoma cells could be 
used, developing an ESC line, then utilising this to create mouse models of disease, 
and later collaborations with clinical researchers.  In contrast, Martin began her 
postdoctoral career in the 1970s alongside Evans in the UK, before moving back to 
the USA to develop her own laboratory.  By the late 1970s, it was becoming clear that 
although useful, it was unlikely that ECCs could be considered ‘normal’ enough for 
them to be a good equivalent for embryonic cells, and that isolation and culture of 
embryonic cells would be especially useful for future research.  Clearly, this is a 
further example highlighting the parallels between ESC and cancer research, as 
previously demonstrated in Chapter 3.  Independently, both Martin and Evans 
developed a method of isolating embryonic stem cells.  
 In the mid-1970s, Evans claimed he described a goal to use mouse 
teratocarcinoma cells as a vector for studying mouse genetics (this was in his 
interview for a post at Cambridge).  This appears to be an updated version of his 1972 
suggestion that cultured pluripotent teratocarcinoma cells could be experimentally 
manipulated to study control of cell differentiation and determination.  In the early 
1970s then, Evans had a clear interest in developmental biology and interpreted his 
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results in response to the possibility of furthering knowledge and understanding in 
this field.  By the later 1970s however, possibly in part due to newer techniques 
becoming available, possibly in response to funding changes, and / or possibly to 
further his chances of getting the post at Cambridge, Evans proposed the study of 
genetic diseases. Evans worked with clinical researchers to advance his work into 
medical applications. 
 This is in contrast to the work of Gail Martin.  In 1981, Martin also noted the 
possibility for genetic manipulation of embryonic stem cells.  She thought this was 
important to mammalian biologists, in particular those interested in development.  
Martin appears to have completely focused on development, from her early 1970s 
work in the UK to the early 1980s work in the USA.  There was no hint at the creation 
of gene targeting as proposed by Evans. 
 In 2006, Davor Solter noted that ESC isolation was considered important in 
the 1980s for potential gene function analysis.  He also stated that the application for 
ESCs in therapeutics and regenerative medicine had not been realised at this time.  
When interpreting such commentaries however, it is important to be aware of the 
values imposed by hindsight; Evans was to win a Nobel Prize for his contribution to 
gene targeting (and enabling the creation of GEMMD), easily creating the possibility 
for history to be reinterpreted based on this achievement.  For example, Solter’s claim 
that in the 1980s there was little consideration of ESC use for regenerative medicine 
is unsurprising; the term did not come into use until at least the 1990s, with few 
biomedical scientists beginning to use the term until the 2000s. 
 To consider why Martin and Evans may have taken different research 
directions, it was useful to consider legislation and politics in the USA and UK that 
may have affected their work.  For example, both US and UK governments aimed at 
reducing the number of laboratory animals used, and in the USA this was put into 
practice via the Improved Standards for Laboratory Animals Act (1985) – with the 
NIH (and continuous funder of Martin’s work) encouraged to move away from 
animal experimentation, it could explain not only why Martin continued developing 
her ECC work to lead to ESC isolation (again showing the impact of cancer research 
on stem cell research), but why she promoted her work after this as circumventing the 
requirement for relatively large numbers of animal embryos. 
 In contrast, Evans did not promote his research applications in the same way.  
For example, when first introduced to PCR, Evans noted that such technology was 
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vital for making mouse mutations possible, which could improve the understanding of 
human health and disease.  Evans did not note that PCR could be used to study 
genetics during development, or to reduce the amount of genetic sample required for 
analysis.  Evans instead explicitly referred to the “practical applications” of studying 
the genetics of health and disease805.  Why would Evans elect to use such 
terminology?  Was this an example of UK science policy transforming the attitudes, 
perceptions, and expectations of UK researchers?  In comparison to the terminology 
and language used by Martin to promote her work in the USA, it is quite feasible for 
this answer to be ‘yes’. 
 This chapter has considered, in some detail, the work of Martin and Evans in 
isolating and culturing mESCs for the first time, and how these new tools were used.  
The next chapter compares the contexts Martin and Evans were labouring under in the 
1980s, to the equivalent in the 1990s: Thomson and Gearhart’s 1998 isolation and 
culture of hESCs. 
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CHAPTER 5: 
“HUMAN ES CELLS ARE NOT THE EQUIVALENT OF 
MOUSE ES CELLS”: A CONSIDERATION OF THE 
MOTIVATIONS AND GOALS OF GENERATING 
HUMAN EMBRYONIC STEM CELLS 
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1. Introduction 
“The significance of the derivation of human embryonic stem cell lines lay in their 
ability to proliferate while remaining in a pluripotent state, without 
differentiating...The therapeutic potential of these cells was apparent from the 
start...”806 
 
This chapter seeks to assess a comment made by historian of biology Michel 
Morange, who queried why there was a gap of seventeen years between the isolation 
of mESCs and hESCs.  After briefly showing that this gap could not have been caused 
by either technical difficulties or ethical concerns, Morange considers what else may 
have resulted in this delay.  Morange eventually concluded that when motivations and 
goals of their creation are considered, mouse and human ESCs are not equivalent807.  
This, claimed Morange, is because of the different scientific contexts through which 
mESCs and hESCs were created.  This scientific context refers to the (initial) 
difficulty in manipulating ECCs and ESCs, and their capacity for tumourigenesis.  
Since Morange has therefore already highlighted the influence of scientific context on 
research, this chapter will add a complementary view, highlighting that the scientific 
climate – i.e. the social, political, ethical, legal, and economical context - must also be 
considered to produce a comprehensive history.  This will support Morange’s claim 
that the motivations and goals were different. 
Close attention was paid to the history of murine embryonic stem cell isolation 
in Chapter 4 demonstrating how political and economic factors, for example, affect 
how researchers work.  This chapter will focus on the history of human embryonic 
stem cell isolation, before comparing the motivations and goals of mouse and human 
ESC generation in order to examine Morange’s claim. 
James Thomson was interested in developmental biology, in particular human 
embryogenesis.  In the 1990s, Thomson was still restricted to using mouse models for 
his research, which were known to have various differences when compared to early 
human development.  Thomson attempted to switch his research focus to non-human 
primates, which would develop in a more similar way to humans (than mice); primate 
research however was expensive, and did not provide Thomson with material on a 
regular basis.  Thomson decided that if he could develop non-human primate 																																																								
806 Thompson 2013 p 70. 
807 Morange, 2006. 
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embryonic stem cell lines, he would have as much material as he wanted, at the low 
cost of cell culture; this led Thomson to develop a method of isolating and culturing 
cells from early embryos808.  Thomson published his results in 1995, and waited for 
another laboratory to use the same techniques to isolate and culture human ESCs – an 
ideal tool for studying human development ex vivo.  When this did not happen, 
Thomson decided to work on the project himself, and reported his success in 1998809. 
John Gearhart’s background was different to that of Thomson’s.  In the 1970s 
and 1980s, Gearhart was researching developmental differences in Down syndrome.  
In the 1980s, mouse models began to emerge, including mouse models for Down 
syndrome.  Eventually however, Gearhart felt that he had exhausted the use of mouse 
models, and would learn more about development in those with Down syndrome by 
working with human cells – in particular, early embryos cultured in vitro from 
hESCs810.   
This chapter offers a complementary argument, which fits alongside 
Morange’s claim that the motivations and goals behind the isolation of mESCs and 
hESCs were different.  This chapter shows that when contextual considerations of 
stem cell research are accounted for, motivations and goals are different; this, in part, 
is related to the political and economic contexts (such as those highlighted in Chapter 
4), and the legal and ethical contexts that become relevant when producing hESCs in 
the laboratory.  This is in addition to the different scientific contexts Morange refers 
to in his 2006 paper.  Although Thomson’s intellectual interest in development (his 
motivation for hESC isolation) was similar to that of Gail Martin’s motivations (i.e. to 
learn more about development) in the late 1970s and early 1980s, it was shown in 
Chapter 4 that Martin was able to pursue this line of research only because in the US 
‘pure’ research was still funded.  Evans’ work in the field of development resulted in 
his creating GEMMD.  As demonstrated in Chapter 4, Evans was essentially coerced 
into this research direction by restraints in funding for pure research.  This chapter 
will show that for Gearhart, the creation of better models of disease was also a result 
of his initial interest in development, however the scientific climate of the 1990s was 
different to that of the 1980s, resulting again in different approaches to the study of 
development.  As Morange has previously highlighted, Gearhart was also working in 																																																								
808 Thomson et al., 1995. 
809 Thomson, Marshall, and Trojanowski, 1998; Thomson et al., 1998. 
810 Shamblott et al., 1998. 
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a different scientific context to Evans.  Lastly, this chapter will also demonstrate the 
versatility possible in stem cell research, allowing researchers to switch between 
fundamental and applied research; this has also previously been shown in Chapters 3 
and 4. 
 
1.1 Morange’s claim 
 Michel Morange (1950-) is a French biological sciences researcher with 
expertise in the history and philosophy of science.  He obtained a in PhD in 
biochemistry and molecular biology from the Pasteur Institute in Paris, in 1978.  
Simultaneously, Morange was supervised by Jacques Merleau-Ponty (1916-2002) in 
the history of molecular biology.  Morange then went to work with François Jacob 
(1920-2013) in his cell biology laboratory, also at the Pasteur Institute.  Morange is 
currently Professor in biology at the University Paris 6 and Ecole Normale 
Supérieure, and Director of the Centre Cavaillès for History and Philosophy of the 
Sciences.  Morange’s work in history and philosophy focus predominantly on the 
history and philosophy of twentieth century life science. 
In 2005, Morange began an ongoing series of articles in the Journal of 
Bioscience, named “What history tells us”.  In December 2006, Morange published 
the seventh article of the series, discussing the anniversary of Gail Martin’s and 
Martin Evans’ and Matthew Kaufman’s isolation of mESCs: “Twenty-five years ago: 
The production of mouse embryonic stem cells”.   
In his 2006 paper, Morange queries why there was a gap of almost two 
decades between the isolation and culture of mESCs in 1981, and hESCs in 1998.  
Morange first questions whether there were technical differences that took time to 
figure out and overcome; however Morange swiftly disposes of this argument by 
highlighting that there were few technical differences between mESC and hESC 
isolation and culture – the requirement for certain factors in the growth media and the 
use of feeder layers are very similar.  Secondly, Morange questions whether ethical 
concerns were a reason for the delay.  Again however, Morange dismisses this 
argument – if there were ethical obstacles, these had still not been satisfactorily 
resolved, and so could hardly have been the cause of such a long delay in the 1980s or 
1990s.  Jane Maienschein has commented on this too, noting that there were few 
ethical concerns raised after the isolation and culture of mESCs; Maienschein claimed 
that bioethics in general was far more concerned with clinical medicine than 
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laboratory research, and it was only in 2007 (after Evans won the Nobel prize for 
work on creating genetic chimeras) that such research was noticed by the public, and 
therefore required more consideration by the bioethicists811.  This is a different view 
to Morange, however the result is the same: “ethical obstacles” were not a significant 
problem for the isolation and culture of hESCs. 
Morange believed that he saw the beginning of an answer to his question in a 
Nature piece following the paper published by Evans and Kaufman in 1981.  In her 
commentary, Brigid Hogan makes no mention of the extension of the method to 
human cells, or of any medical use for the mESCs.  Instead, Hogan identified that the 
mESCs were an ideal in vitro model to study cell fate in mammals.  Hogan also 
mentioned that there was a possibility of generating mosaic animals by injecting 
isolated mESCs into blastocysts, as a way of studying development.  The mESCs 
were seen as an improvement on the ECCs already available.  This point is further 
emphasised by Hogan later in 2007, where again she makes no reference to hESC 
isolation following ‘naturally’ on from mESC isolation, or the potential for 
therapeutics812.  It appeared then when scientists thought about mESCs, their 
immediate respeonse was not to extend this to hESCs, since their application is 
different.  This is the context that Morange is referring to. 
Following this introduction to his paper, Morange then described the link 
between the study of teratomas and eventually the isolation of ECCs and ESCs (as 
covered in greater detail in Chapter 4 of this thesis).  The usefulness of cells that 
could be injected into a developing blastocyst was seen to be a particular triumph of 
this work; the study of gene regulation in microorganisms had been possible for some 
time, with biochemical and genetic studies focusing on Escherichia coli.  However 
similar study of mammalian development had, up until this point, been impossible, as 
there was almost no (if any) experimental access to the post-implantation embryo.  
The development of ECC (and then ESC) lines had enabled different stages of 
development to be studied.  In the 1970s, various researchers experimented with 
mECCs by inserting them into developing blastocysts, and studying cell-cell 
interactions and embryogenesis, up to the fate of injected ECCs in the adult mouse 
(see Chapter 4). 
																																																								
811 Maienschein, 2014 p 187. 
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As highlighted in Chapter 3 of this thesis, Morange also noted that such 
experiments demonstrated confirmation of the similarities between ECCs and ESCs, 
although there were limits to the mosaicism created by injection of ECCs into the 
blastocyst.  For example, there was difficulty in obtaining transmission of the ECCs 
through the germ line of the mosaic mice.  The development of an ESC line however 
would, in theory, overcome such problems. 
In the fourth section of his paper, Morange specifically stated that the 
scientific context is relevant to the way in which ESCs were used to study 
development.  Initially, Morange claimed, ESCs were thought to be a way of creating 
transgenic animals.  The further possibility of examining gene function in 
development also swiftly emerged, as genes similar to those affecting development in 
Drosophila were identified (the homeobox-containing genes)813.  ESCs could be used 
to test the effect these genes had on development, as they could be rendered non-
functional, or different alleles could be specifically selected for.  From this beginning, 
Morange argues, the production of knock-out and knock-in transgenic animals 
emerged as an important application of ESCs814.  The clear follow-up to this then was 
the possibility of gene therapy, such as the replacement of a non-functioning gene 
with a functioning copy; this, suggested Morange, attracted the attention of biotech 
companies in the 1990s.  If the creation of transgenic animals and elucidation of gene 
function were the aims of mESC isolation and culture, this shows that they were 
developed with a different motivation to hESCs, which would not be isolated and 
cultured with the aim of generating transgenic individuals. 
In his concluding statement, Morange justified the study of history of biology 
by identifying that the discipline has two functions: to “discern the permanent 
transformation in science of ‘objects’” and “to learn lessons and retrieve them from 
the past”815.  With the context of this in mind, Morange’s claim that the motivations 
and goals for creation of mouse and human ESCs identify that both types of ESC 
were created in different scientific contexts, and have perhaps developed different 
values since their isolation.  The different scientific context in which human and 
																																																								
813 See Chapter 4, section 5 of this thesis: Martin worked on homeo-box genes in the early 
1980s. 
814 See Chapter 4, section 4 of this thesis: Evans created GEMMD in the 1980s, and this led to 
models of larger mammals in the 1990s. 
815 Morange, 2006 p 540. 
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mouse ESCs were isolated, Morange argued, tells us why there was such a gap of 
seventeen years between the isolation and culture of mESCs and hESCs.  	
1.2 Other reflections 
Unsurprisingly, Morange is not the only scholar to have considered the leap 
from mouse to human ESCs.  For example, Maienschein has also commented on the 
move from mouse to human ESC isolation in her 2014 book Embryos under the 
microscope, where she claimed that “in 1981, with mouse studies, the lines of 
research that lead to human pluripotent stem cell culturing began”817, clearly linking 
the isolation and culture of mESCs with the isolation and culture of hESCs, which 
Morange suggests is not as clear-cut.  Maienschein goes as far to claim that “the story 
of stem cell research from mice to men is well-known”818.  She conceded however 
that there is a difference between the culture of mouse and human ESCs (i.e. the time 
between 1981 and 1998); this was not due to the extension of the technique (as also 
claimed by Morange), but caused by advances made in understanding the genetic 
basis of development819.  This then is partly in agreement with Morange: Morange 
refers to the journey from mECCs to hESCs being “far from straight”, which would 
imply that, as Maienschein says, the difference between mESCs and hESCs was not 
as simple as extending the methods used.  Maienschein instead proposed that between 
1981 and 1998, much had been learned about the genetics of development which was 
relevant to isolation and culture of hESCs.  Morange’s slightly more detailed 
extrapolation of this is that it was specifically the parallels between cancer and 
development that was an obstacle for later researchers. 
Davor Solter has commented on the relationship between murine and human 
stem cells in his review looking at the history of stem cell research820.  Solter claimed 
that whilst research making use of human and mouse tissue ran in parallel, advances 
using human cells “usually lagged behind by a decade or so”, benefiting from the 
experience of mouse research821.  In particular, Solter noted the lag between isolation 
and culture of mESCs and hESCs, like Morange and Maienschein, claiming that since 
the isolation techniques were comparable, and the markers (of pluripotency) were 																																																								
817 Maienschein, 2014 p 207. 
818 ibid p 207. 
819 ibid p 207. 
820 Solter, 2006. 
821 ibid p 319. 
CHAPTER 5  223 
 
already available, there must be another reason for the seventeen year gap between 
mESC and hESC isolation and culture.  Solter suggested that “the reasons for this 
delay are probably the difficulties involved in obtaining suitable embryonic tissue and 
an understandable reluctance of most investigators to work in a field that is fraught 
with potential legal problems and political and moral dilemmas”822.  Success was 
achieved however, with the foresight of those private companies providing funding, 
and useful previous experience with non-human primate (p) ESCs; this is explored 
below in the account of Thomson’s and Gearhart’s research leading to hESC 
isolation.  Although Solter implied that some of the delay may be accounted for by 
social and ethical concerns, he does not refer to the potential delay caused by the 
differences in scientific context Morange specifically refers to. 
This chapter will consider Morange’s claim, however examination of the 
history of human ESC isolation is required (a history of mouse ESC isolation was 
provided in Chapter 4), before returning to assess Morange’s argument. 
 
2. History of human embryos in research 
2.1 History of human embryonic stem cell isolation and culture 
“Studies on cytodifferentiation in mammals might be greatly assisted if 
undifferentiated cells capable of profound differentiation were available in culture.  
A possible source of such cells is the earliest stages of mammalian 
embryogenesis...”851 
 
2.1.1 1980s: Shifting focus from mouse to human 
 Following the isolation of mESCs in 1981, much was learned about 
mammalian development, including the property of pluripotency.  For example, 
cultures were scrutinised for the expression of Oct4, an important transcription factor 
involved in pluripotency, without which cells begin to differentiate (see also Chapter 
6).  Such research became important to understand how mESCs would grow in vitro, 
and availability of mESC lines enabled much to be learned about optimum growth 
conditions ex vivo in the years that followed.  Such research and results ranged from 
the relatively simple selection of appropriate culture media, to more complex theories 
about epigenetic and transcriptional ‘resetting’ of cells once they are in vitro, possibly 																																																								
822 ibid p 324. 
851 Cole, Edwards, and Paul, 1965 p 501. 
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creating an artificial state859.  Eventually, even nuances of mESC culture from 
different mouse strains began to surface860.  Learning such details was important for 
understanding more about mammalian development, since the correct culture 
conditions would enable similar development in vitro as had been identified in vivo861.  
Mouse development could therefore be studied using the mESC lines derived from 
Evans and Kaufman’s and Martin’s techniques (as described in 1981), including the 
creation of murine disease models (as discussed in Chapter 4).  James Thomson 
claimed that “a bunch of people doing really cool developmental biology shifted 
[their focus to knockout mice] and a lot of basic stuff kind of got lost for a while”862.  
This statement provides some support for Morange, who also suggests that some later 
researchers had ‘forgotten’ the paradigms of ECC and ESC research of the late 1970s 
and early 1980s whilst carrying out their work in the 1990s. 
In 1987, Christopher Graham, at Oxford University, submitted a license 
application titled ‘Derivation of cell lines from the human conceptus to investigate the 
growth regulation of embryonic and tumour cells for the development of effective 
preimplantation diagnosis’863.  This is a continuation of the parallel recognised in 
Chapter 3 of this thesis, between normal and pathogenic development – a parallel that 
Morange suggests was forgotten in the 1990s.  Graham had been working towards 
understanding the factors involved in growth regulation of human embryonic cells864.  
In correspondence with Anne Parson, Graham commented that he thought there may 
have appeared to be more groups trying to derive hESCs than were actually working 
to do so, implying that the ethical requirements and considerations may have been a 
hurdle some were not willing to jump865, perhaps waiting for others to do this work, 
and for cell lines to become commercially available.  In further correspondence, 
Graham referred to motivations and goals for those who may have been pursuing 
isolation and culture of hESCs, suggesting that ‘on paper’ (i.e. in official funding 
applications, for example) no-one would be trying to isolate hESCs for therapeutic 
purposes.  That said, “all of us would have been exceptionally stupid not to realise 
																																																								
859 For example, see Buehr and Smith, 2003. 
860 For example, see Ying et al., 2003. 
861 For example, see Nichols et al., 1996; Batlle-Morera, Smith, and Nichols, 2008. 
862 Park, 2011 p 61. 
863 Parson, 2004 p 266. 
864 For example, Hopkins et al., 1987. 
865 Parson, 2004 p 266. 
CHAPTER 5  225 
 
their therapeutic value”866.  Graham’s comments suggest that there was an underlying 
understanding that hESCs may be useful in the long term for therapeutic medicine, 
but in the short term, the isolation and culture of hESCs was required for various 
research projects, including basic and applied biology. 
 
2.1.2 1990s: James Thomson’s hESCs from embryos 
One of those studying development in the 1990s was James A Thomson at the 
University of Wisconsin, Madison.  Thomson had doctoral training in veterinary 
medicine and molecular biology at the University of Pennsylvania, carrying out his 
thesis research on the role of genetic imprinting in early mammalian development at 
the Wistar Institute, Philadelphia.  Thomson then embarked on a two year post-
doctoral fellowship at the Primate IVF and Experimental Embryology Laboratory, 
Oregon Regional Primate Center867. 
Thomson was amongst those developmental biologists using the mESCs first 
isolated and cultured in the 1980s to learn more about early embryonic development; 
mice were an ideal model, since they were small, easy to use868, cheap, and easy to 
keep.  This said, although there are some parallels between murine and human 
development, there are also many differences, particularly in the early stages of 
embryogenesis.  For example, the mouse produces no equivalent of human 
gonadotrophin, and the products of the placenta are different.  Thomson, as a 
developmental biologist, was frustrated with the model available, and decided to 
make use of the primate research going on at the University of Wisconsin, Madison, 
to further his research into early human development.  Thomson’s attempts to obtain 
non-human primate embryos juxtaposed the cheapness and ease of using mice - a 
figure of around $2000 was put on obtaining each in vivo-created rhesus monkey 
embryo869.  “…[T]he primate material was limited”, claimed Thomson: “I thought 
stem cells made a lot of sense, because you could grow as many as you want”870.  
Thomson would use those techniques learned from the creation of mESCs, combined 
with other knowledge and understanding of keeping non-human primate cells in 
culture, to develop a line of pESCs. 																																																								
866 ibid p 156. 
867 Thompson, 2013 p 69-70. 
868 Park, 2011. 
869 ibid p 60. 
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Thomson had previously worked with Peter Andrews at the Wistar Institute in 
the 1980s, working with mECCs.  Thomson claimed that he therefore knew the 
procedures and techniques used for culturing mECCs first-hand, and would combine 
this with the methods presented by Evans and Kaufman, and Martin in 1981 to start 
his work with the rhesus monkey embryos871.  Thomson used trophectoderm-specific 
antibodies to identify and lyse the trophectoderm cells that surround the ICM of the 
developing blastocyst.  The ICM cells were then transferred to a mouse fibroblast 
feeder layer (as Martin had used).  Thomson was able to culture the cells for six 
months, and would carry out a series of tests to demonstrate that the cells were 
embryonic stem cells, and had not begun to differentiate, and that no genetic 
mutations had occurred.  Thomson’s results were published in 1995.  In the last two 
paragraphs of this paper, despite Thomson’s background in developmental biology 
and his claims that he wanted to further developmental biology research by generating 
cells more closely related to human cells than mESCs, Thomson wrote that hESCs 
could one day be isolated using similar methods, and could have many medical 
applications for conditions like Alzheimer’s or Parkinson’s872. 
Thomson said that he was “surprised” that few people seemed to be interested 
in generating hESCs after his ‘proof of principle’ pESC work was published873.  
“[S]everal people tried, but didn’t succeed for whatever reason…we thought 
somebody else would do it, but as the months ticked by, and nobody else had done the 
human work, we decided to pursue that”874. 
Before Thomson could do any work using human embryos however, there 
were a lot of ethical and moral issues to consider875, in addition to legal issues to be 
addressed.  For example, the Dickey-Wicker amendment made federal funding 
unavailable for any research that involved the use of human embryos876.  Alice Park’s 
narrative of Thomson’s efforts in the late 1990s suggest that funding was the main 
sticking-point for research into generating a hESC line.  For example, Thomson could 
not continue working at the University of Wisconsin Primate Center, as this was a 																																																								
871 Parson, 2004 p 143. 
872 Thomson et al., 1995; Parson, 2004; Park, 2011. 
873 Park, 2011 p 65. 
874 ibid; Parson, 2004 p 145. 
875 Park, 2011. 
876 The Dickey-Wicker amendment was passed in 1995, signed by Bill Clinton.  It prohibited 
the Department of Health and Human Services from using funds for research where a human 
embryo would be destroyed, or for the creation of human embryos for research purposes. 
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federally funded facility.  Thomson applied for internal university funding to work on 
creating hESCs, but was refused (Thomson believed that this may have been because 
the university was concerned that funding his human embryo work may cause enough 
controversy to lose the university millions of dollars in NIH funding)877. 
The funding vacuum gave biotechnology company Geron their foot-in-the-
door.    Geron was founded in 1990, and publicly traded (NASDAQ) since 1996.  One 
of many early 1990s biotechnology start-up companies, Geron was funded by venture 
capital, hoping to secure future revenue from patents.  Cooper claimed that Geron 
successfully monopolised the emerging discipline of regenerative medicine878.  Stem 
cells would be a key area of interest for Geron’s founder Michael West; West had 
completed a PhD in cell biology, and followed-up this interest with Geron.  West’s 
other interest was aging (hence “Geron” - Greek for ‘old man’), and the first research 
Geron invested in was telomere research879.  Geron had shown an interest in ESC 
research in the early 1990s, after Howard Cook had demonstrated that the telomeres 
of eggs and sperm did not shorten with age like those in somatic cells.  West’s logic 
was that if germ cells were like stem cells, then stem cells might be the key to aging 
and regenerative medicine880.  Roger Pederson, a biologist at University of California 
at San Francisco, claimed that West had approached him before the Dickey-Wicker 
amendment, offering to fund his research.  Pederson had refused, believing that the 
government would continue to support stem cell research, that federal funding would 
be available, and that any stem cell lines derived would be freely available for sharing 
between laboratories.  After Dickey-Wicker however, Pederson’s views changed.  
Pederson got back in touch with West, and agreed to Geron’s funding terms.  West 
seized the opportunity, and realised that if Pederson would return to Geron for 
funding, others in the field must be desperate for funding as well.  West asked 
Pederson for names of those who he thought might also be suffering from lack of 
federal funding, and the names of James Thomson and John Gearhart were offered881.  
The following day, West flew to Madison to talk to Thomson.  It was good timing - 																																																								
877 Park, 2011. 
878 Cooper, 2008 p 142-3. 
879 Telomeres are repetitive sequences of nucleotides found at each end of the chromosome, 
which are believed to protect the chromosome ends from damage or fusion with other 
chromosomes.  These shorten with age, and are thought to have an effect on the aging 
process. 
880 Parson, 2004 p 147. 
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Thomson’s application for internal funding had been turned down a few days prior.  
Apparently reluctant, but without any viable alternative, Thomson signed-up for 
Geron funding, and it’s intellectual property implications882. 
Although Thomson had obtained financial backing for his project, there were 
other decisions to be made, which were also affected by the Dickey-Wicker 
amendment.  For example, Thomson had to move to a laboratory that was not funded 
by federal money, and equip it (eventually Thomson found space near the university’s 
IVF clinic, and apparently cobbled together a laboratory from discarded equipment 
from other laboratories)883.  Thomson was also concerned by the ethical implications 
of his work, and got in touch with another University of Wisconsin colleague, Alta 
Charo (an expert in law pertaining to scientific research), for advice.  When 
interviewed by Park, Charo claimed that Thomson’s aim was not to make any 
political point, but was solely interested in researching human embryology884.  
Thomson also met with the founder and director of the University of Wisconsin’s 
program in medical ethics, Norman Fost.  Fost has said that Thomson was aware of 
the controversy of the work he was proposing, and cared about doing the right thing.  
Thomson knew others (including at the university) might have been upset about the 
work he was proposing.  Fost would later head the university review board discussing 
approval for Thomson’s project885.  Having discussed the ethical and legal 
implications of Thomson’s proposed work, Charo also asked Thomson whether he 
was personally comfortable with the project he was planning.  Years after Thomson 
had successfully isolated and cultured hESCs, an interviewer asked Thomson a 
similar question; Thomson said that if hESC research did not make you a little 
uncomfortable, you had not given it enough thought886.  Parson wrote that after the 
announcement of Dolly’s birth in 1998, Thomson almost halted his work following 
some public controversy887 - perhaps a hint of what would fall on the shoulders of 
Thomson if he succeeded in his endevours. 
Thomson’s ethical and legal discussions with Charo and Fost were not 
unwarranted - it apparently took the University of Wisconsin two years to approve 																																																								
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Thomson’s project, in July 1995.  Concerns were not only ethical, but legal - again, 
the university did not want to risk losing millions of dollars in federal funding if 
Thomson’s project had not been given the upmost attention to detail.  For example, 
there were concerns about federally-funded utility supplies (water and electricity for 
example) to Thomson’s make-shift laboratory.  Basic equipment, such as computers, 
would also have been previously purchased using federal funds.  Once the university 
had agreed to Thomson’s project and his laboratory space, to avoid further 
complications, Thomson carried out all of the practical work himself888.  Fost reported 
that the institutional review board spent significant time looking at three previous 
reports to help them make their decision: the Warnock Report (UK, 1984), the 
Canadian Royal Commission on New Reproductive Technologies in Canada (1993), 
and the NIH Human Embryo Research Panel (US, 1994).  All of these reports had 
reached the conclusion that although the preimplantation (human) embryo (day 1-7) 
warranted serious moral consideration, it did not have the same moral status as an 
infant.  The institutional review board at the University of Wisconsin concluded that it 
was unlikely to reach a different conclusion to these three reports, and Thomson’s 
project was permitted to go ahead889. 
Again reluctantly however, Thomson found that he needed another 
collaborator.  Although Thomson had arranged with the university’s IVF clinic that he 
could use donated embryos, these were few and far between (since the clinic was very 
small).  Thomson needed more material to work with.  Just as Geron had filled a 
funding vacuum, another collaborator filled the materials vacuum.  Joseph Itzkovitz-
Eldor, at the Rambam Medical Center (Haifa, Israel), had been following Thomson’s 
work after the publication of his pESC paper in 1995, and was keen to collaborate890, 
presumably imagining that a hESC line could be useful for IVF research.  Itzkovitz-
Eldor’s IVF clinic in Haifa was much larger than that in Wisconsin, and could provide 
many more donated embryos.  Thomson, in need of Itzkovitz-Eldor’s embryos for his 
work, agreed to the collaboration, and Itzkovitz-Eldor sent Thomson embryos and a 
student, who would learn more about Thomson’s cell culturing techniques. 
Thomson initially struggled with culturing the embryos he was sent.  For IVF, 
these embryos would have been frozen soon after fertilisation (day 1 post-																																																								
888 Park, 2011. 
889 Parson, 2004 p 151-3. 
890 Park, 2011. 
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fertilisation), and if they were going to be used, defrosted and cultured for 2-3 days 
prior to transfer.  However, Thomson needed the embryos to live in vitro for 5 or 6 
days, and develop normally.  To help achieve this, Thomson sought the expertise of 
the university’s IVF laboratory director, Jeffrey Jones.  At first, the pair were 
unsuccessful.  Jones attended a conference in May 1996, and heard a presentation 
from David Gardner, an embryologist at Monash University (Australia).  Gardner 
spoke about a culture system he had used to keep embryos developing normally in 
vitro for 5 days.  Jones contacted Gardner for help, but American-Australian logistics 
made collaboration difficult.  In 1997, a member of Gardner's laboratory was offered 
a postdoctoral fellowship at Wisconsin, providing Thomson with a contact with 
whom he could work regarding accessing Gardner’s culture formula.  Gardner’s 
approach had been to mimic the mother’s environment in vitro; in practice, this had 
doubled the number of IVF embryos that would survive up to birth.  Thomson and 
Jones’ collaboration with Gardner finally came to fruition when the legalities between 
the US and Australian groups had been worked out.  In January 1998, Thomson and 
Jones could begin culturing embryos in Gardner’s media, and, as expected, healthy 
blastocysts developed.  After this stage, Thomson could use the culturing techniques 
learned from pESCs to isolate and culture the hESCs891. 
Within a few weeks of Itzkovitz-Eldor’s embryos arriving, and alongside an 
additional few embryos from the university clinic, Thomson had successfully 
replicated the rhesus monkey technique and was culturing human embryonic stem 
cells. The method Thomson used to isolate the hESCs was to culture 36 donated 
cleavage-stage embryos to the blastocyst stage (20 embryos developed to this stage); 
this process took 4-5 days.  From these blastocysts, 14 inner cell masses were isolated 
(named H1 to H14), five of which developed into cell lines in vitro.  In the 1995 
pESC paper (which Thomson referred to regarding the method for isolating and 
culturing hESCs in 1998), the method noted that a blastocyst was flushed from the 
uterus of a rhesus monkey, the trophectoderm lysed, and the inner cell mass cells 
separated.  The cells were then cultured on a feeder layer of irradiated mouse 
embryonic fibroblasts.  The first outgrowths could usually be seen after 9-15 days.  
After five weeks, the cells morphologically resembling human ECCs were isolated, 
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and clonal colonies established892.  This, according to the account in Park, appeared to 
be the most difficult work.  It would take only a few days for the growing cell 
colonies to begin stratifying (i.e. growing on top of one another), or for a few outlying 
cells to begin differentiating.  Every few days, Thomson would need to change the 
nutrient media the cells were growing in, and remove any differentiating cells.  When 
there were too many cells present in a single flask, Thomson would have needed to 
‘split’ the cells.  Small clusters of hESCs would be collected and re-plated into a fresh 
flask.  Thomson needed to do this approximately once per week.  The hESC lines 
developed by Thomson were not created from isolated cells, but from small colonies 
(of between approximately 50 and 100 cells); i.e. the hESCs described in 1998 by 
Thomson were not clonal colonies.  Thomson defended this by claiming that the cells 
shared a uniform morphology (similar to hECCs and pESCs), making it “extremely 
unlikely” that a mixed population of cells was expanded; Thomson conceded however 
that they “cannot rule out the possibility” that there may be some variation in the 
differentiation potential amongst the cells of each line893.  One reason Thomson may 
have had to generate heterogeneous hESC colonies was that he learned that the human 
cells preferred to be cultured at higher densities than the pESCs.  When re-plating his 
cells, Thomson would have needed to make sure that there were enough hESCs 
present for them to be in contact with each other; if there were too few hESCs in each 
flask, then those present would die. 
Park’s narrative suggested that the isolation and culture of the cells was not 
the most testing part of Thomson’s project however: this would be demonstrating that 
the cells growing were unequivocally hESCs.  Thomson’s continuing publications 
detailed the work carried out to present evidence that the cell lines developed were 
ESCs; this was more difficult than the ‘standard test’ for other laboratory based 
animals - which was the ability to contribute to all tissue types in chimaeras - since it 
was not legally possible to do this with human cells.  Thomson’s previous work on 
pESCs was again useful, as chimeras could not be generated to demonstrate 
pluripotency of these cells either.  Based on this experience, Thomson et al. proposed 
that the essential characteristics required to demonstrate that the cells were ESCs 
were: 
1) derivation from the pre-implantation embryo 																																																								
892 Thomson et al., 1995. 
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2) prolonged undifferentiated proliferation 
3) stable developmental potential to form derivatives of all three embryonic 
germ layers894. 
Thomson et al. used a significant part of the paper to describe how they had 
demonstrated the three criteria identified, and potential hESC uses. 
Thomson applied for patents for his work on hESCs, being no stranger to 
patent applications.  The Wisconsin Alumni Research Foundation (WARF) filed 
Thomson’s first patent on 20 January 1995, which referred to Thomson’s pESCs 
(seven marmoset pESC lines, and two rhesus pESC lines), and the method for their 
derivation.  This was added to a year later, when Thomson applied for the 1995 patent 
to be abandoned in favour of new matter not included in the original application; this 
new matter was the characterisation of two pESC lines, and isolation of another, 
developed from rhesus monkeys.  A continuation of this patent was applied for in 
December 1998, following criticism that the work was not sufficiently different from 
those of other patent holders.  Eventually, WARF obtained patent 5843780 for the 
pESCs cultured.  A year later, WARF filed a separate application, for the human cell 
lines Thomson had developed.  The application was almost identical to the primate 
cell patent895.  US Patent 6200806 was issued in 2001, and covers the method for 
isolation and the five original hESC lines generated (i.e. both the process and the 
product).  This patent gave WARF control over who may work with the cell lines, 
who may use Thomson’s method, and therefore the purpose of future research using 
hESCs.  WARF established an exclusive licensing agreement with Geron.  Geron had 
rights to three modified cell lines (and WARF retained the rights to the five 
unmodified cell lines).  It is not possible to patent hESCs in the UK; hESCs can not 
be patented since they have the potential to develop into an entire human body, and 
human beings / persons can not be patented896. 
 
2.1.3 1990s: John Gearhart’s isolation and culture of hEGCs 
It is possible that the work of Leroy Stevens on teratocarcinomas (see Chapter 
3)897 inspired the theory that pluripotent cells may be derived from PGCs.  When this 																																																								
894 Thomson et al., 1998 p 1145. 
895 Rohrbaugh, 2003. 
896 Cooper, 2008 p 144, 146. 
897 For example, see Stevens, 1962. 
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research was carried out in the early 1990s, it was possible to culture early embryos in 
vitro with a relatively high success rate, and, with the echos of Stevens’ work behind 
them, researchers began to isolate the PGCs and culture them.  Just as with mESCs, 
the correct culture conditions for isolated embryonic germ cells (EGCs) were honed. 
John Gearhart grew up in Philadelphia, attending school whilst his mother and 
older brother worked on the family farm898.  With ambitions of becoming a fruit-tree 
grower, Gearhart studied plant genetics and the University of New Hampshire.  
Gearhart would remain in academia however, moving to Cornell for a PhD in D. 
melanogaster genetics.  Anne Parson claimed that Gearhart was working in the newly 
emerging, more interdisciplinary field of developmental biology that had evolved 
from embryology (see also Chapter 2)899.  Although Gearhart’s PhD project focused 
on fruit fly genetics, he was still able to follow his previous interest in plant genetics 
and development; close to Gearhart’s laboratory space at Cornell was Frederick 
Steward’s bench; Steward had recently cloned a carrot plant from a single, mature 
cell.  Parson noted that Gearhart did not collaborate with Steward, but that his work 
was influential; after completing his PhD, Gearhart was set to go and work in France 
with Jean Paul Nitsch, who had recently grown a tobacco plant from a pollen grain.  
Unfortunately, as Gearhart was about to leave for France, Nitsch was killed in a car 
accident.  Finding alternative employment, Gearhart would move to the Institute for 
Cancer Research in Philadelphia, to the laboratory of Beatrice Mintz (see Chapter 3), 
in autumn 1970.  Under the direction of Mintz, Gearhart would spend his time 
learning about the culture of mECCs - in particular, Stevens’ teratomas and strain 129 
mice (see Chapter 3).  Gearhart had the opportunity to briefly meet Stevens at a 
conference in Venice, in 1972900. 
Mintz had previously worked with Tibby Russell at JAX, where they had 
determined the migratory route of PGCs in mouse embryos.  This had helped Stevens 
to demonstrate that these cells were involved in later teratoma formation.  Mintz, 
having already successfully created murine chimeras, was looking to use mECCs to 
generate new chimeras.  Gearhart’s role was to culture the mECCs, however he 																																																								
898 Wu, 2011. 
899 Parson, 2004 p 157-9. 
900 However, Stevens went missing one evening after becoming inebriated; a group searched 
for him, but to no avail.  Eventually Stevens re-established contact with his colleagues from 
Istanbul, having decided to leave the conference, take a vaporetti along the Grand Canal to 
the train station, and board the Orient Express.  Parson, 2004 p 162-3. 
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struggled to prevent the cells from differentiating in culture.  Eventually the group 
succeeded, and in 1975, Mintz’ laboratory published their results, showing that 
mECCs could contribute to normal development of a mouse chimera901.  Gearhart left 
Mintz’ laboratory the same year, to move to the University of Maryland.  Whilst 
there, Gearhart continued researching mouse development.  He worked closely with 
the anatomist Gladys Wadsworth, and the pair would spend time together dissecting 
(human) stillbirths.  Wadsworth would narrate her dissections aloud, and here 
Gearhart learned about foetal anatomy.  Parson claimed that Wadsworth would ask 
Gearhart questions about embryogenesis during these dissections, in particular how 
each region of the foetus would develop from cells in the embryo. 
In 1979, Gearhart moved to Johns Hopkins University to teach human 
embryology and conduct research into mammalian embryogenesis.  Gearhart 
followed the trend in transgenics, attempting to use the methods to learn more about 
the genes involved in embryogenesis, and the role of trisomy 21 in development of 
Down syndrome symptoms (this included the creation of a Down syndrome mouse 
model). 
Gearhart’s work utilising the mouse model of Down syndrome (during the late 
1980s) was a ‘peak’ time for mouse models of disease.  Historically, researchers used 
mice in the laboratory as they were easy and cheap to care for, and would reproduce 
relatively easily and frequently (every nine weeks).  Genetically and physiologically, 
mice are also relatively similar to humans.  Initially, mouse models of disease were 
identified as those conditions present in both mice and humans, and selectively bred 
for; strains were developed that had increased incidence of certain diseases (such as 
strain 129 mouse teratomas, noted in Chapter 3).  Once mutagens had been found, 
these were used as a relatively crude way of causing genetic mutations.  Later, newer 
techniques were developed for affecting specific genes or chromosome regions, 
referred to as transgenics.  As noted in Chapter 4, Martin Evans would share a Nobel 
Prize for his research that, in part, led to development of very specific mouse models 
of disease in the 1980s902. 
In 1986, Gearhart and colleagues wrote about a mouse model for Down 
syndrome; although the condition is caused by trisomy 21 in humans, this was not the 
case in mice.  However, many of the genes on human chromosome 21 were found to 																																																								
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902 For a detailed discussion on the history of transgenic mice, see Myelnikov, 2015. 
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have murine analogs on mouse chromosome 16.  The trisomy 16 mouse, Gearhart 
argued, would be useful for examining the development of the Down syndrome 
phenotype, and an increased understanding of the molecular mechanisms of the 
syndrome.  In particular, the mouse model of Down syndrome would provide “the 
opportunity for detailed anatomical, biochemical, and physiological studies 
throughout development, as well as after experimental manipulations which cannot be 
performed in humans” (my emphasis)903.  Gearhart is here showing his hand: that the 
mouse model would allow greater understanding of the syndrome as a phenotype (as 
opposed to cell cultures, samples from patients etc.), and could be subject to 
experimentation.  Mouse models would allow Gearhart to study the embryonic 
development of mice with ‘Down syndrome’.  These aims would shape his later 
motivations in generating hEGCs for further study. 
By the early 1990s, Gearhart was a leading expert in mouse models of Down 
syndrome, but was keen to expand his research to learn more about the syndrome in 
humans.  Gearhart believed that if he could retrieve stem cells from human embryos 
with and without trisomy 21, he could compare the two, particularly with a focus on 
differentiation and embryogenesis.  To this end, Gearhart approached David Blake, 
the assistant dean of the medical school at Johns Hopkins, for advice.  When asked 
about derivation of hESCs, Blake belived that obtaining hESCs from surplus IVF 
embryos may be too controversial, and asked if Gearhart could think of another 
source of stem cells for his research.  Reaching back to his experiences and 
knowledge of mice, Gearhart recalled the work carried out by a contemporary, Peter 
Donovan.  At the National Cancer Institute, Donovan had isolated and cultured 
mPGCs.  In the foetus, these cells would only exist for a few days before 
differentiating.  In culture however, Donovan had transformed the cells into 
embryonic germ cells (EGCs), capable of differentiating into a range of cell types.  
Gearhart reasoned that if he were to isolate and culture the primordial germ cells of 
human foetuses, he would be able to culture hEGCs.  Blake agreed that this method 
could be less ethically troublesome904. 
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Discussing this potential line of research with his postdoctoral fellow, Michael 
Shamblott, and colleague John Littlefield905, the group decided that they would obtain 
their hPGCs from therapeutically aborted foetuses.  This would prevent any 
controversy from obtaining foetal material from elective abortions, and would also 
benefit their work by arriving at their laboratory quickly.  The next discussion 
considered funding; although Gearhart’s group were eligible for federal funding 
(since they would be using tissue from therapeutic abortions), Gearhart, Shamblott, 
and Littlefield opted to try and obtain private funding; this way, they would not have 
to justify their spending of taxpayers money906.  Johns Hopkins review board, like 
their counterparts at the University of Wisconsin, took time to discuss Gearhart’s 
proposal; Gearhart submitted his project to the review board in 1993, and it was given 
the go-ahead in 1996.  Again, enter Geron’s Michael West.  Initially, Gearhart’s 
project was running on internal funding granted by the university, however West 
convinced Gearhart to accept his funding offer, made just a few months after funding 
Thomson’s work. West decided that funding Gearhart was a hedge – West did not 
know whether Thomson’s project would be successful, and saw Gearhart’s work as a 
back-up907. 
Gearhart was able to obtain fresh, therapeutically aborted fetuses from a Johns 
Hopkins-affiliated hospital, the Bayview Medical Center.  Once the foetus was in 
Gearhart’s laboratory, Shamblott would carry out much of the work dissecting out the 
genital ridge, and culturing the tissue.  After a short amount of time, Shamblott had 
begun the culture of the removed genital ridges, however the initial culturing attempts 
failed.  The cells stopped proliferating after a very short amount of time (as had 
previously been observed in vivo).  Gearhart returned to the work he knew had been 
carried out previously – that by Donovan (Brigid Hogan had also carried out similar 
work to Donovan at the same time, however the narration provided to Parson by 
Gearhart suggests that it was Donovan’s work that he was familiar with)908.  Gearhart 
looked again at Donovan’s culturing techniques, and adapted them for Shamblott’s 
cultures in early 1997.  The cultures began proliferating over longer periods of time, 																																																								
905 Shamblott is still an active researcher, making use of various types of embryonic stem 
cells.  Littlefield was a pioneer of amniocentesis. 
906 Parson, 2004 p 166-7. 
907 ibid p 167-8.  There is no reference to Thomson and Gearhart believing that they were in 
competition with each other; this may have been because they were unaware of each other’s 
work. 
908 Parson, 2004, p 165, 169. 
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lasting for weeks.  In July 1997, Gearhart announced at the International Congress of 
Developmental Biology in Utah that he and Shamblott had been culturing their cells 
continuously for months.  However, the group still needed to demonstrate 
pluripotency, and publish their results909. 
Ultimately, both Gearhart and Thomson would publish their work within days 
of each other – Thomson in 6 November 1998 issue of Science, and Gearhart in 10 
November 1998 issue of Proceedings of the National Academy of Science (PNAS).  
Both groups had demonstrated that the cells would proliferate without differentiating 
for months, and were capable of differentiating into cells of all three germ layers910.  
Gearhart demonstrated this potential by publishing images of immunohistochemical 
analysis of embryoid bodies cultured from the cells isolated.  Using this method, cells 
would stain depending on their type.  Gearhart provided evidence of cells expressing 
various proteins of all three germ layers in embryoid bodies developed from six 
different cell lines isolated911.  Thomson demonstrated the pluripotency potential of 
his hESCs by comparing the surface markers expressed with those from pESCs, 
mESCs, and hECCs.  Thomson also demonstrated that his cells could create cells 
from all three germ layers by creating teratomas; Thomson injected the cells into 
mice, where the cells expanded and developed into teratomas, which included a 
variety of cell types (such as epithelium, bone, muscle, and embryonic ganglia)912. 
 
3.“Motivations and goals”: a comparison of mouse and human 
embryonic stem cell isolation 
 
3.1 Morange re-visited 
In 2006, Morange’s historical reflections on the isolation of mESCs in 1981 
led him to claim that there were no “ethical obstacles” or “technical difficulties” that 
would have resulted in significant time passing between the isolation and culture of 
mESCs and hESCs913.  Since technical nor ethical difficulties could have been 
resulted in the seventeen-year gap, Morange stated that hESCs are not the equivalent 
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of mESCs if the motivations and goals of their creation are considered914; it was this 
that resulted in the long period of time between mESC and hESC isolation.  The 
motivations and goals differed, argued Morange, because of the change in scientific 
context between the 1980s and 1990s.    In Chapter 4, I detailed the history of 
Martin’s and Evans’ work isolating and culturing mESCs in 1981.  In the current 
chapter, I similarly recorded the history of Thomson’s and Gearhart’s work towards 
the isolation and culture of hESCs in 1998.  These narratives will now be utilised to 
examine Morange’s claim further. 
 
3.2 Reflections on motivations and goals for isolation of mESCs 
It has been suggested that the work of Gail Martin and Martin Evans (with 
Matthew Kaufman) was part of an initiative to derive pluripotent cells from embryos; 
the techniques established using teratocarcinomas and ECCs enabled the move to 
ESCs (as established in Chapter 4)915.  Martin, an expert in cell culture, observed the 
embryoid bodies that form in mECC culture, and extrapolated this observation: ECCs 
(and therefore ESCs) could be used as laboratory models for early development916.  It 
was this idea, Brigid Hogan argued, that led mESC isolation and culture to follow-on 
from mECC isolation and culture917.  However, the research into ESCs (following 
from ECC research) was not only motivated by intellectual curiosity; as highlighted in 
Chapter 4, Martin was able to develop mESCs to further her research on development, 
due to the political and economic situation in the USA (where funding was available 
for such ‘pure’ research.  Evans meanwhile utilised the isolated mESCs to create 
GEMMD, since funding in the UK was available primarily to those conducting 
applied research.  The routes and decisions taken by Martin and Evans appear to have 
been dictated by several elements, including social, political, legal, and economic 
factors in the USA and UK respectively (as considered in detail in Chapter 4), as well 
as intellectual curiosity (see Figure 12). 
																																																								
914 ibid p 540. 
915 Nichols and Smith, 2011. 
916 Hogan, 2007; Martin, 1980. 
917 Hogan, 2007. 
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Figure 12: Notes from Evans’ notebook about his expectations for isolated EK cells.  
From Evans’ Nobel Lecture, 2007. 
 
Morange also commented on the uses of mESCs after their isolation in 1981 in his 
2006 discussion.  Morange claimed that “ES cells were first seen as another way to 
generate transgenic animals”918; as noted in Chapter 4, this was the work initiated by 
Evans.  In the mid-1980s, Evans visited the USA (in particular to see Richard 
Mulligan at MIT, and Oliver Smithies at Wisconsin) to look into methods of gene 
targeting and recombination via PCR (polymerase chain reaction).  So successful was 
this line of work, that in 1989, Evans was able to publish a review of methods for 
mECCs and chimeric animals for genetic manipulation, which he claimed was “likely 
to have a major impact both in genetics studies and, especially if it can be extended to 
larger mammalian species, in practical applications”919.  Manipulation of cell fate then 
was an important consideration in Evans’ work. 
  Although Morange does not refer specifically to Martin’s work on 
development, his argument is still valid: the scientific environment of the 1980s was 
different to that of the 1990s, and therefore motivations and goals had to be different.  
As discussed in Chapter 4, the improved ability to study development was a goal for 
the isolation and culture of mESCs by Martin (and Evans) – interest in development 																																																								
918 Morange, 2006 p 539. 
919 Evans, 1989 p 557. 
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would initially preclude any other motivations, however, Martin’s ‘pure’ research was 
enabled by the political and economic situation of biomedical and biological research 
in the USA.  One reason for this is that this identifies a need to move away from 
ECCs for research.  When ECCs were initially isolated in the 1970s, they were 
praised as a viable, useful alternative to actual embryonic cells since they were 
accessible and could be practically used in the laboratory; further research would 
show that they were no more tumourigenic than other embryonic cells, and had a 
stable karyotype920.  ECCs could also be used to generate chimeras, which would not 
develop any tissue abnormalities despite their oncogenic history. 
 Morange’s suggestion that “a biochemical study of the differentiation process 
ex vivo”921 may have been a motivating factor in the isolation of mESCs demonstrates 
that Morange implicitly considers developmental research (such as that carried out by 
Martin), however phrases it as research into differentiation as opposed to development 
(this again perhaps a reference to the value placed on cell fate research through the 
late twentienth century).  Examination of Martin’s published work, I argue, clearly 
shows that Martin was concerned with development (and particularly mammalian 
embryogenesis).  For example, in 1985, Martin’s laboratory published a paper which 
compared human and murine homeo-box genes, which have a role during 
development922.  (Morange also highlighted the relevance of homeo-box genes in 
development research923.)  Martin has recently stated that the work she carried out in 
the 1970s and 1980s showed that mECC and mESC cells could be used to study 
embryogenesis, which led her to study mammalian development in the 1980s924.  This 
shows that Martin was interested in cell fate research, in the context of 
embryogenesis. 
Morange claimed that in the early 1980s, interest in mESCs was at “the 
fundamental level”, and that there was no mention of extention to humans or medical 
research925.  This, Morange argued, was because mESCs were isolated under a 
specific scientific context that would not apply to hESCs.  For example, Evans was 
motivated by political, social, and economic factors to create murine disease models 																																																								
920 For example, see Mintz and Illmensee, 1975; see also Chapter 4. 
921 Morange, 2006 p 539. 
922 Hauser et al., 1985; also see Chapter 4. 
923 Morange, 2006. 
924 Martin, 2015; also see Chapter 4. 
925 Morange, 2006 p 537. 
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(see Chapter 4); no legitimate researcher would attempt to create human models of 
disease using the same method, so hESCs were of no use in this context.  Morange is 
therefore correct – Evans’ mESCs were sufficient for any research he wanted to carry 
out.   
This leads us closer to answering why it took seventeen years to isolate hESCs 
after mESCs; Morange has argued that it was because there was a gap after mESC 
isolation before the realisation came that hESCs may be useful for medicine.  This 
argument supposes that biological research is not carried out to establish 
‘fundamentals’, but rather to ultimately provide more sophisticated medicines.  As 
argued in Chapter 4 however, this is often encouraged in certain political and social 
climates. 
 
3.3 Reflections on motivations and goals for isolation of hESCs 
In 2006, Morange claimed that mESCs were used for fundamental research 
post-isolation, with little thought given to isolation of hESCs or potential medical 
benefits for several years.  For some researchers, this appears to have been true; 
Evans could not create human models of disease (as he did with mice), and Martin 
could not culture large numbers of human embryos in her laboratory to study their 
development. 
In this chapter, I have shown that just as Martin and Evans each had initial 
similar intellectual curiosity for development, leading to the isolation and culture of 
mESCs in the 1980s, Thomson and Gearhart had the same precluding motivation for 
the isolation and culture of hESCs in the 1990s.  What differed however was the 
scientific context (as argued by Morange), and the social, political, ethical, economic, 
and legal contexts (as shown in Chapter 4 and this chapter).  Martin, Evans, Gearhart, 
and Thomson were interested intellectually in development; the scientific, social, 
political, economic and legal context of the 1980s and 1990s however resulted in 
changing how each researcher was motivated to achieve their intellectual goals. 
Thomson’s work benefitted from the research carried out into culturing 
blastocysts for successful uterine transfer after IVF.  (Ironically, whereas this research 
focused on attempting to keep the blastocyst alive and healthy in culture in order for 
more successful IVF, Thomson made use of this to allow blastocysts to mature prior 
to splitting open and extracting the ICM cells.)  This IVF research was concerned 
with establishing normal development in vitro prior to uterine transfer – such research 
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then was heavily focused on establishing normal development under laboratory 
conditions.  After Thomson had isolated and cultured hESCs, then demonstrated their 
ability to proliferate for extended periods of time and differentiate into cells from all 
three germ layers (i.e. the isolated and cultured cells were capable of both self-
renewal and differentiation), Thomson made use of his cells for learning even more 
about development and cell fate – for example, after isolation and culture of pESCs, 
Thomson published a paper detailing his investigation of neural differentiation of 
pESCs, with a view to examining neural tube formation926.  Thomson would work 
with hESCs to establish something similar regarding human development; in 2001, 
Thomson published a paper explaining that hESCs would differentiate and form 
neural tube-like structures927. 
Gearhart’s work appears to have approached human embryonic cells from an 
entirely different angle.  From the late 1970s, Gearhart had been studying Down 
syndrome, and in particular how the effects of human trisomy 21 affected 
embryogenesis.  By the 1990s, Gearhart was a leading expert in mouse models of 
Down syndrome, however was becoming frustrated at the limitations of the murine 
models for studying a human condition.  Discussions with colleagues suggested that 
using surplus IVF embryos for his research may be too controversial, leading 
Gearhart to return to his previous experiences with Wadsworth and dissections of 
both embryos and foetuses, and expertise in murine biology.  Following Donovan’s 
work isolating PGCs from mice, Gearhart attempted to carry out the same work in 
therapeutically aborted foetuses.  Using these cells would, Gearhart believed, help 
him to more accurately model what was occurring during development in those with 
Down syndrome. 
 
4. Conclusions 
In 2006, philosopher of biology Michel Morange reflected on what had 
occurred in stem cell research on the twenty-fifth anniversary of the isolation and 
culture of mESCs in 1981.  In the concluding remarks of the paper, Morange mooted 
																																																								
926 Thomson, Marshall, and Trojanowski, 1998. 
927 Zhang et al., 2001.  In this paper, it is noted that there is a potential for hESCs to be useful 
in transplant therapy.  However, I do not believe that this is necessarily because this was a 
key motivation or goal for Thomson’s work.  As noted by Graham, it was clear that 
transplantation therapy was always a potential for isolated hESCs. 
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that the reason that there was a relatively long time between isolation of mESCs and 
hESCs (seventeen years), was because the “motivations and goals attendant upon 
their creation” were so different928.  This chapter has been used to examine Morange’s 
claim in detail, by looking in particular at the work by James Thomson and John 
Gearhart (since Chapter 4 has previously considered the work by Martin and Evans).  
Thomson and Gearhart both isolated human embryonic cells in the late 1990s, 
publishing their papers within days of each other in 1998. 
The developmental biologist Thomson was working throughout this era, 
carrying out research focused on the role of genetics in embryogenesis – in particular, 
Thomson was interested in primate development.  Frustrated with the mouse models 
available (where, for example, there are key differences between mouse and human in 
products of the placenta), Thomson tried to make use of non-human primate models.  
These however proved expensive and impractical; Thomson’s solution was to culture 
the non-human primate embryo cells himself.  This resulted in the isolation and 
culture of pESCs in 1995.  Although Thomson waited to see whether another 
laboratory would be successful in generating hESCs using the same technique, no 
such results were forthcoming.  Thomson applied to do the work himself, and, after 
agreement from his university, funding from Geron, and enough fertilised eggs, he 
began his work.  Thomson reported the successful isolation and long-term culture of 
hESCs in 1998. 
John Gearhart’s approach was somewhat different.  Gearhart’s expertise in 
embryology were being utilised in Down syndrome research; by the 1990s, Gearhart 
was a leading expert in the field, where he was making use of mouse models to try 
and understand the effects of human trisomy 21 (trisomy 16 in the mouse) in 
development.  Like Thomson, Gearhart found himself frustrated with the mouse 
model available, and believed that more could be learned from human embryonic 
cells.  After discussion with colleagues, Gearhart decided that isolating stem cells 
from blastocysts would be controversial, and elected to obtain stem cells from a 
different source – PGCs.  Recalling his previous experience in mouse research and 
anatomy of human embryos, Gearhart would take inspiration from Donovan’s work 
isolating mPGCs.  Gearhart’s postdoctoral fellow, Shamblott, would work on the 
																																																								
928 Morange, 2006 p 540. 
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therapeutically aborted foetuses, carefully dissecting out the hPGCs and culturing 
them, generating hEGCs. 
Following the review of Thomson and Gearhart’s work, a closer examination 
of the isolation and culture of mESCs and hESCs with regard to their motivations and 
goals was required.  Morange argued that the motivations and goals between mESC 
and hESC isolation occurred because of the different scientific contexts of the 1980s 
and the 1990s.  Although all four researchers (Martin, Evans, Gearhart, and Thomson) 
had similar intellectual goals (i.e. the study of development), they were motivated to 
achieve these in different ways.  In addition, I have shown in this chapter and Chapter 
4, that the researchers were particularly motivated to apply their research down 
particular routes based on the political, economic, ethical, and legal contexts they 
were working in. 
 In order to fully examine Morange’s claim, I have revisited the motivations of 
Martin and Evans; Martin and Evans both had an intellectual focus on development.  
Although in the USA Martin was able to attract funding to carry out fundamental 
research without significantly changing her research programme, Evans, in the UK, 
where there was political pressure to fund applied research, had to re-direct his goal 
and study development in a way that would have practical outcomes.  Evans’ work 
resulted in the creation of GEMMD (for which he won a Nobel Prize).  Nature writer 
Gretchen Vogel added that most research post-1981 focused on creating transgenic 
mice rather than culturing tissues, with only a few working on cell fate research.  This 
work gained prominence post-1998 however when hESCs were isolated and cultured, 
and the work on mouse cells could be applied to human cells929.  It can be seen from 
Vogel’s commentary that cell fate research was considered to be a prominent feature 
of stem cell research up until at least the 1980s; a theory supported by this thesis.  
Although this thesis will also argue that cell fate research continues into the twenty-
first century (see Chapter 6), it is clear from Vogel’s comments that consideration of 
cell fate is a prominent theme of stem cell research. 
Whilst the scientific context that Morange refers to is the same for both Evans 
and Martin, in Chapter 4 I demonstrated that other factors could influence the 
direction of intellectual curiosity.  The history of hESC isolation provided in this 
chapter suggests that there were further different motivators for the isolation of 																																																								
929 Vogel, 2000. 
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hESCs in the 1990s.  In his 2006 review, Morange already identified the different 
scientific contexts between the 1980s and 1990s, in particular the capacity of various 
cells to generate tumours, and how difficult the cells are to manage.  Both Thomson 
and Gearhart had an intellectual interest in development – just like Martin and Evans.  
Thomson was keen to use hESCs to better understand human embryogenesis.  
Gearhart’s isolation of hEGCs was motivated by the need to find a more useful model 
of Down syndrome during development.  Morange’s article highlights that the 
scientific context was different – particularly concerning the relationship between 
undifferentiated cells and tumourigenicity.  Morange claims that after the early 1980s, 
this characteristic was forgotten, only to be rediscovered later.  The political, social, 
economic, legal, and, in addition, ethical context of the work Thomson and Gearhart 
wanted to carry out were again different to the scientific climate of the 1980s, 
resulting in the motivations for their research (such as obtaining funding, working 
ethically) being different for Thomson and Gearhart as compared to Martin and 
Evans.  This has been shown to be the case in this chapter. 
Here, therefore, I offer a complementary addition to Morange’s claim, and 
demonstrate that context is important for assessing the motivations and results of 
research. Although this chapter has shown that there are some parallels – all of the 
researchers had a fundamental interest in development and cell fate – these are 
outweighed by the different scientific, social, political, legal, ethical, and ecomonic 
contexts of science in the 1980s and the 1990s.  The overall interest in development 
clearly precluded the differences in research direction taken by each individual.  
Evidence from Thomson and Gearhart suggest that the relatively long period of time 
between isolation and culture of mESCs and hESCs was significantly affected by 
ethical, legal, and ecomonical concerns (such as the influence of the Dickey-Wicker 
amendment); their narratives suggest that the research would have been carried out 
sooner if, for example, their research had been allowed immediately following 
application to their university boards.  This chapter has shown that these contexts then 
influenced how the researchers were motivated to achieve their aims, and therefore 
supports Morange’s view that the motivations and goals for the isolation and culture 
of mESCs and hESCs were different.  This chapter has shown that motivations of 
researchers need to be considered in order to provide an accurate history that takes 
into account the ‘before, during, and after’ of research – i.e. the initial intellectual 
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curiosity, the motivations pushing research in a particular direction, and interpretation 
of results – to create an accurate, comprehensive historical account.  The following 
chapter will consider how the interpretation of these results is also needed to 
appreciate a scientists understanding, and how this is used to develop theories and 
influence future experimental design.  The following chapter will consider this in the 
context of whether stem cells are entities, and how cell fate can help to unpack this 
theory. 
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CHAPTER 6: 
ARE STEM CELLS ENTITIES? 
A VIEW FROM HISTORY 
 
CHAPTER 6  248 
 
1. Introduction 
The aim of this last chapter is to examine whether stem cells are entities, or 
whether ‘stemness’ is a state, or phase, that cells move through during their lifetime.  
It has been assumed, since the idea of a stem cell first arose (Chapter 1), that the stem 
cell was a physical entity.  Initially, Haeckel suggested that this was the first 
unicellular organism from which all multicellular organisms developed.  A little later, 
Haeckel also used the term Stammzelle to refer to the fertilised egg – a single cell with 
the potential to create an entire organism.  Since the mid-nineteenth century, 
theoretical, then later experimental work (such as those experiments described earlier 
in this thesis), relied on or were designed on the basis that stem cells were entities – 
there was a specific population of cells which that had properties of self-renewal and 
differentiation, and that could be isolated and cultured in the laboratory. 
However, at the beginning of the twenty-first century, a new theory regarding 
stem cells emerged: the idea that stem cells are not entities.  Instead, the theory 
proposed that all cells have the ability to become stem cells.  This required cells to 
change their state in order to become a cell type capable of both self-renewal and 
differentiation.  This theory proposed that there is not a single ‘pool’ of stem cells that 
remain in the adult body for repair and maintenance, but that any cell can move into a 
stem cell state as required; this acquiring of stem cell properties (i.e. self-renewal and 
differentiation) has been referred to as ‘stemness’. 
The stemness view has been advocated particularly by Lucie Laplane as a tool 
through which CSCs could be targeted for treatment.  In her 2014 chapter Stem cell 
epistemological issues, Laplane set-out her philosophical arguments supporting the 
stemness theory, and noted some recent experimental work also potentially supporting 
the need for a different way to think about stem cells.  In this chapter, I expand on the 
ideas and experimental work highlighted by Laplane.  Laplane began her chapter by 
considering whether it is possible to distinguish stem cells from non-stem cells by 
looking at the properties of self-renewal and differentiation.  In particular, to establish 
this, Laplane considered whether there are molecular markers of stem cells, referring 
to the findings of three research groups, led by Lemischka at Princeton, Melton at 
Harvard, and Lim at Singapore.  I also examine the results of these groups in this 
chapter, to determine whether any molecular marker of stemness has been identified.  
Laplane then asked whether a stem cell could be a natural kind, making use of 
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Richard Boyd’s ‘homeostatic property cluster’ and the defense provided by Wilson, 
Barker and Brigandt that stem cells are natural kinds (if the homeostatic property 
cluster method is used).  Devloping on Laplane’s work, I conclude that the property 
cluster provided by Wilson, Barker, and Brigandt is not specific enough to separate 
non-stem cells from stem cells, and therefore does not support the stem cells as 
natural kinds argument.  Considering her account of the lack of molecular markers of 
stem cells, and the arguments against stem cells being a natural kind, Laplane then 
debated whether “the concept of stem cell refers to “entities” or it refers to a particular 
cell “state””931.  In order to explore this concept further, in addition to looking at the 
molecular marker and natural kind arguments covered by Laplane, I also consider the 
role of the niche, and what we can learn from ESCs and plasticity932.  In order to add 
to Laplane’s work, I consider whether this new approach to stem cells can be applied 
to historical research, and whether the results of historical ESC research in particular 
can be re-interpreted in light of this potentially paradigm-shifting theory. 
 
2. Definitions of stem cells 
“Descending, as cells thus do, from an original mother-cell, and this by cleavage of 
the nucleus of that mother-cell, and all subsequent nuclei being propagated in the 
same way, by fissiparous generation…every nucleus…is a sort of centre, inheriting 
more or less the properties of the original nucleus…and exercising an assimilative 
power”.933 
 
“The name ‘stem cell’ seems to me the most simple and appropriate one, because 
all other cells stem from it and because it is in its most literal sense the stem father 
as well as the stem mother of all the countless generations of cells of which the 
multicellular organism is later composed”.934 
 
“This stem-cell maintains its own existence by uninterrupted multiplication, on the 
one hand, and on the other it differentiates…”.935 
 
The definition of a stem cell as typically used in late twentieth and early 
twenty-first century biology was written by Russian biologist Vera Danchakoff in 																																																								
931 Laplane 2014 p 700. 
932 Laplane also considers SCNT and iPSCs in her 2015 paper, Reprogramming and 
Stemness. 
933 Barry, 1847 p 213. 
934 Haeckel, 1877 p 144 (transl. Maehle, 2011). 
935 Danchakoff, 1916 p 401. 
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1916.  As demonstrated in the selected quotations above however, Danchakoff was 
not the first to identify that there appeared a requirement for a cell population to exist 
which was capable of both self-renewal and differentiation.  In the 1840s, considering 
early embryonic development and the role of the nucleus, English physician Martin 
Barry suggested that all cells descended from the fertilised egg, and all of the 
information needed to create the adult was contained within the nucleus (the product 
of mixing the parental germ cells)936.  The first to use the term Stammzelle, or ‘stem 
cell’, was Ernst Haeckel, in his lectures on Natürliche Schöpfungsgeschichte, 
published in 1868; Haeckel used the term to refer to unicellular organisms, which he 
believed to be the phylogenetic ancestors of multicellular organisms.  The quotation 
given above is from a later text by Haeckel, Anthropogenie (1877), where he 
identified a stem cell as the fertilised egg (in order to differentiate this from the pre-
fertilised egg)937.  The last quotation above is from a paper on the origin of blood, by 
Danchakoff, written soon after her move to the USA from Russia.  Danchakoff also 
used the term ‘mother-cell’ in her work; Danchakoff was not the only academic to do 
this.  For example, Harvey E Jordan (1878-1963) would use the term mother cell to 
refer to those cells at the base of the epidermis that would give rise to other cells of 
the skin938.  During the early years of the twentieth century then, ‘stem cell’ referred 
to the fertilised egg, or embryonic cells, whilst those which we now call adult stem 
cells, were referred to as mother cells. 
Danchakoff’s succinct definition, considering both the potential for 
asymmetric division and differentiation into several cell types, is typical of definitions 
and descriptions still in use in the twenty-first century; for example: 
 
“What is a stem cell?  The traditional answer to this question is that a stem cell has 
two properties: the ability to self-renew and the potential of differentiation”.939 
 
“Stem cells are defined as cells that can give rise to more cells like themselves, as 
well as more specialized, or differentiated, cells”.940 
 																																																								
936 See Chapter 1. 
937 See Chapter 1, and Maehle, 2011. 
938 For example, “A densely packed mother cell of [the basal] layer gives rise to two daughter 
cells of very similar constitution which are only slightly altered as they pass to the upper 
layers”.  Jordan, 1911 p 463. 
939 Laplane, 2014 p 693. 
940 Fagan, 2013a p 1147. 
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“HSCs [haematopoietic stem cells] make a choice of either self-renewal or 
committing to differentiation.  The balance between self-renewal and differentiation 
is considered to be critical to the maintenance of stem cell numbers”.941 
 
In both philosophy of biology and biological science then, the potential for 
self-renewal and differentiation are typical properties of those cells referred to as stem 
cells. 
 
2.1 The potential for self-renewal 
Self-renewal is understood as the creation of one or two daughter cells that 
share the same properties as their parent cell.  Philosopher of biology Melinda Fagan 
has referred to this as sameness942 (which implies comparison against a set of 
characteristics).  Fagan noted initially that no two cells can ever be the same in all 
respects (for example, cells may differ in position or in their interaction with the cells 
around them).  In this instance however, sameness refers to a set of characteristics that 
Fagan calls traits.  For Fagan, “Self-renewal occurs within cell lineage L relative to a 
set of characters C for duration τ, if and only if offspring cells have the same values 
for those characteristics as the parent cell(s)”943. 
 
2.2 The potential for differentiation 
As the original parent cell divides, one or two daughter cells created may not 
share all of the same properties as their parent; Fagan referred to this as difference, 
again comparing a set of characters (C), which vary between two time points (t1-t2), 
including 0 ≤ τ ≤ ∞ cell divisions944.  The other difference Fagan noted was the 
process of differentiation, which caused cells to become increasingly different from 
their parent, whist becoming increasingly similar to specialised, or mature, cell 
types945.  As highlighted by Laplane, such difference is not sufficient to claim that 
differentiation has occurred however; instead, in addition to being different to its 
parent, the daughter cell must have also changed in a particular direction (on its way 
																																																								
941 Mosaad, 2014 p 68. 
942 Fagan, 2013b. 
943 ibid p 22. 
944 ibid p 23. 
945 ibid. 
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to developing into a specialised cell).  Differentiation therefore implies a directional 
change and diversification946. 
 
2.3 Is the current working definition enough to differentiate stem cells from non-stem 
cells? 
Neither the processes of self-renewal or differentiation are specific to stem 
cells.  Some cells that are not currently classed as stem cells have the potential to self-
renew (such as macrophages947), whilst others have the potential to differentiate 
(neural progenitor cells, for instance948).  However, Seaberg and van der Kooy (for 
example) have argued that every cell that have the properties of both self-renewal and 
differentiation are stem cells, relying on these properties as practical indicators of 
stem cells (i.e. a useful concept to identify, isolate, and utilise stem cells in the 
laboratory)949.  There is a problem with this however, as highlighted by Fagan.  Cells 
reproduce by division; when this occurs the parent cell ceases to exist and only two 
daughter cells remain.  These daughter cells may either be copies of its parent (i.e. 
demonstrating self-renewal), or be differentiated.  Assymmetric division cannot be 
achieved under experimental conditions because of the different environments 
required for self-renewal and differentiation.  At the single cell level then, both 
properties cannot be demonstrated simultaneously in the laboratory950.  Other 
scientists have argued that there is too much heterogeneity amongst ‘stem cell’ 
populations to support the position of self-renewal and differentiation as being finite 
enough properties to isolate stem cells (in the laboratory)951.  The following sections 
of this chapter will consider various examples to demonstrate that whilst the self-
renewal and differentiation definition may have been useful at the beginning of the 
twentieth century, it may be beneficial to consider ‘stemness’ as a state, or function, at 
the beginning of the twenty-first. 
 
 
																																																								
946 Laplane, 2014 p 695. 
947 Soucie et al., 2016. 
948 Varga and Nagy, 2017. 
949 Seaberg and van der Kooy, 2003. 
950 Fagan 2013a p 1152.  Single cell transplants achieving organ regeneration in living 
organisms may be a counter-example to this, but in vivo self-renewal can only be inferred (not 
measured) and differentiation potential cannot be determined (Fagan, 2013a p 1157). 
951 Blau, Brazelton, and Weimann, 2001. 
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3. Natural kinds 
In her 2014 chapter Stem cell epistemological issues, Laplane sought to clarify 
the stem cell concept, whilst emphasising its ambiguities952.  Laplane began by 
discussing the properties of self-renewal and differentiation, then assessing whether 
this meant that they would belong to a natural kind.  In particular, Laplane assesses 
the validity of the claim made by Wilson, Barker, and Brigandt that, using the 
homeostatic property cluster approach (typically utilised to argue for natural kinds in 
biology), stem cells are a natural kind.  Fagan has also commented on Wilson, Barker, 
and Brigandt’s assessment; since this has therefore demonstrated itself to be a key 
issue in stem cell philosophy, it deserves consideration here.  In this section, I expand 
on Laplane’s and Fagan’s work with further exploration of the homeostatic property 
cluster approach to designating natural kinds, and exploring the application of this to 
stem cells. 
Laplane and Fagan are not the only philosophers who have asked whether cell 
types can be a natural kind.  In his 2013 paper, Cell types as natural kinds, Matthew 
H Slater considered various arguments to establish whether different cell types, such 
as blood cells, or muscle cells, could be natural kinds.  Slater asked on which grounds 
cell types could be separated, suggesting, for example, developmental history (similar 
to separating species based on their evolutionary history), whether the cells have 
particular structural features, or their function.  This latter may be problematic since 
cell function is not fixed, but is temporally and environmentally dependent (for 
instance, the stage in a cell’s cell cycle will affect its function and structure)953.  Even 
considering genetic homogeneity (particularly since the genetic paradigm is so 
influential in current biological science) fails to enable us to separate species or cell 
types (for example) enough to be used as a categorising tool.  Highlighting the issue 
that arises with categorising or separating many things in biology, Slater noted that 
biological diversity is very different from, for instance, chemical diversity, where 
each element is clearly distinct from each other.  In biological organisms, or cell 
types, there is no “continuum of similarity”, and perhaps then suggesting that there is 
no biological ‘essence’954.  Slater highlighted that there are few examples of 
																																																								
952 Laplane 2014 p 693. 
953 Slater, 2013. 
954 Slater, 2013 p 170. 
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biological essences that have been suggested, in comparison to chemistry, which 
appears to be littered with natural kinds. 
The claim that stem cells are natural kinds implies that 
a) stem cells exist in nature, and 
b) stem cells belong to a kind - all stem cells share common properties that make 
them similar to each other, and different from other cell types. 
As previously noted, the properties of self-renewal and differentiation are not enough 
to support the above, since other cells are capable of these properties; i.e., stem cells 
cannot be a natural kind. 
There are those who disagree with this logic however, based on other agreed 
natural kinds in biology.  In particular, discussions concerning natural kinds in 
biology have previously focused on the ‘species problem’ (i.e. are species definitions 
natural divisions, or are they constructed?).  The theory of evolutionary development 
has also suggested that a species cannot be a natural kind, since, by definition, species 
are constantly changing.  If this is the case, species cannot have a static set of intrinsic 
properties which make them the same as each other but different from other natural 
kinds.  As philosopher David Hull (1935-2010) observed, taxonomy was suffering 
because of the difficulty in identifying properties of species that were both necessary 
and sufficient955.  Similar arguments can be used to argue against cell types being 
natural kinds.  In response to this, Hull instead discussed the use of ‘clusters’ (as 
opposed to the previously dichotomous phylogenetic taxonomies)956.  Ian Hacking 
(1936-) proposed that a natural kind is: 
a) defined by a set of necessary and sufficient properties (relations etc.) such that 
b) the possession of these properties is, as a matter of fact rather than logic, 
indicative of a very large number of other methodologically interesting 
properties, such that 
c) these defining properties are natural rather than social properties957. 
The theory of property cluster kinds do not appeal to Hacking since the 
properties in the cluster are not natural, but rather defined by human social 
decisions958.  In response, Richard Boyd (1942-) developed the idea of the 																																																								
955 Hull, 1965. 
956 ibid. 
957 Boyd, 1991 p 127; Hacking, 1991. 
958 Boyd, 1991 p 140-141. 
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“homeostatic property cluster” to define a set of properties that often co-exist in 
nature959.  Boyd argued that there are “scientifically important” (i.e. natural) 
properties, which are not clustered by social decision, since the determination of the 
cluster is “causal rather than conceptual” (i.e., are not accidental and homeostatic)960.  
Boyd argued that the properties he promoted for his approach needed to be “causal 
homeostatic mechanisms”961; only kinds elucidated from such properties would “cut 
the world at its joints”962.  To test his theory, Boyd considered the species problem, 
arguing that his homeostatic property clusters support the claim that biological species 
are natural kinds, since they share “homeostatically related morphological, 
physiological and behavioral features which characterize [their] members”963.  The 
homeostatic property cluster then also allows for evolutionary development and 
speciation, which requires the existence of populations intermediate between the 
parent species and emerging species964.  The homeostatic property cluster, argued 
Slater, continued what he refered to as a “bottom-up” approach, since it was 
developed around causal mechanisms; although not perhaps traditional essentialism, 
Boyd’s homeostatic property cluster account used essentialism as a starting point965. 
The homeostatic property cluster approach appears then to support the view 
that cells are natural kinds, with a population of parent cells, a population of 
intermediate cells, and a population of specialised, differentiated cells.  I argue that 
this supports the view that stem cells are not natural kinds, but that stemness is a 
property that falls into the cell homeostatic property cluster. 
As highlighted by Laplane, Robert Wilson, Matthew Barker and Ingo Brigandt 
however have utilised Boyd’s homeostatic property cluster as support for stem cells 
as a natural kind.  Wilson, Barker, and Brigandt identify stem cells as heterogeneous, 
however believe that a certain combination of properties, which are specific to stem 
cells, can define them (as a natural kind): 
 		
 																																																								
959 Boyd, 1999. 
960 Boyd, 1991 p 141. 
961 Slater, 2013 p 175. 
962 Boyd, 1991 p 139. 
963 Boyd, 1999 p 142. 
964 ibid p 142. 
965 Slater, 2013. 
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• morphologically undifferentiated 
• ability to self-renew (cell division with at least one daughter cell of the same type) 
over an extended period of time 
• ability to give rise to various differentiated cell types (pluripotency, or at least 
multipotency) 
• developmentally derived from certain cells or tissues 
• located in specific parts of tissues 
• particular complex profile of gene expression and presence of transcription factors 
• found in a certain cellular-molecular microenvironment (“niche”), which 
influences the stem cell’s behaviour 
• low rate of cell division966 
As stated in the definition of the homeostatic property cluster theory, none of these 
properties are necessary, whilst different subsets are sufficient, for a cell to be defined 
as a stem cell, and a natural kind967.  Slater tested ways of categorising cell types in 
his paper to examine whether the homeostatic property cluster method might enable 
us to view cell types as natural kinds.  In one example, Slater tested whether genetic 
properties may be used to separate out biological things, particularly, as he suggested, 
genetic properties are the “obvious candidate for essences”968.  Perhaps 
subconsciously, Wilson, Barker, and Brigandt have been influenced by the strong 
genetic paradigm influencing current biology when generating their property cluster.  
For example, they refer sepecifically in one property to the complex gene expression 
profile; a lack of genetic homogenetity has already been identified as an issue with 
enabling the classification of different biological species as natural kinds.  A further 
problem with the property cluster provided by Wilson, Barker, and Brigandt is that it 
refers to the developmental history of stem cells.  As highlighted by Slater, at the 
moment, we do not know enough about the development of individual cell types in 
the body for this to be an appropriate property.  A single cell type may arise from a 
variety of regions in the body – dedifferentiation and redifferentiation being possible 
(as demonstrated by iPSCs – see below) suggests that many differentiated cell types 
may be capable of reverting back to a stem cell-like state – dedifferentiating – and 																																																								
966 Wilson, Barker, and Brigandt, 2007 p 208. 
967 Laplane, 2014. 
968 Slater, 2013 p 172. 
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becoming a different cell type – redifferentiating – afterwards.  Morphology could 
also be a problematic property to usefully identify stem cells. 
Not only are there some problems with the properties identified, but a further 
difficulty arises when other cell types, not currently considered to be stem cells, also 
have properties that are subsets of the above definition. Laplane has argued that 
Wilson, Barker, and Brigandt’s definition then is not specific enough to “provide any 
positive demonstration that stem cells do belong to a natural kind”969. Furthermore, 
Fagan has argued that Wilson, Barker, and Brigandt’s list is unsatisfactory since it 
offers no explanatory or predictive power, ignores the differences between in vivo 
stem cells and those artificially created in the laboratory (such as iPSCs), and lastly 
gives no guidance to diversity (i.e. the properties on the list are too ambiguous)970.  It 
requires more than having a set of propeties in common (more or less) for something 
to be a natural kind; the somewhat essentialist homeostatic property cluster approach 
should explain why natural kinds are projectable971.  The arguments presented above 
suggest that this is not the case.  Slater concluded that the homeostatic property 
cluster approach was “not well suited…to accommodate our classificatory practices 
regarding cellular kinds”972.  Slater offered an alternative: the stable property cluster 
account of natural kinds, which “avoids the vagueness and theoretical difficulties 
involving causal mechanism” attributed to the homeostatic property cluster 
approach973.  The aim of Slater’s stable property cluster approach is to enable 
philosophers to focus on the stability of natural kinds, as opposed to dwelling on the 
way in which stability may be achieved974.  Slater conceded however that even his 
new approach may not enable all cell types to be defined as a natural kind.  Although 
he believed that there is a “common phenomenon” behind our conceptualisation of 
erythrocytes being a kind of item, just as one would conclude an electron to be975 (and 
this may be explained by the stable property cluster account), Slater does not appear 
convinced that a cell type may neatly be defined as a natural kind. 
If we can not use the homeostatic property cluster (or the stable property 
cluster) to establish that stem cells are natural kinds, this, claimed Laplane, leaves 																																																								
969 Laplane, 2014 p 700. 
970 Fagan, 2013a p 1149. 
971 Slater, 2013. 
972 ibid p 176. 
973 ibid. 
974 Slater, 2013 p 177. 
975 Slater, 2013 p 178. 
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biology in an uncertain state concerning the ontology of stem cells: is stemness the 
essence required for a stem cell natural kind, or is stemness a property that can be 
transiently expressed by many cells976?  Based on their critiques, Slater, Fagan, and 
Laplane appear to agree that stem cells are not a natural kind, also unconvinced by 
Wilson, Barker, and Brigandt, or the general approach of the homeostatic property 
cluster to identify cell types as natural kinds.   
 
4. The niche 
The ‘niche’ was a term used initially in the context of stem cells by Schofield, 
specificially referring to the nature of haematopoietic stem cells.  In his 1978 paper, 
the first to use the term ‘niche’ in this context, Schofield assessed whether the colony-
forming units identified by Till and McCulloch were stem cells978.  Schofield 
hypothesised that the haematopoietic stem cell becomes “essentially a fixed tissue 
cell” when it is in close proximity to other cells in the bone marrow979.  “The cellular 
environment which retains the stem cell”, Schofield continued, “I shall call a stem cell 
‘niche’”980.  When the stem cell is in this ‘fixed’ state, it can only produce copies of 
itself (i.e. self-renewal), and not differentiate.  Where there is no niche, a resulting 
daughter cell will differentiate.  Schofield implied that the size of the niche dictates 
how many stem cells there are in the pool.  By Schofield’s initial definition then, and 
the way that ‘niche’ has been interpreted since, it is an active participant in the 
functionality of stem cells.  Further evidence supporting the niche theory would be 
found in invertebrates, specifically D. melanogaster and Caenorhabditis elegans.  In 
these species, germ cells were observed to reside in a very particular distal end of a 
tapered structure in the gonads, where they were able to communicate with other 
somatic cells981 (although it is currently understood that similar contact with a 
																																																								
976 Laplane, 2014 p 700. 
978 Schofield concluded from his findings that CFU-S (colony-forming units – spleen) cells 
are not stem cells, since their ability to self-renew appears to be finite.  Schofield, 1978.  For a 
review of Till and McCulloch’s work identifying CFU-S cells in the mouse, see Lancaster, 
2009. 
979 Schofield, 1978 p 13. 
980 Schofield, 1978 p 13. 
981 For example, see Xie and Sprading, 2000; Crittenden et al., 2002. 
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basement membrane may also be an active participant of the microenvironment982, 
and the extracellular matrix is likely to have a role too983).  If, as suggested 
previously, stem cells are to be defined by their function, our current understanding is 
that it is often the niche that controls such functions (i.e. self-renewal and 
differentiation).  For example, in adult mammals, haematopoietic stem cells circulate 
freely, but can only self-renew and differentiate in specific locations, in response to 
biological cues984.  Generally, the role of the stem cell niche is to provide a 
microenvironment to enable the cells that reside within to maintain their stem cell 
properties.  Stem cells are also required to react to changes in their system or 
surrounding tissue; the niche also has a role to play here. 
Many niches have now also been identified in mammalian tissues, including 
the bone marrow, subventricular zone (in the brain), and hair follicle bulge, for 
example.  Just as the expression of particular genes or proteins have been linked with 
maintaining ‘stemness’ in stem cells (see section 6), several extracellular factors have 
been purported to have a role in maintaining the microenvironment of various stem 
cell niches, such as fibroblast growth factor in the bone marrow989, tenascin C in the 
brain990, and β1 integrin in the skin991.  Varying numbers of such factors are important 
in controlling proliferation and differentiation of cells in the niche.  For example, the 
protein Sonic hedgehog992 is required to distribute different subsets of skin cells to 
either the interfollicular epidermis or the hair follicle bulge993.  The factors affecting 
cells in the niche (or directing cells towards the niche) are not limited to proteins 
however.  For example, at the point where the two cell types responsible for bone 
remodelling (osteoblasts and osteoclasts) meet, there is a high concentration of 
calcium ions (Ca2+).  Bone marrow haematopoieteic stem cells are particularly 
sensitive to surrounding calcium levels, since they have calcium-sensing receptors in 
their membranes.  Genetically engineered mice, created to lack these calcium-sensing 																																																								
982 For example, there are cells in the gut of Drosophila that have the ability to self-renew and 
differentiate, and are primarily in contact with a basement membrane (which separates the 
stem cells from surrounding muscle cells).  Ohlstein and Spradling, 2006. 
983 For example, see Jenson, Lowell, and Watt, 1999. 
984 Scadden, 2006. 
989 For example, Li and Li, 2006. 
990 For example, Garcion et al., 2004. 
991 For example, see Tumbar et al., 2004. 
992 A protein involved in vertebrate embryo organogenesis, cell division in the adult, and 
possibly cancer development.  For a review, see Varjosalo and Taipale, 2008. 
993 For example, see Levy et al., 2005. 
CHAPTER 6  260 
 
receptors, demonstrated that haematopoietic stem cells were unable to populate the 
bone marrow994.  The niche appears to have a further function in the haematopoietic 
system: stem cell trafficking995.  Whilst cell entry and exit to and from the niche is 
important biologically, it has also provided a useful model for experimentation.  For 
example, blood cell production in the early foetus begins in the liver (possibly from 
cells which migrate from the placenta and / or yolk sac [aorto-gonadomesonephros]), 
before moving to the bone marrow later on in development.  It is thought that calcium 
signalling is an integral part of this process, since mice genetically modified to lack 
calcium-sensing receptors do not have the movement of haematopoietic stem cells 
away from the foetal liver to the bone marrow996.  The above example shows that 
migration and trafficking are essential to haematopoietic development and function, 
which are only possible due to a functional niche. 
In addition to maintaining stemness then, can the niche induce it?  
Experiments carried out in fruit flies suggest that this may be a possibility.  For 
example, experimentally removing the stem cells from the ovarian germ cell niche 
resulted in re-occupation of the niche by somatic cells, which began proliferating997.  
Furthermore, alteration of the niche’s microenvironment induced mature progenitor 
cells to revert to stem cells998.  Similar research has been carried out investigating the 
niche of mouse testes, where similar dedifferentiation has been observed999. 
It is also possible that a misplaced niche may result in cancer, where a vacancy 
may result in occupancy by a somatic cell, or where altered niche signalling may 
increase proliferation or induce dedifferentiation, resulting in significant disruption in 
the tissue.  Despite some suggesting that the cancer stem cell concept is only a few 
decades old1000, Robert Remak proposed in 1854 that cancer may arise from 
“misplaced somatic cells comprising embryonic “rests” or residues” which had not 
																																																								
994 Adams et al., 2004. 
995 Trafficking of cells in the body is a process whereby signals or ‘honing mechanisms’ cause 
cells to deliberately move from one region to another.  In other instances, cells may migrate; 
this movement is passive, as cells are not provided with any honing signal.  For example, the 
haematopoietic cells which populate the liver in the foetus migrate to the liver; the 
haematopoietic cells which move from the liver to the bone marrow later in development are 
trafficked.  For example, see Moore, 2001.  
996 Adams et al., 2004. 
997 Kai and Spradling, 2003. 
998 Kai and Spradling, 2004. 
999 Nakagawa, Nabeshima, and Yoshida, 2007. 
1000 For example, Scadden, 2006. 
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migrated to the appropriate region of the body1001; a theory popularised by Julius 
Cohnheim.  Another German pathologist, Hugo Ribbert, added to the embryonic rest 
theory, suggesting that cancer could arise from cells which “had a disturbed 
relationship with their neighbours”, causing abnormal proliferation1002.  (For more on 
the embryonic rest theory of cancer, see Chapter 3.)  The niche then, initially 
understood as a place of stem cell residence, has more recently been shown to have an 
active role in proliferation, differentiation, and trafficking.  Cells moving into the 
niche can adopt the ability to redifferentiate and self-renew, supporting the state view 
of stemness. 
 
5. Embryonic cells 
A particular type of embryonic cell, the totipotent cell, has been the victim of 
“surprising confusion” particularly with regards to the ethics of research1003.  Much of 
this confusion arises given the conflicting definitions given of totipotency, in 
comparison to what experimental procedures have indicated their properties to be.  
For the purposes of this section, totipotency is taken to be the capability of 
differentiating into any cell type of the adult organism, in addition to extra-embryonic 
cells (such as the placenta).  These are the cells that arise from the first few divisions 
of the fertilised egg (zygote) (and maybe only up to the four-cell stage); by five days 
post-fertilisation, there are cells in the blastocyst that are no longer capable of 
developing into extra-embryonic tissue, nor other components of the blastocyst itself.  
These cells, the cells of the inner cell mass (ICM), are now pluripotent, capable of 
producing those cell types observed in the adult1004 (Figure 13).  I argue that the 
totipotent cells, those first few daughter cells of the zygote, cannot be considered stem 
cells if the traditional definition of self-renewal and differentiation is used. 
																																																								
1001 Krebs, 1947 p 270. 
1002 Witkowski, 1983 p 271; see also Maehle, 2011. 
1003 Condic, 2014 p 796. 
1004 For a brief overview, see Condic, 2014. 
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Figure 13: A diagrammatic representation of development of the early embryo, from 
the two-cell stage, to development of the blastocyst. (a) shows the embryo at the 
two-cell stage, surrounded by the zona pellucida.  (b) and (c) shows the four-cell 
stage and eight-cell stage respectively, where there has been some differentiation 
of the cells.  After three cell divisions (c), there are no totipotent cells remaining, 
since all cells at the eight-cell stage have started to differentiate.  The polarity of the 
embryo is also established at this stage, and when the blastocyst begins to form (e), 
the inner cell mass compresses on one side of the embryo, whilst the trophectoderm 
cells move to the outside.  Once organised (f), the blastocyst contains four cell 
types: the polar trophectoderm (light grey), the mural trophectoderm (dark grey), 
the primitive endoderm (pink), and the epiblast (blue). 
 
It is true that totipotent cells have a greater ability to differentiate than any 
other cell type, since they can contribute to (and organise) all cells of the developing 
embryo and adult, plus extra-embryonic tissues.  However, this totipotency is lost 
after the first two cell divisions, with polarity being established after the third round 
of cell division (in mice)1005.  During the fourth and fifth cell divisions, asymmetrical 
division is again possible1006, resulting in the formation of ‘outside’ and ‘inside’ cells, 																																																								
1005 See Takaoka and Hamada, 2012, for an overview.  Establishing polarity early on in 
embryonic development is essential, as different cell types develop at each pole, and later this 
will orient head and tail of the mammalian embryo. 
1006 Tarkowski and Wroblewska, 1967; Johnson and Ziomek, 1981. 
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creating the morula1007 (Figure 14).  By the blastocyst stage (at five to six days post-
fertilisation in humans), there are at least four cell types present: polar trophectoderm, 
mural trophectoderm1008, primitive endoderm1009, and epiblast1010 (the latter two cell 
types forming the ICM).  All of these cell types can be identified by the different 
genes expressed1011. 
 
Figure 14: A diagrammatic representation of the possible lineage of cells of the 
early embryo up to the sixteen-cell stage (four cell divisions).  Solid arrows show self-
renewal, and dashed arrows show differentiation.  No totipotent cells (beige) remain 
after the four-cell stage. 
 
What is clear from our current understanding of mammalian development is 
that the ability of the totipotent cells to divide asymmetrically, creating a copy of 
itself and a more differentiated daughter cell, does not occur.  Instead, changes in 
gene expression as early as the eight-cell stage result in different cell types with 
different differentiation potentials.  By this stage of development then there are no 
totipotent cells remaining; if stem cells are capable of self-renewal as well as 
differentiation, there should be a remaining totipotent cell population in the 
developing embryo, and the adult.  However, this is not the case, and no totipotent 
cells remain by the third cell division post-fertilisation.  Totipotent cells are therefore 
																																																								
1007 Nishioka et al., 2009. 
1008 The trophectoderm is the epithelial outer layer of the blastocyst; the polar trophectoderm 
lines the ICM, whilst the mural trophectoderm lines the blastocoel, the fluid-filled space 
adjacent to the ICM. 
1009 This is a layer of epithelial cells which contributes to further development in the post-
implantation embryo. 
1010 These cells will give rise to the three germ layers (ectoderm, endoderm, and mesoderm). 
1011 For an overview, see Tarkowski and Wroblewska, 1967. 
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not stem cells if one adopts a definition for stem cells that require self-renewal and 
differentiation as properties. 
This appears to be something of a contradiction however; how can the first 
cells created as the zygote divides not be stem cells?  After all, the fertilised egg was 
considered to be the ultimate Stammzelle as Haeckel developed his concept: the cell 
all other cells stem from.  Our current understanding however causes totipotency to 
support the state view of stemness. 
Why is it then that cells in the embryo appear to lose stemness (as in the 
totipotent example given above) when cells of the adult are quite capable of gaining 
stemness (see sections 4, 7)?  Although there are one or two examples of commitment 
reversal reported in the embryo1012, this is at a very low frequency in comparison to 
the occurrence in the adult. Biologist Dov Zipori suggested that this may be a safety 
mechanism: that reversibility during embryogenesis would “hamper the process, and 
introduce a huge and intolerable number of mistakes”1013.  The program of 
embryogenesis is supposed to be unidirectional, and too much potential for 
commitment reversal could be harmful.  Instead, it is kept to a minimum, particularly 
during very early development (as described above).  Alternatively, Zipori claimed, 
such plasticity is a useful property.  The adult is more defined in size and structure, 
where mistakes from commitment reversal could be less detrimental.  However, as 
highlighted in Chapter 3, studies into the likelihood of a cancer stem cell (CSC) 
propose that not only may an adult stem cell develop cancer properties (uncontrolled 
differentiation, for example), any cell may dedifferentiate enough to become a CSC, 
and generate a tumour (or tumours).  Cancer has been described as “a derangement of 
normal tissue homeostasis”, demonstrating unregulated proliferation and abnormal 
differentiation1014.  Tumours have often been described historically as having an 
undifferentiated appearance, which supports the notion that perhaps dedifferentiation 
is occurring.  The pathways that control mechanisms of differentiation and self-
renewal are the same in both normal and pathological tissue growth, as highlighted in 
Chapter 3.  In some cancer theories of the latter half of the twentieth century, cancer 
was caused by uncontrolled self-renewal of progenitor cells; more recently, the 																																																								
1012 Such as epithelial cells dedifferentiating, or the epiblast cells being less potent than cells 
of the later, gastrulating embryo (Zipori, 2009 p 201).  See Blanpain et al., 2004 and Rossant, 
2008. 
1013 Zipori, 2009 p 201. 
1014 Daley, 2008 p 171. 
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possibility of dedifferentiation and the presence of a CSC have gained support, and 
the seach for this cell began. 
Summarising the evidence provided for the potential of somatic cells to 
dedifferentiate (and become CSCs), Daley provided an overview of those tissues 
where the CSC was clearly implicated in cancer development.  In particular, epithelial 
tissues (such as the gut and skin) and blood tissues have well-known cancers that may 
arise from mutations in a single stem cell, or from a progenitor cell.  These progenitor 
cells would normally have a limited capacity for self-renewal and differentiation, 
however “alterations in the physiology” of these cells may make them candidates for 
the CSC1015.  Studies of some types of leukaemias suggest that there is a genetic 
change in progenitor cells that change them into cells with stem cell properties; for 
example, granulocyte-macrophage progenitor cells may acquire a mutation in the 
oncogene MLL-AF9.  This oncogene is associated with human acute myeloid 
leukaemia; those granulocyte-macrophage progenitor cells that begin expressing this 
gene begin self-renewing in a pattern typical of haematopoietic stem cells1016.  Since 
these cells do not normally self-renew at such a rate or so indefinitiely, this event is 
pathological. 
There is a slight questionmark over the theory that differentiated cells may 
become dedifferentiated in cancer, primarily since stem cells remain in many adult 
tissues and can become the CSC themselves.  For example, there are stem cells that 
have mutated and begin expressing features of embryonic development; these cancers 
arise from the processes of EMT that are normal (essential!) for embryonic 
development, however are pathological in the adult (see Chapter 3 for detail on this 
physiological event)1017. 
Zipori’s observation gives sound reasoning for the apparent loss of stemness 
in the cells of the embryo, and the potential for gaining stemness in the cells of the 
adult. This hypothesis supports the stemness as a state claim. 
 
																																																								
1015 Daley, 2008 p 171. 
1016 Krivtsov et al. 2006; Daley, 2008. 
1017 Daley, 2008 also reviews a few studies demonstrating EMT in cancer. 
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6. Genetic and molecular markers 
 “Life is a one-way trip.  Plants and animals start as embryos and progress through 
irreversible developmental stages to eventual death”.1018 
 
Until the late twentieth century, differentiation was considered to be a 
unidirectional, irreversible process.  Definitions of development often suggest such 
irreversibility, since through development, cells progressively differentiate whilst 
their potential to become other cell types diminishes.  Such differentiation and loss of 
potential can be observed early in development, with the cells of the ICM eventually 
developing into the foetus, whilst the trophectoderm cells manage attachment and 
placenta formation (see above).  As cells of the ICM differentiate into endoderm, 
ectoderm, or mesoderm, they lose the potential to become cells of the other two types.  
Eventually, in the adult organism, specialised pools of stem cells remain for 
maintenance of tissues.  As noted by Maienschein, the concept of irreversibility 
through development has persisted since the beginning of cell biology1019. 
 
6.1 The epigenetic landscape: Waddington’s model 
In 1957, developmental biologist Conrad Hal Waddington (1905-1975) 
proposed a model of development, depicting cells as rolling down different 
bifurcating channels, acquiring irreversible changes on the way1020; the well-known 
diagrammatic representation of this appeared in Waddington’s 1966 book, Principles 
of development and differentiation (Figure 15).   
																																																								
1018 Vogel and Normile, 2012 p 178. 
1019 Maienschein, 2014. 
1020 Waddington’s aim was not only to pictorially describe the process of cellular 
differentiation and cell fate, but to include a range of biological phenomena, including 
evolutionary theory.  Allen, 2015. 
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Figure 15: Waddington’s illustration of the epigenetic landscape, from The strategy 
of the genes: A discussion of some aspects of theoretical biology, (1957), p 29. 
 
Waddington first used the term “epigenetic landscape” in 1940; he would assert that 
the channelled, sloped landscape would act as a mediator between genes and the adult 
organism.  The term ‘epigenetic’ would refer to the environmental (or external) 
influences that would have an effect during development1021.  In this particular work, 
Waddington was attempting to understand the mechanisms involved in development, 
and in particular embryological development, from the single cell zygote to 
development of different cell types, tissues, and organs.  Drawing on the continuing 
popularity of the tree metaphor in describing changes in animals and cells1022, 
Waddington explained that cell differentiation occurred as a “series of branching 
decisions, taken under the control of genes”1023.  Alongside a photograph of a 
complex arrangement of railway lines, Waddingdon wrote that “You are looking at an 
incline called the Hump.  The wagons are pushed over the Hump and go running 
downhill and are sorted out by the systems of points into the various sidings.  Now an 
embryo is in some ways analogous to a set of trucks sliding down the Hump”1024; for 
Waddington, cell fate was a one-way journey, with cells becoming more and more 
differentiated as they rolled down the hill, the path taken determined by the 
expression of a particular set of genes. 
																																																								
1021 Allen, 2015. 
1022 Dröscher, 2014. 
1023 Waddington, 1940 p 12. 
1024 Waddington, 1935 p 96. 
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Waddington’s epigenetic landscape would support the entity view of stem 
cells.  Here, we begin with the zygote, the ultimate stem cell, capable of forming an 
entire organism.  With each cell division, cells become more and more differentiated, 
until they end up at the bottom of the hill or end of the track, in a final, differentiated, 
specialised cell state.  Waddington did not suggest that there was any opportunity for 
cells to move back up the hill or reverse back along the tracks. 
 
6.2 ‘Stem cell genes’ 
The use of genetic and molecular markers to identify stem cells was thought to 
be a potentially useful, practical way to isolate stem cells from non-stem cells in the 
laboratory.  The suggestion that stem cells could be identified based on molecular 
markers is not new; for example, when reviewing haematopoeitic stem cells in 1980, 
Till and McCulloch suggested that identification of cell surface markers would be a 
particularly useful way of isolating stem cells and purifying stem cell populations1025.  
Why would we not believe that stem cell markers exist?  After all, it’s how we have 
learned to classify differentiated cells1026.  More recently, using techniques such as 
DNA microarrays and oligonucleotide arrays, it is possible to separate cells based on 
the expression of particular surface proteins, or by the expression of particular genes.  
If a stem cell molecular fingerprint was identified, it would mean that stem cells from 
any tissue could be swiftly and easily isolated in vitro: a potentially important tool for 
research and medicine.  Therefore, many researchers have spent considerable time 
and effort attempting to identify those genes or proteins that are expressed only by 
stem cells - myself included1027.  In Chapter 5 for example, I have highlighted those 
genes identified by James Thomson when he submitted patents for methods to isolate 
pESCs.  I will now discuss three such studies in detail. 
In one study, carried out by a group under Harvard geneticist Douglas Melton, 
216 unique genes were identified that were expressed in mouse embryonic stem cells, 
neural stem cells, and haematopoietic stem cells1028.  Whilst 100 of these genes had 
no known function, the function of the others are understood to be involved 
predominately in cell signalling (35), transcriptional regulation (14), and cell cycle 																																																								
1025 Till and McCulloch, 1980. 
1026 Zipori, 2009. 
1027 Lancaster,  2012. 
1028 Ramalho-Santos et. al., 2002. 
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regulation (13).  Another group, under Princeton molecular biologist Ihor Lemischka, 
carried out a similar study to Melton’s group, also published in 20021029.  In this 
study, murine and human haematopoietic stem cells were examined alongside 
embryonic stem cells, allowing the group to identify those genes that were specific for 
foetal and adult murine haematopoietic stem cells, genes specific for murine and 
human haematopoietic stem cells, and genes in cultured embryonic stem cells.  In 
total, 283 genes were identified as being expressed in all murine stem cell populations 
tested.  Thirdly, a group under Bing Lim at the Genome Institute of Singapore 
commented on Melton and Lemischka’s studies (both published in Science) and 
included additional analysis.  Lim’s group identified 385 genes expressed in 
embryonic, neural, and haematopoietic stem cells. 
However, in their paper considering ‘stemness’, Yan Leychkis, Stephen 
Munzer and Jessica Richardson note that only six of these genes (less than 2%) were 
identified as potential stem cell markers by both Melton and Lemischka’s groups1030.  
Lim’s group themselves identified that only one gene was commonly identified by all 
three studies: α6 integrin.  This is part of a small group of proteins that act at the cell 
surface, affecting adhesion and signalling.  Integrin proteins have also been 
implicated in promoting tumourigenesis.  The integrin family of proteins are found in 
a large variety of cell types throughout the body (for example, epicardium1031, dental 
pulp cells1032, and more than thirty types of stem cell1033.  The groups themselves 
identified potential reasons why their results were so different: the varying nature of 
cells cultured in vitro as opposed to in vivo cells, and the differences in microarray 
techniques used.  As Leychkis, Munzer and Richardson note however, this is not 
enough to explain such significant discrepancies.  Commenting on the Melton, 
Lemischka, and Lim results, Science news reporter Gretchen Vogel suggested that an 
additional problem may have been isolating pure populations of stem cells to examine 
initially.  This is typical of sociologist of science Harry Collins’ experimenter’s 
regress1034; it is not possible to identify pure populations of stem cells without 
identifying their molecular markers, yet it is not possible to identify the molecular 																																																								
1029 Ivanova et al., 2002. 
1030 Leychkis, Munzer, and Richardson, 2009. 
1031 Ryzhov et al., 2017. 
1032 Shi et al., 2017. 
1033 Krebsbach and Villa-Diaz, 2017. 
1034 Collins, 1985; Franklin and Perovic, 2015. 
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markers without pure populations of stem cells to test.  As the Melton, Lemischka, 
and Lim groups found out, the experimenter’s regress raises concerns regarding the 
usefulness of their experimental evidence for evaluation of their hypothesis. 
Further critiques of Melton, Lemischka, and Lim’s results claimed that 
perhaps the research demonstrated that “there is no such thing as intrinsic stemness at 
the molecular level, such that perhaps stemness should be understood as a relational 
property between cells and their microenvironment generating the functionality of 
stem cells”1035.  Here, Jason Robert is suggesting that stemness itself is a property that 
can be gained or lost depending on environmental cues; i.e., a stem cell is not a 
natural kind, or an entity, but that stemness can be a state, or phase of a cell’s life.  
Zipori has also written on the potential reasons for a lack of stem cell molecular 
markers, suggesting that the “stem state” is equivalent to a “standby state”, from 
which differentiation is able to occur1036; expression of many genes allows the stem 
state to retain its flexible character (see also section 7).  Lack of specific molecular 
markers supports the state view. 
 
6.3 Haematopoietic stem cells 
One of the most well-characterised tissue-specific stem cell populations (of 
the adult) is the pluripotent haematopoietic stem cell1037.  Haematopoietic stem cells 
are also considered important for repair and maintenance of tissues outside of the 
blood system; their ability to make use of the circulatory system to move around the 
body has shown that bone marrow-derived stem cells have functioned in the brain1038, 
in oocyte generation1039, gastric epithelium1040, pancreas1041, liver1042, retina1043, heart, 
and muscle1044.  A traditional protocol for isolating haematopoietic stem cells has 
been to use fluorescence-activated cell sorting (FACS), which allows cells to be 
separated based on the expression of surface proteins.  Presumptive haematopoietic 
stem cell populations isolated using this method however can contain up to 20% non-																																																								
1035 Robert, 2004 p 1007. 
1036 Zipori, 2009 p 179. 
1037 Blau, Brazelton, and Weimann, 2001. 
1038 For example, Brazelton et al., 2000. 
1039 For example, Johnson et al., 2005. 
1040 For example, Houghton et al., 2004. 
1041 For example, Iskovich et al., 2007. 
1042 For example, Theise et al., 2000. 
1043 For example, Dorell et al., 2004. 
1044 For example, Bittner et al., 1999. 
CHAPTER 6  271 
 
stem cell cells; “Even the most rigorous isolation protocols currently available result 
in heterogeneous populations that are enriched for HSC [haematopoietic stem cells] 
but in which some of the cells fail to demonstrate pluripotency and/or long-term 
reconstituting ability”1045. 
The examples selected in 6.2, and 6.3, concerning molecular and genetic 
markers of stemness indicate that it is, if not impossible, extremely difficult to isolate 
pure populations of stem cells1046.  This then supports the state view of stemness. 
 
7. Plasticity 
Plasticity in cell biology refers to the capacity for cells “to alter their 
phenotype in response to changes in their environment”1047.  The plasticity of cells is 
a relatively new finding; previously held views suggested that once specialised, cells 
were unable to dedifferentiate and re-specialise (as proposed by Waddington, for 
example [see section 6.1]).  In his description of the niche in 1978, Schofield 
suggested that cells that were not necessarily stem cells could re-enter the niche to 
replenish the stem cell population1048; an indicator that there was some plasticity of 
cell fate.  Although the exact molecular mechanisms underlying such plasticity are not 
completely understood, research has been able to produce two clear examples of cell 
plasticity: somatic cell nuclear transfer, and induced pluripotency.  For the current 
discussion, plasticity is an important concept; if cells are capable of differentiating 
and dedifferentiating (to the point of being able to recreate an entire organism), is it 
possible that ‘stemness’ is therefore a state cells can pass through (perhaps more than 
once), as directed by intra- and extra-cellular signals?  In order to examine this, 
somatic cell nuclear transfer and induced pluripotency are discussed in further detail. 
 
7.1 Somatic cell nuclear transfer 
Somatic cell nuclear transfer history and procedure was previously discussed 
in Chapter 2; in this method, a nucleus is transferred from a differentiated cell into an 
enucleated oocyte, which, if allowed to develop, can create a genetic clone of the 																																																								
1045 Blau, Brazelton, and Weimann, 2001 p 831.  See also Morrison and Weissman, 1994. 
1046 This may be in part due to the many other factors believed to be involved in stemness, 
such as DNA methylation, intracellular protein distribution, and post-translational protein 
modifications (see Zipori, 2009 p 179-80 for a review). 
1047 Skipper, Weiss, and Gray, 2010. 
1048 Schofield, 1978. 
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nuclear donor.  The success of this method has demonstrated not only that all genes 
required for formation of an entire new organism are retained in differentiated cell 
nuclei, but that these genes can be ‘reactivated’ when exposed to factors present in the 
enucleated oocyte.  It is not a stem cell that enables the creation of a new organism in 
SCNT: it is a nucleus.  Therefore, SCNT cannot demonstrate stemness alone – it only 
shows that the nucleus is capable of plasticity (i.e. that many genes can be ‘switched 
on’ or ‘switched off’ given the appropriate signals).  Importantly for this discussion is 
the additional demonstration of plasticity; given the correct signals and cellular 
machinery, the nuclei of differentiated cells are still able to recreate an entire 
organism, including the appropriate organisation and multiple cell types (including 
extra-embryonic cells) such a task requires.  This has also been referred to as 
‘reprogramming’ (for example, by Zipori), as the nucleus is modified by the 
cytoplasm of the receiving cell.  It is likely that such reprogramming or 
dedifferentiation reverses the processes of DNA methylation, enabling expression of a 
wider set of genes1049.  Yamanaka’s work has provided clear indications of what these 
signals are, however, as yet, we only know that this occurs in vitro.  We have no 
evidence that this occurs in vivo. 
 
7.2 Induced pluripotency 
In 2006, Kazutoshi Takahashi and Shinya Yamanaka published a paper in Cell 
demonstrating that overexpressing four transcription factors (Sox2, Klf4, cMyc and 
Oct4) in somatic mouse cells was sufficient to induce pluripotency.  This method 
worked for several types of somatic cells, and the resulting cells termed iPSCs 
(induced pluripotent stem cells).  In a review of methods demonstrating cell plasticity 
published in 2010, Yamanaka and fellow stem cell biologist Helen Blau refer to 
iPSCs as “the strongest example so far of the plasticity of cells”1050, presumably since 
the nucleus is not removed and transplanted (as in somatic cell nuclear transfer), but 
the entire cell can be induced to dedifferentiate by triggering overexpression of 
certain transcription factors.  In 2012, Yamanaka (alongside John Gurdon - see 
Chapter 2) was awarded the Nobel Prize in Physiology or Medicine for his work 																																																								
1049 Zipori, 2009. 
1050 Yamanaka and Blau, 2010 p 709.  Yamanaka and Blau’s paper refers in the title to “a 
pluripotent state” (my emphasis), suggesting that pluripotency is a state cells may pass 
through and return to. 
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demonstrating that differentiated cells may re-acquire stem cell properties.  Already 
(and, perhaps, prematurely), the demonstration of cell plasticity has been referred to 
as ‘paradigm shifting’1051. 
It is interesting to note that Sox2, Klf4, Myc, and Oct4 are also transcription 
factors associated with dedifferentiation of somatic cells in vivo, associated with 
cancer formation.  Expression of either Oct4 or Sox2 is been associated with irregular 
homeostasis and tumourigenesis1052.  Both Oct4 and Sox2 are expressed in tumours 
lacking differentiation1053.  Myc is an oncogene that was established in the 1990s as 
having a role in ‘immortalising’ tumour cells, enabling them to continue replicating 
and perpetuating cancer1054.  Klf4 has been previously associated with colorectal 
cancers1055; it’s close relative, Lin28, is also associated with liver cancer1056.  The 
above examples demonstrate that the transcription factors identified by Takahashi and 
Yamanaka not only dedifferentiate somatic cells into a stem cell state in vitro, but 
cancer research has demonstrated that abnormal upregulation of these factors in vivo 
are significant in the development of tumours. 
Both somatic cell nuclear transfer and induced pluripotency demonstrate the 
potential plasticity of somatic cells by altering the epigenome, ‘forcing’ the 
expression of pluripotency genes in otherwise stable cells.  Zipori has argued that this 
is only possible with such relative ease in the laboratory because it is part of a 
program that also occurs in vivo, where cells revert back to a “standby” state1057.  
Takahashi and Yamanaka’s 2006 work then is not definitive in our quest for 
stemness, since their creation of iPSCs was carried out in vitro.  Yamanaka and Blau 
suggest that there must be mechanisms to regulate the pluripotency-inducing 
transcription factors noted above, and those cell type-specific transcription factors 
maintaining the differentiated state of somatic cells.  As described above, and in 
further detail in Chapter 3, there are clear indications that dedifferentiation of somatic 
cells is not a phenomenon that only occurs through artificial means in vitro.  
Abnormal expression of Sox2, Klf4, Myc, and Oct4 occur in vivo and are thought to 
be, at least in part, responsible for dedifferentiation of somatic cells to a stem cell 																																																								
1051 For example, see Cox and Rizzino 2010; Burns and Blau, 2014; Laplane, 2015. 
1052 Hochedlinger et al., 2005; Chen et al., 2006. 
1053 Ben-Porath et al., 2008. 
1054 For example, Wang et al., 1998. 
1055 Wei et al., 2006. 
1056 Guo et al., 2006. 
1057 Zipori, 2009 p 199. 
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state.  That this phenomenon can occur both in vitro and in vivo is strong evidence for 
the stem cell state argument, clearly showing how cells can acquire properties of self-
renewal and differentiation long after previously being specialised. 
 
8. Historical overview of the entity and state views 
When the earliest stem cell research began in the nineteenth century, much 
hypothesising was based on microscopical observation combined with an effort to 
understand general biological systems (evolution, or development, for instance); a 
useful example of this is the work carried out by Haeckel (see Chapter 1).  Haeckel, 
as previously noted, was the first to use the term Stammzelle, which came to mean the 
fertilised egg1058: the single cell with the potential to form an entire organism.  
Haeckel was influenced by the Stammbaum of Charles Darwin to explain the 
‘differentiation’ of species from one another, which Haeckel adapted to apply to cells.  
The inference was then that the stem cell (fertilised egg) was an entity, and after its 
first cell division, the cells began to differentiate towards their own cell fates, now 
lacking the potential to recreate an entire organism that the original fertilised egg had.  
This can be particularly seen in Weismann’s work in the late nineteenth century 
(Chapter 2); Weismann argued that ‘determinants’ were divided between daughter 
cells as each parent cell divided.  This ongoing loss of the ‘id’ meant that cells would 
become less and less diverse after each cell division, eventually containing only the 
information needed to function as a single cell type.  In Weismann’s germ plasm 
model then, no cell could dedifferentiate - the information to do this was not available 
inside the cell.  Hans Driesch would also ponder over vitalistic properties, following 
his own experiments separating sea urchin embryos (see Chapter 1); Driesch 
considered the impact of his results on “‘mechanistic’ causality”, observing that one 
could “cut up a thousand-celled embryo at will and from the fragments obtain the 
whole organization as the result of development”1059.  The epigenetic landscape 
model, which Waddington began to develop in the 1930s (see 6.1), like Weismann’s 
germ plasm theory, suggested that cell fate was a linear process.  Wherever 
development was considered to be this linear process, the stem cell entity view 
worked.  These early hypotheses however were only that: hypotheses.  It was not until 																																																								
1058 Haeckel, 1877. 
1059 Driesch, 1951 p 108.  See also Baltzer, 1969 p 109-10. 
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the mid-twentieth century that stem cells were isolated and made available for use in 
the laboratory by Till and McCulloch.  This turning-point was not only important for 
providing the tools for practical experimental work on stem cells, but also perhaps the 
beginning of a conceptual change. 
Up until Till and McCulloch’s work, no stem cell had been (knowingly) 
isolated and cultured1060.  All work prior to this point then could only be hypothetical; 
experimental methods could not make use of stem cells to test any hypotheses.  As 
highlighted by Fagan, without information from experiments, “claims about stem 
cells are massively ambiguous – we don’t know what is being talked about”1061.  After 
the work of Till and McCulloch, and many others who followed (such as Stevens, 
Martin, Evans, and Thomson), stem cells became available for experimentation in the 
laboratory.  It is at this point, I argue, the shift concerning entity and state views of the 
stem cell began.  Haeckel’s view of the Stammzelle stuck because it appeared to fit 
the information gathered by observational work.  For example, Weismann’s germ 
plasm theory suited the original stem cell concept.  Likewise, the cell lineage studies 
described (Chapter 1) also assumed that stem cells were larger, since they contained 
more chromatin than somatic cell types – this again fit with the early stem cell 
concepts.  Moving into the twentieth century, and experimental embryology, 
experiments were designed and results were interpreted based on the theoretical stem 
cell concept – for example, Danchakoff’s work was carried out on the understanding 
that stem cells were entities, and her results were interpreted using this model.  As the 
stem cell moved from being theoretical, to being observed, to being an experimental 
agent, the underlying suppositions remained, and influenced stem cell research 
throughout the twentieth century, and into the twenty-first.  I argue that the practical 
work that has been carried out in the latter half of the twentieth century and beyond 
has in fact demonstrated that stemness is a state, and that stem cells are not an entity. 
Very soon after stem cells became available for experimental work their 
plasticity became clear.  For example, Briggs and King’s, and Gurdon’s work on 
somatic cell nuclear transfer (Chapter 2), research demonstrating the role of the niche 
in creating and maintaining stemness, Martin and Evans’ work on embryonal 																																																								
1060 It is possible that Ross G Harrison possibly had some experience culturing stem cells, 
however this was prior to experimental understanding of stem cell culture (for a review, see 
Maienschein, 2010).  It is also possible that Alexis Carrel may also have cultured cells 
capable of self-renewal (see Wilson, 2011). 
1061 Fagan, 2013a p 1151. 
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carcinoma cells (Chapter 4), the groups led by Melton, Lemischka, and Lim showing 
lack of a stem cell molecular fingerprint, and Yamanaka’s demonstration that 
pluripotency can be induced, all support a different concept: that stemness is a state. 
It is not only the work of Yamanaka or Gurdon that is important to support the 
stemness view.  The work studying cell plasticity only occurred in vitro.  The 
historical experimental work highlighted included some examples of in vivo results 
that support the stemness view, such as the lack of molecular markers.  It is also 
important to review historical observations and experiments and review these results; 
if these results did not support the stemness view, it would significantly weaken its 
claim. 
 
9. Conclusions 
This chapter has discussed several examples and considered whether they 
support the entity or state view of stem cells.  Initial consideration of the traditional 
definitions of ‘stem cell’ or ‘stemness’ has shown that the traditional definition (of 
potential to self-renew and differentiate) was first proposed in the nineteenth century 
(for example by Martin Barry and Ernst Haeckel), and became the clear, concise 
definition in the early twentieth century, pioneered by developmental biologists such 
as Vera Danchakoff.  Later examples show that this is a definition still in use by 
researchers in the twenty-first century.  This definition however is now inadequate: 
non-stem cells also have the potential to self-renew or differentiate, leaving twenty-
first century biology to require a different definition, considering stemness as a 
function, and as a state, or phase, cells move through. 
In order to further clarify this argument, an examination of the possibility for 
stem cells to be natural kinds was carried out; if stem cells could be demonstrated to 
be a natural kind, it would support the entity view.  The difficulty that self-renewal 
and differentiation potential are not specific enough to stem cell only populations 
damages the natural kind claim.  However, Wilson, Barker, and Brigandt have argued 
that the requirements for natural kinds should be updated, adapting Boyd’s proposal 
for homeostatic property clusters; regardless of the heterogeneity of stem cell 
populations, the homeostatic property cluster, covering other properties as well as 
self-renewal and differentiation potential, allows stem cells to be considered a natural 
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kind, supporting the entity view.  Others disagree however, claiming that the 
homeostatic property cluster is still not specific enough to exclude non-stem cells. 
The importance of the stem cell niche is also examined.  The niche, a specific 
microenvironment in the adult organism where stem cells reside, is considered to be 
an active participant in the functionality of stem cells; this is because it provides 
signals to the residing cells, telling them to be quiescent, to divide, or to migrate.  If 
this is the case, then the niche has an active role in maintaining stemness.  
Experimental work has demonstrated that removal of the cells from the niche induces 
previously differentiated cells to move into the niche; altering the protein expression 
pattern of the niche also causes somatic cells to dedifferentiate.  Historically, 
embryonic cells that are away from their niche, were once thought to be a cause of 
cancer, and gave rise to the CSC theory (see Chapter 3). 
As a further example to examine the state and entity views of stem cells, 
embryonic cells are discussed, and in particular those cells created early on in 
development, following the first few cell divisions.  The first cells created by division 
of the zygote have been named totipotent stem cells.  However, I argue that since 
these cells begin to differentiate after the second cell division, and there is no 
asymmetrical division at this stage, totipotent cells cease to exist at this point (i.e. the 
four-cell stage), with a different cell population existing by the eight-cell stage (third 
division).  The upshot of this is that, given the traditional definition of stemness (i.e. 
the potential to self-renew and differentiate), the first cells of the developing embryo, 
the totipotent cells, cannot be considered stem cells.  This then supports the state 
view. 
Referring back to the work of Conrad Waddington in the mid-twentieth 
century, I then begin to examine the evidence provided by genetic and molecular 
markers of stem cells.  As has been previously noted, up until the late twentieth 
century, differentiation was considered to be both unidirectional and irreversible.  An 
example of such an understanding of development is given by Waddington’s 
epigenetic landscape model, that proposes cells are like marbles, running down a 
slope (irreversible), navigating a series of channels (unidirectional).  Waddington’s 
model supports the entity view - cells may begin as a stem cell, however intra- and 
extracellular cues will cause the cell to differentiate along a specific pathway, until it 
is mature and completely specialised.  I then move on to consider the search for 
genetic and molecular stem cell markers; research that has been contributed to by 
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many researchers worldwide in the late twentieth century and early twenty-first.  In 
particular, I note the comparison made between the findings of three distinct research 
groups, all of which have compared different stem cell populations in order to identify 
similar gene expression patterns.  The only gene all groups found to be expressed in 
all populations tested was α6 integrin, a gene expressed by many different cell types 
throughout mammalian organisms.  This research then supports the state view, since 
there appears to be “no such thing as intrinsic stemness at the molecular level”1062.  
Haematopoietic stem cells, possibly the population that has been studied the most, 
also does not have a distinctive molecular signature; the use of FACS to separate cell 
populations is still unable to isolate a stem cell population from a non-stem cell 
population, as up to 20% of the cells isolated using FACS are non-stem cells (i.e. 
cannot both self-renew and differentiate).  Again, this supports the state view. 
Lastly, I examine our historical and current understanding of plasticity, 
considering the examples of somatic cell nuclear transfer (a mid-twentieth century 
technique), and induced pluripotency (a twenty-first century technique).  Plasticity 
was demonstrated by developmental biologist John Gurdon in the 1960s, as he began 
somatic cell nuclear transfer work in amphibians (see Chapter 2), and the nucleus of a 
differentiated cell was shown to be capable of regenerating an entire organism if it 
was injected into an enucleated oocyte.  Demonstration of such plasticity supports the 
state view.  Further demonstration of plasticity is provided by Yamanaka’s induced 
plurpotency technique, which involved inducing overexpression of a series of 
transcription factors in somatic cells.  These differentiated cells then dedifferentiate, 
and become pluripotent cells.  This then is particularly strong evidence for the state 
view; it demonstrates that differentiated cells can revert to a stem cell-state with 
relatively little interference.  Such is the significance of this research, induced 
pluripotency has been described as paradigm shifting. 
 
This thesis has identified several aspects of embryonic stem cell history which 
were relevant to their conceptualisation, isolation, and to our knowledge and 
understanding of stem cells.  This sixth chapter has, to an extent, brought together the 
previous chapters to consider whether stem cells should be considered as states or 
entities. 																																																								
1062 Robert, 2004 p 1007. 
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What is highlighted by considering examples through the nineteenth, 
twentieth, and twenty-first centuries, is that initially, evidence supported the entity 
view of stem cells.  Barry and Haeckel’s theoretical stem cells, hypothesised based on 
their observations and understanding of development and evolution, were entities.  
These were cells that, in theory, were created from the first cell divisions of the 
fertilised egg, and could multiply and change, giving rise to all of the cells of the 
organism.  In the mid-twentieth century, Waddington’s ambition to find unifying laws 
in biology led him to his epigenetic landscape model, which dictated that cells would 
begin as immature and undifferentiated, follow a single path towards their fate, as 
they would become mature, specialised cells. 
It was only research that began with somatic cell nuclear transfer, technical 
improvements (which allowed for more genetic and molecular research, such as 
FACS), continued learning about the properties of the stem cell niche, and lastly (and 
most recently) induced pluripotency that has suggested that a different concept of the 
stem cell is required.  One suggestion for this is the state view: that cells may begin as 
stem cells, differentiate, then become stem cells again during their lifetime.  The 
examples highlighted above suggest that, at the very least, an expansion of the 
‘traditional’ definition of stem cells is needed; this was highlighted fifteen years ago 
by Blau, Brazelton, and Weimann in their short discussion in Cell.  It is this change in 
the stem cell concept that is potentially paradigm shifting. 
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1. Thesis summary 
As yet, there have been no larger scale contributions to the history of ESC 
research; as noted in the Introduction, research into the history and philosophy of 
stem cell research has so far been distinct (with little or no integration), and covering 
only sections of stem cell history at a time.  The aim of this thesis was to provide a 
more extensive overview and discussion of stem cell research history, with a 
particular focus on embryonic stem cell history.  This history has been somewhat 
neglected in favour of other stem cell histories (such as the work on haematopoietic 
stem cell history), or relegated to the after-thoughts of ethical or legislative 
discussions.  This thesis, in part, aims to remedy this by analysing several facets of 
embryonic stem cell history that may already be more widely known (such as the 
work of Gail Martin, Martin Evans, John Gearhart and James Thomson), but from a 
previously little-considered view-point, or in order to examine some wider questions 
about the history and philosophy of biological science more generally. 
 
The first chapter of this thesis explored how the term ‘stem cell’ arose.  This 
began with Stammzelle, a concept developed by Ernst Haeckel.  Initially, Haeckel 
referred to the first unicellular organism as the stem cell.  Later, this definition also 
encompassed the fertilised egg, from which all other cells of the embryo could 
develop.  The popularisation of the term ‘stem cell’ in English was likely to be 
significantly influenced by the publication of EB Wilson’s The Cell in 1896 (and 
further editions thereafter); in The Cell, Wilson refered to the progenitor cells of 
gametes as stem cells, which arise in the first divisions of the fertilised egg.  Wilson 
was part of a groups of researchers focused on cell lineage at the time, who observed 
embryos of various species in order to establish the role of each early cell of the 
embryo.  Also of interest is the work of Vera Danchakoff, who used ‘stem cell’ in a 
slightly different way to Wilson in the early twentieth century; Danchakoff referred to 
the progenitor cells of the haematopoietic system as stem cells.  This appears to have 
been influenced from German research, which also refered to ancestors of blood cells 
as Stammzellen. 
The second chapter begins in a similar fashion to Chapter 1, with a focus on the 
cell nucleus.  In order to examine how genetics became such an influential paradigm 
in stem cell research, the second chapter tested the claim of Garland Allen, who 
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argued that genetics initially developed under the embryology paradigm.  The 
examples in Chapter 2 however suggest that there may be alternate explanations to the 
development of disciplines in biology.  Both Meunier and Winther dismiss Allen’s 
claim, since, they argue, genetics and embryology were always separate; Allen’s 
account was too focused on Morgan, who actually separated development from 
heredity studies, not genetics from embryology, claimed Meunier.  Winther argued 
that genetics followed a formal style of thought, whereas embryology followed the 
compositional style, and therefore the disciplines were not initially connected as Allen 
suggested.  Chapter 2 made use of Radick’s explanation of Weldonian genetics, early 
embryology experiments, and twentieth century work (such as SCNT) to argue that 
the disciplines of genetics and embryology were linked, and remain linked through 
into the twenty-first century. 
Chapter 3 considered the parallels between ESC research and cancer, in 
particularly CSCs.  Following a brief history of cancer, focusing on the nineteenth-
century suggestion that cancer could arise form cells left over from embryonic 
development, twentieth-century research into teratomas becomes an important focal 
point.  This chapter identified several ways in which cancer and embryonic 
development were studied in parallel, or direct comparisons were made.  Lastly, this 
chapter considered the CSC concept, in a similar way to the ESC concept was 
explored in Chapter 1. 
Continuing to examine the links between the normal and abnormal, Chapter 4 
resumed chronologically where Chapter 3 concluded.  Since ESCs were not available 
for research in the mid-twentieth century, teratoma cells were thought to be a viable 
alternative.  Chapter 4 described how ECC lines were developed, and then how these 
techniques were used in the isolation and culture of mESCs by Martin and Evans, in 
the USA and UK respectively.  The chapter goes on to elucidate what Martin and 
Evans used these new tools for, and what their motivations were.  Exploration of the 
social, political, and economic situation that Martin and Evans were working in 
demonstrated that these contexts affected their research.  Whilst in the USA, Martin 
was able to continue with fundamental research into development, Evans was 
motivated into pursuing more practical applications. 
Chapter 5 examined a claim by Michel Morange that hESCs were not the 
equivalent of mESCs, since they were each produced in different scientific contexts.  
Since Chapter 4 had previously considered the motivations and goals of mESC 
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isolation and culture, Chapter 5 focused on the isolation and culture of hESCs; this 
was achieved independently by Thomson and Gearhart in 1998.  Also demonstrating 
that political and economic factors affected stem cell research, the chapter explored 
the role of Geron (who funded the research), as well as the backgrounds of Gearhart 
and Thomson prior to their hESC research; this enabled testing of Morange’s claim.  
The chapter concluded that Morange was correct in asserting that the scientific 
context of work in the 1980s and 1990s was different; Chapter 5 also offers a 
complementary view: that the political, social, legal, ethical, and economical contexts 
also affected the delay in isolating and culturing hESCs after the isolation and culture 
of mESCs. 
Chapter 6 of this thesis explored the underlying paradigm of stem cell research 
since stem cells were conceptualised in the nineteenth century; the presumption that 
stem cells were entities.  This chapter was influenced by Laplane’s suggestion that we 
should instead think of stem cells as cells that are in a stem cell ‘state’; this is called 
‘stemness’.   Cells in this state have stem cell properties, however can move into and 
out of this state through their lives.  In this chapter, several examples are provided 
from both philosophy and history to provide evidence for this new way of thinking 
about stem cells.  This includes asking whether stem cells are natural kinds, what the 
role of the niche is, the fate of early embryonic cells, whether there are molecular 
markers of stem cells, and what plasticity studies have shown us.  Although 
historically, stem cell research functioned under the stem cell entity paradigm, this 
chapter showed that as we learn more about stem cell, experimental results indicate 
that the stem cell state model may be more accurate than the stem cell entity model.  
Historical results could be re-interpreted under the stem cell state paradigm.  This 
suggests that stem cell research may now be undergoing a paradigm shift, from 
treating stem cells as entities, towards needing to think about stemness as a state. 
 
Through these chapters, this thesis aimed to answer three research questions.  
Firstly, what was the significance of social and political factors on (embryonic) stem 
cell research?  Secondly, what was the role of cell fate, and cell fate research, on ESC 
research?  And thirdly, which paradigms have been influential in (embryonic) stem 
cell research? 
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2. Answering the questions 
 Firstly, there was the query regarding the role of social and political context in 
stem cell research.  Bensaude-Vincent has already claimed that the effect of society 
on scientific research has been made clear, however its effects have not been 
specifically considered in mESC research and its implications, as in Chapter 4 of this 
thesis.  Chapter 4 shows very specifically the interacting roles of the public, politics, 
economics and science in the resulting research carried out.  It was argued that by the 
mid-twentieth century, science could no longer be “value-free”, and was dependent on 
social framing1063.  This was particularly the case for biological sciences research 
dependent on animal experimentation.  Fleck’s suggestion that science could not be 
considered in isolation from the 1930s hints that social and political forces were 
influencing research in the early twentieth century, if not before.  This is one of the 
conclusions in Chapter 1 of this thesis, where it is clearly shown that social conflict 
and political power influenced cell biology in nineteenth century Germany. 
 In the mid-nineteenth century, the Berlin School emerged under the leadership 
of Johannes Müller, encompassing figures such as Theodor Schwann and Jakob 
Henle.  Across the country in Breslau, another school was developing, under Johann 
Evangelista Purkynĕ.  Purkynĕ was Czech by birth; the Bohemian peoples east of 
Germany were becoming increasingly Germanised, but remained second-class 
citizens.  In Chapter 1, evidence is presented to support the argument that the Czech-
born Purkynĕ was given less far less credibility for his work than his German 
counterpart in Berlin (i.e. Müller).  For example, it may be that Gabriel Gustav 
Valentin identified the cell as a ‘fundamental unit’ of both plants and animals in 
Breslau, years before Schwann’s Cell Theory was published in 1839.  Purkynĕ 
however continued to use two different terms for animal and plant cells, Zellen and 
Körnchen respectively.  Arguably, Zellen became the favoured term through the 
popularity of Schwann’s Zellentheorie.  It is also likely that one of the reasons for the 
popularity of Schwann’s work over Valentin’s was the underlying racism that 
perceived the Breslau School as lower quality than the Berlin School.  Clearly then, as 
early as the mid-nineteenth century, social and political factors were affecting 
scientific research. 
																																																								
1063 Jacob, 1992 p 488; Fleck, 1979 (1935). 
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 The impact of social and political conflict on research in the mid-nineteenth 
century was not an isolated incident.  After the end of World War I, there was a 
reduction in research through Europe (as finances were diverted to significant re-
building projects), and an increase in the USA.  There are records of many 
researchers, particularly from Eastern Europe and Russia, migrating westwards to 
Britain and the USA.  This resulted in a change of publication language from 
significantly German, to predominantly English.  In Chapter 1, some detail is given of 
the Russian biologist Vera Danchakoff, who moved from Russia to the USA.  Her 
shift to publishing in English is typical of other migrants.  In particular, Danchakoff is 
selected as an example since she was researching embryogenesis, and made use of the 
term ‘stem cell’ in English in the early years of the twentieth century.  Her use 
suggests that the term was familiar to an English audience by that time.  Again then, 
Danchakoff’s move shows how social, political, and economic factors resulted in a 
shift in the physical centre of biology from Europe (and particularly Germany) to the 
USA.  This also affected a change in publication language. 
 Whilst animal experimentation was a particular issue in the late 1970s in the 
UK, it all-but disappeared from public and therefore political concern in light of the 
general economic downturn, and the imminent general election.  Thatcher was elected 
Prime Minister based on her promise to improve the economy.  Meanwhile, in the 
USA, public pressure resulted in a 1973 ban on federal funding availablility for any 
research on human embryos.  In the 1980s, Thatcher reduced funding for scientific 
research in the UK, adding the caveat that any research that was carried out needed to 
contribute to the social and economic needs of the country.  The public would not 
have generally been in a position to oppose this stance, concerned far more with 
general strikes, and the decline of some significant industries (such as coal mining 
and steelworking).  The public during the 1980s would not have been primarily 
concerned with government spending significantly on ‘pure’ or fundamental research.  
In the USA, although there were also effects seen of the global economic downturn, 
there were less significant cuts to science funding in the early 1980s.  Whilst 
President Reagan, like his counterpart Prime Minister Thatcher, was keen to 
emphasise practical applications of scientific research, this became catered for by 
increased marketisation and commercialisation of some sectors.  This meant that 
federal funding could be available for fundamental research.  The upshot of these 
economic policies in the UK and USA respectively meant that Martin Evans was 
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driven towards applied research, whilst Gail Martin, who has said herself that she 
didn’t find funding particularly difficult to obtain during this period, was able to 
continue focusing on fundamental research. 
 The use of the newly-available mESCs then was clearly affected by social, 
political, and economic contexts, which varied between the UK and USA.  Whereas 
instinctively one may believe that US capitalism would encourage the move towards 
applied research, Chapter 4 demonstrated that in fact this was more of a necessity in 
the UK. 
The importance of the social, political, economic (and ethical and legal) 
contexts of scientific research are further highlighted in Chapter 5.  This chapter set-
out to further consider the evidence for Morange’s claim that mESCs and hESCs were 
not equivalent, since they were isolated and cultured in different scientific contexts.  
Chapter 5 agreed with Morange’s claim, and added further, complementary evidence: 
that the social, political, economic, ethical, and legal contexts also had a role, and help 
to explain the seventeen-year gap between the isolation and culture of mESCs and 
hESCs. 
 As previously mentioned, no federal funding was available in the 1990s for 
either Thomson’s or Gearhart’s projects; instead, this had to be provided by the 
private sector (and was, from Geron).  In Chapter 5, it is argued that Thomson and 
Gearhart were  motivated to apply their research skills to the isolation and culture of 
hESCs because of the political, economic, ethical, and legal framework they were 
working in.  Politically, their research was affected by the Dickey-Wicker 
amendment, for example.  Economically, only private sector funding enabled 
Thomson and Gearhart to continue with their individual projects.  The account 
provided by Thomson in particular highlighted how long he waited for ethical 
approval before he could continue with his research.  Again, Thomson’s account 
provided a useful example of the significance of legal context, with his work having 
to take place without federally funded laboratories and equipment. 
Throughout this thesis then, there have been specific examples provided to 
demonstrate the influence of the public, politics, economics, ethics, and legislation on 
stem cell research.  This thesis does not claim that such influences were previously 
unknown – of course this is not the case.  What the examples in this thesis have 
shown however is that throughout history, stem cell research has never been “value-
free”, and has been continually under these influences.  Furthermore, it has been 
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demonstrated that these influences may result in unexpected conclusions, such as the 
availability of funding in the USA for pure research through the 1980s, that was less 
forthcoming in the UK.  Any history of similar research then must be prepared to take 
such contexts into account.  In addition, future changes to, for example, public 
opinion or funding bodies must take into consideration the effects of such changes on 
future research. 
 
The second research question addressed by this thesis queried the importance 
of cell fate; both the significance of cell fate itself, and of research carried out on cell 
fate.  In some ways, this follows on from the first research question, since it asks what 
influenced the decisions made to pursue certain research.  Maienschein argued that 
cell fate has directed much of our research in embryology and stem cell biology; this 
thesis aimed to ascertain exactly how and where cell fate research was influencing 
ESC research, and, to an extent, whether this hundred-year old approach was still 
appropriate for stem cell research in the twenty-first century. 
 In Chapter 1, the conceptualisation of the stem cell already highlighted that 
there may be some future enquiry into cell fate.  In 1877, when making use of the 
word ‘Stammzelle’, to refer to the fertilised egg,  Haeckel stated that the term “seems 
to me the most simple and appropriate one, because all other cells stem from it...all 
the countless generations of cells of which later on the multicellular organism is 
composed”1064.  Haeckel recognised that all of the other specialised cells of the 
organism must, in some way, emerge from this single cell, with all of its potential. 
 At the end of Chapter 1, there is also a brief description of the cell lineage 
studies that became popular in the USA in the late nineteenth and early twentieth 
centuries (the significance of early twentieth-century USA for stem cell research is 
mentioned above).  Of particular influence for example were EB Wilson and CO 
Whitman.  Examination of the earliest stages of development could shed light on 
fundamental biological processes.  This work was intimately linked with Haeckel’s 
work regarding the belief that ontogeny was a record of phylogeny.  Likewise, EG 
Conklin would examine the cleavage patterns of blastomeres in order to learn more 
about phylogenic differences; this work was technically tricky, and dissemination of 
the results somewhat problematic at the time.  The cell fate of stem cells for Wilson 																																																								
1064 Haeckel, 1877 (transl. Maehle, 2011). 
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and those who followed his example in The Cell however was only germ cells.  The 
German tradition however demonstrated that the ancestors of other systems (in 
particular haematopoietic cells) could also be stem cells; arguably, this was 
introduced to an English audience at the beginning of the twentieth century by 
Danchakoff. 
 Later, as explored in Chapter 2, Hans Spemann and others began work 
exploring how each of the early cells of the embryo contributed to later growth, 
organisation, differentiation, and development.  The difference between this work and 
the cell lineage studies in the USA was that the latter relied more on observation, 
whereas the work of Spemann, Roux, and His for example all made greater use of 
experiment (Chapter 1).  In late nineteenth- and early twentieth-century Europe, 
researchers such as Mangold, Roux, Driesch, and Delage would all be carefully 
studying and manipulating the early embryos of various species in order to figure out 
just how the single fertilised egg could manifest and organise all the specialised cells 
required of the embryo and the adult.  This became entwined with the study of 
heredity and later, genetics (see below). 
 Chapter 3 also considered the importance of cell fate and cell fate research, 
although from a different perspective.  Chapter 3 examined the parallels between 
CSCs and ESCs – or abnormal and normal, or pathological and non-pathological.  
Whilst Chapters 1 and 2 focused exclusively on the normal, Chapter 3 demonstrated 
not only that cancer studies were essential for furthering stem cell studies, but that 
specific teratoma studies began because of the continuing curiosity around cell fate.  
Teratomas have historically been found interesting because of the range of specialised 
cell types observed in the mature tumour: specialised cells descended from all three 
germ layers yet developed from a single cell.  How this single CSC (as it is now 
understood) could be responsible for forming a tumour of all these cell types focused 
research on cell fate.  Such was the initial confusion over the ability of cancer cells to 
vary their fate, that Barry Pierce was required to change the title of his 1959 paper, 
replacing the word ‘differentiation’ with ‘metamorphosis’!  It was also from this 
interest in cell fate that the realisation emerged that the ECCs from teratomas would 
make adequate substitutes for ESCs (then unavailable) for cell fate research.  It was 
reasoned that what was occurring in teratomas must have some parallels with normal 
embryonic development.  It was from such studies that Martin’s and Evans’ research 
developed, enabling isolation and culture of mESCs; following this, Martin’s work 
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continued into the study of development – arguably an extension of earlier cell fate 
research (Chapter 4). 
 In Chapter 5, there was also a role for cell fate.  Although the chapter focused 
on the motivations and practical steps taken by Thomson and Gearhart as they found 
ways to isolate and culture hESCs, the brief examination of these steps highlighted 
the importance of cell fate.  This is clearest in the story of John Gearhart’s isolation 
and culture of hESCs.  In the 1970s, Gearhart worked alongside the anatomist 
Wadsworth, as she dissected stillbirths.  Gearhart worked with Wadsworth in order to 
understand how each region of the foetus would develop from cells in the early 
embryo.  When in the 1990s he wanted to produce a better laboratory model for 
Down syndrome from human cells, Gearhart recalled his 1970s exploration of cell 
fate in the embryo, in particular the migration of EGCs along the genital ridge, from 
which Shamblott could dissect out and culture the hESCs. 
 Lastly, in Chapter 6, the importance of differentiation ability as a property, 
and the potential to change cell fate becomes a key consideration.  The ability to 
differentiate (i.e. decide cell fate) is one of the two properties that traditionally 
distinguished stem cells from any other cell type (the other property being the ability 
to self-renew).  Historically, August Weismann implied that differentiation was 
unidirectional with his germ plasm theory, where ‘determinants’ would be split 
between cells, meaning that once a cell had only its specific set of ‘determinants’, it 
could only function as that cell type.  Following this idea, Waddington developed a 
thesis of cell fate in the 1930s, producing his famous epigenetic landscape.  Again, 
this depicted cells as rolling down a hill or rail track, on a one-way route to 
specialisation. 
This notion of cell fate began to change following the results of Briggs and 
King’s then Gurdon’s research on SCNT.  Briggs and King demonstrated that nuclear 
transfer was practically possible, whilst Gurdon’s work showed that adults could 
develop and survive from SCNT.  Gurdon’s work was the first to suggest perhaps cell 
fate was not the one-way street it was previously envisaged to be.  Just as Gurdon 
demonstrated this at the organism level, Yamanaka demonstrated this at the cellular 
level; that each cell, transcribing the correct genes, and given the correct environment, 
can dedifferentiate and redifferentiate.  iPSCs are a clear indicator that cell fate is not 
unidirectional. 
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 The plasticity of cells (alongside other properties described in Chapter 6) 
result in the conclusion drawn by Laplane and others that the properties of stem cells 
(the ability to self-renew and differentiate) are transient – i.e. ‘stemness’ is a state that 
cells can move into or out of, and stem cells as entities do not exist.  This, potentially, 
may herald a change in the paradigm that stem cell research is currently carried out 
under. 
 
This leads into the third and final question of this project: the importance of 
paradigms in stem cell research.  As the concept of the stem cell was developing 
through the nineteenth century, queries regarding heredity and evolution were 
developing alongside.  This arguably resulted in the studies becoming intertwined, 
especially through the research on embryology and evolution.  This is explored 
through the second chapter of this thesis. 
 In 1985, Allen proposed that heredity research developed under the paradigm 
of embryology.  After heredity became the discipline of genetics in the twentieth 
century, Allen claimed that the field was then able to distance itself.  This occurred 
specifically following the work of TH Morgan.  Chapter 2 concluded that Allen’s 
assertion was correct - initially.  Examples studied later in the chapter, including 
Meunier’s critique (that Allen’s work was too Morgan-centric), Radick’s description 
and use of Weldonian genetics, and examples of nuclear transfer through the 
twentieth century, lead to the conclusion that the disciplines of genetics and 
embryology are still closely linked in the twenty-first century. 
 Experimental embryology arguably began with His’ work, testing Weismann’s 
germ plasm theory; this was the view taken by Spemann.  Heredity studies were 
carried out through the new experimental embryology techniques that were 
developing in the late nineteenth and early twentieth centuries.  Weismann and 
Haeckel each proposed that there was the initial ‘transmission’ of information from 
parents to offspring, then ‘translation’ into traits observed in the adult; Allen used this 
as evidence to suggest that during this period, there was no distinction between 
genotype and phenotype.  The changing methods of science during this period 
however required that testable hypotheses were developed – Morgan was one of the 
younger generation keen to develop experiments through which such presumptions 
about embryology and genetics could be tested.  Conklin was also part of this 
movement, claiming that more could be learned about heredity through 
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developmental studies.  Allen argued that this was where the split occurred however; 
although theoretically it made sense to study transmission and translation together, 
experimentally it was difficult.  Allen argued that the study of heredity then became 
separated from its embryology paradigm, enabling the development of ‘genetics’. 
 Meunier however argued that this split never actually occurred, instead 
suggesting that genetics and embryology developed out of different research 
traditions.  Meunier actually argued that Morgan’s role in the early twentieth century 
was to separate development from heredity, not genetics from embryology.  This is 
supported by Winther’s view that there were two styles of thought in biology: formal, 
and compositional.  Genetics followed the formal style, whilst development was 
compositional.  In Chapter 2, this is explored further by looking at another example 
from the era: Weldon’s studies of genetics. 
 Weldon criticised the re-discovered Mendelian genetics by claiming it was 
over-simplified.  For example, it was not simple to separate peas into either green or 
yellow categories, as Mendel had.  Weldon spent most of the first decade of the 
twentieth century formulating an alternative explanation to Mendelian genetics.  
Radick’s studies of Weldon’s work highlighted the use of experimental embryology; 
although Radick referred to this as surprising, from the previous examination of 
experimental embryology supplied in Chapter 2, it does not really seem surprising at 
all.  Weldon’s research led him to believe that gene expression was contextually 
dependent, and that the interaction of several genes in fact affected phenotypes.  
Radick’s work comparing Mendelian and Weldonian genetics showed that without 
embryology, a clearer explanation of complex genetic mechanisms could not have 
been demonstrated.  Weldonian genetics needed the embryological paradigm. 
 This effect continued after the early twentieth century work of Weldon.  In 
Chapter 2, this is demonstrated by detailing the work of researchers in the mid- and 
late twentieth century, who carried out nuclear transfer experiments; experiments 
proposed by Yves Delage in the late nineteenth century, and called ‘fantastical’ by 
Spemann, for the new knowledge and understanding that could be gained if such a 
technique could be developed.  Delage and Spemann proposed such experiments to 
establish a better understanding of two functions: the way in which information could 
be passed from parent to offspring (heredity), and how information that would 
provide for development could be held (genetics).  These functions of the nucleus 
could only be better understood using techniques from embryology.  Thus far then, 
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Allen’s argument that genetics developed under the paradigm of embryology could be 
viewed as correct.  Chapter 2 then goes on to describe the work of, for example, 
Briggs and King, Gurdon, and Illmensee in the development of nuclear transfer 
techniques.  The over-riding requirement for these techniques was to enable the 
function of the nucleus to be better understood. 
 Briggs, King, Gurdon, and Illmensee all utilised nuclear transfer as an 
(eventually established) embryological technique to learn more about genetics.  
Therefore, Allen was incorrect to suggest that the field of genetics separated from 
embryology in the early twentieth century, following the work of Morgan.  Instead, 
there are plenty of examples available to show that the disciplines of genetics and 
embryology remained closely linked throughout the twentieth century. 
 Further discussion of paradigms is particularly important for the arguments 
presented in Chapter 6.  The aim of this chapter was to establish whether a case could 
be made for a new theory of stem cells: the stem cell state theory.  This itself has 
already been suggested as potentially paradigm-shifting, so needed to be examined as 
part of the research question querying the role of paradigms in stem cell research.  
Chapter 1 described the manner in which the concept of the stem cell was developed; 
this assumed that the stem cell was an entity.  Haeckel proposed that the stem cell was 
the fertilised egg, for example.  More recently, a theory emerged suggesting that stem 
cells were not entities, but that cells could acquire stem cell properties (i.e. the ability 
to both self-renew and differentiate) at various points throughout their life.  This is 
referred to as ‘stemness’.  This new view has been advocated by several researchers, 
most clearly and most recently by Laplane, who suggested that this new approach to 
stem cell research could be useful in developing treatments for cancer.  Chapter 6 of 
this thesis examined whether the new proposed view of stemness is philosophically, 
historically, and practically sound. 
Through Chapter 6, it emerged that the theoretical work on stem cells, 
produced up to the mid-twentieth century, assumed that stem cells were entities.  
Stem cells became available for experiments after the mid-twentieth century, and 
experiments were designed based on the assumption that stem cells were entities; this 
continued right into the twenty-first century.  For example, research groups headed by 
Lemischka, Melton, and Lim all based their search for molecular markers of stem 
cells on the assumption that stem cells were entities.  This work arguably also 
demonstrated the continuing influence of the genetics paradigm over stem cell 
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research; the potential discovery of a genetic marker that would identify all stem cells 
(as distinct from non-stem cells) was considered to be a pinnacle of achievement – if 
genetics could be used to separate stem cells, then this would be a definitive 
identification tool.  Instead, none of these groups were able to find either a genetic 
marker, or a specific genetic profile that could be used to separate stem cells from 
non-stem cells. 
 Through Chapter 6, further evidence is provided that suggested historical 
experimental results could be re-interpreted under the new stemness view, as could 
more recent experimental work.  The role of the niche, the differentiation of early 
embryonic cells, and lack of molecular markers (as above) all point towards the 
stemness view being the most accurate.  Also in Chapter 6, cell plasticity is explored, 
again in order to test which view of stem cells is likely to be the most accurate.  This 
is arguably the clearest evidence available for demonstrating the stemness view: the 
nucleus of any cell can be placed in an enucleated fertilised egg, which contains and 
can activate the information required for an entire organism to be created.  The 
SCNT, or ‘cloning’ technique demonstrated not only that the potential to develop into 
another entire organism is present in each nucleus, but again highlighted our reliance 
on genetics to provide knowledge and understanding in biology.  The emphasis on 
SCNT is that all that is needed to grow, organise, and develop a new organism is 
contained within the nucleus, and, more specifically, with the genetic information 
contained within.  This clearly showed that when trying to define new knowledge and 
understanding in biology, that knowledge and understanding produced under the 
genetics paradigm is considered to be the most convincing. 
Lastly, regarding stem cell research specifically, it may now be that in the 
twenty-first century, stem cell research becomes increasingly influenced by the 
stemness view, instead of relying on the stem cell state view.  Laplane showed how 
useful this new view of stem cells may be in the practical search for cancer 
treatments.  When reviewing her book for Nature, stem cell scientist Hans Cleavers 
referred to the stemness view as a new way for researchers to design their 
experiments, and to interpret results.  Although this is an approach still strongly 
linked with the importance of genetics, it may also be accurate to suggest that this is 
the beginning of a paradigm shift in stem cell research, away from the old paradigm 
that assumed stem cells were entities, and towards the view that any cell, given the 
appropriate environment and genetic signals, can become a stem cell. 
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3. Outlook 
Previous work into the research directions taken by scientists has been carried 
out on some scale (such as the identification of American work of the late nineteenth 
and early twentieth centuries being concerned with cell lineage studies), although the 
evidence provided in this thesis suggests that there is a rich seam of research to be 
mined on the shifts in research directions (based on experimental design, theoretical 
to experimental objects of research, social, political, cultural effects etc.), particularly 
in the twentieth century.  This could include, for example, closer analysis of the 
interaction between the national politics of science and research, especially focusing 
on specific examples (previous studies have tended to generalise to an extent).  It 
might also include the effects of global politics, such as the effects on research caused 
by the influx of migrants to America from Eastern Europe, Russia, and Germany 
before and during WWII. 
It will also be possible to continue examining the influence of the potential 
paradigm shift in stem cell research, from the entitiy view to the state view.  Future 
interdisciplinary work alongside biological sciences researchers using ESCs, would 
enable the historical and philosophical perspectives suggested in this thesis to be 
tested.  It would also be potentially beneficial to scientists, as they would have a 
different stem cell concept as the basis on which to design their experiments, and 
interpret results.  This may not only have uses in cancer therapies (as suggested by 
Laplane’s ongoing work), but for other areas of research, including developmental 
and genetics studies; scientists appear to be open to this new way of thinking about 
stem cells (as suggested by Cleavers’ review of Laplane’s work in Nature), and 
seeing how this emerges in the near future will be of particular interest. 
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